CHROM,POS,ID,REF,ALT,QUAL,FILTER,INFO,FORMAT,PharmCAT,level_0,Name,Gene(s),Protein change,Condition(s),Accession,GRCh37Chromosome,GRCh37Location,GRCh38Chromosome,GRCh38Location,VariationID,AlleleID(s),dbSNP ID,Canonical SPDI,Variant type,Molecular consequence,Germline classification,Germline date last evaluated,Germline review status,Somatic clinical impact,Somatic clinical impact date last evaluated,Somatic clinical impact review status,Oncogenicity classification,Oncogenicity date last evaluated,Oncogenicity review status,Unnamed: 24
chr1,97078987,rs114096998,G,T,.,PASS,PX=DPYD,GT,0/0,DYPD_NM,NM_000110.4(DPYD):c.3067C>T (p.Pro1023Ser),DPYD,P1023S,Dihydropyrimidine dehydrogenase deficiency|not specified|Inborn genetic diseases,VCV000876925,1.0,97544543,1.0,97078987,876925,864896,rs114096998,NC_000001.11:97078986:G:A,single nucleotide variant,missense variant,Uncertain significance,"Oct 25, 2024","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chr1,97078987,rs114096998,G,T,.,PASS,PX=DPYD,GT,0/0,DYPD_NM,NM_000110.4(DPYD):c.3067C>A (p.Pro1023Thr),DPYD,P1023T,not specified|not provided|Dihydropyrimidine dehydrogenase deficiency,VCV000100069,1.0,97544543,1.0,97078987,100069,105946,rs114096998,NC_000001.11:97078986:G:T,single nucleotide variant,missense variant,Conflicting classifications of pathogenicity,"Dec 10, 2021","criteria provided, conflicting classifications",nan,nan,nan,nan,nan,nan,nan
chr1,97078993,rs148799944,C,G,.,PASS,PX=DPYD,GT,0/0,DYPD_NM,NM_000110.4(DPYD):c.3061G>C (p.Val1021Leu),DPYD,V1021L,not provided,VCV004071714,1.0,97544549,1.0,97078993,4071714,4185587,nan,NC_000001.11:97078992:C:G,single nucleotide variant,missense variant,Uncertain significance,"Jan 22, 2025","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chr1,97079005,rs140114515,C,T,.,PASS,PX=DPYD,GT,0/0,DYPD_NM,NM_000110.4(DPYD):c.3049G>A (p.Val1017Ile),DPYD,V1017I,Inborn genetic diseases,VCV001799224,1.0,97544561,1.0,97079005,1799224,1854833,rs140114515,NC_000001.11:97079004:C:T,single nucleotide variant,missense variant,Uncertain significance,"Jul 17, 2022","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chr1,97079071,rs1801268,C,A,.,PASS,PX=DPYD,GT,0/0,DYPD_NM,NM_000110.4(DPYD):c.2983G>T (p.Val995Phe),DPYD,V995F,fluorouracil response - Other,VCV000635267,1.0,97544627,1.0,97079071,635267,623098,rs1801268,NC_000001.11:97079070:C:A,single nucleotide variant,missense variant,drug response,"Mar 24, 2021",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr1,97079076,rs139459586,A,C,.,PASS,PX=DPYD,GT,0/0,DYPD_NM,NM_000110.4(DPYD):c.2978T>G (p.Leu993Arg),DPYD,L993R,not specified,VCV003768464,1.0,97544632,1.0,97079076,3768464,3884624,nan,NC_000001.11:97079075:A:C,single nucleotide variant,missense variant,Uncertain significance,"Dec 24, 2024","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chr1,97079077,rs202144771,G,A,.,PASS,PX=DPYD,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr1,97079121,rs72547601,T,C,.,PASS,PX=DPYD,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr1,97079133,rs72547602,T,A,.,PASS,PX=DPYD,GT,0/0,DYPD_NM,NM_000110.4(DPYD):c.2921A>T (p.Asp974Val),DPYD,D974V,Fluorouracil response,VCV000000433,1.0,97544689,1.0,97079133,433,15472,rs72547602,NC_000001.11:97079132:T:A,single nucleotide variant,missense variant,Pathogenic,"Jan 1, 1997",no assertion criteria provided,nan,nan,nan,nan,nan,nan,nan
chr1,97079139,rs145529148,T,C,.,PASS,PX=DPYD,GT,0/0,DYPD_NM,NM_000110.4(DPYD):c.2915A>G (p.Gln972Arg),DPYD,Q972R,not specified|not provided,VCV000715550,1.0,97544695,1.0,97079139,715550,719145,rs145529148,NC_000001.11:97079138:T:C,single nucleotide variant,missense variant,Conflicting classifications of pathogenicity,"Feb 20, 2024","criteria provided, conflicting classifications",nan,nan,nan,nan,nan,nan,nan
chr1,97082365,rs141044036,T,C,.,PASS,PX=DPYD,GT,0/0,DYPD_NM,NM_000110.4(DPYD):c.2872A>G (p.Lys958Glu),DPYD,K958E,Dihydropyrimidine dehydrogenase deficiency,VCV000551659,1.0,97547921,1.0,97082365,551659,541385,rs141044036,NC_000001.11:97082364:T:C,single nucleotide variant,missense variant,Uncertain significance,"Apr 11, 2023","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chr1,97082391,rs67376798,T,A,.,PASS,PX=DPYD,GT,0/0,DYPD_NM,NM_000110.4(DPYD):c.2846A>T (p.Asp949Val),DPYD,D949V,fluorouracil response - Other|capecitabine response - Toxicity|fluorouracil response - Toxicity|tegafur response - Toxicity,VCV000088974,1.0,97547947,1.0,97082391,88974,94529,rs67376798,NC_000001.11:97082390:T:A,single nucleotide variant,missense variant,drug response,"May 24, 2021",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr1,97098598,rs1801267,C,T,.,PASS,PX=DPYD,GT,0/0,DYPD_NM,NM_000110.4(DPYD):c.2657G>A (p.Arg886His),DPYD|DPYD-AS1,R886H,Dihydropyrimidine dehydrogenase deficiency|not specified,VCV000000437,1.0,97564154,1.0,97098598,437,15476,rs1801267,NC_000001.11:97098597:C:T,single nucleotide variant,missense variant,Uncertain significance,"Apr 11, 2023","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chr1,97098599,rs147545709,G,A,.,PASS,PX=DPYD,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr1,97098616,rs55674432,C,A,.,PASS,PX=DPYD,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr1,97098632,rs201035051,T,G,.,PASS,PX=DPYD,GT,0/0,DYPD_NM,NM_000110.4(DPYD):c.2623A>C (p.Lys875Gln),DPYD|DPYD-AS1,K875Q,Inborn genetic diseases,VCV003273700,1.0,97564188,1.0,97098632,3273700,3434643,nan,NC_000001.11:97098631:T:G,single nucleotide variant,missense variant,Uncertain significance,"Mar 18, 2024","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chr1,97193109,rs60139309,T,C,.,PASS,PX=DPYD,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr1,97193209,rs200687447,C,T,.,PASS,PX=DPYD,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr1,97234958,rs199634007,G,T,.,PASS,PX=DPYD,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr1,97234991,rs56005131,G,T,.,PASS,PX=DPYD,GT,0/0,DYPD_NM,NM_000110.4(DPYD):c.2303C>A (p.Thr768Lys),DPYD|DPYD-AS1,T768K,fluorouracil response - Other,VCV000287480,1.0,97700547,1.0,97234991,287480,271717,rs56005131,NC_000001.11:97234990:G:T,single nucleotide variant,missense variant,drug response,"May 25, 2021",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr1,97305279,rs112766203,G,A,.,PASS,PX=DPYD,GT,0/0,DYPD_NM,NM_000110.4(DPYD):c.2279C>T (p.Thr760Ile),DPYD|DPYD-AS1,T760I,Dihydropyrimidine dehydrogenase deficiency|not provided,VCV000874135,1.0,97770835,1.0,97305279,874135,864899,rs112766203,NC_000001.11:97305278:G:A,single nucleotide variant,missense variant,Conflicting classifications of pathogenicity,"Oct 22, 2019","criteria provided, conflicting classifications",nan,nan,nan,nan,nan,nan,nan
chr1,97305363,rs60511679,A,C,.,PASS,PX=DPYD,GT,0/0,DYPD_NM,NM_000110.4(DPYD):c.2195T>G (p.Val732Gly),DPYD|DPYD-AS1,V732G,not provided,VCV003352671,1.0,97770919,1.0,97305363,3352671,3511893,nan,NC_000001.11:97305362:A:C,single nucleotide variant,missense variant,Uncertain significance,"Jun 27, 2024","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chr1,97305364,rs1801160,C,T,.,PASS,PX=DPYD,GT,0/0,DYPD_NM,NM_000110.4(DPYD):c.2194G>A (p.Val732Ile),DPYD|DPYD-AS1,V732I,fluorouracil response - Other|capecitabine response - Toxicity|fluorouracil response - Toxicity,VCV000100080,1.0,97770920,1.0,97305364,100080,105957,rs1801160,NC_000001.11:97305363:C:T,single nucleotide variant,missense variant,drug response,"Mar 24, 2021",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr1,97305372,rs146529561,G,A,.,PASS,PX=DPYD,GT,0/0,DYPD_NM,NM_000110.4(DPYD):c.2186C>T (p.Ala729Val),DPYD|DPYD-AS1,A729V,Dihydropyrimidine dehydrogenase deficiency|DPYD-related disorder,VCV000298284,1.0,97770928,1.0,97305372,298284,283499,rs146529561,NC_000001.11:97305371:G:A,single nucleotide variant,missense variant,Uncertain significance,"Apr 8, 2022","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chr1,97306195,rs145548112,C,T,.,PASS,PX=DPYD,GT,0/0,DYPD_NM,NM_000110.4(DPYD):c.2161G>A (p.Ala721Thr),DPYD|DPYD-AS1,A721T,not provided,VCV000100082,1.0,97771751,1.0,97306195,100082,105959,rs145548112,NC_000001.11:97306194:C:T,single nucleotide variant,non-coding transcript variant|missense variant,Uncertain significance,"Oct 1, 2024","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chr1,97373598,rs137999090,C,T,.,PASS,PX=DPYD,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr1,97373629,rs138545885,C,A,.,PASS,PX=DPYD,GT,0/0,DYPD_NM,NM_000110.4(DPYD):c.1990G>T (p.Ala664Ser),DPYD,A664S,not provided|Dihydropyrimidine dehydrogenase deficiency|Inborn genetic diseases,VCV001256250,1.0,97839185,1.0,97373629,1256250,1246180,rs138545885,NC_000001.11:97373628:C:A,single nucleotide variant,missense variant,Uncertain significance,"Apr 11, 2023","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chr1,97382461,rs55971861,T,G,.,PASS,PX=DPYD,GT,0/0,DYPD_NM,NM_000110.4(DPYD):c.1906A>C (p.Ile636Leu),DPYD,I636L,not provided|not specified|Inborn genetic diseases,VCV001782389,1.0,97848017,1.0,97382461,1782389,1842773,rs55971861,NC_000001.11:97382460:T:G,single nucleotide variant,missense variant,Uncertain significance,"Dec 24, 2024","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chr1,97450058,rs3918290,C,T,.,PASS,PX=DPYD,GT,0/0,DYPD_NM,NM_000110.4(DPYD):c.1905+1G>C,DPYD,nan,not provided|Dihydropyrimidine dehydrogenase deficiency,VCV002429124,1.0,97915614,1.0,97450058,2429124,362495,rs3918290,NC_000001.11:97450057:C:G,single nucleotide variant,splice donor variant,Pathogenic/Likely pathogenic,"Nov 22, 2023","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chr1,97450058,rs3918290,C,T,.,PASS,PX=DPYD,GT,0/0,DYPD_NM,NM_000110.4(DPYD):c.1905+1G>A,DPYD,nan,tegafur response - Toxicity|fluorouracil response - Toxicity|capecitabine response - Toxicity|fluorouracil response - Other,VCV000000432,1.0,97915614,1.0,97450058,432,15471,rs3918290,NC_000001.11:97450057:C:T,single nucleotide variant,splice donor variant,drug response,"May 24, 2021",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr1,97450059,rs3918289,G,C,.,PASS,PX=DPYD,GT,0/0,DYPD_NM,NM_000110.4(DPYD):c.1905C>T (p.Asn635=),DPYD,nan,not provided|Dihydropyrimidine dehydrogenase deficiency|Inborn genetic diseases,VCV000100087,1.0,97915615,1.0,97450059,100087,105964,rs3918289,NC_000001.11:97450058:G:A,single nucleotide variant,synonymous variant,Conflicting classifications of pathogenicity,"Apr 1, 2022","criteria provided, conflicting classifications",nan,nan,nan,nan,nan,nan,nan
chr1,97450065,rs72549303,TG,T,.,PASS,PX=DPYD,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr1,97450068,rs17376848,A,G,.,PASS,PX=DPYD,GT,0/0,DYPD_NM,NM_000110.4(DPYD):c.1896del (p.Pro633fs),DPYD,P633fs,Dihydropyrimidine dehydrogenase deficiency,VCV003241357,1.0,97915624,1.0,97450068,3241357,3400336,rs2523871765,NC_000001.11:97450067:AAA:AA,Deletion,frameshift variant,Likely pathogenic,"Mar 25, 2024","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chr1,97450068,rs17376848,A,G,.,PASS,PX=DPYD,GT,0/0,DYPD_NM,NM_000110.4(DPYD):c.1896T>C (p.Phe632=),DPYD,nan,capecitabine response - Toxicity|fluorouracil response - Toxicity,VCV000100088,1.0,97915624,1.0,97450068,100088,105965,rs17376848,NC_000001.11:97450067:A:G,single nucleotide variant,synonymous variant,drug response,"Mar 24, 2021",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr1,97450168,rs147601618,A,G,.,PASS,PX=DPYD,GT,0/0,DYPD_NM,NM_000110.4(DPYD):c.1796T>C (p.Met599Thr),DPYD,M599T,not provided|not specified|Dihydropyrimidine dehydrogenase deficiency,VCV000550673,1.0,97915724,1.0,97450168,550673,541350,rs147601618,NC_000001.11:97450167:A:G,single nucleotide variant,missense variant,Conflicting classifications of pathogenicity,"Sep 10, 2024","criteria provided, conflicting classifications",nan,nan,nan,nan,nan,nan,nan
chr1,97450187,rs145773863,C,T,.,PASS,PX=DPYD,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr1,97450189,rs138616379,C,T,.,PASS,PX=DPYD,GT,0/0,DYPD_NM,NM_000110.4(DPYD):c.1775G>A (p.Arg592Gln),DPYD,R592Q,Dihydropyrimidine dehydrogenase deficiency,VCV000554703,1.0,97915745,1.0,97450189,554703,541399,rs138616379,NC_000001.11:97450188:C:T,single nucleotide variant,missense variant,Uncertain significance,"Nov 14, 2017",no assertion criteria provided,nan,nan,nan,nan,nan,nan,nan
chr1,97450190,rs59086055,G,A,.,PASS,PX=DPYD,GT,0/0,DYPD_NM,NM_000110.4(DPYD):c.1774C>T (p.Arg592Trp),DPYD,R592W,fluorouracil response - Other|fluorouracil response - Toxicity,VCV000282919,1.0,97915746,1.0,97450190,282919,267156,rs59086055,NC_000001.11:97450189:G:A,single nucleotide variant,missense variant,drug response,"Mar 24, 2021",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr1,97515784,rs201615754,C,A,.,PASS,PX=DPYD,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr1,97515787,rs55886062,A,C,.,PASS,PX=DPYD,GT,0/0,DYPD_NM,NM_000110.4(DPYD):c.1679T>G (p.Ile560Ser),DPYD,I560S,fluorouracil response - Other|capecitabine response - Toxicity|fluorouracil response - Toxicity|tegafur response - Toxicity,VCV000088975,1.0,97981343,1.0,97515787,88975,94530,rs55886062,NC_000001.11:97515786:A:C,single nucleotide variant,missense variant,drug response,"May 26, 2021",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr1,97515839,rs1801159,T,C,.,PASS,PX=DPYD,GT,0/0,DYPD_NM,NM_000110.4(DPYD):c.1627A>G (p.Ile543Val),DPYD,I543V,capecitabine response - Toxicity|fluorouracil response - Toxicity,VCV000100092,1.0,97981395,1.0,97515839,100092,105969,rs1801159,NC_000001.11:97515838:T:C,single nucleotide variant,missense variant,drug response,"Mar 24, 2021",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr1,97515851,rs142619737,C,T,.,PASS,PX=DPYD,GT,0/0,DYPD_NM,NM_000110.4(DPYD):c.1615G>A (p.Gly539Arg),DPYD,G539R,not specified|not provided|Dihydropyrimidine dehydrogenase deficiency,VCV000100093,1.0,97981407,1.0,97515851,100093,105970,rs142619737,NC_000001.11:97515850:C:T,single nucleotide variant,missense variant,Conflicting classifications of pathogenicity,"Sep 19, 2024","criteria provided, conflicting classifications",nan,nan,nan,nan,nan,nan,nan
chr1,97515865,rs1801158,C,T,.,PASS,PX=DPYD,GT,0/0,DYPD_NM,NM_000110.4(DPYD):c.1601G>A (p.Ser534Asn),DPYD,S534N,capecitabine response - Toxicity|fluorouracil response - Toxicity,VCV000100094,1.0,97981421,1.0,97515865,100094,105971,rs1801158,NC_000001.11:97515864:C:T,single nucleotide variant,missense variant,drug response,"Mar 24, 2021",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr1,97515889,rs190951787,G,C,.,PASS,PX=DPYD,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr1,97515923,rs148994843,C,T,.,PASS,PX=DPYD,GT,0/0,DYPD_NM,NM_000110.4(DPYD):c.1543G>A (p.Val515Ile),DPYD,V515I,fluorouracil response - Other,VCV001327419,1.0,97981479,1.0,97515923,1327419,1317931,rs148994843,NC_000001.11:97515922:C:T,single nucleotide variant,missense variant,drug response,"May 25, 2021",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr1,97549565,rs138391898,C,T,.,PASS,PX=DPYD,GT,0/0,DYPD_NM,NM_000110.4(DPYD):c.1519G>A (p.Val507Ile),DPYD,V507I,Inborn genetic diseases,VCV002567628,1.0,98015121,1.0,97549565,2567628,2731270,rs138391898,NC_000001.11:97549564:C:T,single nucleotide variant,missense variant,Likely benign,"Jun 12, 2023","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chr1,97549600,rs111858276,T,C,.,PASS,PX=DPYD,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr1,97549609,rs72549304,G,A,.,PASS,PX=DPYD,GT,0/0,DYPD_NM,NM_000110.4(DPYD):c.1475C>T (p.Ser492Leu),DPYD,S492L,Dihydropyrimidine dehydrogenase deficiency,VCV000298293,1.0,98015165,1.0,97549609,298293,282026,rs72549304,NC_000001.11:97549608:G:A,single nucleotide variant,missense variant,Pathogenic/Likely pathogenic,"Jun 17, 2025","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chr1,97549681,rs199549923,G,T,.,PASS,PX=DPYD,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr1,97549713,rs57918000,G,A,.,PASS,PX=DPYD,GT,0/0,DYPD_NM,NM_000110.4(DPYD):c.1371C>T (p.Asn457=),DPYD,nan,Inborn genetic diseases|not provided|Dihydropyrimidine dehydrogenase deficiency,VCV000100097,1.0,98015269,1.0,97549713,100097,105974,rs57918000,NC_000001.11:97549712:G:A,single nucleotide variant,synonymous variant,Benign/Likely benign,"Oct 11, 2024","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chr1,97549726,rs144395748,G,C,.,PASS,PX=DPYD,GT,0/0,DYPD_NM,NM_000110.4(DPYD):c.1358C>G (p.Pro453Arg),DPYD,P453R,Dihydropyrimidine dehydrogenase deficiency|not specified|not provided,VCV000100098,1.0,98015282,1.0,97549726,100098,105975,rs144395748,NC_000001.11:97549725:G:C,single nucleotide variant,missense variant,Uncertain significance,"Jul 12, 2025","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chr1,97549735,rs72975710,G,A,.,PASS,PX=DPYD,GT,0/0,DYPD_NM,NM_000110.4(DPYD):c.1349C>T (p.Ala450Val),DPYD,A450V,not provided|Dihydropyrimidine dehydrogenase deficiency,VCV000876977,1.0,98015291,1.0,97549735,876977,864903,rs72975710,NC_000001.11:97549734:G:A,single nucleotide variant,missense variant,Uncertain significance,"Sep 19, 2024","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chr1,97549735,rs72975710,G,A,.,PASS,PX=DPYD,GT,0/0,DYPD_NM,NM_000110.4(DPYD):c.1349C>G (p.Ala450Gly),DPYD,A450G,Dihydropyrimidine dehydrogenase deficiency|not provided,VCV000298294,1.0,98015291,1.0,97549735,298294,281396,rs72975710,NC_000001.11:97549734:G:C,single nucleotide variant,missense variant,Uncertain significance,"Jan 1, 2025","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chr1,97573785,rs186169810,A,C,.,PASS,PX=DPYD,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr1,97573805,rs142512579,C,T,.,PASS,PX=DPYD,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr1,97573821,rs764666241,C,A,.,PASS,PX=DPYD,GT,0/0,DYPD_NM,NM_000110.4(DPYD):c.1278G>T (p.Met426Ile),DPYD,M426I,Inborn genetic diseases,VCV002520613,1.0,98039377,1.0,97573821,2520613,2682620,rs764666241,NC_000001.11:97573820:C:A,single nucleotide variant,missense variant,Likely benign,"May 31, 2023","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chr1,97573839,rs200064537,A,T,.,PASS,PX=DPYD,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr1,97573863,rs56038477,C,T,.,PASS,PX=DPYD,GT,0/0,DYPD_NM,NM_000110.4(DPYD):c.1236G>A (p.Glu412=),DPYD,nan,fluorouracil response - Toxicity|capecitabine response - Toxicity,VCV000100100,1.0,98039419,1.0,97573863,100100,105977,rs56038477,NC_000001.11:97573862:C:T,single nucleotide variant,synonymous variant,drug response,"Oct 27, 2022",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr1,97573881,rs61622928,C,T,.,PASS,PX=DPYD,GT,0/0,DYPD_NM,NM_000110.4(DPYD):c.1218G>A (p.Met406Ile),DPYD,M406I,not specified|not provided|Dihydropyrimidine dehydrogenase deficiency,VCV000100101,1.0,98039437,1.0,97573881,100101,105978,rs61622928,NC_000001.11:97573880:C:T,single nucleotide variant,missense variant,Conflicting classifications of pathogenicity,"Feb 22, 2021","criteria provided, conflicting classifications",nan,nan,nan,nan,nan,nan,nan
chr1,97573918,rs143815742,C,A,.,PASS,PX=DPYD,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr1,97573919,rs140602333,G,A,.,PASS,PX=DPYD,GT,0/0,DYPD_NM,NM_000110.4(DPYD):c.1180C>A (p.Arg394=),DPYD,nan,Inborn genetic diseases,VCV003505084,1.0,98039475,1.0,97573919,3505084,3663700,nan,NC_000001.11:97573918:G:T,single nucleotide variant,synonymous variant,Likely benign,"Jul 30, 2024","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chr1,97573919,rs140602333,G,A,.,PASS,PX=DPYD,GT,0/0,DYPD_NM,NM_000110.4(DPYD):c.1180C>T (p.Arg394Trp),DPYD,R394W,not provided,VCV000585799,1.0,98039475,1.0,97573919,585799,576558,rs140602333,NC_000001.11:97573918:G:A,single nucleotide variant,missense variant,Uncertain significance,"Jul 12, 2018","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chr1,97573943,rs78060119,C,A,.,PASS,PX=DPYD,GT,0/0,DYPD_NM,NM_000110.4(DPYD):c.1156G>T (p.Glu386Ter),DPYD,E386*,fluorouracil response - Other|fluorouracil response - Toxicity,VCV001032887,1.0,98039499,1.0,97573943,1032887,1019440,rs78060119,NC_000001.11:97573942:C:A,single nucleotide variant,nonsense,drug response,"Mar 24, 2021",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr1,97579893,rs75017182,G,C,.,PASS,PX=DPYD,GT,0/0,DYPD_NM,NM_000110.4(DPYD):c.1129-5923C>G,DPYD,nan,fluorouracil response - Other|capecitabine response - Toxicity|fluorouracil response - Toxicity,VCV000635263,1.0,98045449,1.0,97579893,635263,623100,rs75017182,NC_000001.11:97579892:G:C,single nucleotide variant,intron variant,drug response,"Oct 27, 2022",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr1,97593238,rs72549305,T,C,.,PASS,PX=DPYD,GT,0/0,DYPD_NM,NM_000110.4(DPYD):c.1108A>G (p.Ile370Val),DPYD,I370V,Dihydropyrimidine dehydrogenase deficiency|not specified,VCV000552935,1.0,98058794,1.0,97593238,552935,541352,rs72549305,NC_000001.11:97593237:T:C,single nucleotide variant,missense variant,Uncertain significance,"Apr 11, 2023","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chr1,97593289,rs143154602,G,A,.,PASS,PX=DPYD,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr1,97593322,rs183385770,C,T,.,PASS,PX=DPYD,GT,0/0,DYPD_NM,NM_000110.4(DPYD):c.1024G>A (p.Asp342Asn),DPYD,D342N,Dihydropyrimidine dehydrogenase deficiency,VCV000550741,1.0,98058878,1.0,97593322,550741,541411,rs183385770,NC_000001.11:97593321:C:T,single nucleotide variant,missense variant,Uncertain significance,"Feb 10, 2017",no assertion criteria provided,nan,nan,nan,nan,nan,nan,nan
chr1,97593343,rs72549306,C,A,.,PASS,PX=DPYD,GT,0/0,DYPD_NM,NM_000110.4(DPYD):c.1003G>T (p.Val335Leu),DPYD,V335L,fluorouracil response - Other,VCV001327416,1.0,98058899,1.0,97593343,1327416,1317929,rs72549306,NC_000001.11:97593342:C:A,single nucleotide variant,missense variant,drug response,"Mar 24, 2021",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr1,97593379,rs201018345,C,T,.,PASS,PX=DPYD,GT,0/0,DYPD_NM,NM_000110.4(DPYD):c.967G>A (p.Ala323Thr),DPYD,A323T,not specified,VCV002573364,1.0,98058935,1.0,97593379,2573364,2738312,rs201018345,NC_000001.11:97593378:C:T,single nucleotide variant,missense variant,Uncertain significance,"Jun 6, 2023","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chr1,97595083,rs145112791,G,A,.,PASS,PX=DPYD,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr1,97595088,rs150437414,A,G,.,PASS,PX=DPYD,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr1,97595149,rs146356975,T,C,.,PASS,PX=DPYD,GT,0/0,DYPD_NM,NM_000110.4(DPYD):c.868A>G (p.Lys290Glu),DPYD,K290E,not provided|not specified|Dihydropyrimidine dehydrogenase deficiency,VCV001328879,1.0,98060705,1.0,97595149,1328879,1319566,rs146356975,NC_000001.11:97595148:T:C,single nucleotide variant,missense variant,Uncertain significance,"Jul 12, 2025","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chr1,97679170,rs45589337,T,C,.,PASS,PX=DPYD,GT,0/0,DYPD_NM,NM_000110.4(DPYD):c.775A>G (p.Lys259Glu),DPYD,K259E,Inborn genetic diseases|not provided|not specified|Dihydropyrimidine dehydrogenase deficiency,VCV000235464,1.0,98144726,1.0,97679170,235464,237147,rs45589337,NC_000001.11:97679169:T:C,single nucleotide variant,missense variant,Conflicting classifications of pathogenicity,"Jan 1, 2025","criteria provided, conflicting classifications",nan,nan,nan,nan,nan,nan,nan
chr1,97691776,rs1801266,G,A,.,PASS,PX=DPYD,GT,0/0,DYPD_NM,NM_000110.4(DPYD):c.703C>T (p.Arg235Trp),DPYD,R235W,fluorouracil response - Other,VCV000298300,1.0,98157332,1.0,97691776,298300,282038,rs1801266,NC_000001.11:97691775:G:A,single nucleotide variant,missense variant,drug response,"Mar 24, 2021",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr1,97699399,rs72549307,T,C,.,PASS,PX=DPYD,GT,0/0,DYPD_NM,NM_000110.4(DPYD):c.632A>G (p.Tyr211Cys),DPYD,Y211C,not specified|Dihydropyrimidine dehydrogenase deficiency|Inborn genetic diseases,VCV000554571,1.0,98164955,1.0,97699399,554571,541349,rs72549307,NC_000001.11:97699398:T:C,single nucleotide variant,missense variant,Conflicting classifications of pathogenicity,"Nov 28, 2023","criteria provided, conflicting classifications",nan,nan,nan,nan,nan,nan,nan
chr1,97699430,rs72549308,T,G,.,PASS,PX=DPYD,GT,0/0,DYPD_NM,NM_000110.4(DPYD):c.601A>C (p.Ser201Arg),DPYD,S201R,not provided|Dihydropyrimidine dehydrogenase deficiency,VCV002674903,1.0,98164986,1.0,97699430,2674903,2834176,rs72549308,NC_000001.11:97699429:T:G,single nucleotide variant,missense variant,Likely pathogenic,"Mar 20, 2025","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chr1,97699474,rs115232898,T,C,.,PASS,PX=DPYD,GT,0/0,DYPD_NM,NM_000110.4(DPYD):c.557A>G (p.Tyr186Cys),DPYD,Y186C,fluorouracil response - Other|fluorouracil response - Toxicity,VCV000100113,1.0,98165030,1.0,97699474,100113,105990,rs115232898,NC_000001.11:97699473:T:C,single nucleotide variant,missense variant,drug response,"Mar 24, 2021",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr1,97699506,rs6670886,C,T,.,PASS,PX=DPYD,GT,0/0,DYPD_NM,NM_000110.4(DPYD):c.525G>A (p.Ser175=),DPYD,nan,not provided|Inborn genetic diseases,VCV000100115,1.0,98165062,1.0,97699506,100115,105992,rs6670886,NC_000001.11:97699505:C:T,single nucleotide variant,synonymous variant,Likely benign,"Sep 15, 2023","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chr1,97699533,rs139834141,C,T,.,PASS,PX=DPYD,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr1,97699535,rs2297595,T,C,.,PASS,PX=DPYD,GT,0/0,DYPD_NM,NM_000110.4(DPYD):c.496A>G (p.Met166Val),DPYD,M166V,capecitabine response - Toxicity|fluorouracil response - Toxicity,VCV000100116,1.0,98165091,1.0,97699535,100116,105993,rs2297595,NC_000001.11:97699534:T:C,single nucleotide variant,missense variant,drug response,"Mar 29, 2021",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr1,97721542,rs200562975,T,C,.,PASS,PX=DPYD,GT,0/0,DYPD_NM,NM_000110.4(DPYD):c.451A>G (p.Asn151Asp),DPYD,N151D,Dihydropyrimidine dehydrogenase deficiency|not specified|not provided,VCV000633188,1.0,98187098,1.0,97721542,633188,621091,rs200562975,NC_000001.11:97721541:T:C,single nucleotide variant,missense variant,Conflicting classifications of pathogenicity,"Dec 31, 2019","criteria provided, conflicting classifications",nan,nan,nan,nan,nan,nan,nan
chr1,97721650,rs141462178,T,C,.,PASS,PX=DPYD,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr1,97740400,rs150385342,C,T,.,PASS,PX=DPYD,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr1,97740410,rs72549309,GATGA,G,.,PASS,PX=DPYD,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr1,97883329,rs1801265,A,G,.,PASS,PX=DPYD,GT,0/0,DYPD_NM,NM_000110.4(DPYD):c.85= (p.Cys29=),DPYD,nan,not provided|not specified,VCV000100123,1.0,98348885,1.0,97883329,100123,106000,rs1801265,NC_000001.11:97883328:A:A,single nucleotide variant,no sequence alteration,Conflicting classifications of pathogenicity,"Jul 1, 2024","criteria provided, conflicting classifications",nan,nan,nan,nan,nan,nan,nan
chr1,97883329,rs1801265,A,G,.,PASS,PX=DPYD,GT,0/0,DYPD_NM,NM_000110.4(DPYD):c.85T>C (p.Cys29Arg),DPYD,C29R,capecitabine response - Toxicity|fluorouracil response - Toxicity,VCV000000435,1.0,98348885,1.0,97883329,435,15474,rs1801265,NC_000001.11:97883328:A:G,single nucleotide variant,missense variant,drug response,"Mar 24, 2021",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr1,97883352,rs80081766,C,T,.,PASS,PX=DPYD,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr1,97883353,rs72549310,G,A,.,PASS,PX=DPYD,GT,0/0,DYPD_NM,NM_000110.4(DPYD):c.61C>T (p.Arg21Ter),DPYD,R21*,not provided|Dihydropyrimidine dehydrogenase deficiency,VCV000188848,1.0,98348909,1.0,97883353,188848,186636,rs72549310,NC_000001.11:97883352:G:A,single nucleotide variant,nonsense,Pathogenic/Likely pathogenic,"Mar 11, 2024","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chr1,97883368,rs150036960,G,C,.,PASS,PX=DPYD,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr1,201060815,rs1800559,C,T,.,PASS,PX=CACNA1S,GT,0/0,CACNA1S_NM,NM_000069.3(CACNA1S):c.3257G>T (p.Arg1086Leu),CACNA1S,R1086L,"Malignant hyperthermia, susceptibility to, 5",VCV003386330,1,201029943,1,201060815,3386330,623096,nan,NC_000001.11:201060814:C:A,single nucleotide variant,missense variant,Uncertain significance,"Apr 30, 2024","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chr1,201060815,rs1800559,C,T,.,PASS,PX=CACNA1S,GT,0/0,CACNA1S_NM,NM_000069.3(CACNA1S):c.3257G>A (p.Arg1086His),CACNA1S,R1086H,succinylcholine response - Toxicity|desflurane response - Toxicity|enflurane response - Toxicity|halothane response - Toxicity|isoflurane response - Toxicity|methoxyflurane response - Toxicity|sevoflurane response - Toxicity,VCV000017626,1,201029943,1,201060815,17626,32665,rs1800559,NC_000001.11:201060814:C:T,single nucleotide variant,missense variant,drug response,"Mar 24, 2021",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr1,201091993,rs772226819,G,A,.,PASS,PX=CACNA1S,GT,0/0,CACNA1S_NM,NM_000069.3(CACNA1S):c.520C>A (p.Arg174=),CACNA1S,nan,"Hypokalemic periodic paralysis, type 1",VCV000874924,1,201061121,1,201091993,874924,863262,rs772226819,NC_000001.11:201091992:G:T,single nucleotide variant,synonymous variant,Uncertain significance,"Apr 28, 2017","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chr1,201091993,rs772226819,G,A,.,PASS,PX=CACNA1S,GT,0/0,CACNA1S_NM,NM_000069.3(CACNA1S):c.520C>T (p.Arg174Trp),CACNA1S,R174W,desflurane response - Toxicity|enflurane response - Toxicity|halothane response - Toxicity|isoflurane response - Toxicity|methoxyflurane response - Toxicity|sevoflurane response - Toxicity|succinylcholine response - Toxicity,VCV000575733,1,201061121,1,201091993,575733,557106,rs772226819,NC_000001.11:201091992:G:A,single nucleotide variant,missense variant,drug response,"Mar 24, 2021",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr2,233759924,rs887829,C,T,.,PASS,PX=UGT1A1,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr2,233760233,rs3064744,CAT,"C,CATAT,CATATAT",.,PASS,PX=UGT1A1,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr2,233760498,rs4148323,G,A,.,PASS,PX=UGT1A1,GT,0/0,UGT1A1_NM,UGT1A1*6,UGT1A|UGT1A1|UGT1A10|UGT1A3|UGT1A4|UGT1A5|UGT1A6|UGT1A7|UGT1A8|UGT1A9,G71R,"Gilbert syndrome|Crigler-Najjar syndrome type 1|Crigler-Najjar syndrome, type II|BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1|Lucey-Driscoll syndrome|Gilbert syndrome|Crigler-Najjar syndrome type 1|Crigler-Najjar syndrome, type II|Lucey-Driscoll syndrome|UGT1A1-related disorder|not specified|not provided|Gilbert syndrome|Crigler-Najjar syndrome, type II|Crigler-Najjar syndrome type 1|Lucey-Driscoll syndrome|Irinotecan response",VCV000012280,2,234669144,2,233760498,12280,27319,rs4148323,NC_000002.12:233760497:G:A,single nucleotide variant,missense variant|intron variant,Conflicting classifications of pathogenicity; drug response,"Mar 4, 2025","criteria provided, conflicting classifications",nan,nan,nan,nan,nan,nan,nan
chr2,233760973,rs35350960,C,A,.,PASS,PX=UGT1A1,GT,0/0,UGT1A1_NM,NM_000463.3(UGT1A1):c.686C>T (p.Pro229Leu),UGT1A1|UGT1A7|UGT1A8|UGT1A9|UGT1A6|UGT1A4|UGT1A5|UGT1A3|UGT1A10|UGT1A,P229L,"Lucey-Driscoll syndrome|Crigler-Najjar syndrome, type II|Gilbert syndrome|Crigler-Najjar syndrome type 1|BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1|not provided",VCV001409267,2,234669619,2,233760973,1409267,1497056,rs35350960,NC_000002.12:233760972:C:T,single nucleotide variant,missense variant|intron variant,Conflicting classifications of pathogenicity,"May 21, 2024","criteria provided, conflicting classifications",nan,nan,nan,nan,nan,nan,nan
chr2,233760973,rs35350960,C,A,.,PASS,PX=UGT1A1,GT,0/0,UGT1A1_NM,NM_000463.3(UGT1A1):c.686C>A (p.Pro229Gln),UGT1A5|UGT1A|UGT1A1|UGT1A10|UGT1A3|UGT1A4|UGT1A6|UGT1A7|UGT1A8|UGT1A9,P229Q,"Crigler-Najjar syndrome, type II|Lucey-Driscoll syndrome|Crigler-Najjar syndrome type 1|Gilbert syndrome|Gilbert syndrome|not specified|Crigler-Najjar syndrome, type II|Lucey-Driscoll syndrome|Crigler-Najjar syndrome type 1|Gilbert syndrome|BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1|not provided",VCV000012274,2,234669619,2,233760973,12274,27313,rs35350960,NC_000002.12:233760972:C:A,single nucleotide variant,missense variant|intron variant,Conflicting classifications of pathogenicity; other,"Dec 24, 2024","criteria provided, conflicting classifications",nan,nan,nan,nan,nan,nan,nan
chr4,88131171,rs2231142,G,T,.,PASS,PX=ABCG2,GT,0/0,ABCG2_NM,NM_004827.3(ABCG2):c.421C>A (p.Gln141Lys),ABCG2,Q141K,rosuvastatin response - Metabolism/PK|rosuvastatin response - Efficacy,VCV000030389,4,89052323,4,88131171,30389,39346,rs2231142,NC_000004.12:88131170:G:T,single nucleotide variant,missense variant,drug response,"Mar 24, 2021",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr6,18130687,rs1142345,T,"C,G",.,PASS,PX=TPMT,GT,0/0,TPMT_NM,NM_000367.5(TPMT):c.719A>G (p.Tyr240Cys),TPMT,"Y240C, Y225C",not provided,VCV000012725,6,18130918,6,18130687,12725,27764,rs1142345,NC_000006.12:18130686:T:C,single nucleotide variant,missense variant,Likely benign; other,"Jul 1, 2024","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chr6,18130687,rs1142345,T,"C,G",.,PASS,PX=TPMT,GT,0/0,TPMT_NM,TPMT*3A,TPMT,"Y240C, Y225C, A154T",Thiopurine S-methyltransferase deficiency,VCV000012722,6|6,18130918,6|6,18130687,12722,27764|27761,rs1142345|rs1800460,NC_000006.12:18130686:T:C|NC_000006.12:18138996:C:T,Haplotype,missense variant,drug response,"Jun 28, 2005",no assertion criteria provided,nan,nan,nan,nan,nan,nan,nan
chr6,18130694,rs150900439,T,C,.,PASS,PX=TPMT,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr6,18130725,rs72552736,A,C,.,PASS,PX=TPMT,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr6,18130729,rs139392616,C,T,.,PASS,PX=TPMT,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr6,18130758,rs398122996,A,T,.,PASS,PX=TPMT,GT,0/0,TPMT_NM,NM_000367.5(TPMT):c.648T>A (p.Cys216Ter),TPMT,"C216*, C201*",not provided,VCV000092243,6,18130989,6,18130758,92243,98155,rs398122996,NC_000006.12:18130757:A:T,single nucleotide variant,nonsense,not provided,nan,no classification provided,nan,nan,nan,nan,nan,nan,nan
chr6,18130762,rs56161402,C,T,.,PASS,PX=TPMT,GT,0/0,TPMT_NM,NM_000367.5(TPMT):c.644G>A (p.Arg215His),TPMT,"R215H, R200H",Thiopurine S-methyltransferase deficiency,VCV000012726,6,18130993,6,18130762,12726,27765,rs56161402,NC_000006.12:18130761:C:T,single nucleotide variant,missense variant,drug response,"Feb 1, 1999",no assertion criteria provided,nan,nan,nan,nan,nan,nan,nan
chr6,18130772,rs377085266,A,G,.,PASS,PX=TPMT,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr6,18130781,rs1800584,C,T,.,PASS,PX=TPMT,GT,0/0,TPMT_NM,NM_000367.5(TPMT):c.626-1G>A,TPMT,nan,Thiopurine S-methyltransferase deficiency,VCV000012723,6,18131012,6,18130781,12723,27762,rs1800584,NC_000006.12:18130780:C:T,single nucleotide variant,splice acceptor variant,drug response,"May 15, 2019",no assertion criteria provided,nan,nan,nan,nan,nan,nan,nan
chr6,18132136,rs72556347,A,G,.,PASS,PX=TPMT,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr6,18132147,rs79901429,A,G,.,PASS,PX=TPMT,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr6,18132163,.,C,T,.,PASS,PX=TPMT,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr6,18133845,rs75543815,T,A,.,PASS,PX=TPMT,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr6,18133847,rs6921269,C,A,.,PASS,PX=TPMT,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr6,18133870,rs772832951,A,G,.,PASS,PX=TPMT,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr6,18133884,rs74423290,G,C,.,PASS,PX=TPMT,GT,0/0,TPMT_NM,NM_000367.5(TPMT):c.500C>G (p.Ala167Gly),TPMT,A167G,Thiopurine S-methyltransferase deficiency,VCV000012727,6,18134115,6,18133884,12727,27766,rs74423290,NC_000006.12:18133883:G:C,single nucleotide variant,missense variant,drug response,"Oct 1, 2007",no assertion criteria provided,nan,nan,nan,nan,nan,nan,nan
chr6,18133887,rs201695576,T,C,.,PASS,PX=TPMT,GT,0/0,TPMT_NM,NM_000367.5(TPMT):c.497A>G (p.Tyr166Cys),TPMT,Y166C,Thiopurine response,VCV000625175,6,18134118,6,18133887,625175,613515,rs201695576,NC_000006.12:18133886:T:C,single nucleotide variant,missense variant,drug response,"Dec 1, 2014",no assertion criteria provided,nan,nan,nan,nan,nan,nan,nan
chr6,18133890,rs9333570,C,T,.,PASS,PX=TPMT,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr6,18138969,rs144041067,C,"G,T",.,PASS,PX=TPMT,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr6,18138970,rs112339338,G,A,.,PASS,PX=TPMT,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr6,18138997,rs1800460,C,T,.,PASS,PX=TPMT,GT,0/0,TPMT_NM,NM_000367.5(TPMT):c.460G>A (p.Ala154Thr),TPMT,A154T,not provided,VCV000037126,6,18139228,6,18138997,37126,27761,rs1800460,NC_000006.12:18138996:C:T,single nucleotide variant,missense variant,Benign/Likely benign; other,"Jul 1, 2024","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chr6,18139027,rs72552737,C,G,.,PASS,PX=TPMT,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr6,18139689,rs72552738,C,T,.,PASS,PX=TPMT,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr6,18139710,rs200220210,G,A,.,PASS,PX=TPMT,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr6,18143597,.,T,G,.,PASS,PX=TPMT,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr6,18143606,rs151149760,T,G,.,PASS,PX=TPMT,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr6,18143613,.,C,G,.,PASS,PX=TPMT,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr6,18143622,rs115106679,C,T,.,PASS,PX=TPMT,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr6,18143643,.,A,C,.,PASS,PX=TPMT,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr6,18143700,rs753545734,C,T,.,PASS,PX=TPMT,GT,0/0,TPMT_NM,NM_000367.5(TPMT):c.262G>A (p.Gly88Ser),TPMT,G88S,Thiopurine response,VCV000625174,6,18143931,6,18143700,625174,613516,rs753545734,NC_000006.12:18143699:C:T,single nucleotide variant,missense variant,drug response,"Mar 1, 2015",no assertion criteria provided,nan,nan,nan,nan,nan,nan,nan
chr6,18143718,rs111901354,G,A,.,PASS,PX=TPMT,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr6,18143724,rs1800462,C,G,.,PASS,PX=TPMT,GT,0/0,TPMT_NM,NM_000367.2(TPMT):c.238G>C (p.Ala80Pro),TPMT,A80P,Thiopurine S-methyltransferase deficiency,VCV000012721,6,18143955,6,18143724,12721,27760,rs1800462,NC_000006.12:18143723:C:G,single nucleotide variant,missense variant,drug response,"Feb 1, 1999",no assertion criteria provided,nan,nan,nan,nan,nan,nan,nan
chr6,18143728,rs1256618794,C,A,.,PASS,PX=TPMT,GT,0/0,TPMT_NM,NM_000367.5(TPMT):c.234G>T (p.Trp78Cys),TPMT,W78C,Thiopurine response,VCV000625173,6,18143959,6,18143728,625173,613517,rs1256618794,NC_000006.12:18143727:C:A,single nucleotide variant,missense variant,drug response,"Mar 1, 2015",no assertion criteria provided,nan,nan,nan,nan,nan,nan,nan
chr6,18147838,rs281874771,G,A,.,PASS,PX=TPMT,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr6,18147845,rs777686348,C,T,.,PASS,PX=TPMT,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr6,18147851,rs200591577,G,C,.,PASS,PX=TPMT,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr6,18147856,.,A,G,.,PASS,PX=TPMT,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr6,18147910,rs72552740,A,G,.,PASS,PX=TPMT,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr6,18149004,.,G,C,.,PASS,PX=TPMT,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr6,18149022,rs750424422,C,T,.,PASS,PX=TPMT,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr6,18149032,rs759836180,C,CT,.,PASS,PX=TPMT,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr6,18149045,rs72552742,T,A,.,PASS,PX=TPMT,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr6,18149126,rs267607275,A,G,.,PASS,PX=TPMT,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr6,18149127,rs9333569,T,C,.,PASS,PX=TPMT,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr7,99652770,rs41303343,T,TA,.,PASS,PX=CYP3A5,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr7,99660516,rs28383479,C,T,.,PASS,PX=CYP3A5,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr7,99665212,rs10264272,C,T,.,PASS,PX=CYP3A5,GT,0/0,CYP3A5_NM,NM_000777.5(CYP3A5):c.624G>A (p.Lys208=),CYP3A5|ZSCAN25,nan,CYP3A5-related disorder,VCV003039123,7,99262835,7,99665212,3039123,3210224,rs10264272,NC_000007.14:99665211:C:T,single nucleotide variant,synonymous variant|non-coding transcript variant|intron variant,Likely benign,"Jul 21, 2021",no assertion criteria provided,nan,nan,nan,nan,nan,nan,nan
chr7,99672916,rs776746,T,C,.,PASS,PX=CYP3A5,GT,0/0,CYP3A5_NM,NM_000777.5(CYP3A5):c.219-237=,CYP3A5|ZSCAN25,nan,not provided,VCV000226021,7,99270539,7,99672916,226021,227764,rs776746,NC_000007.14:99672915:T:T,single nucleotide variant,intron variant|splice acceptor variant,Benign,"Mar 14, 2018","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chr7,99672916,rs776746,T,C,.,PASS,PX=CYP3A5,GT,0/0,CYP3A5_NM,NM_000777.5(CYP3A5):c.219-237A>G,CYP3A5|ZSCAN25,nan,"Hypertension, salt-sensitive essential, susceptibility to|refractory myasthenia gravis|Tacrolimus response",VCV000005066,7,99270539,7,99672916,5066,20105,rs776746,NC_000007.14:99672915:T:C,single nucleotide variant,intron variant|splice acceptor variant,association; drug response; risk factor,"Apr 15, 2022",no assertion criteria provided,nan,nan,nan,nan,nan,nan,nan
chr7,99676198,rs55817950,G,A,.,PASS,PX=CYP3A5,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr7,99758183,rs67666821,G,GT,.,PASS,PX=CYP3A4,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr7,99758228,rs1584538410,T,A,.,PASS,PX=CYP3A4,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr7,99760836,rs4986913,G,A,.,PASS,PX=CYP3A4,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr7,99760901,rs4986910,A,G,.,PASS,PX=CYP3A4,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr7,99760956,rs774109750,T,C,.,PASS,PX=CYP3A4,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr7,99762047,rs4986909,G,A,.,PASS,PX=CYP3A4,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr7,99762054,.,A,T,.,PASS,PX=CYP3A4,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr7,99762069,.,T,G,.,PASS,PX=CYP3A4,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr7,99762177,rs12721629,G,A,.,PASS,PX=CYP3A4,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr7,99762186,rs756833413,C,A,.,PASS,PX=CYP3A4,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr7,99762206,rs67784355,G,A,.,PASS,PX=CYP3A4,GT,0/0,CYP3A4_NM,NM_017460.6(CYP3A4):c.1088C>T (p.Thr363Met),CYP3A4,"T362M, T363M",not provided,VCV000670902,7,99359829,7,99762206,670902,655823,rs67784355,NC_000007.14:99762205:G:A,single nucleotide variant,missense variant,Likely benign,"Apr 19, 2018","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chr7,99762234,rs1318364992,C,T,.,PASS,PX=CYP3A4,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr7,99763877,rs368296206,A,G,.,PASS,PX=CYP3A4,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr7,99763909,rs1303250043,G,T,.,PASS,PX=CYP3A4,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr7,99763925,rs201821708,T,C,.,PASS,PX=CYP3A4,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr7,99764003,rs28371759,A,G,.,PASS,PX=CYP3A4,GT,0/0,CYP3A4_NM,NM_017460.6(CYP3A4):c.878T>C (p.Leu293Pro),CYP3A4|CYP3A4-AS1,"L293P, L292P","Vitamin D-dependent rickets, type 3",VCV003594977,7,99361626,7,99764003,3594977,3725632,nan,NC_000007.14:99764002:A:G,single nucleotide variant,missense variant,Uncertain significance,"Jun 11, 2024","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chr7,99766411,rs4646438,G,GT,.,PASS,PX=CYP3A4,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr7,99766424,rs1429705359,T,C,.,PASS,PX=CYP3A4,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr7,99766439,rs145582851,C,T,.,PASS,PX=CYP3A4,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr7,99766440,rs138105638,G,A,.,PASS,PX=CYP3A4,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr7,99768360,rs55785340,A,G,.,PASS,PX=CYP3A4,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr7,99768371,rs55901263,G,C,.,PASS,PX=CYP3A4,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr7,99768424,rs113667357,T,A,.,PASS,PX=CYP3A4,GT,0/0,CYP3A4_NM,NM_017460.6(CYP3A4):c.600A>G (p.Gln200=),CYP3A4,nan,CYP3A4-related disorder,VCV003054024,7,99366047,7,99768424,3054024,3221444,rs113667357,NC_000007.14:99768423:T:C,single nucleotide variant,synonymous variant,Likely benign,"Nov 10, 2023",no assertion criteria provided,nan,nan,nan,nan,nan,nan,nan
chr7,99768447,rs3208361,T,C,.,PASS,PX=CYP3A4,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr7,99768458,rs4987161,A,G,.,PASS,PX=CYP3A4,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr7,99768470,rs12721627,G,C,.,PASS,PX=CYP3A4,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr7,99768693,rs35599367,G,A,.,PASS,PX=CYP3A4,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr7,99769769,rs4986908,C,G,.,PASS,PX=CYP3A4,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr7,99769781,rs72552798,C,T,.,PASS,PX=CYP3A4,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr7,99769804,rs4986907,C,T,.,PASS,PX=CYP3A4,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr7,99769805,rs57409622,G,A,.,PASS,PX=CYP3A4,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr7,99770165,rs72552799,C,T,.,PASS,PX=CYP3A4,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr7,99770166,rs778013004,G,A,.,PASS,PX=CYP3A4,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr7,99770196,.,T,C,.,PASS,PX=CYP3A4,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr7,99770202,rs55951658,T,C,.,PASS,PX=CYP3A4,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr7,99770217,rs1449865051,A,T,.,PASS,PX=CYP3A4,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr7,99778079,rs56324128,C,T,.,PASS,PX=CYP3A4,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr7,99780036,.,G,A,.,PASS,PX=CYP3A4,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr7,99784018,rs570051168,G,C,.,PASS,PX=CYP3A4,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr7,99784038,rs12721634,A,G,.,PASS,PX=CYP3A4,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr7,99784075,rs188389063,G,C,.,PASS,PX=CYP3A4,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr7,99784078,rs1226205448,C,T,.,PASS,PX=CYP3A4,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr7,117509035,rs397508256,G,A,.,PASS,PX=CFTR,GT,0/0,CFTR_NM,NM_000492.4(CFTR):c.166G>T (p.Glu56Ter),CFTR|LOC113664106,E56*,Cystic fibrosis,VCV000618926,7,117149089,7,117509035,618926,610296,rs397508256,NC_000007.14:117509034:G:T,single nucleotide variant,nonsense,Pathogenic,"Nov 5, 2018","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chr7,117509035,rs397508256,G,A,.,PASS,PX=CFTR,GT,0/0,CFTR_NM,NM_000492.4(CFTR):c.166G>A (p.Glu56Lys),CFTR|LOC113664106,E56K,ivacaftor response - Efficacy|Cystic fibrosis,VCV000053325,7,117149089,7,117509035,53325,67993,rs397508256,NC_000007.14:117509034:G:A,single nucleotide variant,missense variant,Pathogenic; drug response,"Mar 24, 2021",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr7,117509069,rs368505753,C,T,.,PASS,PX=CFTR,GT,0/0,CFTR_NM,NM_000492.4(CFTR):c.200C>T (p.Pro67Leu),CFTR,P67L,Cystic fibrosis|ivacaftor response - Efficacy,VCV000053425,7,117149123,7,117509069,53425,68093,rs368505753,NC_000007.14:117509068:C:T,single nucleotide variant,missense variant,Pathogenic; drug response,"Mar 24, 2021",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr7,117509089,rs115545701,C,T,.,PASS,PX=CFTR,GT,0/0,CFTR_NM,NM_000492.4(CFTR):c.220C>A (p.Arg74=),CFTR,nan,Cystic fibrosis,VCV002587617,7,117149143,7,117509089,2587617,2763955,rs115545701,NC_000007.14:117509088:C:A,single nucleotide variant,synonymous variant,Likely benign,"Aug 30, 2023","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chr7,117509089,rs115545701,C,T,.,PASS,PX=CFTR,GT,0/0,CFTR_NM,NM_000492.4(CFTR):c.220C>T (p.Arg74Trp),CFTR,R74W,ivacaftor response - Efficacy,VCV000196277,7,117149143,7,117509089,196277,193438,rs115545701,NC_000007.14:117509088:C:T,single nucleotide variant,missense variant,drug response,"Mar 24, 2021",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr7,117530953,rs113993958,G,C,.,PASS,PX=CFTR,GT,0/0,CFTR_NM,NM_000492.4(CFTR):c.328G>A (p.Asp110Asn),CFTR,D110N,Cystic fibrosis,VCV000553436,7,117171007,7,117530953,553436,544445,rs113993958,NC_000007.14:117530952:G:A,single nucleotide variant,missense variant,Likely pathogenic,"Apr 7, 2025","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chr7,117530953,rs113993958,G,C,.,PASS,PX=CFTR,GT,0/0,CFTR_NM,NM_000492.4(CFTR):c.328del (p.Asp110fs),CFTR,D110fs,Cystic fibrosis,VCV000053706,7,117171007,7,117530953,53706,68374,rs397508530,NC_000007.14:117530952:G:,Deletion,frameshift variant,not provided,nan,no classification provided,nan,nan,nan,nan,nan,nan,nan
chr7,117530953,rs113993958,G,C,.,PASS,PX=CFTR,GT,0/0,CFTR_NM,NM_000492.4(CFTR):c.328G>T (p.Asp110Tyr),CFTR,D110Y,not specified|not provided|Cystic fibrosis|CFTR-related disorder,VCV000053705,7,117171007,7,117530953,53705,68373,rs113993958,NC_000007.14:117530952:G:T,single nucleotide variant,missense variant,Conflicting classifications of pathogenicity,"Jan 16, 2024","criteria provided, conflicting classifications",nan,nan,nan,nan,nan,nan,nan
chr7,117530953,rs113993958,G,C,.,PASS,PX=CFTR,GT,0/0,CFTR_NM,NM_000492.4(CFTR):c.328G>C (p.Asp110His),CFTR,D110H,ivacaftor response - Efficacy|Cystic fibrosis,VCV000007108,7,117171007,7,117530953,7108,22147,rs113993958,NC_000007.14:117530952:G:C,single nucleotide variant,missense variant,Pathogenic; drug response,"Mar 24, 2021",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr7,117530955,rs397508537,C,A,.,PASS,PX=CFTR,GT,0/0,CFTR_NM,NM_000492.4(CFTR):c.330C>G (p.Asp110Glu),CFTR,D110E,Cystic fibrosis,VCV003019253,7,117171009,7,117530955,3019253,3175617,rs397508537,NC_000007.14:117530954:C:G,single nucleotide variant,missense variant,Pathogenic,"Nov 1, 2022","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chr7,117530955,rs397508537,C,A,.,PASS,PX=CFTR,GT,0/0,CFTR_NM,NM_000492.4(CFTR):c.330C>T (p.Asp110=),CFTR,nan,Cystic fibrosis,VCV001730061,7,117171009,7,117530955,1730061,1792267,rs397508537,NC_000007.14:117530954:C:T,single nucleotide variant,synonymous variant,Likely benign,"Apr 20, 2022","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chr7,117530955,rs397508537,C,A,.,PASS,PX=CFTR,GT,0/0,CFTR_NM,NM_000492.4(CFTR):c.332del (p.Pro111fs),CFTR,P111fs,Cystic fibrosis,VCV001456427,7,117171009,7,117530955,1456427,1458366,rs2116670123,NC_000007.14:117530954:CCC:CC,Deletion,frameshift variant,Pathogenic/Likely pathogenic,"Nov 20, 2024","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chr7,117530955,rs397508537,C,A,.,PASS,PX=CFTR,GT,0/0,CFTR_NM,NM_000492.4(CFTR):c.330C>A (p.Asp110Glu),CFTR,D110E,ivacaftor response - Efficacy,VCV000053714,7,117171009,7,117530955,53714,68382,rs397508537,NC_000007.14:117530954:C:A,single nucleotide variant,missense variant,drug response,"Mar 24, 2021",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr7,117530974,rs77834169,C,T,.,PASS,PX=CFTR,GT,0/0,CFTR_NM,NM_000492.4(CFTR):c.349C>G (p.Arg117Gly),CFTR,R117G,CFTR-related disorder|Cystic fibrosis|Bronchiectasis with or without elevated sweat chloride 1|Cystic fibrosis|Bronchiectasis with or without elevated sweat chloride 1|Congenital bilateral aplasia of vas deferens from CFTR mutation|not provided,VCV000053762,7,117171028,7,117530974,53762,68430,rs77834169,NC_000007.14:117530973:C:G,single nucleotide variant,missense variant,Pathogenic/Likely pathogenic,"Dec 11, 2024","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chr7,117530974,rs77834169,C,T,.,PASS,PX=CFTR,GT,0/0,CFTR_NM,NM_000492.4(CFTR):c.349C>T (p.Arg117Cys),CFTR,R117C,Cystic fibrosis|ivacaftor response - Efficacy,VCV000048688,7,117171028,7,117530974,48688,57850,rs77834169,NC_000007.14:117530973:C:T,single nucleotide variant,missense variant,Pathogenic; drug response,"Mar 24, 2021",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr7,117530975,rs78655421,G,A,.,PASS,PX=CFTR,GT,0/0,CFTR_NM,NM_000492.3(CFTR):c.[350G>A;1210-12[5]],CFTR|CFTR-AS1,R117H,Cystic fibrosis,VCV000209047,7|7,117171029,7|7,117530975,209047,22148|205614,rs78655421|rs1805177,NC_000007.14:117530974:G:A|NC_000007.14:117548628:TTTTTTT:TTTTT,Haplotype,missense variant|intron variant,Pathogenic,nan,reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr7,117530975,rs78655421,G,A,.,PASS,PX=CFTR,GT,0/0,CFTR_NM,NM_000492.4(CFTR):c.350G>T (p.Arg117Leu),CFTR,R117L,Cystic fibrosis|not provided|Bronchiectasis with or without elevated sweat chloride 1,VCV000053765,7,117171029,7,117530975,53765,68433,rs78655421,NC_000007.14:117530974:G:T,single nucleotide variant,missense variant,Pathogenic/Likely pathogenic,"May 29, 2025","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chr7,117530975,rs78655421,G,A,.,PASS,PX=CFTR,GT,0/0,CFTR_NM,NM_000492.4(CFTR):c.350G>C (p.Arg117Pro),CFTR,R117P,Cystic fibrosis,VCV000053764,7,117171029,7,117530975,53764,68432,rs78655421,NC_000007.14:117530974:G:C,single nucleotide variant,missense variant,Pathogenic,"Jan 10, 2020",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr7,117530975,rs78655421,G,A,.,PASS,PX=CFTR,GT,0/0,CFTR_NM,NM_000492.4(CFTR):c.350G>A (p.Arg117His),CFTR,R117H,Cystic fibrosis,VCV000007109,7,117171029,7,117530975,7109,22148,rs78655421,NC_000007.14:117530974:G:A,single nucleotide variant,missense variant,Pathogenic,"Mar 3, 2004",practice guideline,nan,nan,nan,nan,nan,nan,nan
chr7,117534318,rs80282562,G,A,.,PASS,PX=CFTR,GT,0/0,CFTR_NM,NM_000492.4(CFTR):c.532G>C (p.Gly178Arg),CFTR,G178R,Hereditary pancreatitis,VCV001685614,7,117174372,7,117534318,1685614,1677630,rs80282562,NC_000007.14:117534317:G:C,single nucleotide variant,missense variant,Pathogenic,"May 4, 2022","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chr7,117534318,rs80282562,G,A,.,PASS,PX=CFTR,GT,0/0,CFTR_NM,NM_000492.4(CFTR):c.532G>A (p.Gly178Arg),CFTR,G178R,Cystic fibrosis|ivacaftor response - Efficacy,VCV000048692,7,117174372,7,117534318,48692,57854,rs80282562,NC_000007.14:117534317:G:A,single nucleotide variant,missense variant,Pathogenic; drug response,"Mar 24, 2021",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr7,117534363,rs397508759,G,A,.,PASS,PX=CFTR,GT,0/0,CFTR_NM,NM_000492.4(CFTR):c.577G>T (p.Glu193Ter),CFTR,E193*,Cystic fibrosis,VCV000054007,7,117174417,7,117534363,54007,68674,rs397508759,NC_000007.14:117534362:G:T,single nucleotide variant,nonsense,Pathogenic,"Mar 17, 2017",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr7,117534363,rs397508759,G,A,.,PASS,PX=CFTR,GT,0/0,CFTR_NM,NM_000492.4(CFTR):c.577G>A (p.Glu193Lys),CFTR,E193K,Cystic fibrosis|ivacaftor response - Efficacy,VCV000054006,7,117174417,7,117534363,54006,68673,rs397508759,NC_000007.14:117534362:G:A,single nucleotide variant,missense variant,Pathogenic; drug response,"Mar 24, 2021",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr7,117534368,rs397508761,A,G,.,PASS,PX=CFTR,GT,0/0,CFTR_NM,NM_000492.4(CFTR):c.579+3A>T,CFTR,nan,Cystic fibrosis,VCV000054011,7,117174422,7,117534368,54011,68678,rs397508761,NC_000007.14:117534367:A:T,single nucleotide variant,intron variant,not provided,nan,no classification provided,nan,nan,nan,nan,nan,nan,nan
chr7,117534368,rs397508761,A,G,.,PASS,PX=CFTR,GT,0/0,CFTR_NM,NM_000492.4(CFTR):c.579+3A>G,CFTR,nan,Cystic fibrosis,VCV000054010,7,117174422,7,117534368,54010,68677,rs397508761,NC_000007.14:117534367:A:G,single nucleotide variant,intron variant,Pathogenic,"Mar 17, 2017",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr7,117535285,rs121908752,T,G,.,PASS,PX=CFTR,GT,0/0,CFTR_NM,NM_000492.4(CFTR):c.617T>A (p.Leu206Ter),CFTR,L206*,Cystic fibrosis,VCV001726890,7,117175339,7,117535285,1726890,1784417,rs121908752,NC_000007.14:117535284:T:A,single nucleotide variant,nonsense,Likely pathogenic,"Jan 2, 2022","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chr7,117535285,rs121908752,T,G,.,PASS,PX=CFTR,GT,0/0,CFTR_NM,NM_000492.4(CFTR):c.617T>G (p.Leu206Trp),CFTR,L206W,Cystic fibrosis|ivacaftor response - Efficacy,VCV000007190,7,117175339,7,117535285,7190,22229,rs121908752,NC_000007.14:117535284:T:G,single nucleotide variant,missense variant,Pathogenic; drug response,"Mar 24, 2021",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr7,117540270,rs77932196,G,A,.,PASS,PX=CFTR,GT,0/0,CFTR_NM,NM_000492.4(CFTR):c.1040G>A (p.Arg347His),CFTR,R347H,Cystic fibrosis,VCV000007182,7,117180324,7,117540270,7182,22221,rs77932196,NC_000007.14:117540269:G:A,single nucleotide variant,missense variant,Pathogenic,"Mar 17, 2017",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr7,117540270,rs77932196,G,A,.,PASS,PX=CFTR,GT,0/0,CFTR_NM,NM_000492.4(CFTR):c.1040G>T (p.Arg347Leu),CFTR,R347L,Cystic fibrosis|Congenital bilateral aplasia of vas deferens from CFTR mutation|Hereditary pancreatitis|Bronchiectasis with or without elevated sweat chloride 1|Cystic fibrosis|Bronchiectasis with or without elevated sweat chloride 1|Cystic fibrosis|Congenital bilateral aplasia of vas deferens from CFTR mutation,VCV000007171,7,117180324,7,117540270,7171,22210,rs77932196,NC_000007.14:117540269:G:T,single nucleotide variant,missense variant,Pathogenic/Likely pathogenic,"Mar 15, 2024","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chr7,117540270,rs77932196,G,A,.,PASS,PX=CFTR,GT,0/0,CFTR_NM,NM_000492.4(CFTR):c.1040G>C (p.Arg347Pro),CFTR,R347P,Cystic fibrosis,VCV000007110,7,117180324,7,117540270,7110,22149,rs77932196,NC_000007.14:117540269:G:C,single nucleotide variant,missense variant,Pathogenic,"Mar 3, 2004",practice guideline,nan,nan,nan,nan,nan,nan,nan
chr7,117540285,rs121908753,G,A,.,PASS,PX=CFTR,GT,0/0,CFTR_NM,NM_000492.4(CFTR):c.1055G>A (p.Arg352Gln),CFTR,R352Q,ivacaftor response - Efficacy|Cystic fibrosis,VCV000007198,7,117180339,7,117540285,7198,22237,rs121908753,NC_000007.14:117540284:G:A,single nucleotide variant,missense variant,Pathogenic; drug response,"Mar 24, 2021",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr7,117548795,rs74551128,C,A,.,PASS,PX=CFTR,GT,0/0,CFTR_NM,NM_000492.4(CFTR):c.1364C>G (p.Ala455Gly),CFTR|CFTR-AS1,A455G,Cystic fibrosis,VCV003341327,7,117188849,7,117548795,3341327,3500563,nan,NC_000007.14:117548794:C:G,single nucleotide variant,missense variant,Uncertain significance,"May 20, 2023","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chr7,117548795,rs74551128,C,A,.,PASS,PX=CFTR,GT,0/0,CFTR_NM,NM_000492.4(CFTR):c.1364C>T (p.Ala455Val),CFTR|CFTR-AS1,A455V,not specified|not provided|Cystic fibrosis,VCV000411125,7,117188849,7,117548795,411125,395633,rs74551128,NC_000007.14:117548794:C:T,single nucleotide variant,missense variant,Conflicting classifications of pathogenicity,"Apr 10, 2025","criteria provided, conflicting classifications",nan,nan,nan,nan,nan,nan,nan
chr7,117548795,rs74551128,C,A,.,PASS,PX=CFTR,GT,0/0,CFTR_NM,NM_000492.4(CFTR):c.1364C>A (p.Ala455Glu),CFTR|CFTR-AS1,A455E,Cystic fibrosis,VCV000007111,7,117188849,7,117548795,7111,22150,rs74551128,NC_000007.14:117548794:C:A,single nucleotide variant,missense variant,Pathogenic,"Mar 3, 2004",practice guideline,nan,nan,nan,nan,nan,nan,nan
chr7,117587799,rs121908757,A,C,.,PASS,PX=CFTR,GT,0/0,CFTR_NM,NM_000492.4(CFTR):c.1645A>C (p.Ser549Arg),CFTR|LOC111674475,S549R,ivacaftor response - Efficacy|Cystic fibrosis,VCV000038733,7,117227853,7,117587799,38733,47338,rs121908757,NC_000007.14:117587798:A:C,single nucleotide variant,missense variant,Pathogenic; drug response,"Mar 24, 2021",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr7,117587800,rs121908755,G,A,.,PASS,PX=CFTR,GT,0/0,CFTR_NM,NM_000492.4(CFTR):c.1646G>C (p.Ser549Thr),CFTR|LOC111674475,S549T,not specified,VCV003339392,7,117227854,7,117587800,3339392,3498658,nan,NC_000007.14:117587799:G:C,single nucleotide variant,missense variant,Uncertain significance,"Jul 23, 2024","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chr7,117587800,rs121908755,G,A,.,PASS,PX=CFTR,GT,0/0,CFTR_NM,NM_000492.4(CFTR):c.1646G>T (p.Ser549Ile),LOC111674475|CFTR,S549I,Cystic fibrosis,VCV000007117,7,117227854,7,117587800,7117,22156,rs121908755,NC_000007.14:117587799:G:T,single nucleotide variant,missense variant,Pathogenic,"Nov 1, 1990",no assertion criteria provided,nan,nan,nan,nan,nan,nan,nan
chr7,117587800,rs121908755,G,A,.,PASS,PX=CFTR,GT,0/0,CFTR_NM,NM_000492.4(CFTR):c.1646G>A (p.Ser549Asn),CFTR|LOC111674475,S549N,Cystic fibrosis|ivacaftor response - Efficacy,VCV000007116,7,117227854,7,117587800,7116,22155,rs121908755,NC_000007.14:117587799:G:A,single nucleotide variant,missense variant,Pathogenic; drug response,"Mar 24, 2021",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr7,117587801,rs121909005,T,G,.,PASS,PX=CFTR,GT,0/0,CFTR_NM,NM_000492.4(CFTR):c.1647T>C (p.Ser549=),CFTR|LOC111674475,nan,Cystic fibrosis,VCV001559542,7,117227855,7,117587801,1559542,1542133,rs121909005,NC_000007.14:117587800:T:C,single nucleotide variant,synonymous variant,Likely benign,"Oct 14, 2022","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chr7,117587801,rs121909005,T,G,.,PASS,PX=CFTR,GT,0/0,CFTR_NM,NM_000492.4(CFTR):c.1647T>A (p.Ser549Arg),CFTR|LOC111674475,S549R,Cystic fibrosis,VCV000487375,7,117227855,7,117587801,487375,480441,rs121909005,NC_000007.14:117587800:T:A,single nucleotide variant,missense variant,Pathogenic,"Mar 17, 2017",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr7,117587801,rs121909005,T,G,.,PASS,PX=CFTR,GT,0/0,CFTR_NM,NM_000492.4(CFTR):c.1647T>G (p.Ser549Arg),CFTR|LOC111674475,S549R,ivacaftor response - Efficacy|Cystic fibrosis,VCV000040190,7,117227855,7,117587801,40190,22157,rs121909005,NC_000007.14:117587800:T:G,single nucleotide variant,missense variant,Pathogenic; drug response,"Mar 24, 2021",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr7,117587805,rs121909013,G,A,.,PASS,PX=CFTR,GT,0/0,CFTR_NM,NM_000492.4(CFTR):c.1652del (p.Gly551fs),LOC111674475|CFTR,G551fs,Cystic fibrosis,VCV000053320,7,117227859,7,117587805,53320,67988,rs397508252,NC_000007.14:117587804:GG:G,Deletion,frameshift variant,Likely pathogenic,"Feb 2, 2021","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chr7,117587805,rs121909013,G,A,.,PASS,PX=CFTR,GT,0/0,CFTR_NM,NM_000492.4(CFTR):c.1651G>A (p.Gly551Ser),CFTR|LOC111674475,G551S,Cystic fibrosis|ivacaftor response - Efficacy,VCV000007142,7,117227859,7,117587805,7142,22181,rs121909013,NC_000007.14:117587804:G:A,single nucleotide variant,missense variant,Pathogenic; drug response,"Mar 24, 2021",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr7,117587806,rs75527207,G,A,.,PASS,PX=CFTR,GT,0/0,CFTR_NM,NM_000492.4(CFTR):c.1652G>T (p.Gly551Val),CFTR|LOC111674475,G551V,Cystic fibrosis,VCV001333303,7,117227860,7,117587806,1333303,1324078,rs75527207,NC_000007.14:117587805:G:T,single nucleotide variant,missense variant,Likely pathogenic,"Jan 3, 2022","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chr7,117587806,rs75527207,G,A,.,PASS,PX=CFTR,GT,0/0,CFTR_NM,NM_000492.4(CFTR):c.1652G>A (p.Gly551Asp),CFTR|LOC111674475,G551D,Cystic fibrosis,VCV000007120,7,117227860,7,117587806,7120,22159,rs75527207,NC_000007.14:117587805:G:A,single nucleotide variant,missense variant,Pathogenic,"Mar 3, 2004",practice guideline,nan,nan,nan,nan,nan,nan,nan
chr7,117590409,rs397508288,A,G,.,PASS,PX=CFTR,GT,0/0,CFTR_NM,NM_000492.4(CFTR):c.1736A>T (p.Asp579Val),CFTR,D579V,not specified,VCV003896579,7,117230463,7,117590409,3896579,4012447,nan,NC_000007.14:117590408:A:T,single nucleotide variant,missense variant,Uncertain significance,"Apr 30, 2025","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chr7,117590409,rs397508288,A,G,.,PASS,PX=CFTR,GT,0/0,CFTR_NM,NM_000492.4(CFTR):c.1736A>C (p.Asp579Ala),CFTR,D579A,not specified,VCV003233738,7,117230463,7,117590409,3233738,68032,rs397508288,NC_000007.14:117590408:A:C,single nucleotide variant,missense variant,Uncertain significance,"Mar 27, 2024","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chr7,117590409,rs397508288,A,G,.,PASS,PX=CFTR,GT,0/0,CFTR_NM,NM_000492.4(CFTR):c.1736A>G (p.Asp579Gly),CFTR,D579G,ivacaftor response - Efficacy,VCV000053365,7,117230463,7,117590409,53365,68033,rs397508288,NC_000007.14:117590408:A:G,single nucleotide variant,missense variant,drug response,"Mar 24, 2021",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr7,117594930,rs397508387,G,T,.,PASS,PX=CFTR,GT,0/0,CFTR_NM,NM_000492.4(CFTR):c.2491G>T (p.Glu831Ter),CFTR,E831*,Cystic fibrosis,VCV000053501,7,117234984,7,117594930,53501,68169,rs397508387,NC_000007.14:117594929:G:T,single nucleotide variant,nonsense,Pathogenic,"Mar 17, 2017",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr7,117602868,rs80224560,G,A,.,PASS,PX=CFTR,GT,0/0,CFTR_NM,NM_000492.4(CFTR):c.2657+5G>A,CFTR,nan,Cystic fibrosis,VCV000038497,7,117242922,7,117602868,38497,47062,rs80224560,NC_000007.14:117602867:G:A,single nucleotide variant,intron variant,Pathogenic,"Mar 3, 2004",practice guideline,nan,nan,nan,nan,nan,nan,nan
chr7,117603708,rs397508442,C,T,.,PASS,PX=CFTR,GT,0/0,CFTR_NM,NM_000492.4(CFTR):c.2834C>T (p.Ser945Leu),CFTR,S945L,ivacaftor response - Efficacy|Cystic fibrosis,VCV000053575,7,117243762,7,117603708,53575,68243,rs397508442,NC_000007.14:117603707:C:T,single nucleotide variant,missense variant,Pathogenic; drug response,"Mar 24, 2021",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr7,117606695,rs141033578,C,T,.,PASS,PX=CFTR,GT,0/0,CFTR_NM,NM_000492.4(CFTR):c.2930C>T (p.Ser977Phe),CFTR|CFTR-AS2,S977F,ivacaftor response - Efficacy,VCV000053601,7,117246749,7,117606695,53601,68269,rs141033578,NC_000007.14:117606694:C:T,single nucleotide variant,missense variant,drug response,"Mar 24, 2021",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr7,117611555,rs76151804,A,G,.,PASS,PX=CFTR,GT,0/0,CFTR_NM,NM_000492.4(CFTR):c.3140-26A>G,CFTR|CFTR-AS2|LOC111674472,nan,Cystic fibrosis,VCV000035864,7,117251609,7,117611555,35864,44528,rs76151804,NC_000007.14:117611554:A:G,single nucleotide variant,intron variant,Pathogenic,"Mar 17, 2017",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr7,117611595,rs150212784,T,G,.,PASS,PX=CFTR,GT,0/0,CFTR_NM,NM_000492.4(CFTR):c.3154T>G (p.Phe1052Val),CFTR|CFTR-AS2|LOC111674472,F1052V,ivacaftor response - Efficacy,VCV000035865,7,117251649,7,117611595,35865,44529,rs150212784,NC_000007.14:117611594:T:G,single nucleotide variant,missense variant,drug response,"Mar 24, 2021",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr7,117611620,rs397508513,A,C,.,PASS,PX=CFTR,GT,0/0,CFTR_NM,NM_000492.4(CFTR):c.3179A>C (p.Lys1060Thr),CFTR|CFTR-AS2|LOC111674472,K1060T,ivacaftor response - Efficacy,VCV000053671,7,117251674,7,117611620,53671,68339,rs397508513,NC_000007.14:117611619:A:C,single nucleotide variant,missense variant,drug response,"Mar 24, 2021",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr7,117611640,rs121909020,G,A,.,PASS,PX=CFTR,GT,0/0,CFTR_NM,NM_000492.4(CFTR):c.3199G>C (p.Ala1067Pro),CFTR|CFTR-AS2|LOC111674472,A1067P,Cystic fibrosis,VCV000053679,7,117251694,7,117611640,53679,68347,rs121909020,NC_000007.14:117611639:G:C,single nucleotide variant,missense variant,Uncertain significance,"Jun 7, 2018",no assertion criteria provided,nan,nan,nan,nan,nan,nan,nan
chr7,117611640,rs121909020,G,A,.,PASS,PX=CFTR,GT,0/0,CFTR_NM,NM_000492.4(CFTR):c.3199G>A (p.Ala1067Thr),CFTR|CFTR-AS2|LOC111674472,A1067T,ivacaftor response - Efficacy,VCV000007159,7,117251694,7,117611640,7159,22198,rs121909020,NC_000007.14:117611639:G:A,single nucleotide variant,missense variant,drug response,"Mar 24, 2021",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr7,117611646,rs200321110,G,A,.,PASS,PX=CFTR,GT,0/0,CFTR_NM,NM_000492.4(CFTR):c.3205G>A (p.Gly1069Arg),CFTR|CFTR-AS2|LOC111674472,G1069R,CFTR-related disorder|Cystic fibrosis|Congenital bilateral aplasia of vas deferens from CFTR mutation|not specified|not provided|Bronchiectasis with or without elevated sweat chloride 1|Cystic fibrosis|Hereditary pancreatitis|Congenital bilateral aplasia of vas deferens from CFTR mutation|Bronchiectasis with or without elevated sweat chloride 1|Hereditary pancreatitis|Cystic fibrosis,VCV000053684,7,117251700,7,117611646,53684,68352,rs200321110,NC_000007.14:117611645:G:A,single nucleotide variant,missense variant,Conflicting classifications of pathogenicity,"May 6, 2025","criteria provided, conflicting classifications",nan,nan,nan,nan,nan,nan,nan
chr7,117611649,rs202179988,C,T,.,PASS,PX=CFTR,GT,0/0,CFTR_NM,NM_000492.4(CFTR):c.3208C>T (p.Arg1070Trp),CFTR|CFTR-AS2|LOC111674472,R1070W,ivacaftor response - Efficacy,VCV000053685,7,117251703,7,117611649,53685,68353,rs202179988,NC_000007.14:117611648:C:T,single nucleotide variant,missense variant,drug response,"Mar 24, 2021",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr7,117611650,rs78769542,G,A,.,PASS,PX=CFTR,GT,0/0,CFTR_NM,NM_000492.4(CFTR):c.3209G>C (p.Arg1070Pro),CFTR|CFTR-AS2|LOC111674472,R1070P,Cystic fibrosis,VCV000053686,7,117251704,7,117611650,53686,68354,rs78769542,NC_000007.14:117611649:G:C,single nucleotide variant,missense variant,Likely pathogenic,"Jun 6, 2022","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chr7,117611650,rs78769542,G,A,.,PASS,PX=CFTR,GT,0/0,CFTR_NM,NM_000492.4(CFTR):c.3209G>A (p.Arg1070Gln),CFTR|CFTR-AS2|LOC111674472,R1070Q,ivacaftor response - Efficacy,VCV000035866,7,117251704,7,117611650,35866,44530,rs78769542,NC_000007.14:117611649:G:A,single nucleotide variant,missense variant,drug response,"Mar 24, 2021",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr7,117611663,rs186045772,T,A,.,PASS,PX=CFTR,GT,0/0,CFTR_NM,NM_000492.4(CFTR):c.3222T>A (p.Phe1074Leu),CFTR|CFTR-AS2|LOC111674472,F1074L,ivacaftor response - Efficacy,VCV000053688,7,117251717,7,117611663,53688,68356,rs186045772,NC_000007.14:117611662:T:A,single nucleotide variant,missense variant,drug response,"Mar 24, 2021",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr7,117614699,rs75541969,G,C,.,PASS,PX=CFTR,GT,0/0,CFTR_NM,NM_000492.4(CFTR):c.3454G>C (p.Asp1152His),CFTR|CFTR-AS2,D1152H,ivacaftor response - Efficacy,VCV000035867,7,117254753,7,117614699,35867,44531,rs75541969,NC_000007.14:117614698:G:C,single nucleotide variant,missense variant,drug response,"Mar 24, 2021",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr7,117639961,rs75039782,C,T,.,PASS,PX=CFTR,GT,0/0,CFTR_NM,NM_000492.4(CFTR):c.3718-2477C>G,CFTR|CFTR-AS2|LOC113633877,nan,Hereditary pancreatitis,VCV002664046,7,117280015,7,117639961,2664046,362498,rs75039782,NC_000007.14:117639960:C:G,single nucleotide variant,intron variant,Uncertain significance,"Nov 24, 2023",no assertion criteria provided,nan,nan,nan,nan,nan,nan,nan
chr7,117639961,rs75039782,C,T,.,PASS,PX=CFTR,GT,0/0,CFTR_NM,NM_000492.4(CFTR):c.3718-2477C>A,CFTR|CFTR-AS2|LOC113633877,nan,Cystic fibrosis,VCV001550682,7,117280015,7,117639961,1550682,1574371,rs75039782,NC_000007.14:117639960:C:A,single nucleotide variant,intron variant,Likely benign,"Jul 13, 2022","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chr7,117639961,rs75039782,C,T,.,PASS,PX=CFTR,GT,0/0,CFTR_NM,NM_000492.3(CFTR):c.3718-2477C>T,CFTR|CFTR-AS2|LOC113633877,nan,Cystic fibrosis,VCV000007166,7,117280015,7,117639961,7166,22205,rs75039782,NC_000007.14:117639960:C:T,single nucleotide variant,intron variant,Pathogenic,"Mar 3, 2004",practice guideline,nan,nan,nan,nan,nan,nan,nan
chr7,117642451,rs267606723,G,A,.,PASS,PX=CFTR,GT,0/0,CFTR_NM,NM_000492.4(CFTR):c.3731G>T (p.Gly1244Val),CFTR|CFTR-AS2,G1244V,Cystic fibrosis,VCV000053798,7,117282505,7,117642451,53798,22278,rs267606723,NC_000007.14:117642450:G:T,single nucleotide variant,missense variant,Likely pathogenic,"Dec 5, 2023","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chr7,117642451,rs267606723,G,A,.,PASS,PX=CFTR,GT,0/0,CFTR_NM,NM_000492.4(CFTR):c.3731G>A (p.Gly1244Glu),CFTR|CFTR-AS2,G1244E,Cystic fibrosis|ivacaftor response - Efficacy,VCV000053797,7,117282505,7,117642451,53797,68465,rs267606723,NC_000007.14:117642450:G:A,single nucleotide variant,missense variant,Pathogenic; drug response,"Mar 24, 2021",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr7,117642472,rs74503330,G,A,.,PASS,PX=CFTR,GT,0/0,CFTR_NM,NM_000492.4(CFTR):c.3752G>C (p.Ser1251Thr),CFTR|CFTR-AS2,S1251T,Cystic fibrosis,VCV002109356,7,117282526,7,117642472,2109356,2167221,rs74503330,NC_000007.14:117642471:G:C,single nucleotide variant,missense variant,Uncertain significance,"Mar 11, 2022","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chr7,117642472,rs74503330,G,A,.,PASS,PX=CFTR,GT,0/0,CFTR_NM,NM_000492.4(CFTR):c.3752G>A (p.Ser1251Asn),CFTR|CFTR-AS2,S1251N,Cystic fibrosis|ivacaftor response - Efficacy,VCV000007217,7,117282526,7,117642472,7217,22256,rs74503330,NC_000007.14:117642471:G:A,single nucleotide variant,missense variant,Pathogenic; drug response,"Mar 24, 2021",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr7,117642483,rs121909041,T,C,.,PASS,PX=CFTR,GT,0/0,CFTR_NM,NM_000492.4(CFTR):c.3763T>A (p.Ser1255Thr),CFTR|CFTR-AS2,S1255T,Cystic fibrosis|not specified,VCV001683255,7,117282537,7,117642483,1683255,1675154,rs121909041,NC_000007.14:117642482:T:A,single nucleotide variant,missense variant,Uncertain significance,"May 27, 2025","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chr7,117642483,rs121909041,T,C,.,PASS,PX=CFTR,GT,0/0,CFTR_NM,NM_000492.4(CFTR):c.3763T>C (p.Ser1255Pro),CFTR|CFTR-AS2,S1255P,Cystic fibrosis|ivacaftor response - Efficacy,VCV000007192,7,117282537,7,117642483,7192,22231,rs121909041,NC_000007.14:117642482:T:C,single nucleotide variant,missense variant,Pathogenic; drug response,"Mar 24, 2021",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr7,117642528,rs11971167,G,A,.,PASS,PX=CFTR,GT,0/0,CFTR_NM,NM_000492.4(CFTR):c.3808G>T (p.Asp1270Tyr),CFTR|CFTR-AS2,D1270Y,ivacaftor response - Efficacy,VCV002502286,7,117282582,7,117642528,2502286,68481,rs11971167,NC_000007.14:117642527:G:T,single nucleotide variant,missense variant,drug response,"Mar 24, 2021",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr7,117642528,rs11971167,G,A,.,PASS,PX=CFTR,GT,0/0,CFTR_NM,NM_000492.4(CFTR):c.[220C>T;3808G>A],CFTR-AS2|CFTR,"D1270N, R74W",not specified,VCV000977735,7|7,117282582,7|7,117642528,977735,22203|193438,rs11971167|rs115545701,NC_000007.14:117642527:G:A|NC_000007.14:117509088:C:T,Haplotype,missense variant,Uncertain significance,"Oct 6, 2023","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chr7,117642528,rs11971167,G,A,.,PASS,PX=CFTR,GT,0/0,CFTR_NM,NM_000492.4(CFTR):c.3808del (p.Asp1270fs),CFTR|CFTR-AS2,D1270fs,Cystic fibrosis|not provided,VCV000439078,7,117282582,7,117642528,439078,432636,rs763843966,NC_000007.14:117642527:G:,Deletion,frameshift variant,Pathogenic,"Jan 25, 2024","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chr7,117642528,rs11971167,G,A,.,PASS,PX=CFTR,GT,0/0,CFTR_NM,NM_000492.4(CFTR):c.3808G>A (p.Asp1270Asn),CFTR|CFTR-AS2,D1270N,CFTR-related disorder|not provided|not specified|Bronchiectasis with or without elevated sweat chloride 1|Congenital bilateral aplasia of vas deferens from CFTR mutation|Hereditary pancreatitis|Cystic fibrosis|Hereditary pancreatitis|Cystic fibrosis,VCV000007164,7,117282582,7,117642528,7164,22203,rs11971167,NC_000007.14:117642527:G:A,single nucleotide variant,missense variant,Conflicting classifications of pathogenicity,"Mar 1, 2025","criteria provided, conflicting classifications",nan,nan,nan,nan,nan,nan,nan
chr7,117664770,rs193922525,G,A,.,PASS,PX=CFTR,GT,0/0,CFTR_NM,NM_000492.4(CFTR):c.4046G>A (p.Gly1349Asp),CFTR,G1349D,ivacaftor response - Efficacy|Cystic fibrosis,VCV000035881,7,117304824,7,117664770,35881,44545,rs193922525,NC_000007.14:117664769:G:A,single nucleotide variant,missense variant,Pathogenic; drug response,"Mar 24, 2021",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr10,94645745,rs12777823,G,A,.,PASS,POI,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr10,94761900,rs12248560,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,NM_000769.1(CYP2C19):c.-806C>T,CYP2C19|LOC110599570,nan,CYP2C19: increased function,VCV000039357,10,96521657.0,10,94761900,39357,47956,rs12248560,NC_000010.11:94761899:C:T,single nucleotide variant,nan,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762706,rs28399504,A,G,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*4B/*4B,CYP2C19|LOC110599570,M1V,Voriconazole response|Clopidogrel response|Citalopram response|Escitalopram response|Sertraline response,VCV000638790,10|10,96522463.0,10|10,94762706,638790,31939|47956,rs28399504|rs12248560,NC_000010.11:94762705:A:G|NC_000010.11:94761899:C:T,Diplotype,missense variant|initiator_codon_variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762706,rs28399504,A,G,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*4B/*23,LOC110599570|CYP2C19,"M1V, G91R",Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634419,10|10|10,96522463.0,10|10|10,94762706,634419,31939|47956|622285,rs28399504|rs12248560|rs118203756,NC_000010.11:94762705:A:G|NC_000010.11:94761899:C:T|NC_000010.11:94775159:G:C,Diplotype,missense variant|initiator_codon_variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762706,rs28399504,A,G,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*4B/*14,LOC110599570|CYP2C19,"M1V, L17P",Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634342,10|10|10,96522463.0,10|10|10,94762706,634342,31939|47956|622280,rs28399504|rs12248560|rs55752064,NC_000010.11:94762705:A:G|NC_000010.11:94761899:C:T|NC_000010.11:94762754:T:C,Diplotype,missense variant|initiator_codon_variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762706,rs28399504,A,G,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*4B/*7,CYP2C19|LOC110599570,M1V,Voriconazole response|Clopidogrel response|Citalopram response|Escitalopram response|Sertraline response,VCV000634251,10|10,96522463.0,10|10,94762706,634251,31939|47956,rs28399504|rs12248560,NC_000010.11:94762705:A:G|NC_000010.11:94761899:C:T,Diplotype,missense variant|initiator_codon_variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762706,rs28399504,A,G,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*4B/*17,CYP2C19|LOC110599570,M1V,Voriconazole response|Clopidogrel response|Citalopram response|Escitalopram response|Sertraline response,VCV000634216,10|10,96522463.0,10|10,94762706,634216,31939|47956,rs28399504|rs12248560,NC_000010.11:94762705:A:G|NC_000010.11:94761899:C:T,Diplotype,missense variant|initiator_codon_variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762706,rs28399504,A,G,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*4B/*15,LOC110599570|CYP2C19,"M1V, I19L",Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634215,10|10|10,96522463.0,10|10|10,94762706,634215,31939|47956|622281,rs28399504|rs12248560|rs17882687,NC_000010.11:94762705:A:G|NC_000010.11:94761899:C:T|NC_000010.11:94762759:A:C,Diplotype,missense variant|initiator_codon_variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762706,rs28399504,A,G,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*4B/*29,LOC110599570|CYP2C19,"M1V, K28I",Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634166,10|10|10,96522463.0,10|10|10,94762706,634166,31939|47956|622282,rs28399504|rs12248560|rs1564656981,NC_000010.11:94762705:A:G|NC_000010.11:94761899:C:T|NC_000010.11:94762787:A:T,Diplotype,missense variant|initiator_codon_variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762706,rs28399504,A,G,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*4B/*8,CYP2C19|LOC110599570,M1V,Voriconazole response|Clopidogrel response|Citalopram response|Escitalopram response|Sertraline response,VCV000634023,10|10,96522463.0,10|10,94762706,634023,31939|47956,rs28399504|rs12248560,NC_000010.11:94762705:A:G|NC_000010.11:94761899:C:T,Diplotype,missense variant|initiator_codon_variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762706,rs28399504,A,G,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*4B/*24,LOC110599570|CYP2C19,"M1V, R335Q",Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634021,10|10|10|10,96522463.0,10|10|10|10,94762706,634021,31939|47956|622292|166407,rs28399504|rs12248560|rs118203757|rs377184510,NC_000010.11:94762705:A:G|NC_000010.11:94761899:C:T|NC_000010.11:94842878:G:A|NC_000010.11:94849963:A:G,Diplotype,missense variant|initiator_codon_variant|synonymous variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762706,rs28399504,A,G,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*3/*4B,CYP2C19|LOC110599570,M1V,Voriconazole response|Clopidogrel response|Citalopram response|Escitalopram response|Sertraline response,VCV000634015,10|10,96522463.0,10|10,94762706,634015,31939|47956,rs28399504|rs12248560,NC_000010.11:94762705:A:G|NC_000010.11:94761899:C:T,Diplotype,missense variant|initiator_codon_variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762706,rs28399504,A,G,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*4B/*9,CYP2C19|LOC110599570,M1V,Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000633989,10|10,96522463.0,10|10,94762706,633989,31939|47956,rs28399504|rs12248560,NC_000010.11:94762705:A:G|NC_000010.11:94761899:C:T,Diplotype,missense variant|initiator_codon_variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762706,rs28399504,A,G,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*4B/*25,LOC110599570|CYP2C19,"M1V, F448L",Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000633987,10|10|10,96522463.0,10|10|10,94762706,633987,31939|47956|622296,rs28399504|rs12248560|rs118203759,NC_000010.11:94762705:A:G|NC_000010.11:94761899:C:T|NC_000010.11:94852784:C:G,Diplotype,missense variant|initiator_codon_variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762706,rs28399504,A,G,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*4B/*19,LOC110599570|CYP2C19,"M1V, S51G",Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000633986,10|10|10,96522463.0,10|10|10,94762706,633986,31939|47956|166410,rs28399504|rs12248560|rs1564657013,NC_000010.11:94762705:A:G|NC_000010.11:94761899:C:T|NC_000010.11:94762855:A:G,Diplotype,missense variant|initiator_codon_variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762706,rs28399504,A,G,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*4B/*6,CYP2C19|LOC110599570,M1V,Voriconazole response|Clopidogrel response|Citalopram response|Escitalopram response|Sertraline response,VCV000633877,10|10,96522463.0,10|10,94762706,633877,31939|47956,rs28399504|rs12248560,NC_000010.11:94762705:A:G|NC_000010.11:94761899:C:T,Diplotype,missense variant|initiator_codon_variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762706,rs28399504,A,G,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*4B/*5,CYP2C19|LOC110599570,M1V,Voriconazole response|Clopidogrel response|Citalopram response|Escitalopram response|Sertraline response,VCV000633876,10|10,96522463.0,10|10,94762706,633876,31939|47956,rs28399504|rs12248560,NC_000010.11:94762705:A:G|NC_000010.11:94761899:C:T,Diplotype,missense variant|initiator_codon_variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762706,rs28399504,A,G,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*4A/*4B,CYP2C19|LOC110599570,M1V,Escitalopram response|Sertraline response|Voriconazole response|Clopidogrel response|Citalopram response,VCV000633871,10|10,96522463.0,10|10,94762706,633871,31939|47956,rs28399504|rs12248560,NC_000010.11:94762705:A:G|NC_000010.11:94761899:C:T,Diplotype,missense variant|initiator_codon_variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762706,rs28399504,A,G,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*4B,CYP2C19|LOC110599570,M1V,CYP2C19: no function,VCV000633860,10|10,96522463.0,10|10,94762706,633860,31939|47956,rs28399504|rs12248560,NC_000010.11:94762705:A:G|NC_000010.11:94761899:C:T,Haplotype,missense variant|initiator_codon_variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762706,rs28399504,A,G,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,NM_000769.1(CYP2C19):c.1A>G (p.Met1Val),CYP2C19,M1V,CYP2C19: no function,VCV000016900,10,96522463.0,10,94762706,16900,31939,rs28399504,NC_000010.11:94762705:A:G,single nucleotide variant,missense variant|initiator_codon_variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762712,rs367543002,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*34/*34,CYP2C19|LOC110599570,"P3S, F4L",Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000638787,10|10|10,96522469.0,10|10|10,94762712,638787,622278|622279|622277,rs367543002|rs367543003|rs367543001,NC_000010.11:94762711:C:T|NC_000010.11:94762714:T:C|NC_000010.11:94762692:G:A,Diplotype,missense variant|5 prime UTR variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762712,rs367543002,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,NM_000769.4(CYP2C19):c.7C>T (p.Pro3Ser),CYP2C19,P3S,nan,VCV000634864,10,96522469.0,10,94762712,634864,622278,rs367543002,NC_000010.11:94762711:C:T,single nucleotide variant,missense variant,no classification for the single variant,nan,no classification for the single variant,no classification for the single variant,nan,no classification for the single variant,no classification for the single variant,nan,no classification for the single variant,nan
chr10,94762712,rs367543002,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*5/*34,CYP2C19|LOC110599570,"P3S, F4L",Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634422,10|10|10,96522469.0,10|10|10,94762712,634422,622278|622279|622277,rs367543002|rs367543003|rs367543001,NC_000010.11:94762711:C:T|NC_000010.11:94762714:T:C|NC_000010.11:94762692:G:A,Diplotype,missense variant|5 prime UTR variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762712,rs367543002,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*3/*34,CYP2C19|LOC110599570,"P3S, F4L",Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634416,10|10|10,96522469.0,10|10|10,94762712,634416,622278|622279|622277,rs367543002|rs367543003|rs367543001,NC_000010.11:94762711:C:T|NC_000010.11:94762714:T:C|NC_000010.11:94762692:G:A,Diplotype,missense variant|5 prime UTR variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762712,rs367543002,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*1/*34,CYP2C19|LOC110599570,"P3S, F4L",Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634394,10|10|10|,96522469.0,10|10|10|10,94762712,634394,622278|622279|622277|622276,rs367543002|rs367543003|rs367543001,NC_000010.11:94762711:C:T|NC_000010.11:94762714:T:C|NC_000010.11:94762692:G:A,Diplotype,missense variant|5 prime UTR variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762712,rs367543002,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*8/*34,CYP2C19|LOC110599570,"P3S, F4L",Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634345,10|10|10,96522469.0,10|10|10,94762712,634345,622278|622279|622277,rs367543002|rs367543003|rs367543001,NC_000010.11:94762711:C:T|NC_000010.11:94762714:T:C|NC_000010.11:94762692:G:A,Diplotype,missense variant|5 prime UTR variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762712,rs367543002,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*16/*34,LOC110599570|CYP2C19,"P3S, F4L, R442C",Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634331,10|10|10|10,96522469.0,10|10|10|10,94762712,634331,622278|622279|622277|622295,rs367543002|rs367543003|rs367543001|rs192154563,NC_000010.11:94762711:C:T|NC_000010.11:94762714:T:C|NC_000010.11:94762692:G:A|NC_000010.11:94852764:C:T,Diplotype,missense variant|5 prime UTR variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762712,rs367543002,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*9/*34,CYP2C19|LOC110599570,"P3S, F4L",Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634319,10|10|10,96522469.0,10|10|10,94762712,634319,622278|622279|622277,rs367543002|rs367543003|rs367543001,NC_000010.11:94762711:C:T|NC_000010.11:94762714:T:C|NC_000010.11:94762692:G:A,Diplotype,missense variant|5 prime UTR variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762712,rs367543002,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*4B/*34,CYP2C19|LOC110599570,"P3S, F4L, M1V",Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634308,10|10|10|10|10,96522469.0,10|10|10|10|10,94762712,634308,622278|622279|622277|31939|47956,rs367543002|rs367543003|rs367543001|rs28399504|rs12248560,NC_000010.11:94762711:C:T|NC_000010.11:94762714:T:C|NC_000010.11:94762692:G:A|NC_000010.11:94762705:A:G|NC_000010.11:94761899:C:T,Diplotype,missense variant|5 prime UTR variant|initiator_codon_variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762712,rs367543002,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*27/*34,LOC110599570|CYP2C19,"P3S, F4L",Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634297,10|10|10|10,96522469.0,10|10|10|10,94762712,634297,622278|622279|622277|622275,rs367543002|rs367543003|rs367543001|rs7902257,NC_000010.11:94762711:C:T|NC_000010.11:94762714:T:C|NC_000010.11:94762692:G:A|NC_000010.11:94761664:G:A,Diplotype,missense variant|5 prime UTR variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762712,rs367543002,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*2/*34,LOC110599570|CYP2C19,"P3S, F4L",Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634285,10|10|10|10|10,96522469.0,10|10|10|10|10,94762712,634285,622278|622279|622277|31936|622287,rs367543002|rs367543003|rs367543001|rs4244285|rs12769205,NC_000010.11:94762711:C:T|NC_000010.11:94762714:T:C|NC_000010.11:94762692:G:A|NC_000010.11:94781858:G:A|NC_000010.11:94775366:A:G,Diplotype,missense variant|5 prime UTR variant|synonymous variant|intron variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762712,rs367543002,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*19/*34,LOC110599570|CYP2C19,"P3S, F4L, S51G",Escitalopram response|Voriconazole response|Citalopram response|Sertraline response,VCV000634283,10|10|10|10,96522469.0,10|10|10|10,94762712,634283,622278|622279|622277|166410,rs367543002|rs367543003|rs367543001|rs1564657013,NC_000010.11:94762711:C:T|NC_000010.11:94762714:T:C|NC_000010.11:94762692:G:A|NC_000010.11:94762855:A:G,Diplotype,missense variant|5 prime UTR variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762712,rs367543002,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*17/*34,CYP2C19|LOC110599570,"P3S, F4L",Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634279,10|10|10,96522469.0,10|10|10,94762712,634279,622278|622279|622277,rs367543002|rs367543003|rs367543001,NC_000010.11:94762711:C:T|NC_000010.11:94762714:T:C|NC_000010.11:94762692:G:A,Diplotype,missense variant|5 prime UTR variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762712,rs367543002,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*15/*34,LOC110599570|CYP2C19,"P3S, F4L, I19L",Sertraline response|Voriconazole response|Citalopram response|Escitalopram response,VCV000634275,10|10|10|10,96522469.0,10|10|10|10,94762712,634275,622278|622279|622277|622281,rs367543002|rs367543003|rs367543001|rs17882687,NC_000010.11:94762711:C:T|NC_000010.11:94762714:T:C|NC_000010.11:94762692:G:A|NC_000010.11:94762759:A:C,Diplotype,missense variant|5 prime UTR variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762712,rs367543002,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*12/*34,LOC110599570|CYP2C19,"P3S, F4L",Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634266,10|10|10|10,96522469.0,10|10|10|10,94762712,634266,622278|622279|622277|622297,rs367543002|rs367543003|rs367543001|rs55640102,NC_000010.11:94762711:C:T|NC_000010.11:94762714:T:C|NC_000010.11:94762692:G:A|NC_000010.11:94852913:A:C,Diplotype,missense variant|5 prime UTR variant|stop lost,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762712,rs367543002,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*7/*34,CYP2C19|LOC110599570,"P3S, F4L",Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634189,10|10|10,96522469.0,10|10|10,94762712,634189,622278|622279|622277,rs367543002|rs367543003|rs367543001,NC_000010.11:94762711:C:T|NC_000010.11:94762714:T:C|NC_000010.11:94762692:G:A,Diplotype,missense variant|5 prime UTR variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762712,rs367543002,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*6/*34,CYP2C19|LOC110599570,"P3S, F4L",Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634182,10|10|10,96522469.0,10|10|10,94762712,634182,622278|622279|622277,rs367543002|rs367543003|rs367543001,NC_000010.11:94762711:C:T|NC_000010.11:94762714:T:C|NC_000010.11:94762692:G:A,Diplotype,missense variant|5 prime UTR variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762712,rs367543002,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*4A/*34,CYP2C19|LOC110599570,"P3S, F4L",Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634164,10|10|10,96522469.0,10|10|10,94762712,634164,622278|622279|622277,rs367543002|rs367543003|rs367543001,NC_000010.11:94762711:C:T|NC_000010.11:94762714:T:C|NC_000010.11:94762692:G:A,Diplotype,missense variant|5 prime UTR variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762712,rs367543002,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*34/*35,LOC110599570|CYP2C19,"P3S, F4L",Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634157,10|10|10|10,96522469.0,10|10|10|10,94762712,634157,622278|622279|622277|622287,rs367543002|rs367543003|rs367543001|rs12769205,NC_000010.11:94762711:C:T|NC_000010.11:94762714:T:C|NC_000010.11:94762692:G:A|NC_000010.11:94775366:A:G,Diplotype,missense variant|5 prime UTR variant|intron variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762712,rs367543002,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*31/*34,LOC110599570|CYP2C19,"P3S, F4L, H78Y",Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634153,10|10|10|10,96522469.0,10|10|10|10,94762712,634153,622278|622279|622277|622284,rs367543002|rs367543003|rs367543001|rs1564660997,NC_000010.11:94762711:C:T|NC_000010.11:94762714:T:C|NC_000010.11:94762692:G:A|NC_000010.11:94775120:C:T,Diplotype,missense variant|5 prime UTR variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762712,rs367543002,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*30/*34,LOC110599570|CYP2C19,"P3S, F4L, R73C",Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634152,10|10|10|10,96522469.0,10|10|10|10,94762712,634152,622278|622279|622277|622283,rs367543002|rs367543003|rs367543001|rs145328984,NC_000010.11:94762711:C:T|NC_000010.11:94762714:T:C|NC_000010.11:94762692:G:A|NC_000010.11:94775105:C:T,Diplotype,missense variant|5 prime UTR variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762712,rs367543002,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*29/*34,LOC110599570|CYP2C19,"P3S, F4L, K28I",Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634143,10|10|10|10,96522469.0,10|10|10|10,94762712,634143,622278|622279|622277|622282,rs367543002|rs367543003|rs367543001|rs1564656981,NC_000010.11:94762711:C:T|NC_000010.11:94762714:T:C|NC_000010.11:94762692:G:A|NC_000010.11:94762787:A:T,Diplotype,missense variant|5 prime UTR variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762712,rs367543002,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*26/*34,LOC110599570|CYP2C19,"P3S, F4L, D256N",Escitalopram response|Voriconazole response|Citalopram response|Sertraline response,VCV000634131,10|10|10|10,96522469.0,10|10|10|10,94762712,634131,622278|622279|622277|166409,rs367543002|rs367543003|rs367543001|rs375781227,NC_000010.11:94762711:C:T|NC_000010.11:94762714:T:C|NC_000010.11:94762692:G:A|NC_000010.11:94781943:G:A,Diplotype,missense variant|5 prime UTR variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762712,rs367543002,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*25/*34,LOC110599570|CYP2C19,"P3S, F4L, F448L",Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634127,10|10|10|10,96522469.0,10|10|10|10,94762712,634127,622278|622279|622277|622296,rs367543002|rs367543003|rs367543001|rs118203759,NC_000010.11:94762711:C:T|NC_000010.11:94762714:T:C|NC_000010.11:94762692:G:A|NC_000010.11:94852784:C:G,Diplotype,missense variant|5 prime UTR variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762712,rs367543002,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*24/*34,LOC110599570|CYP2C19,"P3S, F4L, R335Q",Sertraline response|Voriconazole response|Citalopram response|Escitalopram response,VCV000634123,10|10|10|10|10,96522469.0,10|10|10|10|10,94762712,634123,622278|622279|622277|622292|166407,rs367543002|rs367543003|rs367543001|rs118203757|rs377184510,NC_000010.11:94762711:C:T|NC_000010.11:94762714:T:C|NC_000010.11:94762692:G:A|NC_000010.11:94842878:G:A|NC_000010.11:94849963:A:G,Diplotype,missense variant|5 prime UTR variant|synonymous variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762712,rs367543002,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*23/*34,LOC110599570|CYP2C19,"P3S, F4L, G91R",Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634118,10|10|10|10,96522469.0,10|10|10|10,94762712,634118,622278|622279|622277|622285,rs367543002|rs367543003|rs367543001|rs118203756,NC_000010.11:94762711:C:T|NC_000010.11:94762714:T:C|NC_000010.11:94762692:G:A|NC_000010.11:94775159:G:C,Diplotype,missense variant|5 prime UTR variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762712,rs367543002,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*14/*34,LOC110599570|CYP2C19,"P3S, F4L, L17P",Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634080,10|10|10|10,96522469.0,10|10|10|10,94762712,634080,622278|622279|622277|622280,rs367543002|rs367543003|rs367543001|rs55752064,NC_000010.11:94762711:C:T|NC_000010.11:94762714:T:C|NC_000010.11:94762692:G:A|NC_000010.11:94762754:T:C,Diplotype,missense variant|5 prime UTR variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762712,rs367543002,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*34,CYP2C19|LOC110599570,"P3S, F4L",CYP2C19: uncertain function,VCV000633847,10|10|10,96522469.0,10|10|10,94762712,633847,622278|622279|622277,rs367543002|rs367543003|rs367543001,NC_000010.11:94762711:C:T|NC_000010.11:94762714:T:C|NC_000010.11:94762692:G:A,Haplotype,missense variant|5 prime UTR variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762715,rs367543003,T,C,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,NM_000769.4(CYP2C19):c.10T>C (p.Phe4Leu),CYP2C19,F4L,nan,VCV000634875,10,96522472.0,10,94762715,634875,622279,rs367543003,NC_000010.11:94762714:T:C,single nucleotide variant,missense variant,no classification for the single variant,nan,no classification for the single variant,no classification for the single variant,nan,no classification for the single variant,no classification for the single variant,nan,no classification for the single variant,nan
chr10,94762755,rs55752064,T,C,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*14/*14,CYP2C19,L17P,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000638791,10,96522512.0,10,94762755,638791,622280,rs55752064,NC_000010.11:94762754:T:C,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762755,rs55752064,T,C,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*9/*14,CYP2C19,L17P,Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634426,10,96522512.0,10,94762755,634426,622280,rs55752064,NC_000010.11:94762754:T:C,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762755,rs55752064,T,C,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*14/*17,CYP2C19,L17P,Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634327,10,96522512.0,10,94762755,634327,622280,rs55752064,NC_000010.11:94762754:T:C,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762755,rs55752064,T,C,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*8/*14,CYP2C19,L17P,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634314,10,96522512.0,10,94762755,634314,622280,rs55752064,NC_000010.11:94762754:T:C,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762755,rs55752064,T,C,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*5/*14,CYP2C19,L17P,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634310,10,96522512.0,10,94762755,634310,622280,rs55752064,NC_000010.11:94762754:T:C,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762755,rs55752064,T,C,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*3/*14,CYP2C19,L17P,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634300,10,96522512.0,10,94762755,634300,622280,rs55752064,NC_000010.11:94762754:T:C,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762755,rs55752064,T,C,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*7/*14,CYP2C19,L17P,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634184,10,96522512.0,10,94762755,634184,622280,rs55752064,NC_000010.11:94762754:T:C,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762755,rs55752064,T,C,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*6/*14,CYP2C19,L17P,Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634177,10,96522512.0,10,94762755,634177,622280,rs55752064,NC_000010.11:94762754:T:C,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762755,rs55752064,T,C,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*4A/*14,CYP2C19,L17P,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634159,10,96522512.0,10,94762755,634159,622280,rs55752064,NC_000010.11:94762754:T:C,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762755,rs55752064,T,C,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*14/*23,CYP2C19,"L17P, G91R",Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634073,10|10,96522512.0,10|10,94762755,634073,622280|622285,rs55752064|rs118203756,NC_000010.11:94762754:T:C|NC_000010.11:94775159:G:C,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762755,rs55752064,T,C,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*14,CYP2C19,L17P,CYP2C19: uncertain function,VCV000634040,10,96522512.0,10,94762755,634040,622280,rs55752064,NC_000010.11:94762754:T:C,"Haplotype, single variant",missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762760,rs17882687,A,C,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*15/*15,CYP2C19,I19L,Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000638799,10,96522517.0,10,94762760,638799,622281,rs17882687,NC_000010.11:94762759:A:C,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762760,rs17882687,A,C,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*28/*28,CYP2C19|LOC110599570,"I19L, V374I",Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000638789,10|10|10|10|10,96522517.0,10|10|10|10|10,94762760,638789,622281|622272|622273|622293|622274,rs17882687|rs113164681|rs111490789|rs113934938|rs17878739,NC_000010.11:94762759:A:C|NC_000010.11:94760675:C:T|NC_000010.11:94760685:C:A|NC_000010.11:94842994:G:A|NC_000010.11:94761266:T:C,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762760,rs17882687,A,C,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*17/*28,CYP2C19|LOC110599570,"I19L, V374I",Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634427,10|10|10|10|10,96522517.0,10|10|10|10|10,94762760,634427,622281|622272|622273|622293|622274,rs17882687|rs113164681|rs111490789|rs113934938|rs17878739,NC_000010.11:94762759:A:C|NC_000010.11:94760675:C:T|NC_000010.11:94760685:C:A|NC_000010.11:94842994:G:A|NC_000010.11:94761266:T:C,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762760,rs17882687,A,C,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*28/*34,CYP2C19|LOC110599570,"I19L, V374I, P3S, F4L",Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634414,10|10|10|10|10|10|10|10,96522517.0,10|10|10|10|10|10|10|10,94762760,634414,622281|622272|622273|622293|622274|622278|622279|622277,rs17882687|rs113164681|rs111490789|rs113934938|rs17878739|rs367543002|rs367543003|rs367543001,NC_000010.11:94762759:A:C|NC_000010.11:94760675:C:T|NC_000010.11:94760685:C:A|NC_000010.11:94842994:G:A|NC_000010.11:94761266:T:C|NC_000010.11:94762711:C:T|NC_000010.11:94762714:T:C|NC_000010.11:94762692:G:A,Diplotype,missense variant|5 prime UTR variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762760,rs17882687,A,C,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*25/*28,LOC110599570|CYP2C19,"I19L, V374I, F448L",Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634375,10|10|10|10|10|10,96522517.0,10|10|10|10|10|10,94762760,634375,622281|622272|622273|622293|622274|622296,rs17882687|rs113164681|rs111490789|rs113934938|rs17878739|rs118203759,NC_000010.11:94762759:A:C|NC_000010.11:94760675:C:T|NC_000010.11:94760685:C:A|NC_000010.11:94842994:G:A|NC_000010.11:94761266:T:C|NC_000010.11:94852784:C:G,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762760,rs17882687,A,C,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*8/*15,CYP2C19,I19L,Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634367,10,96522517.0,10,94762760,634367,622281,rs17882687,NC_000010.11:94762759:A:C,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762760,rs17882687,A,C,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*5/*28,CYP2C19|LOC110599570,"I19L, V374I",Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634365,10|10|10|10|10,96522517.0,10|10|10|10|10,94762760,634365,622281|622272|622273|622293|622274,rs17882687|rs113164681|rs111490789|rs113934938|rs17878739,NC_000010.11:94762759:A:C|NC_000010.11:94760675:C:T|NC_000010.11:94760685:C:A|NC_000010.11:94842994:G:A|NC_000010.11:94761266:T:C,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762760,rs17882687,A,C,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*4A/*15,CYP2C19,I19L,Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634363,10,96522517.0,10,94762760,634363,622281,rs17882687,NC_000010.11:94762759:A:C,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762760,rs17882687,A,C,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*13/*28,LOC110599570|CYP2C19,"I19L, V374I, R410C",Escitalopram response|Voriconazole response|Citalopram response|Sertraline response,VCV000634355,10|10|10|10|10|10,96522517.0,10|10|10|10|10|10,94762760,634355,622281|622272|622273|622293|622274|622294,rs17882687|rs113164681|rs111490789|rs113934938|rs17878739|rs17879685,NC_000010.11:94762759:A:C|NC_000010.11:94760675:C:T|NC_000010.11:94760685:C:A|NC_000010.11:94842994:G:A|NC_000010.11:94761266:T:C|NC_000010.11:94849994:C:T,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762760,rs17882687,A,C,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*9/*15,CYP2C19,I19L,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634347,10,96522517.0,10,94762760,634347,622281,rs17882687,NC_000010.11:94762759:A:C,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762760,rs17882687,A,C,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*15/*23,CYP2C19,"I19L, G91R",Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634330,10|10,96522517.0,10|10,94762760,634330,622281|622285,rs17882687|rs118203756,NC_000010.11:94762759:A:C|NC_000010.11:94775159:G:C,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762760,rs17882687,A,C,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*15/*29,CYP2C19,"I19L, K28I",Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634274,10|10,96522517.0,10|10,94762760,634274,622281|622282,rs17882687|rs1564656981,NC_000010.11:94762759:A:C|NC_000010.11:94762787:A:T,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762760,rs17882687,A,C,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*14/*28,LOC110599570|CYP2C19,"I19L, V374I, L17P",Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634272,10|10|10|10|10|10,96522517.0,10|10|10|10|10|10,94762760,634272,622281|622272|622273|622293|622274|622280,rs17882687|rs113164681|rs111490789|rs113934938|rs17878739|rs55752064,NC_000010.11:94762759:A:C|NC_000010.11:94760675:C:T|NC_000010.11:94760685:C:A|NC_000010.11:94842994:G:A|NC_000010.11:94761266:T:C|NC_000010.11:94762754:T:C,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762760,rs17882687,A,C,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*19/*28,LOC110599570|CYP2C19,"I19L, V374I, S51G",Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634232,10|10|10|10|10|10,96522517.0,10|10|10|10|10|10,94762760,634232,622281|622272|622273|622293|622274|166410,rs17882687|rs113164681|rs111490789|rs113934938|rs17878739|rs1564657013,NC_000010.11:94762759:A:C|NC_000010.11:94760675:C:T|NC_000010.11:94760685:C:A|NC_000010.11:94842994:G:A|NC_000010.11:94761266:T:C|NC_000010.11:94762855:A:G,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762760,rs17882687,A,C,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*7/*15,CYP2C19,I19L,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634220,10,96522517.0,10,94762760,634220,622281,rs17882687,NC_000010.11:94762759:A:C,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762760,rs17882687,A,C,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*28/*35,LOC110599570|CYP2C19,"I19L, V374I",Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634213,10|10|10|10|10|10,96522517.0,10|10|10|10|10|10,94762760,634213,622281|622272|622273|622293|622274|622287,rs17882687|rs113164681|rs111490789|rs113934938|rs17878739|rs12769205,NC_000010.11:94762759:A:C|NC_000010.11:94760675:C:T|NC_000010.11:94760685:C:A|NC_000010.11:94842994:G:A|NC_000010.11:94761266:T:C|NC_000010.11:94775366:A:G,Diplotype,missense variant|intron variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762760,rs17882687,A,C,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*24/*28,LOC110599570|CYP2C19,"I19L, V374I, R335Q",Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634212,10|10|10|10|10|10|10,96522517.0,10|10|10|10|10|10|10,94762760,634212,622281|622272|622273|622293|622274|622292|166407,rs17882687|rs113164681|rs111490789|rs113934938|rs17878739|rs118203757|rs377184510,NC_000010.11:94762759:A:C|NC_000010.11:94760675:C:T|NC_000010.11:94760685:C:A|NC_000010.11:94842994:G:A|NC_000010.11:94761266:T:C|NC_000010.11:94842878:G:A|NC_000010.11:94849963:A:G,Diplotype,missense variant|synonymous variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762760,rs17882687,A,C,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*15/*24,CYP2C19,"I19L, R335Q",Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634210,10|10|10,96522517.0,10|10|10,94762760,634210,622281|622292|166407,rs17882687|rs118203757|rs377184510,NC_000010.11:94762759:A:C|NC_000010.11:94842878:G:A|NC_000010.11:94849963:A:G,Diplotype,missense variant|synonymous variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762760,rs17882687,A,C,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*1/*28,CYP2C19|LOC110599570,"I19L, V374I",Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634205,10|10|10|10|10|,96522517.0,10|10|10|10|10|10,94762760,634205,622281|622272|622273|622293|622274|622276,rs17882687|rs113164681|rs111490789|rs113934938|rs17878739,NC_000010.11:94762759:A:C|NC_000010.11:94760675:C:T|NC_000010.11:94760685:C:A|NC_000010.11:94842994:G:A|NC_000010.11:94761266:T:C,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762760,rs17882687,A,C,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*15/*17,CYP2C19,I19L,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634203,10,96522517.0,10,94762760,634203,622281,rs17882687,NC_000010.11:94762759:A:C,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762760,rs17882687,A,C,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*28/*31,LOC110599570|CYP2C19,"I19L, V374I, H78Y",Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634138,10|10|10|10|10|10,96522517.0,10|10|10|10|10|10,94762760,634138,622281|622272|622273|622293|622274|622284,rs17882687|rs113164681|rs111490789|rs113934938|rs17878739|rs1564660997,NC_000010.11:94762759:A:C|NC_000010.11:94760675:C:T|NC_000010.11:94760685:C:A|NC_000010.11:94842994:G:A|NC_000010.11:94761266:T:C|NC_000010.11:94775120:C:T,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762760,rs17882687,A,C,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*28/*30,LOC110599570|CYP2C19,"I19L, V374I, R73C",Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634137,10|10|10|10|10|10,96522517.0,10|10|10|10|10|10,94762760,634137,622281|622272|622273|622293|622274|622283,rs17882687|rs113164681|rs111490789|rs113934938|rs17878739|rs145328984,NC_000010.11:94762759:A:C|NC_000010.11:94760675:C:T|NC_000010.11:94760685:C:A|NC_000010.11:94842994:G:A|NC_000010.11:94761266:T:C|NC_000010.11:94775105:C:T,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762760,rs17882687,A,C,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*28/*29,LOC110599570|CYP2C19,"I19L, V374I, K28I",Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634136,10|10|10|10|10|10,96522517.0,10|10|10|10|10|10,94762760,634136,622281|622272|622273|622293|622274|622282,rs17882687|rs113164681|rs111490789|rs113934938|rs17878739|rs1564656981,NC_000010.11:94762759:A:C|NC_000010.11:94760675:C:T|NC_000010.11:94760685:C:A|NC_000010.11:94842994:G:A|NC_000010.11:94761266:T:C|NC_000010.11:94762787:A:T,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762760,rs17882687,A,C,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*27/*28,LOC110599570|CYP2C19,"I19L, V374I",Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634132,10|10|10|10|10|10,96522517.0,10|10|10|10|10|10,94762760,634132,622281|622272|622273|622293|622274|622275,rs17882687|rs113164681|rs111490789|rs113934938|rs17878739|rs7902257,NC_000010.11:94762759:A:C|NC_000010.11:94760675:C:T|NC_000010.11:94760685:C:A|NC_000010.11:94842994:G:A|NC_000010.11:94761266:T:C|NC_000010.11:94761664:G:A,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762760,rs17882687,A,C,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*23/*28,LOC110599570|CYP2C19,"I19L, V374I, G91R",Escitalopram response|Voriconazole response|Citalopram response|Sertraline response,VCV000634114,10|10|10|10|10|10,96522517.0,10|10|10|10|10|10,94762760,634114,622281|622272|622273|622293|622274|622285,rs17882687|rs113164681|rs111490789|rs113934938|rs17878739|rs118203756,NC_000010.11:94762759:A:C|NC_000010.11:94760675:C:T|NC_000010.11:94760685:C:A|NC_000010.11:94842994:G:A|NC_000010.11:94761266:T:C|NC_000010.11:94775159:G:C,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762760,rs17882687,A,C,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*14/*15,CYP2C19,"I19L, L17P",Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634071,10|10,96522517.0,10|10,94762760,634071,622281|622280,rs17882687|rs55752064,NC_000010.11:94762759:A:C|NC_000010.11:94762754:T:C,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762760,rs17882687,A,C,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*12/*28,LOC110599570|CYP2C19,"I19L, V374I",Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634060,10|10|10|10|10|10,96522517.0,10|10|10|10|10|10,94762760,634060,622281|622272|622273|622293|622274|622297,rs17882687|rs113164681|rs111490789|rs113934938|rs17878739|rs55640102,NC_000010.11:94762759:A:C|NC_000010.11:94760675:C:T|NC_000010.11:94760685:C:A|NC_000010.11:94842994:G:A|NC_000010.11:94761266:T:C|NC_000010.11:94852913:A:C,Diplotype,missense variant|stop lost,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762760,rs17882687,A,C,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*9/*28,CYP2C19|LOC110599570,"I19L, V374I",Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000633965,10|10|10|10|10,96522517.0,10|10|10|10|10,94762760,633965,622281|622272|622273|622293|622274,rs17882687|rs113164681|rs111490789|rs113934938|rs17878739,NC_000010.11:94762759:A:C|NC_000010.11:94760675:C:T|NC_000010.11:94760685:C:A|NC_000010.11:94842994:G:A|NC_000010.11:94761266:T:C,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762760,rs17882687,A,C,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*26/*28,LOC110599570|CYP2C19,"I19L, V374I, D256N",Sertraline response|Voriconazole response|Citalopram response|Escitalopram response,VCV000633958,10|10|10|10|10|10,96522517.0,10|10|10|10|10|10,94762760,633958,622281|622272|622273|622293|622274|166409,rs17882687|rs113164681|rs111490789|rs113934938|rs17878739|rs375781227,NC_000010.11:94762759:A:C|NC_000010.11:94760675:C:T|NC_000010.11:94760685:C:A|NC_000010.11:94842994:G:A|NC_000010.11:94761266:T:C|NC_000010.11:94781943:G:A,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762760,rs17882687,A,C,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*16/*28,LOC110599570|CYP2C19,"I19L, V374I, R442C",Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000633952,10|10|10|10|10|10,96522517.0,10|10|10|10|10|10,94762760,633952,622281|622272|622273|622293|622274|622295,rs17882687|rs113164681|rs111490789|rs113934938|rs17878739|rs192154563,NC_000010.11:94762759:A:C|NC_000010.11:94760675:C:T|NC_000010.11:94760685:C:A|NC_000010.11:94842994:G:A|NC_000010.11:94761266:T:C|NC_000010.11:94852764:C:T,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762760,rs17882687,A,C,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*15/*25,CYP2C19,"I19L, F448L",Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000633948,10|10,96522517.0,10|10,94762760,633948,622281|622296,rs17882687|rs118203759,NC_000010.11:94762759:A:C|NC_000010.11:94852784:C:G,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762760,rs17882687,A,C,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*15/*19,CYP2C19,"I19L, S51G",Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000633947,10|10,96522517.0,10|10,94762760,633947,622281|166410,rs17882687|rs1564657013,NC_000010.11:94762759:A:C|NC_000010.11:94762855:A:G,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762760,rs17882687,A,C,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*8/*28,CYP2C19|LOC110599570,"I19L, V374I",Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000633930,10|10|10|10|10,96522517.0,10|10|10|10|10,94762760,633930,622281|622272|622273|622293|622274,rs17882687|rs113164681|rs111490789|rs113934938|rs17878739,NC_000010.11:94762759:A:C|NC_000010.11:94760675:C:T|NC_000010.11:94760685:C:A|NC_000010.11:94842994:G:A|NC_000010.11:94761266:T:C,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762760,rs17882687,A,C,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*7/*28,CYP2C19|LOC110599570,"I19L, V374I",Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000633927,10|10|10|10|10,96522517.0,10|10|10|10|10,94762760,633927,622281|622272|622273|622293|622274,rs17882687|rs113164681|rs111490789|rs113934938|rs17878739,NC_000010.11:94762759:A:C|NC_000010.11:94760675:C:T|NC_000010.11:94760685:C:A|NC_000010.11:94842994:G:A|NC_000010.11:94761266:T:C,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762760,rs17882687,A,C,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*6/*28,CYP2C19|LOC110599570,"I19L, V374I",Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000633925,10|10|10|10|10,96522517.0,10|10|10|10|10,94762760,633925,622281|622272|622273|622293|622274,rs17882687|rs113164681|rs111490789|rs113934938|rs17878739,NC_000010.11:94762759:A:C|NC_000010.11:94760675:C:T|NC_000010.11:94760685:C:A|NC_000010.11:94842994:G:A|NC_000010.11:94761266:T:C,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762760,rs17882687,A,C,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*6/*15,CYP2C19,I19L,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000633922,10,96522517.0,10,94762760,633922,622281,rs17882687,NC_000010.11:94762759:A:C,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762760,rs17882687,A,C,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*5/*15,CYP2C19,I19L,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000633919,10,96522517.0,10,94762760,633919,622281,rs17882687,NC_000010.11:94762759:A:C,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762760,rs17882687,A,C,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*4B/*28,CYP2C19|LOC110599570,"I19L, V374I, M1V",Citalopram response|Escitalopram response|Sertraline response|Voriconazole response,VCV000633916,10|10|10|10|10|10|10,96522517.0,10|10|10|10|10|10|10,94762760,633916,622281|622272|622273|622293|622274|31939|47956,rs17882687|rs113164681|rs111490789|rs113934938|rs17878739|rs28399504|rs12248560,NC_000010.11:94762759:A:C|NC_000010.11:94760675:C:T|NC_000010.11:94760685:C:A|NC_000010.11:94842994:G:A|NC_000010.11:94761266:T:C|NC_000010.11:94762705:A:G|NC_000010.11:94761899:C:T,Diplotype,missense variant|initiator_codon_variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762760,rs17882687,A,C,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*4A/*28,CYP2C19|LOC110599570,"I19L, V374I",Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000633913,10|10|10|10|10,96522517.0,10|10|10|10|10,94762760,633913,622281|622272|622273|622293|622274,rs17882687|rs113164681|rs111490789|rs113934938|rs17878739,NC_000010.11:94762759:A:C|NC_000010.11:94760675:C:T|NC_000010.11:94760685:C:A|NC_000010.11:94842994:G:A|NC_000010.11:94761266:T:C,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762760,rs17882687,A,C,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*3/*28,CYP2C19|LOC110599570,"I19L, V374I",Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000633910,10|10|10|10|10,96522517.0,10|10|10|10|10,94762760,633910,622281|622272|622273|622293|622274,rs17882687|rs113164681|rs111490789|rs113934938|rs17878739,NC_000010.11:94762759:A:C|NC_000010.11:94760675:C:T|NC_000010.11:94760685:C:A|NC_000010.11:94842994:G:A|NC_000010.11:94761266:T:C,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762760,rs17882687,A,C,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*3/*15,CYP2C19,I19L,Voriconazole response|Escitalopram response|Sertraline response|Citalopram response,VCV000633907,10,96522517.0,10,94762760,633907,622281,rs17882687,NC_000010.11:94762759:A:C,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762760,rs17882687,A,C,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*2/*28,LOC110599570|CYP2C19,"I19L, V374I",Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000633904,10|10|10|10|10|10|10,96522517.0,10|10|10|10|10|10|10,94762760,633904,622281|622272|622273|622293|622274|31936|622287,rs17882687|rs113164681|rs111490789|rs113934938|rs17878739|rs4244285|rs12769205,NC_000010.11:94762759:A:C|NC_000010.11:94760675:C:T|NC_000010.11:94760685:C:A|NC_000010.11:94842994:G:A|NC_000010.11:94761266:T:C|NC_000010.11:94781858:G:A|NC_000010.11:94775366:A:G,Diplotype,missense variant|synonymous variant|intron variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762760,rs17882687,A,C,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*15/*28,LOC110599570|CYP2C19,"I19L, V374I, I19L",Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000633887,10|10|10|10|10|10,96522517.0,10|10|10|10|10|10,94762760,633887,622281|622272|622273|622293|622274|622281,rs17882687|rs113164681|rs111490789|rs113934938|rs17878739|rs17882687,NC_000010.11:94762759:A:C|NC_000010.11:94760675:C:T|NC_000010.11:94760685:C:A|NC_000010.11:94842994:G:A|NC_000010.11:94761266:T:C|NC_000010.11:94762759:A:C,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762760,rs17882687,A,C,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*11/*28,LOC110599570|CYP2C19,"I19L, V374I, R150H",Escitalopram response|Voriconazole response|Citalopram response|Sertraline response,VCV000633885,10|10|10|10|10|10,96522517.0,10|10|10|10|10|10,94762760,633885,622281|622272|622273|622293|622274|622288,rs17882687|rs113164681|rs111490789|rs113934938|rs17878739|rs58973490,NC_000010.11:94762759:A:C|NC_000010.11:94760675:C:T|NC_000010.11:94760685:C:A|NC_000010.11:94842994:G:A|NC_000010.11:94761266:T:C|NC_000010.11:94775506:G:A,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762760,rs17882687,A,C,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*15,CYP2C19,I19L,CYP2C19: normal function,VCV000633881,10,96522517.0,10,94762760,633881,622281,rs17882687,NC_000010.11:94762759:A:C,"Haplotype, single variant",missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762760,rs17882687,A,C,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*28,CYP2C19|LOC110599570,"I19L, V374I",CYP2C19: normal function,VCV000633844,10|10|10|10|10,96522517.0,10|10|10|10|10,94762760,633844,622281|622272|622273|622293|622274,rs17882687|rs113164681|rs111490789|rs113934938|rs17878739,NC_000010.11:94762759:A:C|NC_000010.11:94760675:C:T|NC_000010.11:94760685:C:A|NC_000010.11:94842994:G:A|NC_000010.11:94761266:T:C,Haplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762788,rs1564656981,A,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*29/*29,CYP2C19,K28I,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000638784,10,96522545.0,10,94762788,638784,622282,rs1564656981,NC_000010.11:94762787:A:T,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762788,rs1564656981,A,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*7/*29,CYP2C19,K28I,Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634423,10,96522545.0,10,94762788,634423,622282,rs1564656981,NC_000010.11:94762787:A:T,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762788,rs1564656981,A,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*14/*29,CYP2C19,"K28I, L17P",Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634400,10|10,96522545.0,10|10,94762788,634400,622282|622280,rs1564656981|rs55752064,NC_000010.11:94762787:A:T|NC_000010.11:94762754:T:C,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762788,rs1564656981,A,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*23/*29,CYP2C19,"K28I, G91R",Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634337,10|10,96522545.0,10|10,94762788,634337,622282|622285,rs1564656981|rs118203756,NC_000010.11:94762787:A:T|NC_000010.11:94775159:G:C,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762788,rs1564656981,A,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*4A/*29,CYP2C19,K28I,Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634306,10,96522545.0,10,94762788,634306,622282,rs1564656981,NC_000010.11:94762787:A:T,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762788,rs1564656981,A,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*17/*29,CYP2C19,K28I,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634278,10,96522545.0,10,94762788,634278,622282,rs1564656981,NC_000010.11:94762787:A:T,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762788,rs1564656981,A,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*9/*29,CYP2C19,K28I,Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634198,10,96522545.0,10,94762788,634198,622282,rs1564656981,NC_000010.11:94762787:A:T,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762788,rs1564656981,A,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*8/*29,CYP2C19,K28I,Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634191,10,96522545.0,10,94762788,634191,622282,rs1564656981,NC_000010.11:94762787:A:T,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762788,rs1564656981,A,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*6/*29,CYP2C19,K28I,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634180,10,96522545.0,10,94762788,634180,622282,rs1564656981,NC_000010.11:94762787:A:T,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762788,rs1564656981,A,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*5/*29,CYP2C19,K28I,Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634173,10,96522545.0,10,94762788,634173,622282,rs1564656981,NC_000010.11:94762787:A:T,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762788,rs1564656981,A,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*3/*29,CYP2C19,K28I,Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634146,10,96522545.0,10,94762788,634146,622282,rs1564656981,NC_000010.11:94762787:A:T,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762788,rs1564656981,A,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*29,CYP2C19,K28I,CYP2C19: uncertain function,VCV000634036,10,96522545.0,10,94762788,634036,622282,rs1564656981,NC_000010.11:94762787:A:T,"Haplotype, single variant",missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762856,rs1564657013,A,G,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*19/*19,CYP2C19,S51G,Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000638801,10,96522613.0,10,94762856,638801,166410,rs1564657013,NC_000010.11:94762855:A:G,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762856,rs1564657013,A,G,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*19/*23,CYP2C19,"S51G, G91R",Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634334,10|10,96522613.0,10|10,94762856,634334,166410|622285,rs1564657013|rs118203756,NC_000010.11:94762855:A:G|NC_000010.11:94775159:G:C,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762856,rs1564657013,A,G,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*19/*29,CYP2C19,"S51G, K28I",Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634282,10|10,96522613.0,10|10,94762856,634282,166410|622282,rs1564657013|rs1564656981,NC_000010.11:94762855:A:G|NC_000010.11:94762787:A:T,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762856,rs1564657013,A,G,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*14/*19,CYP2C19,"S51G, L17P",Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634269,10|10,96522613.0,10|10,94762856,634269,166410|622280,rs1564657013|rs55752064,NC_000010.11:94762855:A:G|NC_000010.11:94762754:T:C,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762856,rs1564657013,A,G,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*5/*19,CYP2C19,S51G,Sertraline response|Voriconazole response|Citalopram response|Escitalopram response,VCV000634243,10,96522613.0,10,94762856,634243,166410,rs1564657013,NC_000010.11:94762855:A:G,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762856,rs1564657013,A,G,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*8/*19,CYP2C19,S51G,Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634001,10,96522613.0,10,94762856,634001,166410,rs1564657013,NC_000010.11:94762855:A:G,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762856,rs1564657013,A,G,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*7/*19,CYP2C19,S51G,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000633998,10,96522613.0,10,94762856,633998,166410,rs1564657013,NC_000010.11:94762855:A:G,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762856,rs1564657013,A,G,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*6/*19,CYP2C19,S51G,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000633995,10,96522613.0,10,94762856,633995,166410,rs1564657013,NC_000010.11:94762855:A:G,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762856,rs1564657013,A,G,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*4A/*19,CYP2C19,S51G,Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000633983,10,96522613.0,10,94762856,633983,166410,rs1564657013,NC_000010.11:94762855:A:G,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762856,rs1564657013,A,G,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*3/*19,CYP2C19,S51G,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000633980,10,96522613.0,10,94762856,633980,166410,rs1564657013,NC_000010.11:94762855:A:G,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762856,rs1564657013,A,G,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*9/*19,CYP2C19,S51G,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000633962,10,96522613.0,10,94762856,633962,166410,rs1564657013,NC_000010.11:94762855:A:G,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762856,rs1564657013,A,G,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*19/*25,CYP2C19,"S51G, F448L",Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000633956,10|10,96522613.0,10|10,94762856,633956,166410|622296,rs1564657013|rs118203759,NC_000010.11:94762855:A:G|NC_000010.11:94852784:C:G,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762856,rs1564657013,A,G,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*17/*19,CYP2C19,S51G,Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000633953,10,96522613.0,10,94762856,633953,166410,rs1564657013,NC_000010.11:94762855:A:G,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94762856,rs1564657013,A,G,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*19,CYP2C19,S51G,CYP2C19: decreased function,VCV000633933,10,96522613.0,10,94762856,633933,166410,rs1564657013,NC_000010.11:94762855:A:G,"Haplotype, single variant",missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775106,rs145328984,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*30/*30,CYP2C19,R73C,Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000638803,10,96534863.0,10,94775106,638803,622283,rs145328984,NC_000010.11:94775105:C:T,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775106,rs145328984,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*7/*30,CYP2C19,R73C,Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634424,10,96534863.0,10,94775106,634424,622283,rs145328984,NC_000010.11:94775105:C:T,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775106,rs145328984,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*24/*30,CYP2C19,"R73C, R335Q",Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634409,10|10|10,96534863.0,10|10|10,94775106,634409,622283|622292|166407,rs145328984|rs118203757|rs377184510,NC_000010.11:94775105:C:T|NC_000010.11:94842878:G:A|NC_000010.11:94849963:A:G,Diplotype,missense variant|synonymous variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775106,rs145328984,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*14/*30,CYP2C19,"R73C, L17P",Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634401,10|10,96534863.0,10|10,94775106,634401,622283|622280,rs145328984|rs55752064,NC_000010.11:94775105:C:T|NC_000010.11:94762754:T:C,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775106,rs145328984,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*30/*35,CYP2C19,R73C,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634341,10|10,96534863.0,10|10,94775106,634341,622283|622287,rs145328984|rs12769205,NC_000010.11:94775105:C:T|NC_000010.11:94775366:A:G,Diplotype,missense variant|intron variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775106,rs145328984,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*25/*30,CYP2C19,"R73C, F448L",Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634338,10|10,96534863.0,10|10,94775106,634338,622283|622296,rs145328984|rs118203759,NC_000010.11:94775105:C:T|NC_000010.11:94852784:C:G,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775106,rs145328984,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*6/*30,CYP2C19,R73C,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634311,10,96534863.0,10,94775106,634311,622283,rs145328984,NC_000010.11:94775105:C:T,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775106,rs145328984,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*4A/*30,CYP2C19,R73C,Sertraline response|Voriconazole response|Citalopram response|Escitalopram response,VCV000634307,10,96534863.0,10,94775106,634307,622283,rs145328984,NC_000010.11:94775105:C:T,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775106,rs145328984,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*23/*30,CYP2C19,"R73C, G91R",Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634289,10|10,96534863.0,10|10,94775106,634289,622283|622285,rs145328984|rs118203756,NC_000010.11:94775105:C:T|NC_000010.11:94775159:G:C,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775106,rs145328984,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*9/*30,CYP2C19,R73C,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634199,10,96534863.0,10,94775106,634199,622283,rs145328984,NC_000010.11:94775105:C:T,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775106,rs145328984,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*8/*30,CYP2C19,R73C,Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634192,10,96534863.0,10,94775106,634192,622283,rs145328984,NC_000010.11:94775105:C:T,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775106,rs145328984,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*5/*30,CYP2C19,R73C,Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634174,10,96534863.0,10,94775106,634174,622283,rs145328984,NC_000010.11:94775105:C:T,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775106,rs145328984,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*4B/*30,CYP2C19|LOC110599570,"R73C, M1V",Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634167,10|10|10,96534863.0,10|10|10,94775106,634167,622283|31939|47956,rs145328984|rs28399504|rs12248560,NC_000010.11:94775105:C:T|NC_000010.11:94762705:A:G|NC_000010.11:94761899:C:T,Diplotype,missense variant|initiator_codon_variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775106,rs145328984,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*30/*31,CYP2C19,"R73C, H78Y",Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634149,10|10,96534863.0,10|10,94775106,634149,622283|622284,rs145328984|rs1564660997,NC_000010.11:94775105:C:T|NC_000010.11:94775120:C:T,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775106,rs145328984,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*3/*30,CYP2C19,R73C,Sertraline response|Voriconazole response|Citalopram response|Escitalopram response,VCV000634147,10,96534863.0,10,94775106,634147,622283,rs145328984,NC_000010.11:94775105:C:T,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775106,rs145328984,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*29/*30,CYP2C19,"R73C, K28I",Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634139,10|10,96534863.0,10|10,94775106,634139,622283|622282,rs145328984|rs1564656981,NC_000010.11:94775105:C:T|NC_000010.11:94762787:A:T,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775106,rs145328984,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*27/*30,LOC110599570|CYP2C19,R73C,Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634134,10|10,96534863.0,10|10,94775106,634134,622283|622275,rs145328984|rs7902257,NC_000010.11:94775105:C:T|NC_000010.11:94761664:G:A,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775106,rs145328984,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*26/*30,CYP2C19,"R73C, D256N",Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634130,10|10,96534863.0,10|10,94775106,634130,622283|166409,rs145328984|rs375781227,NC_000010.11:94775105:C:T|NC_000010.11:94781943:G:A,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775106,rs145328984,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*2/*30,CYP2C19,R73C,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634104,10|10|10,96534863.0,10|10|10,94775106,634104,622283|31936|622287,rs145328984|rs4244285|rs12769205,NC_000010.11:94775105:C:T|NC_000010.11:94781858:G:A|NC_000010.11:94775366:A:G,Diplotype,missense variant|synonymous variant|intron variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775106,rs145328984,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*19/*30,CYP2C19,"R73C, S51G",Escitalopram response|Voriconazole response|Citalopram response|Sertraline response,VCV000634098,10|10,96534863.0,10|10,94775106,634098,622283|166410,rs145328984|rs1564657013,NC_000010.11:94775105:C:T|NC_000010.11:94762855:A:G,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775106,rs145328984,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*17/*30,CYP2C19,R73C,Sertraline response|Voriconazole response|Citalopram response|Escitalopram response,VCV000634089,10,96534863.0,10,94775106,634089,622283,rs145328984,NC_000010.11:94775105:C:T,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775106,rs145328984,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*16/*30,CYP2C19,"R73C, R442C",Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634085,10|10,96534863.0,10|10,94775106,634085,622283|622295,rs145328984|rs192154563,NC_000010.11:94775105:C:T|NC_000010.11:94852764:C:T,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775106,rs145328984,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*15/*30,CYP2C19,"R73C, I19L",Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634081,10|10,96534863.0,10|10,94775106,634081,622283|622281,rs145328984|rs17882687,NC_000010.11:94775105:C:T|NC_000010.11:94762759:A:C,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775106,rs145328984,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*12/*30,CYP2C19,R73C,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634062,10|10,96534863.0,10|10,94775106,634062,622283|622297,rs145328984|rs55640102,NC_000010.11:94775105:C:T|NC_000010.11:94852913:A:C,Diplotype,missense variant|stop lost,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775106,rs145328984,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*1/*30,CYP2C19|LOC110599570,R73C,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634038,10|,96534863.0,10|10,94775106,634038,622283|622276,rs145328984,NC_000010.11:94775105:C:T,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775106,rs145328984,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*30,CYP2C19,R73C,CYP2C19: uncertain function,VCV000633848,10,96534863.0,10,94775106,633848,622283,rs145328984,NC_000010.11:94775105:C:T,"Haplotype, single variant",missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775121,rs1564660997,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*31/*31,CYP2C19,H78Y,Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000638804,10,96534878.0,10,94775121,638804,622284,rs1564660997,NC_000010.11:94775120:C:T,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775121,rs1564660997,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*24/*31,CYP2C19,"H78Y, R335Q",Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634410,10|10|10,96534878.0,10|10|10,94775121,634410,622284|622292|166407,rs1564660997|rs118203757|rs377184510,NC_000010.11:94775120:C:T|NC_000010.11:94842878:G:A|NC_000010.11:94849963:A:G,Diplotype,missense variant|synonymous variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775121,rs1564660997,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*6/*31,CYP2C19,H78Y,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634312,10,96534878.0,10,94775121,634312,622284,rs1564660997,NC_000010.11:94775120:C:T,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775121,rs1564660997,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*26/*31,CYP2C19,"H78Y, D256N",Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634294,10|10,96534878.0,10|10,94775121,634294,622284|166409,rs1564660997|rs375781227,NC_000010.11:94775120:C:T|NC_000010.11:94781943:G:A,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775121,rs1564660997,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*25/*31,CYP2C19,"H78Y, F448L",Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634292,10|10,96534878.0,10|10,94775121,634292,622284|622296,rs1564660997|rs118203759,NC_000010.11:94775120:C:T|NC_000010.11:94852784:C:G,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775121,rs1564660997,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*23/*31,CYP2C19,"H78Y, G91R",Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634290,10|10,96534878.0,10|10,94775121,634290,622284|622285,rs1564660997|rs118203756,NC_000010.11:94775120:C:T|NC_000010.11:94775159:G:C,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775121,rs1564660997,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*9/*31,CYP2C19,H78Y,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634200,10,96534878.0,10,94775121,634200,622284,rs1564660997,NC_000010.11:94775120:C:T,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775121,rs1564660997,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*8/*31,CYP2C19,H78Y,Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634193,10,96534878.0,10,94775121,634193,622284,rs1564660997,NC_000010.11:94775120:C:T,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775121,rs1564660997,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*7/*31,CYP2C19,H78Y,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634186,10,96534878.0,10,94775121,634186,622284,rs1564660997,NC_000010.11:94775120:C:T,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775121,rs1564660997,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*5/*31,CYP2C19,H78Y,Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634175,10,96534878.0,10,94775121,634175,622284,rs1564660997,NC_000010.11:94775120:C:T,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775121,rs1564660997,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*4B/*31,CYP2C19|LOC110599570,"H78Y, M1V",Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634168,10|10|10,96534878.0,10|10|10,94775121,634168,622284|31939|47956,rs1564660997|rs28399504|rs12248560,NC_000010.11:94775120:C:T|NC_000010.11:94762705:A:G|NC_000010.11:94761899:C:T,Diplotype,missense variant|initiator_codon_variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775121,rs1564660997,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*4A/*31,CYP2C19,H78Y,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634161,10,96534878.0,10,94775121,634161,622284,rs1564660997,NC_000010.11:94775120:C:T,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775121,rs1564660997,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*3/*31,CYP2C19,H78Y,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634148,10,96534878.0,10,94775121,634148,622284,rs1564660997,NC_000010.11:94775120:C:T,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775121,rs1564660997,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*29/*31,CYP2C19,"H78Y, K28I",Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634140,10|10,96534878.0,10|10,94775121,634140,622284|622282,rs1564660997|rs1564656981,NC_000010.11:94775120:C:T|NC_000010.11:94762787:A:T,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775121,rs1564660997,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*2/*31,CYP2C19,H78Y,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634105,10|10|10,96534878.0,10|10|10,94775121,634105,622284|31936|622287,rs1564660997|rs4244285|rs12769205,NC_000010.11:94775120:C:T|NC_000010.11:94781858:G:A|NC_000010.11:94775366:A:G,Diplotype,missense variant|synonymous variant|intron variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775121,rs1564660997,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*19/*31,CYP2C19,"H78Y, S51G",Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634099,10|10,96534878.0,10|10,94775121,634099,622284|166410,rs1564660997|rs1564657013,NC_000010.11:94775120:C:T|NC_000010.11:94762855:A:G,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775121,rs1564660997,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*17/*31,CYP2C19,H78Y,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634090,10,96534878.0,10,94775121,634090,622284,rs1564660997,NC_000010.11:94775120:C:T,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775121,rs1564660997,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*15/*31,CYP2C19,"H78Y, I19L",Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634082,10|10,96534878.0,10|10,94775121,634082,622284|622281,rs1564660997|rs17882687,NC_000010.11:94775120:C:T|NC_000010.11:94762759:A:C,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775121,rs1564660997,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*14/*31,CYP2C19,"H78Y, L17P",Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634077,10|10,96534878.0,10|10,94775121,634077,622284|622280,rs1564660997|rs55752064,NC_000010.11:94775120:C:T|NC_000010.11:94762754:T:C,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775121,rs1564660997,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*12/*31,CYP2C19,H78Y,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634063,10|10,96534878.0,10|10,94775121,634063,622284|622297,rs1564660997|rs55640102,NC_000010.11:94775120:C:T|NC_000010.11:94852913:A:C,Diplotype,missense variant|stop lost,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775121,rs1564660997,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*1/*31,CYP2C19|LOC110599570,H78Y,Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634039,10|,96534878.0,10|10,94775121,634039,622284|622276,rs1564660997,NC_000010.11:94775120:C:T,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775121,rs1564660997,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*31,CYP2C19,H78Y,CYP2C19: uncertain function,VCV000633852,10,96534878.0,10,94775121,633852,622284,rs1564660997,NC_000010.11:94775120:C:T,"Haplotype, single variant",missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775160,rs118203756,G,C,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*23/*23,CYP2C19,G91R,Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000638805,10,96534917.0,10,94775160,638805,622285,rs118203756,NC_000010.11:94775159:G:C,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775160,rs118203756,G,C,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*17/*23,CYP2C19,G91R,Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634332,10,96534917.0,10,94775160,634332,622285,rs118203756,NC_000010.11:94775159:G:C,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775160,rs118203756,G,C,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*8/*23,CYP2C19,G91R,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634315,10,96534917.0,10,94775160,634315,622285,rs118203756,NC_000010.11:94775159:G:C,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775160,rs118203756,G,C,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*9/*23,CYP2C19,G91R,Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634196,10,96534917.0,10,94775160,634196,622285,rs118203756,NC_000010.11:94775159:G:C,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775160,rs118203756,G,C,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*7/*23,CYP2C19,G91R,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634185,10,96534917.0,10,94775160,634185,622285,rs118203756,NC_000010.11:94775159:G:C,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775160,rs118203756,G,C,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*6/*23,CYP2C19,G91R,Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634178,10,96534917.0,10,94775160,634178,622285,rs118203756,NC_000010.11:94775159:G:C,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775160,rs118203756,G,C,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*5/*23,CYP2C19,G91R,Escitalopram response|Voriconazole response|Citalopram response|Sertraline response,VCV000634171,10,96534917.0,10,94775160,634171,622285,rs118203756,NC_000010.11:94775159:G:C,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775160,rs118203756,G,C,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*4A/*23,CYP2C19,G91R,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634160,10,96534917.0,10,94775160,634160,622285,rs118203756,NC_000010.11:94775159:G:C,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775160,rs118203756,G,C,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*3/*23,CYP2C19,G91R,Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634144,10,96534917.0,10,94775160,634144,622285,rs118203756,NC_000010.11:94775159:G:C,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775160,rs118203756,G,C,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*23,CYP2C19,G91R,CYP2C19: uncertain function,VCV000634042,10,96534917.0,10,94775160,634042,622285,rs118203756,NC_000010.11:94775159:G:C,"Haplotype, single variant",missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775185,rs1288601658,A,G,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*32/*32,CYP2C19,H99R,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000638788,10,96534942.0,10,94775185,638788,622286,rs1288601658,NC_000010.11:94775184:A:G,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775185,rs1288601658,A,G,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*26/*32,CYP2C19,"H99R, D256N",Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634411,10|10,96534942.0,10|10,94775185,634411,622286|166409,rs1288601658|rs375781227,NC_000010.11:94775184:A:G|NC_000010.11:94781943:G:A,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775185,rs1288601658,A,G,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*13/*32,CYP2C19,"H99R, R410C",Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634399,10|10,96534942.0,10|10,94775185,634399,622286|622294,rs1288601658|rs17879685,NC_000010.11:94775184:A:G|NC_000010.11:94849994:C:T,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775185,rs1288601658,A,G,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*5/*32,CYP2C19,H99R,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634343,10,96534942.0,10,94775185,634343,622286,rs1288601658,NC_000010.11:94775184:A:G,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775185,rs1288601658,A,G,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*2/*32,CYP2C19,H99R,Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634335,10|10|10,96534942.0,10|10|10,94775185,634335,622286|31936|622287,rs1288601658|rs4244285|rs12769205,NC_000010.11:94775184:A:G|NC_000010.11:94781858:G:A|NC_000010.11:94775366:A:G,Diplotype,missense variant|synonymous variant|intron variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775185,rs1288601658,A,G,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*12/*32,CYP2C19,H99R,Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634325,10|10,96534942.0,10|10,94775185,634325,622286|622297,rs1288601658|rs55640102,NC_000010.11:94775184:A:G|NC_000010.11:94852913:A:C,Diplotype,missense variant|stop lost,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775185,rs1288601658,A,G,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*9/*32,CYP2C19,H99R,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634317,10,96534942.0,10,94775185,634317,622286,rs1288601658,NC_000010.11:94775184:A:G,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775185,rs1288601658,A,G,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*6/*32,CYP2C19,H99R,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634313,10,96534942.0,10,94775185,634313,622286,rs1288601658,NC_000010.11:94775184:A:G,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775185,rs1288601658,A,G,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*32/*35,CYP2C19,H99R,Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634304,10|10,96534942.0,10|10,94775185,634304,622286|622287,rs1288601658|rs12769205,NC_000010.11:94775184:A:G|NC_000010.11:94775366:A:G,Diplotype,missense variant|intron variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775185,rs1288601658,A,G,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*31/*32,CYP2C19,"H99R, H78Y",Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634302,10|10,96534942.0,10|10,94775185,634302,622286|622284,rs1288601658|rs1564660997,NC_000010.11:94775184:A:G|NC_000010.11:94775120:C:T,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775185,rs1288601658,A,G,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*3/*32,CYP2C19,H99R,Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634301,10,96534942.0,10,94775185,634301,622286,rs1288601658,NC_000010.11:94775184:A:G,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775185,rs1288601658,A,G,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*28/*32,CYP2C19|LOC110599570,"H99R, I19L, V374I",Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634298,10|10|10|10|10|10,96534942.0,10|10|10|10|10|10,94775185,634298,622286|622281|622272|622273|622293|622274,rs1288601658|rs17882687|rs113164681|rs111490789|rs113934938|rs17878739,NC_000010.11:94775184:A:G|NC_000010.11:94762759:A:C|NC_000010.11:94760675:C:T|NC_000010.11:94760685:C:A|NC_000010.11:94842994:G:A|NC_000010.11:94761266:T:C,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775185,rs1288601658,A,G,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*27/*32,LOC110599570|CYP2C19,H99R,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634295,10|10,96534942.0,10|10,94775185,634295,622286|622275,rs1288601658|rs7902257,NC_000010.11:94775184:A:G|NC_000010.11:94761664:G:A,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775185,rs1288601658,A,G,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*25/*32,CYP2C19,"H99R, F448L",Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634293,10|10,96534942.0,10|10,94775185,634293,622286|622296,rs1288601658|rs118203759,NC_000010.11:94775184:A:G|NC_000010.11:94852784:C:G,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775185,rs1288601658,A,G,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*22/*32,CYP2C19,"H99R, R186P",Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634287,10|10,96534942.0,10|10,94775185,634287,622286|622289,rs1288601658|rs140278421,NC_000010.11:94775184:A:G|NC_000010.11:94780573:G:C,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775185,rs1288601658,A,G,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*1/*32,CYP2C19|LOC110599570,H99R,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634257,10|,96534942.0,10|10,94775185,634257,622286|622276,rs1288601658,NC_000010.11:94775184:A:G,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775185,rs1288601658,A,G,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*8/*32,CYP2C19,H99R,Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634194,10,96534942.0,10,94775185,634194,622286,rs1288601658,NC_000010.11:94775184:A:G,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775185,rs1288601658,A,G,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*7/*32,CYP2C19,H99R,Escitalopram response|Voriconazole response|Citalopram response|Sertraline response,VCV000634187,10,96534942.0,10,94775185,634187,622286,rs1288601658,NC_000010.11:94775184:A:G,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775185,rs1288601658,A,G,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*4B/*32,CYP2C19|LOC110599570,"H99R, M1V",Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634169,10|10|10,96534942.0,10|10|10,94775185,634169,622286|31939|47956,rs1288601658|rs28399504|rs12248560,NC_000010.11:94775184:A:G|NC_000010.11:94762705:A:G|NC_000010.11:94761899:C:T,Diplotype,missense variant|initiator_codon_variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775185,rs1288601658,A,G,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*4A/*32,CYP2C19,H99R,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634162,10,96534942.0,10,94775185,634162,622286,rs1288601658,NC_000010.11:94775184:A:G,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775185,rs1288601658,A,G,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*32/*34,CYP2C19|LOC110599570,"H99R, P3S, F4L",Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634156,10|10|10|10,96534942.0,10|10|10|10,94775185,634156,622286|622278|622279|622277,rs1288601658|rs367543002|rs367543003|rs367543001,NC_000010.11:94775184:A:G|NC_000010.11:94762711:C:T|NC_000010.11:94762714:T:C|NC_000010.11:94762692:G:A,Diplotype,missense variant|5 prime UTR variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775185,rs1288601658,A,G,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*30/*32,CYP2C19,"H99R, R73C",Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634150,10|10,96534942.0,10|10,94775185,634150,622286|622283,rs1288601658|rs145328984,NC_000010.11:94775184:A:G|NC_000010.11:94775105:C:T,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775185,rs1288601658,A,G,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*29/*32,CYP2C19,"H99R, K28I",Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634141,10|10,96534942.0,10|10,94775185,634141,622286|622282,rs1288601658|rs1564656981,NC_000010.11:94775184:A:G|NC_000010.11:94762787:A:T,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775185,rs1288601658,A,G,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*24/*32,CYP2C19,"H99R, R335Q",Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634121,10|10|10,96534942.0,10|10|10,94775185,634121,622286|622292|166407,rs1288601658|rs118203757|rs377184510,NC_000010.11:94775184:A:G|NC_000010.11:94842878:G:A|NC_000010.11:94849963:A:G,Diplotype,missense variant|synonymous variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775185,rs1288601658,A,G,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*23/*32,CYP2C19,"H99R, G91R",Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634115,10|10,96534942.0,10|10,94775185,634115,622286|622285,rs1288601658|rs118203756,NC_000010.11:94775184:A:G|NC_000010.11:94775159:G:C,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775185,rs1288601658,A,G,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*19/*32,CYP2C19,"H99R, S51G",Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634100,10|10,96534942.0,10|10,94775185,634100,622286|166410,rs1288601658|rs1564657013,NC_000010.11:94775184:A:G|NC_000010.11:94762855:A:G,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775185,rs1288601658,A,G,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*18/*32,CYP2C19,"H99R, R329H",Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634095,10|10,96534942.0,10|10,94775185,634095,622286|622291,rs1288601658|rs138142612,NC_000010.11:94775184:A:G|NC_000010.11:94842860:G:A,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775185,rs1288601658,A,G,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*17/*32,CYP2C19,H99R,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634091,10,96534942.0,10,94775185,634091,622286,rs1288601658,NC_000010.11:94775184:A:G,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775185,rs1288601658,A,G,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*16/*32,CYP2C19,"H99R, R442C",Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634087,10|10,96534942.0,10|10,94775185,634087,622286|622295,rs1288601658|rs192154563,NC_000010.11:94775184:A:G|NC_000010.11:94852764:C:T,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775185,rs1288601658,A,G,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*15/*32,CYP2C19,"H99R, I19L",Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634083,10|10,96534942.0,10|10,94775185,634083,622286|622281,rs1288601658|rs17882687,NC_000010.11:94775184:A:G|NC_000010.11:94762759:A:C,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775185,rs1288601658,A,G,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*14/*32,CYP2C19,"H99R, L17P",Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634078,10|10,96534942.0,10|10,94775185,634078,622286|622280,rs1288601658|rs55752064,NC_000010.11:94775184:A:G|NC_000010.11:94762754:T:C,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775185,rs1288601658,A,G,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*11/*32,CYP2C19,"H99R, R150H",Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634050,10|10,96534942.0,10|10,94775185,634050,622286|622288,rs1288601658|rs58973490,NC_000010.11:94775184:A:G|NC_000010.11:94775506:G:A,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775185,rs1288601658,A,G,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*32,CYP2C19,H99R,CYP2C19: uncertain function,VCV000633841,10,96534942.0,10,94775185,633841,622286,rs1288601658,NC_000010.11:94775184:A:G,"Haplotype, single variant",missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775367,rs12769205,A,G,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*35/*35,CYP2C19,nan,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000638786,10,96535124.0,10,94775367,638786,622287,rs12769205,NC_000010.11:94775366:A:G,Diplotype,intron variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775367,rs12769205,A,G,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*24/*35,CYP2C19,R335Q,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634390,10|10|10,96535124.0,10|10|10,94775367,634390,622287|622292|166407,rs12769205|rs118203757|rs377184510,NC_000010.11:94775366:A:G|NC_000010.11:94842878:G:A|NC_000010.11:94849963:A:G,Diplotype,intron variant|missense variant|synonymous variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775367,rs12769205,A,G,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*9/*35,CYP2C19,nan,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634389,10,96535124.0,10,94775367,634389,622287,rs12769205,NC_000010.11:94775366:A:G,Diplotype,intron variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775367,rs12769205,A,G,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*29/*35,CYP2C19,K28I,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634340,10|10,96535124.0,10|10,94775367,634340,622287|622282,rs12769205|rs1564656981,NC_000010.11:94775366:A:G|NC_000010.11:94762787:A:T,Diplotype,intron variant|missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775367,rs12769205,A,G,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*14/*35,CYP2C19,L17P,Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634329,10|10,96535124.0,10|10,94775367,634329,622287|622280,rs12769205|rs55752064,NC_000010.11:94775366:A:G|NC_000010.11:94762754:T:C,Diplotype,intron variant|missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775367,rs12769205,A,G,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*7/*35,CYP2C19,nan,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634254,10,96535124.0,10,94775367,634254,622287,rs12769205,NC_000010.11:94775366:A:G,Diplotype,intron variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775367,rs12769205,A,G,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*19/*35,CYP2C19,S51G,Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634236,10|10,96535124.0,10|10,94775367,634236,622287|166410,rs12769205|rs1564657013,NC_000010.11:94775366:A:G|NC_000010.11:94762855:A:G,Diplotype,intron variant|missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775367,rs12769205,A,G,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*15/*35,CYP2C19,I19L,Sertraline response|Voriconazole response|Citalopram response|Escitalopram response,VCV000634211,10|10,96535124.0,10|10,94775367,634211,622287|622281,rs12769205|rs17882687,NC_000010.11:94775366:A:G|NC_000010.11:94762759:A:C,Diplotype,intron variant|missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775367,rs12769205,A,G,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*31/*35,CYP2C19,H78Y,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634154,10|10,96535124.0,10|10,94775367,634154,622287|622284,rs12769205|rs1564660997,NC_000010.11:94775366:A:G|NC_000010.11:94775120:C:T,Diplotype,intron variant|missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775367,rs12769205,A,G,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*27/*35,LOC110599570|CYP2C19,nan,Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634135,10|10,96535124.0,10|10,94775367,634135,622287|622275,rs12769205|rs7902257,NC_000010.11:94775366:A:G|NC_000010.11:94761664:G:A,Diplotype,intron variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775367,rs12769205,A,G,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*23/*35,CYP2C19,G91R,Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634119,10|10,96535124.0,10|10,94775367,634119,622287|622285,rs12769205|rs118203756,NC_000010.11:94775366:A:G|NC_000010.11:94775159:G:C,Diplotype,intron variant|missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775367,rs12769205,A,G,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*12/*35,CYP2C19,nan,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634064,10|10,96535124.0,10|10,94775367,634064,622287|622297,rs12769205|rs55640102,NC_000010.11:94775366:A:G|NC_000010.11:94852913:A:C,Diplotype,intron variant|stop lost,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775367,rs12769205,A,G,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*8/*35,CYP2C19,nan,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634034,10,96535124.0,10,94775367,634034,622287,rs12769205,NC_000010.11:94775366:A:G,Diplotype,intron variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775367,rs12769205,A,G,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*6/*35,CYP2C19,nan,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634028,10,96535124.0,10,94775367,634028,622287,rs12769205,NC_000010.11:94775366:A:G,Diplotype,intron variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775367,rs12769205,A,G,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*5/*35,CYP2C19,nan,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634026,10,96535124.0,10,94775367,634026,622287,rs12769205,NC_000010.11:94775366:A:G,Diplotype,intron variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775367,rs12769205,A,G,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*4B/*35,CYP2C19|LOC110599570,M1V,Sertraline response|Voriconazole response|Citalopram response|Escitalopram response,VCV000634022,10|10|10,96535124.0,10|10|10,94775367,634022,622287|31939|47956,rs12769205|rs28399504|rs12248560,NC_000010.11:94775366:A:G|NC_000010.11:94762705:A:G|NC_000010.11:94761899:C:T,Diplotype,intron variant|missense variant|initiator_codon_variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775367,rs12769205,A,G,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*4A/*35,CYP2C19,nan,Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634019,10,96535124.0,10,94775367,634019,622287,rs12769205,NC_000010.11:94775366:A:G,Diplotype,intron variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775367,rs12769205,A,G,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*3/*35,CYP2C19,nan,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634013,10,96535124.0,10,94775367,634013,622287,rs12769205,NC_000010.11:94775366:A:G,Diplotype,intron variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775367,rs12769205,A,G,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*2/*35,CYP2C19,nan,Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634008,10|10|10,96535124.0,10|10|10,94775367,634008,622287|31936|622287,rs12769205|rs4244285|rs12769205,NC_000010.11:94775366:A:G|NC_000010.11:94781858:G:A|NC_000010.11:94775366:A:G,Diplotype,intron variant|synonymous variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775367,rs12769205,A,G,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*26/*35,CYP2C19,D256N,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000633977,10|10,96535124.0,10|10,94775367,633977,622287|166409,rs12769205|rs375781227,NC_000010.11:94775366:A:G|NC_000010.11:94781943:G:A,Diplotype,intron variant|missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775367,rs12769205,A,G,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*25/*35,CYP2C19,F448L,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000633976,10|10,96535124.0,10|10,94775367,633976,622287|622296,rs12769205|rs118203759,NC_000010.11:94775366:A:G|NC_000010.11:94852784:C:G,Diplotype,intron variant|missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775367,rs12769205,A,G,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*17/*35,CYP2C19,nan,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000633898,10,96535124.0,10,94775367,633898,622287,rs12769205,NC_000010.11:94775366:A:G,Diplotype,intron variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775367,rs12769205,A,G,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*1/*35,CYP2C19|LOC110599570,nan,Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000633889,10|,96535124.0,10|10,94775367,633889,622287|622276,rs12769205,NC_000010.11:94775366:A:G,Diplotype,intron variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775367,rs12769205,A,G,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*35,CYP2C19,nan,CYP2C19: no function,VCV000633850,10,96535124.0,10,94775367,633850,622287,rs12769205,NC_000010.11:94775366:A:G,"Haplotype, single variant",intron variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775416,rs41291556,T,C,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,NM_000769.1(CYP2C19):c.358T>C (p.Trp120Arg),CYP2C19,W120R,CYP2C19: no function,VCV000039351,10,96535173.0,10,94775416,39351,47949,rs41291556,NC_000010.11:94775415:T:C,single nucleotide variant,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775423,rs17885179,A,C,.,PASS,PX=CYP2C19,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr10,94775453,rs72552267,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,NM_000769.1(CYP2C19):c.395G>A (p.Arg132Gln),CYP2C19,R132Q,CYP2C19: no function,VCV000039350,10,96535210.0,10,94775453,39350,47948,rs72552267,NC_000010.11:94775452:G:A,single nucleotide variant,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775489,rs17884712,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,NM_000769.1(CYP2C19):c.431G>A (p.Arg144His),CYP2C19,R144H,CYP2C19: decreased function,VCV000039352,10,96535246.0,10,94775489,39352,47950,rs17884712,NC_000010.11:94775488:G:A,single nucleotide variant,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775507,rs58973490,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*11/*11,CYP2C19,R150H,Escitalopram response|Voriconazole response|Sertraline response|Citalopram response,VCV000638795,10,96535264.0,10,94775507,638795,622288,rs58973490,NC_000010.11:94775506:G:A,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775507,rs58973490,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*11/*31,CYP2C19,"R150H, H78Y",Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634397,10|10,96535264.0,10|10,94775507,634397,622288|622284,rs58973490|rs1564660997,NC_000010.11:94775506:G:A|NC_000010.11:94775120:C:T,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775507,rs58973490,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*11/*30,CYP2C19,"R150H, R73C",Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634396,10|10,96535264.0,10|10,94775507,634396,622288|622283,rs58973490|rs145328984,NC_000010.11:94775506:G:A|NC_000010.11:94775105:C:T,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775507,rs58973490,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*6/*11,CYP2C19,R150H,Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634366,10,96535264.0,10,94775507,634366,622288,rs58973490,NC_000010.11:94775506:G:A,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775507,rs58973490,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*4A/*11,CYP2C19,R150H,Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634361,10,96535264.0,10,94775507,634361,622288,rs58973490,NC_000010.11:94775506:G:A,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775507,rs58973490,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*2/*11,CYP2C19,R150H,Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634359,10|10|10,96535264.0,10|10|10,94775507,634359,622288|31936|622287,rs58973490|rs4244285|rs12769205,NC_000010.11:94775506:G:A|NC_000010.11:94781858:G:A|NC_000010.11:94775366:A:G,Diplotype,missense variant|synonymous variant|intron variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775507,rs58973490,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*11/*26,CYP2C19,"R150H, D256N",Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634346,10|10,96535264.0,10|10,94775507,634346,622288|166409,rs58973490|rs375781227,NC_000010.11:94775506:G:A|NC_000010.11:94781943:G:A,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775507,rs58973490,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*11/*29,CYP2C19,"R150H, K28I",Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634262,10|10,96535264.0,10|10,94775507,634262,622288|622282,rs58973490|rs1564656981,NC_000010.11:94775506:G:A|NC_000010.11:94762787:A:T,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775507,rs58973490,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*11/*27,LOC110599570|CYP2C19,R150H,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634261,10|10,96535264.0,10|10,94775507,634261,622288|622275,rs58973490|rs7902257,NC_000010.11:94775506:G:A|NC_000010.11:94761664:G:A,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775507,rs58973490,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*7/*11,CYP2C19,R150H,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634218,10,96535264.0,10,94775507,634218,622288,rs58973490,NC_000010.11:94775506:G:A,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775507,rs58973490,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*3/*11,CYP2C19,R150H,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634214,10,96535264.0,10,94775507,634214,622288,rs58973490,NC_000010.11:94775506:G:A,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775507,rs58973490,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*11/*13,CYP2C19,"R150H, R410C",Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634206,10|10,96535264.0,10|10,94775507,634206,622288|622294,rs58973490|rs17879685,NC_000010.11:94775506:G:A|NC_000010.11:94849994:C:T,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775507,rs58973490,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*11/*17,CYP2C19,R150H,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634201,10,96535264.0,10,94775507,634201,622288,rs58973490,NC_000010.11:94775506:G:A,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775507,rs58973490,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*11/*34,CYP2C19|LOC110599570,"R150H, P3S, F4L",Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634052,10|10|10|10,96535264.0,10|10|10|10,94775507,634052,622288|622278|622279|622277,rs58973490|rs367543002|rs367543003|rs367543001,NC_000010.11:94775506:G:A|NC_000010.11:94762711:C:T|NC_000010.11:94762714:T:C|NC_000010.11:94762692:G:A,Diplotype,missense variant|5 prime UTR variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775507,rs58973490,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*11/*23,CYP2C19,"R150H, G91R",Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634049,10|10,96535264.0,10|10,94775507,634049,622288|622285,rs58973490|rs118203756,NC_000010.11:94775506:G:A|NC_000010.11:94775159:G:C,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775507,rs58973490,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*11/*14,CYP2C19,"R150H, L17P",Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634048,10|10,96535264.0,10|10,94775507,634048,622288|622280,rs58973490|rs55752064,NC_000010.11:94775506:G:A|NC_000010.11:94762754:T:C,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775507,rs58973490,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*11/*12,CYP2C19,R150H,Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634047,10|10,96535264.0,10|10,94775507,634047,622288|622297,rs58973490|rs55640102,NC_000010.11:94775506:G:A|NC_000010.11:94852913:A:C,Diplotype,missense variant|stop lost,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775507,rs58973490,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*9/*11,CYP2C19,R150H,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000633960,10,96535264.0,10,94775507,633960,622288,rs58973490,NC_000010.11:94775506:G:A,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775507,rs58973490,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*11/*25,CYP2C19,"R150H, F448L",Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000633944,10|10,96535264.0,10|10,94775507,633944,622288|622296,rs58973490|rs118203759,NC_000010.11:94775506:G:A|NC_000010.11:94852784:C:G,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775507,rs58973490,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*11/*19,CYP2C19,"R150H, S51G",Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000633943,10|10,96535264.0,10|10,94775507,633943,622288|166410,rs58973490|rs1564657013,NC_000010.11:94775506:G:A|NC_000010.11:94762855:A:G,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775507,rs58973490,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*11/*16,CYP2C19,"R150H, R442C",Escitalopram response|Voriconazole response|Citalopram response|Sertraline response,VCV000633942,10|10,96535264.0,10|10,94775507,633942,622288|622295,rs58973490|rs192154563,NC_000010.11:94775506:G:A|NC_000010.11:94852764:C:T,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775507,rs58973490,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*8/*11,CYP2C19,R150H,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000633928,10,96535264.0,10,94775507,633928,622288,rs58973490,NC_000010.11:94775506:G:A,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775507,rs58973490,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*5/*11,CYP2C19,R150H,Citalopram response|Escitalopram response|Voriconazole response|Sertraline response,VCV000633917,10,96535264.0,10,94775507,633917,622288,rs58973490,NC_000010.11:94775506:G:A,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775507,rs58973490,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*4B/*11,CYP2C19|LOC110599570,"R150H, M1V",Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000633914,10|10|10,96535264.0,10|10|10,94775507,633914,622288|31939|47956,rs58973490|rs28399504|rs12248560,NC_000010.11:94775506:G:A|NC_000010.11:94762705:A:G|NC_000010.11:94761899:C:T,Diplotype,missense variant|initiator_codon_variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775507,rs58973490,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*11/*35,CYP2C19,R150H,Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000633892,10|10,96535264.0,10|10,94775507,633892,622288|622287,rs58973490|rs12769205,NC_000010.11:94775506:G:A|NC_000010.11:94775366:A:G,Diplotype,missense variant|intron variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775507,rs58973490,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*11/*24,CYP2C19,"R150H, R335Q",Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000633891,10|10|10,96535264.0,10|10|10,94775507,633891,622288|622292|166407,rs58973490|rs118203757|rs377184510,NC_000010.11:94775506:G:A|NC_000010.11:94842878:G:A|NC_000010.11:94849963:A:G,Diplotype,missense variant|synonymous variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775507,rs58973490,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*11/*15,CYP2C19,"R150H, I19L",Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000633883,10|10,96535264.0,10|10,94775507,633883,622288|622281,rs58973490|rs17882687,NC_000010.11:94775506:G:A|NC_000010.11:94762759:A:C,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775507,rs58973490,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*1/*11,CYP2C19|LOC110599570,R150H,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000633879,10|,96535264.0,10|10,94775507,633879,622288|622276,rs58973490,NC_000010.11:94775506:G:A,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94775507,rs58973490,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*11,CYP2C19,R150H,CYP2C19: normal function,VCV000633845,10,96535264.0,10,94775507,633845,622288,rs58973490,NC_000010.11:94775506:G:A,"Haplotype, single variant",missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94780574,rs140278421,G,C,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*22/*22,CYP2C19,R186P,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000638794,10,96540331.0,10,94780574,638794,622289,rs140278421,NC_000010.11:94780573:G:C,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94780574,rs140278421,G,C,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*22/*34,CYP2C19|LOC110599570,"R186P, P3S, F4L",Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634408,10|10|10|10,96540331.0,10|10|10|10,94780574,634408,622289|622278|622279|622277,rs140278421|rs367543002|rs367543003|rs367543001,NC_000010.11:94780573:G:C|NC_000010.11:94762711:C:T|NC_000010.11:94762714:T:C|NC_000010.11:94762692:G:A,Diplotype,missense variant|5 prime UTR variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94780574,rs140278421,G,C,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*6/*22,CYP2C19,R186P,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634393,10,96540331.0,10,94780574,634393,622289,rs140278421,NC_000010.11:94780573:G:C,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94780574,rs140278421,G,C,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*3/*22,CYP2C19,R186P,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634391,10,96540331.0,10,94780574,634391,622289,rs140278421,NC_000010.11:94780573:G:C,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94780574,rs140278421,G,C,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*22/*26,CYP2C19,"R186P, D256N",Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634379,10|10,96540331.0,10|10,94780574,634379,622289|166409,rs140278421|rs375781227,NC_000010.11:94780573:G:C|NC_000010.11:94781943:G:A,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94780574,rs140278421,G,C,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*11/*22,CYP2C19,"R186P, R150H",Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634357,10|10,96540331.0,10|10,94780574,634357,622289|622288,rs140278421|rs58973490,NC_000010.11:94780573:G:C|NC_000010.11:94775506:G:A,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94780574,rs140278421,G,C,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*22/*23,CYP2C19,"R186P, G91R",Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634286,10|10,96540331.0,10|10,94780574,634286,622289|622285,rs140278421|rs118203756,NC_000010.11:94780573:G:C|NC_000010.11:94775159:G:C,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94780574,rs140278421,G,C,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*14/*22,CYP2C19,"R186P, L17P",Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634270,10|10,96540331.0,10|10,94780574,634270,622289|622280,rs140278421|rs55752064,NC_000010.11:94780573:G:C|NC_000010.11:94762754:T:C,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94780574,rs140278421,G,C,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*7/*22,CYP2C19,R186P,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634252,10,96540331.0,10,94780574,634252,622289,rs140278421,NC_000010.11:94780573:G:C,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94780574,rs140278421,G,C,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*15/*22,CYP2C19,"R186P, I19L",Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634209,10|10,96540331.0,10|10,94780574,634209,622289|622281,rs140278421|rs17882687,NC_000010.11:94780573:G:C|NC_000010.11:94762759:A:C,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94780574,rs140278421,G,C,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*1/*22,CYP2C19|LOC110599570,R186P,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634207,10|,96540331.0,10|10,94780574,634207,622289|622276,rs140278421,NC_000010.11:94780573:G:C,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94780574,rs140278421,G,C,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*22/*31,CYP2C19,"R186P, H78Y",Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634109,10|10,96540331.0,10|10,94780574,634109,622289|622284,rs140278421|rs1564660997,NC_000010.11:94780573:G:C|NC_000010.11:94775120:C:T,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94780574,rs140278421,G,C,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*22/*30,CYP2C19,"R186P, R73C",Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634108,10|10,96540331.0,10|10,94780574,634108,622289|622283,rs140278421|rs145328984,NC_000010.11:94780573:G:C|NC_000010.11:94775105:C:T,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94780574,rs140278421,G,C,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*22/*29,CYP2C19,"R186P, K28I",Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634107,10|10,96540331.0,10|10,94780574,634107,622289|622282,rs140278421|rs1564656981,NC_000010.11:94780573:G:C|NC_000010.11:94762787:A:T,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94780574,rs140278421,G,C,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*22/*27,LOC110599570|CYP2C19,R186P,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634106,10|10,96540331.0,10|10,94780574,634106,622289|622275,rs140278421|rs7902257,NC_000010.11:94780573:G:C|NC_000010.11:94761664:G:A,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94780574,rs140278421,G,C,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*12/*22,CYP2C19,R186P,Voriconazole response|Citalopram response|Sertraline response|Escitalopram response,VCV000634057,10|10,96540331.0,10|10,94780574,634057,622289|622297,rs140278421|rs55640102,NC_000010.11:94780573:G:C|NC_000010.11:94852913:A:C,Diplotype,missense variant|stop lost,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94780574,rs140278421,G,C,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*8/*22,CYP2C19,R186P,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634032,10,96540331.0,10,94780574,634032,622289,rs140278421,NC_000010.11:94780573:G:C,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94780574,rs140278421,G,C,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*5/*22,CYP2C19,R186P,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634024,10,96540331.0,10,94780574,634024,622289,rs140278421,NC_000010.11:94780573:G:C,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94780574,rs140278421,G,C,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*4B/*22,CYP2C19|LOC110599570,"R186P, M1V",Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634020,10|10|10,96540331.0,10|10|10,94780574,634020,622289|31939|47956,rs140278421|rs28399504|rs12248560,NC_000010.11:94780573:G:C|NC_000010.11:94762705:A:G|NC_000010.11:94761899:C:T,Diplotype,missense variant|initiator_codon_variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94780574,rs140278421,G,C,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*4A/*22,CYP2C19,R186P,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634017,10,96540331.0,10,94780574,634017,622289,rs140278421,NC_000010.11:94780573:G:C,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94780574,rs140278421,G,C,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*22/*35,CYP2C19,R186P,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634012,10|10,96540331.0,10|10,94780574,634012,622289|622287,rs140278421|rs12769205,NC_000010.11:94780573:G:C|NC_000010.11:94775366:A:G,Diplotype,missense variant|intron variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94780574,rs140278421,G,C,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*22/*24,CYP2C19,"R186P, R335Q",Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634011,10|10|10,96540331.0,10|10|10,94780574,634011,622289|622292|166407,rs140278421|rs118203757|rs377184510,NC_000010.11:94780573:G:C|NC_000010.11:94842878:G:A|NC_000010.11:94849963:A:G,Diplotype,missense variant|synonymous variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94780574,rs140278421,G,C,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*2/*22,CYP2C19,R186P,Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634006,10|10|10,96540331.0,10|10|10,94780574,634006,622289|31936|622287,rs140278421|rs4244285|rs12769205,NC_000010.11:94780573:G:C|NC_000010.11:94781858:G:A|NC_000010.11:94775366:A:G,Diplotype,missense variant|synonymous variant|intron variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94780574,rs140278421,G,C,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*9/*22,CYP2C19,R186P,Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634005,10,96540331.0,10,94780574,634005,622289,rs140278421,NC_000010.11:94780573:G:C,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94780574,rs140278421,G,C,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*22/*25,CYP2C19,"R186P, F448L",Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000633975,10|10,96540331.0,10|10,94780574,633975,622289|622296,rs140278421|rs118203759,NC_000010.11:94780573:G:C|NC_000010.11:94852784:C:G,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94780574,rs140278421,G,C,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*19/*22,CYP2C19,"R186P, S51G",Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000633969,10|10,96540331.0,10|10,94780574,633969,622289|166410,rs140278421|rs1564657013,NC_000010.11:94780573:G:C|NC_000010.11:94762855:A:G,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94780574,rs140278421,G,C,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*16/*22,CYP2C19,"R186P, R442C",Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000633966,10|10,96540331.0,10|10,94780574,633966,622289|622295,rs140278421|rs192154563,NC_000010.11:94780573:G:C|NC_000010.11:94852764:C:T,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94780574,rs140278421,G,C,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*22/*28,CYP2C19|LOC110599570,"R186P, I19L, V374I",Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000633905,10|10|10|10|10|10,96540331.0,10|10|10|10|10|10,94780574,633905,622289|622281|622272|622273|622293|622274,rs140278421|rs17882687|rs113164681|rs111490789|rs113934938|rs17878739,NC_000010.11:94780573:G:C|NC_000010.11:94762759:A:C|NC_000010.11:94760675:C:T|NC_000010.11:94760685:C:A|NC_000010.11:94842994:G:A|NC_000010.11:94761266:T:C,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94780574,rs140278421,G,C,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*17/*22,CYP2C19,R186P,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000633896,10,96540331.0,10,94780574,633896,622289,rs140278421,NC_000010.11:94780573:G:C,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94780574,rs140278421,G,C,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*13/*22,CYP2C19,"R186P, R410C",Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000633893,10|10,96540331.0,10|10,94780574,633893,622289|622294,rs140278421|rs17879685,NC_000010.11:94780573:G:C|NC_000010.11:94849994:C:T,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94780574,rs140278421,G,C,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*22,CYP2C19,R186P,CYP2C19: no function,VCV000633843,10,96540331.0,10,94780574,633843,622289,rs140278421,NC_000010.11:94780573:G:C,"Haplotype, single variant",missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94780579,rs370803989,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*33/*33,CYP2C19,D188N,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000638793,10,96540336.0,10,94780579,638793,622290,rs370803989,NC_000010.11:94780578:G:A,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94780579,rs370803989,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*5/*33,CYP2C19,D188N,Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634421,10,96540336.0,10,94780579,634421,622290,rs370803989,NC_000010.11:94780578:G:A,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94780579,rs370803989,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*33/*35,CYP2C19,D188N,Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634418,10|10,96540336.0,10|10,94780579,634418,622290|622287,rs370803989|rs12769205,NC_000010.11:94780578:G:A|NC_000010.11:94775366:A:G,Diplotype,missense variant|intron variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94780579,rs370803989,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*33/*34,CYP2C19|LOC110599570,"D188N, P3S, F4L",Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634417,10|10|10|10,96540336.0,10|10|10|10,94780579,634417,622290|622278|622279|622277,rs370803989|rs367543002|rs367543003|rs367543001,NC_000010.11:94780578:G:A|NC_000010.11:94762711:C:T|NC_000010.11:94762714:T:C|NC_000010.11:94762692:G:A,Diplotype,missense variant|5 prime UTR variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94780579,rs370803989,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*3/*33,CYP2C19,D188N,Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634415,10,96540336.0,10,94780579,634415,622290,rs370803989,NC_000010.11:94780578:G:A,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94780579,rs370803989,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*28/*33,CYP2C19|LOC110599570,"D188N, I19L, V374I",Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634413,10|10|10|10|10|10,96540336.0,10|10|10|10|10|10,94780579,634413,622290|622281|622272|622273|622293|622274,rs370803989|rs17882687|rs113164681|rs111490789|rs113934938|rs17878739,NC_000010.11:94780578:G:A|NC_000010.11:94762759:A:C|NC_000010.11:94760675:C:T|NC_000010.11:94760685:C:A|NC_000010.11:94842994:G:A|NC_000010.11:94761266:T:C,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94780579,rs370803989,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*26/*33,CYP2C19,"D188N, D256N",Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634412,10|10,96540336.0,10|10,94780579,634412,622290|166409,rs370803989|rs375781227,NC_000010.11:94780578:G:A|NC_000010.11:94781943:G:A,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94780579,rs370803989,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*2/*33,CYP2C19,D188N,Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634336,10|10|10,96540336.0,10|10|10,94780579,634336,622290|31936|622287,rs370803989|rs4244285|rs12769205,NC_000010.11:94780578:G:A|NC_000010.11:94781858:G:A|NC_000010.11:94775366:A:G,Diplotype,missense variant|synonymous variant|intron variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94780579,rs370803989,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*12/*33,CYP2C19,D188N,Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634326,10|10,96540336.0,10|10,94780579,634326,622290|622297,rs370803989|rs55640102,NC_000010.11:94780578:G:A|NC_000010.11:94852913:A:C,Diplotype,missense variant|stop lost,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94780579,rs370803989,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*9/*33,CYP2C19,D188N,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634318,10,96540336.0,10,94780579,634318,622290,rs370803989,NC_000010.11:94780578:G:A,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94780579,rs370803989,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*31/*33,CYP2C19,"D188N, H78Y",Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634303,10|10,96540336.0,10|10,94780579,634303,622290|622284,rs370803989|rs1564660997,NC_000010.11:94780578:G:A|NC_000010.11:94775120:C:T,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94780579,rs370803989,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*27/*33,LOC110599570|CYP2C19,D188N,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634296,10|10,96540336.0,10|10,94780579,634296,622290|622275,rs370803989|rs7902257,NC_000010.11:94780578:G:A|NC_000010.11:94761664:G:A,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94780579,rs370803989,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*22/*33,CYP2C19,"D188N, R186P",Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634288,10|10,96540336.0,10|10,94780579,634288,622290|622289,rs370803989|rs140278421,NC_000010.11:94780578:G:A|NC_000010.11:94780573:G:C,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94780579,rs370803989,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*1/*33,CYP2C19|LOC110599570,D188N,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634258,10|,96540336.0,10|10,94780579,634258,622290|622276,rs370803989,NC_000010.11:94780578:G:A,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94780579,rs370803989,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*8/*33,CYP2C19,D188N,Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634195,10,96540336.0,10,94780579,634195,622290,rs370803989,NC_000010.11:94780578:G:A,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94780579,rs370803989,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*7/*33,CYP2C19,D188N,Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634188,10,96540336.0,10,94780579,634188,622290,rs370803989,NC_000010.11:94780578:G:A,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94780579,rs370803989,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*6/*33,CYP2C19,D188N,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634181,10,96540336.0,10,94780579,634181,622290,rs370803989,NC_000010.11:94780578:G:A,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94780579,rs370803989,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*4B/*33,CYP2C19|LOC110599570,"D188N, M1V",Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634170,10|10|10,96540336.0,10|10|10,94780579,634170,622290|31939|47956,rs370803989|rs28399504|rs12248560,NC_000010.11:94780578:G:A|NC_000010.11:94762705:A:G|NC_000010.11:94761899:C:T,Diplotype,missense variant|initiator_codon_variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94780579,rs370803989,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*4A/*33,CYP2C19,D188N,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634163,10,96540336.0,10,94780579,634163,622290,rs370803989,NC_000010.11:94780578:G:A,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94780579,rs370803989,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*32/*33,CYP2C19,"D188N, H99R",Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634155,10|10,96540336.0,10|10,94780579,634155,622290|622286,rs370803989|rs1288601658,NC_000010.11:94780578:G:A|NC_000010.11:94775184:A:G,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94780579,rs370803989,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*30/*33,CYP2C19,"D188N, R73C",Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634151,10|10,96540336.0,10|10,94780579,634151,622290|622283,rs370803989|rs145328984,NC_000010.11:94780578:G:A|NC_000010.11:94775105:C:T,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94780579,rs370803989,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*29/*33,CYP2C19,"D188N, K28I",Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634142,10|10,96540336.0,10|10,94780579,634142,622290|622282,rs370803989|rs1564656981,NC_000010.11:94780578:G:A|NC_000010.11:94762787:A:T,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94780579,rs370803989,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*25/*33,CYP2C19,"D188N, F448L",Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634126,10|10,96540336.0,10|10,94780579,634126,622290|622296,rs370803989|rs118203759,NC_000010.11:94780578:G:A|NC_000010.11:94852784:C:G,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94780579,rs370803989,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*24/*33,CYP2C19,"D188N, R335Q",Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634122,10|10|10,96540336.0,10|10|10,94780579,634122,622290|622292|166407,rs370803989|rs118203757|rs377184510,NC_000010.11:94780578:G:A|NC_000010.11:94842878:G:A|NC_000010.11:94849963:A:G,Diplotype,missense variant|synonymous variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94780579,rs370803989,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*23/*33,CYP2C19,"D188N, G91R",Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634116,10|10,96540336.0,10|10,94780579,634116,622290|622285,rs370803989|rs118203756,NC_000010.11:94780578:G:A|NC_000010.11:94775159:G:C,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94780579,rs370803989,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*19/*33,CYP2C19,"D188N, S51G",Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634101,10|10,96540336.0,10|10,94780579,634101,622290|166410,rs370803989|rs1564657013,NC_000010.11:94780578:G:A|NC_000010.11:94762855:A:G,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94780579,rs370803989,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*18/*33,CYP2C19,"D188N, R329H",Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634096,10|10,96540336.0,10|10,94780579,634096,622290|622291,rs370803989|rs138142612,NC_000010.11:94780578:G:A|NC_000010.11:94842860:G:A,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94780579,rs370803989,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*17/*33,CYP2C19,D188N,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634092,10,96540336.0,10,94780579,634092,622290,rs370803989,NC_000010.11:94780578:G:A,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94780579,rs370803989,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*16/*33,CYP2C19,"D188N, R442C",Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634088,10|10,96540336.0,10|10,94780579,634088,622290|622295,rs370803989|rs192154563,NC_000010.11:94780578:G:A|NC_000010.11:94852764:C:T,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94780579,rs370803989,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*15/*33,CYP2C19,"D188N, I19L",Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634084,10|10,96540336.0,10|10,94780579,634084,622290|622281,rs370803989|rs17882687,NC_000010.11:94780578:G:A|NC_000010.11:94762759:A:C,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94780579,rs370803989,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*14/*33,CYP2C19,"D188N, L17P",Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634079,10|10,96540336.0,10|10,94780579,634079,622290|622280,rs370803989|rs55752064,NC_000010.11:94780578:G:A|NC_000010.11:94762754:T:C,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94780579,rs370803989,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*13/*33,CYP2C19,"D188N, R410C",Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634069,10|10,96540336.0,10|10,94780579,634069,622290|622294,rs370803989|rs17879685,NC_000010.11:94780578:G:A|NC_000010.11:94849994:C:T,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94780579,rs370803989,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*11/*33,CYP2C19,"D188N, R150H",Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634051,10|10,96540336.0,10|10,94780579,634051,622290|622288,rs370803989|rs58973490,NC_000010.11:94780578:G:A|NC_000010.11:94775506:G:A,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94780579,rs370803989,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*33,CYP2C19,D188N,CYP2C19: uncertain function,VCV000633840,10,96540336.0,10,94780579,633840,622290,rs370803989,NC_000010.11:94780578:G:A,"Haplotype, single variant",missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94780653,rs4986893,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,NM_000769.1(CYP2C19):c.636G>A (p.Trp212Ter),CYP2C19,W212*,CYP2C19: no function,VCV000016899,10,96540410.0,10,94780653,16899,31938,rs4986893,NC_000010.11:94780652:G:A,single nucleotide variant,nonsense,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94781858,rs6413438,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*10/*10,CYP2C19,P227L,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000638206,10,96541615.0,10,94781858,638206,47951,rs6413438,NC_000010.11:94781857:C:T,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94781858,rs6413438,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*10/*12,CYP2C19,P227L,Escitalopram response|Voriconazole response|Citalopram response|Sertraline response,VCV000634395,10|10,96541615.0,10|10,94781858,634395,47951|622297,rs6413438|rs55640102,NC_000010.11:94781857:C:T|NC_000010.11:94852913:A:C,Diplotype,missense variant|stop lost,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94781858,rs6413438,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*4B/*10,CYP2C19|LOC110599570,"P227L, M1V",Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634383,10|10|10,96541615.0,10|10|10,94781858,634383,47951|31939|47956,rs6413438|rs28399504|rs12248560,NC_000010.11:94781857:C:T|NC_000010.11:94762705:A:G|NC_000010.11:94761899:C:T,Diplotype,missense variant|initiator_codon_variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94781858,rs6413438,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*10/*35,CYP2C19,P227L,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634378,10|10,96541615.0,10|10,94781858,634378,47951|622287,rs6413438|rs12769205,NC_000010.11:94781857:C:T|NC_000010.11:94775366:A:G,Diplotype,missense variant|intron variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94781858,rs6413438,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*10/*24,CYP2C19,"P227L, R335Q",Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634377,10|10|10,96541615.0,10|10|10,94781858,634377,47951|622292|166407,rs6413438|rs118203757|rs377184510,NC_000010.11:94781857:C:T|NC_000010.11:94842878:G:A|NC_000010.11:94849963:A:G,Diplotype,missense variant|synonymous variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94781858,rs6413438,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*10/*22,CYP2C19,"P227L, R186P",Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634376,10|10,96541615.0,10|10,94781858,634376,47951|622289,rs6413438|rs140278421,NC_000010.11:94781857:C:T|NC_000010.11:94780573:G:C,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94781858,rs6413438,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*10/*26,CYP2C19,"P227L, D256N",Sertraline response|Voriconazole response|Citalopram response|Escitalopram response,VCV000634371,10|10,96541615.0,10|10,94781858,634371,47951|166409,rs6413438|rs375781227,NC_000010.11:94781857:C:T|NC_000010.11:94781943:G:A,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94781858,rs6413438,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*10/*25,CYP2C19,"P227L, F448L",Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634370,10|10,96541615.0,10|10,94781858,634370,47951|622296,rs6413438|rs118203759,NC_000010.11:94781857:C:T|NC_000010.11:94852784:C:G,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94781858,rs6413438,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*10/*19,CYP2C19,"P227L, S51G",Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634369,10|10,96541615.0,10|10,94781858,634369,47951|166410,rs6413438|rs1564657013,NC_000010.11:94781857:C:T|NC_000010.11:94762855:A:G,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94781858,rs6413438,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*10/*31,CYP2C19,"P227L, H78Y",Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634322,10|10,96541615.0,10|10,94781858,634322,47951|622284,rs6413438|rs1564660997,NC_000010.11:94781857:C:T|NC_000010.11:94775120:C:T,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94781858,rs6413438,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*10/*30,CYP2C19,"P227L, R73C",Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634321,10|10,96541615.0,10|10,94781858,634321,47951|622283,rs6413438|rs145328984,NC_000010.11:94781857:C:T|NC_000010.11:94775105:C:T,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94781858,rs6413438,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*10/*33,CYP2C19,"P227L, D188N",Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634260,10|10,96541615.0,10|10,94781858,634260,47951|622290,rs6413438|rs370803989,NC_000010.11:94781857:C:T|NC_000010.11:94780578:G:A,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94781858,rs6413438,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*10/*32,CYP2C19,"P227L, H99R",Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634259,10|10,96541615.0,10|10,94781858,634259,47951|622286,rs6413438|rs1288601658,NC_000010.11:94781857:C:T|NC_000010.11:94775184:A:G,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94781858,rs6413438,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*8/*10,CYP2C19,P227L,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634246,10,96541615.0,10,94781858,634246,47951,rs6413438,NC_000010.11:94781857:C:T,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94781858,rs6413438,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*2/*10,CYP2C19,P227L,Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634237,10|10|10,96541615.0,10|10|10,94781858,634237,47951|31936|622287,rs6413438|rs4244285|rs12769205,NC_000010.11:94781857:C:T|NC_000010.11:94781858:G:A|NC_000010.11:94775366:A:G,Diplotype,missense variant|synonymous variant|intron variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94781858,rs6413438,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*10/*18,CYP2C19,"P227L, R329H",Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634224,10|10,96541615.0,10|10,94781858,634224,47951|622291,rs6413438|rs138142612,NC_000010.11:94781857:C:T|NC_000010.11:94842860:G:A,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94781858,rs6413438,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*10/*11,CYP2C19,"P227L, R150H",Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634223,10|10,96541615.0,10|10,94781858,634223,47951|622288,rs6413438|rs58973490,NC_000010.11:94781857:C:T|NC_000010.11:94775506:G:A,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94781858,rs6413438,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*10/*34,CYP2C19|LOC110599570,"P227L, P3S, F4L",Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634046,10|10|10|10,96541615.0,10|10|10|10,94781858,634046,47951|622278|622279|622277,rs6413438|rs367543002|rs367543003|rs367543001,NC_000010.11:94781857:C:T|NC_000010.11:94762711:C:T|NC_000010.11:94762714:T:C|NC_000010.11:94762692:G:A,Diplotype,missense variant|5 prime UTR variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94781858,rs6413438,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*10/*29,CYP2C19,"P227L, K28I",Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634045,10|10,96541615.0,10|10,94781858,634045,47951|622282,rs6413438|rs1564656981,NC_000010.11:94781857:C:T|NC_000010.11:94762787:A:T,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94781858,rs6413438,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*10/*27,LOC110599570|CYP2C19,P227L,Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634044,10|10,96541615.0,10|10,94781858,634044,47951|622275,rs6413438|rs7902257,NC_000010.11:94781857:C:T|NC_000010.11:94761664:G:A,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94781858,rs6413438,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*10/*23,CYP2C19,"P227L, G91R",Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634043,10|10,96541615.0,10|10,94781858,634043,47951|622285,rs6413438|rs118203756,NC_000010.11:94781857:C:T|NC_000010.11:94775159:G:C,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94781858,rs6413438,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*10/*14,CYP2C19,"P227L, L17P",Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634041,10|10,96541615.0,10|10,94781858,634041,47951|622280,rs6413438|rs55752064,NC_000010.11:94781857:C:T|NC_000010.11:94762754:T:C,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94781858,rs6413438,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*7/*10,CYP2C19,P227L,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000633996,10,96541615.0,10,94781858,633996,47951,rs6413438,NC_000010.11:94781857:C:T,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94781858,rs6413438,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*6/*10,CYP2C19,P227L,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000633993,10,96541615.0,10,94781858,633993,47951,rs6413438,NC_000010.11:94781857:C:T,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94781858,rs6413438,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*5/*10,CYP2C19,P227L,Sertraline response|Voriconazole response|Citalopram response|Escitalopram response,VCV000633990,10,96541615.0,10,94781858,633990,47951,rs6413438,NC_000010.11:94781857:C:T,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94781858,rs6413438,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*4A/*10,CYP2C19,P227L,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000633981,10,96541615.0,10,94781858,633981,47951,rs6413438,NC_000010.11:94781857:C:T,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94781858,rs6413438,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*3/*10,CYP2C19,P227L,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000633978,10,96541615.0,10,94781858,633978,47951,rs6413438,NC_000010.11:94781857:C:T,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94781858,rs6413438,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*9/*10,CYP2C19,P227L,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000633959,10,96541615.0,10,94781858,633959,47951,rs6413438,NC_000010.11:94781857:C:T,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94781858,rs6413438,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*10/*28,CYP2C19|LOC110599570,"P227L, I19L, V374I",Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000633941,10|10|10|10|10|10,96541615.0,10|10|10|10|10|10,94781858,633941,47951|622281|622272|622273|622293|622274,rs6413438|rs17882687|rs113164681|rs111490789|rs113934938|rs17878739,NC_000010.11:94781857:C:T|NC_000010.11:94762759:A:C|NC_000010.11:94760675:C:T|NC_000010.11:94760685:C:A|NC_000010.11:94842994:G:A|NC_000010.11:94761266:T:C,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94781858,rs6413438,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*10/*17,CYP2C19,P227L,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000633940,10,96541615.0,10,94781858,633940,47951,rs6413438,NC_000010.11:94781857:C:T,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94781858,rs6413438,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*10/*16,CYP2C19,"P227L, R442C",Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000633939,10|10,96541615.0,10|10,94781858,633939,47951|622295,rs6413438|rs192154563,NC_000010.11:94781857:C:T|NC_000010.11:94852764:C:T,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94781858,rs6413438,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*10/*15,CYP2C19,"P227L, I19L",Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000633938,10|10,96541615.0,10|10,94781858,633938,47951|622281,rs6413438|rs17882687,NC_000010.11:94781857:C:T|NC_000010.11:94762759:A:C,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94781858,rs6413438,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*10/*13,CYP2C19,"P227L, R410C",Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000633937,10|10,96541615.0,10|10,94781858,633937,47951|622294,rs6413438|rs17879685,NC_000010.11:94781857:C:T|NC_000010.11:94849994:C:T,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94781858,rs6413438,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*1/*10,CYP2C19|LOC110599570,P227L,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000633931,10|,96541615.0,10|10,94781858,633931,47951|622276,rs6413438,NC_000010.11:94781857:C:T,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94781858,rs6413438,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*10,CYP2C19,P227L,CYP2C19: decreased function,VCV000039353,10,96541615.0,10,94781858,39353,47951,rs6413438,NC_000010.11:94781857:C:T,"Haplotype, single variant",missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94781859,rs4244285,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,NM_000769.4(CYP2C19):c.681G>T (p.Pro227=),CYP2C19,nan,Acute coronary syndrome,VCV001703261,10,96541616.0,10,94781859,1703261,1695652,rs4244285,NC_000010.11:94781858:G:T,single nucleotide variant,synonymous variant,drug response,nan,no assertion criteria provided,nan,nan,nan,nan,nan,nan,nan
chr10,94781859,rs4244285,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*2/*2,CYP2C19,nan,Escitalopram response|Sertraline response|Voriconazole response|Clopidogrel response|Citalopram response,VCV000638797,10|10,96541616.0,10|10,94781859,638797,31936|622287,rs4244285|rs12769205,NC_000010.11:94781858:G:A|NC_000010.11:94775366:A:G,Diplotype,synonymous variant|intron variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94781859,rs4244285,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*2/*23,CYP2C19,G91R,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634407,10|10|10,96541616.0,10|10|10,94781859,634407,31936|622287|622285,rs4244285|rs12769205|rs118203756,NC_000010.11:94781858:G:A|NC_000010.11:94775366:A:G|NC_000010.11:94775159:G:C,Diplotype,synonymous variant|intron variant|missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94781859,rs4244285,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*2/*14,CYP2C19,L17P,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634406,10|10|10,96541616.0,10|10|10,94781859,634406,31936|622287|622280,rs4244285|rs12769205|rs55752064,NC_000010.11:94781858:G:A|NC_000010.11:94775366:A:G|NC_000010.11:94762754:T:C,Diplotype,synonymous variant|intron variant|missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94781859,rs4244285,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*2/*29,CYP2C19,K28I,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634103,10|10|10,96541616.0,10|10|10,94781859,634103,31936|622287|622282,rs4244285|rs12769205|rs1564656981,NC_000010.11:94781858:G:A|NC_000010.11:94775366:A:G|NC_000010.11:94762787:A:T,Diplotype,synonymous variant|intron variant|missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94781859,rs4244285,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*2/*8,CYP2C19,nan,Citalopram response|Escitalopram response|Sertraline response|Voriconazole response|Clopidogrel response,VCV000634010,10|10,96541616.0,10|10,94781859,634010,31936|622287,rs4244285|rs12769205,NC_000010.11:94781858:G:A|NC_000010.11:94775366:A:G,Diplotype,synonymous variant|intron variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94781859,rs4244285,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*2/*7,CYP2C19,nan,Escitalopram response|Sertraline response|Voriconazole response|Clopidogrel response|Citalopram response,VCV000634009,10|10,96541616.0,10|10,94781859,634009,31936|622287,rs4244285|rs12769205,NC_000010.11:94781858:G:A|NC_000010.11:94775366:A:G,Diplotype,synonymous variant|intron variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94781859,rs4244285,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*2/*24,CYP2C19,R335Q,Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634007,10|10|10|10,96541616.0,10|10|10|10,94781859,634007,31936|622287|622292|166407,rs4244285|rs12769205|rs118203757|rs377184510,NC_000010.11:94781858:G:A|NC_000010.11:94775366:A:G|NC_000010.11:94842878:G:A|NC_000010.11:94849963:A:G,Diplotype,synonymous variant|intron variant|missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94781859,rs4244285,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*2/*9,CYP2C19,nan,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000633974,10|10,96541616.0,10|10,94781859,633974,31936|622287,rs4244285|rs12769205,NC_000010.11:94781858:G:A|NC_000010.11:94775366:A:G,Diplotype,synonymous variant|intron variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94781859,rs4244285,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*2/*25,CYP2C19,F448L,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000633972,10|10|10,96541616.0,10|10|10,94781859,633972,31936|622287|622296,rs4244285|rs12769205|rs118203759,NC_000010.11:94781858:G:A|NC_000010.11:94775366:A:G|NC_000010.11:94852784:C:G,Diplotype,synonymous variant|intron variant|missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94781859,rs4244285,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*2/*19,CYP2C19,S51G,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000633971,10|10|10,96541616.0,10|10|10,94781859,633971,31936|622287|166410,rs4244285|rs12769205|rs1564657013,NC_000010.11:94781858:G:A|NC_000010.11:94775366:A:G|NC_000010.11:94762855:A:G,Diplotype,synonymous variant|intron variant|missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94781859,rs4244285,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*2/*17,CYP2C19,nan,Voriconazole response|Clopidogrel response|Citalopram response|Escitalopram response|Sertraline response,VCV000633902,10|10,96541616.0,10|10,94781859,633902,31936|622287,rs4244285|rs12769205,NC_000010.11:94781858:G:A|NC_000010.11:94775366:A:G,Diplotype,synonymous variant|intron variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94781859,rs4244285,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*2/*15,CYP2C19,I19L,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000633901,10|10|10,96541616.0,10|10|10,94781859,633901,31936|622287|622281,rs4244285|rs12769205|rs17882687,NC_000010.11:94781858:G:A|NC_000010.11:94775366:A:G|NC_000010.11:94762759:A:C,Diplotype,synonymous variant|intron variant|missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94781859,rs4244285,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*2/*6,CYP2C19,nan,Escitalopram response|Sertraline response|Voriconazole response|Clopidogrel response|Citalopram response,VCV000633870,10|10,96541616.0,10|10,94781859,633870,31936|622287,rs4244285|rs12769205,NC_000010.11:94781858:G:A|NC_000010.11:94775366:A:G,Diplotype,synonymous variant|intron variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94781859,rs4244285,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*2/*5,CYP2C19,nan,Voriconazole response|Clopidogrel response|Citalopram response|Escitalopram response|Sertraline response,VCV000633869,10|10,96541616.0,10|10,94781859,633869,31936|622287,rs4244285|rs12769205,NC_000010.11:94781858:G:A|NC_000010.11:94775366:A:G,Diplotype,synonymous variant|intron variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94781859,rs4244285,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*2/*4B,CYP2C19|LOC110599570,M1V,Voriconazole response|Clopidogrel response|Citalopram response|Escitalopram response|Sertraline response,VCV000633868,10|10|10|10,96541616.0,10|10|10|10,94781859,633868,31936|622287|31939|47956,rs4244285|rs12769205|rs28399504|rs12248560,NC_000010.11:94781858:G:A|NC_000010.11:94775366:A:G|NC_000010.11:94762705:A:G|NC_000010.11:94761899:C:T,Diplotype,synonymous variant|intron variant|missense variant|initiator_codon_variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94781859,rs4244285,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*2/*4A,CYP2C19,nan,Voriconazole response|Clopidogrel response|Citalopram response|Escitalopram response|Sertraline response,VCV000633867,10|10,96541616.0,10|10,94781859,633867,31936|622287,rs4244285|rs12769205,NC_000010.11:94781858:G:A|NC_000010.11:94775366:A:G,Diplotype,synonymous variant|intron variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94781859,rs4244285,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*2/*3,CYP2C19,nan,Voriconazole response|Clopidogrel response|Citalopram response|Escitalopram response|Sertraline response,VCV000633866,10|10,96541616.0,10|10,94781859,633866,31936|622287,rs4244285|rs12769205,NC_000010.11:94781858:G:A|NC_000010.11:94775366:A:G,Diplotype,synonymous variant|intron variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94781859,rs4244285,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*2,CYP2C19,nan,CYP2C19: no function,VCV000633856,10|10,96541616.0,10|10,94781859,633856,31936|622287,rs4244285|rs12769205,NC_000010.11:94781858:G:A|NC_000010.11:94775366:A:G,Haplotype,synonymous variant|intron variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94781859,rs4244285,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,NM_000769.4(CYP2C19):c.681G>A (p.Pro227=),CYP2C19,nan,not specified|not provided,VCV000016897,10,96541616.0,10,94781859,16897,31936,rs4244285,NC_000010.11:94781858:G:A,single nucleotide variant,synonymous variant,Likely benign; other,"Aug 7, 2018","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chr10,94781944,rs375781227,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*26/*26,CYP2C19,D256N,Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000638800,10,96541701.0,10,94781944,638800,166409,rs375781227,NC_000010.11:94781943:G:A,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94781944,rs375781227,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*6/*26,CYP2C19,D256N,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634386,10,96541701.0,10,94781944,634386,166409,rs375781227,NC_000010.11:94781943:G:A,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94781944,rs375781227,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*24/*26,CYP2C19,"D256N, R335Q",Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634381,10|10|10,96541701.0,10|10|10,94781944,634381,166409|622292|166407,rs375781227|rs118203757|rs377184510,NC_000010.11:94781943:G:A|NC_000010.11:94842878:G:A|NC_000010.11:94849963:A:G,Diplotype,missense variant|synonymous variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94781944,rs375781227,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*25/*26,CYP2C19,"D256N, F448L",Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634374,10|10,96541701.0,10|10,94781944,634374,166409|622296,rs375781227|rs118203759,NC_000010.11:94781943:G:A|NC_000010.11:94852784:C:G,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94781944,rs375781227,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*3/*26,CYP2C19,D256N,Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634240,10,96541701.0,10,94781944,634240,166409,rs375781227,NC_000010.11:94781943:G:A,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94781944,rs375781227,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*17/*26,CYP2C19,D256N,Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634230,10,96541701.0,10,94781944,634230,166409,rs375781227,NC_000010.11:94781943:G:A,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94781944,rs375781227,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*15/*26,CYP2C19,"D256N, I19L",Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634228,10|10,96541701.0,10|10,94781944,634228,166409|622281,rs375781227|rs17882687,NC_000010.11:94781943:G:A|NC_000010.11:94762759:A:C,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94781944,rs375781227,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*1/*26,CYP2C19|LOC110599570,D256N,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634221,10|,96541701.0,10|10,94781944,634221,166409|622276,rs375781227,NC_000010.11:94781943:G:A,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94781944,rs375781227,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*26/*29,CYP2C19,"D256N, K28I",Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634129,10|10,96541701.0,10|10,94781944,634129,166409|622282,rs375781227|rs1564656981,NC_000010.11:94781943:G:A|NC_000010.11:94762787:A:T,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94781944,rs375781227,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*23/*26,CYP2C19,"D256N, G91R",Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634112,10|10,96541701.0,10|10,94781944,634112,166409|622285,rs375781227|rs118203756,NC_000010.11:94781943:G:A|NC_000010.11:94775159:G:C,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94781944,rs375781227,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*14/*26,CYP2C19,"D256N, L17P",Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634076,10|10,96541701.0,10|10,94781944,634076,166409|622280,rs375781227|rs55752064,NC_000010.11:94781943:G:A|NC_000010.11:94762754:T:C,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94781944,rs375781227,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*8/*26,CYP2C19,D256N,Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634003,10,96541701.0,10,94781944,634003,166409,rs375781227,NC_000010.11:94781943:G:A,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94781944,rs375781227,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*7/*26,CYP2C19,D256N,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634000,10,96541701.0,10,94781944,634000,166409,rs375781227,NC_000010.11:94781943:G:A,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94781944,rs375781227,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*5/*26,CYP2C19,D256N,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000633991,10,96541701.0,10,94781944,633991,166409,rs375781227,NC_000010.11:94781943:G:A,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94781944,rs375781227,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*4B/*26,CYP2C19|LOC110599570,"D256N, M1V",Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000633988,10|10|10,96541701.0,10|10|10,94781944,633988,166409|31939|47956,rs375781227|rs28399504|rs12248560,NC_000010.11:94781943:G:A|NC_000010.11:94762705:A:G|NC_000010.11:94761899:C:T,Diplotype,missense variant|initiator_codon_variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94781944,rs375781227,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*4A/*26,CYP2C19,D256N,Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000633985,10,96541701.0,10,94781944,633985,166409,rs375781227,NC_000010.11:94781943:G:A,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94781944,rs375781227,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*2/*26,CYP2C19,D256N,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000633973,10|10|10,96541701.0,10|10|10,94781944,633973,166409|31936|622287,rs375781227|rs4244285|rs12769205,NC_000010.11:94781943:G:A|NC_000010.11:94781858:G:A|NC_000010.11:94775366:A:G,Diplotype,missense variant|synonymous variant|intron variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94781944,rs375781227,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*9/*26,CYP2C19,D256N,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000633964,10,96541701.0,10,94781944,633964,166409,rs375781227,NC_000010.11:94781943:G:A,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94781944,rs375781227,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*19/*26,CYP2C19,"D256N, S51G",Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000633957,10|10,96541701.0,10|10,94781944,633957,166409|166410,rs375781227|rs1564657013,NC_000010.11:94781943:G:A|NC_000010.11:94762855:A:G,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94781944,rs375781227,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*26,CYP2C19,D256N,CYP2C19: decreased function,VCV000633854,10,96541701.0,10,94781944,633854,166409,rs375781227,NC_000010.11:94781943:G:A,"Haplotype, single variant",missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94781999,rs72558186,T,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,NM_000769.1(CYP2C19):c.819+2T>A,CYP2C19,nan,CYP2C19: no function,VCV000039348,10,96541756.0,10,94781999,39348,47946,rs72558186,NC_000010.11:94781998:T:A,single nucleotide variant,splice donor variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94842861,rs138142612,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*18/*18,CYP2C19,R329H,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000638785,10,96602618.0,10,94842861,638785,622291,rs138142612,NC_000010.11:94842860:G:A,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94842861,rs138142612,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*18/*29,CYP2C19,"R329H, K28I",Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634405,10|10,96602618.0,10|10,94842861,634405,622291|622282,rs138142612|rs1564656981,NC_000010.11:94842860:G:A|NC_000010.11:94762787:A:T,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94842861,rs138142612,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*18/*27,LOC110599570|CYP2C19,R329H,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634404,10|10,96602618.0,10|10,94842861,634404,622291|622275,rs138142612|rs7902257,NC_000010.11:94842860:G:A|NC_000010.11:94761664:G:A,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94842861,rs138142612,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*16/*18,CYP2C19,"R329H, R442C",Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634373,10|10,96602618.0,10|10,94842861,634373,622291|622295,rs138142612|rs192154563,NC_000010.11:94842860:G:A|NC_000010.11:94852764:C:T,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94842861,rs138142612,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*8/*18,CYP2C19,R329H,Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634368,10,96602618.0,10,94842861,634368,622291,rs138142612,NC_000010.11:94842860:G:A,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94842861,rs138142612,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*5/*18,CYP2C19,R329H,Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634364,10,96602618.0,10,94842861,634364,622291,rs138142612,NC_000010.11:94842860:G:A,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94842861,rs138142612,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*18/*35,CYP2C19,R329H,Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634358,10|10,96602618.0,10|10,94842861,634358,622291|622287,rs138142612|rs12769205,NC_000010.11:94842860:G:A|NC_000010.11:94775366:A:G,Diplotype,missense variant|intron variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94842861,rs138142612,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*15/*18,CYP2C19,"R329H, I19L",Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634356,10|10,96602618.0,10|10,94842861,634356,622291|622281,rs138142612|rs17882687,NC_000010.11:94842860:G:A|NC_000010.11:94762759:A:C,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94842861,rs138142612,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*13/*18,CYP2C19,"R329H, R410C",Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634349,10|10,96602618.0,10|10,94842861,634349,622291|622294,rs138142612|rs17879685,NC_000010.11:94842860:G:A|NC_000010.11:94849994:C:T,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94842861,rs138142612,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*1/*18,CYP2C19|LOC110599570,R329H,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634348,10|,96602618.0,10|10,94842861,634348,622291|622276,rs138142612,NC_000010.11:94842860:G:A,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94842861,rs138142612,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*18/*34,CYP2C19|LOC110599570,"R329H, P3S, F4L",Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634333,10|10|10|10,96602618.0,10|10|10|10,94842861,634333,622291|622278|622279|622277,rs138142612|rs367543002|rs367543003|rs367543001,NC_000010.11:94842860:G:A|NC_000010.11:94762711:C:T|NC_000010.11:94762714:T:C|NC_000010.11:94762692:G:A,Diplotype,missense variant|5 prime UTR variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94842861,rs138142612,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*14/*18,CYP2C19,"R329H, L17P",Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634328,10|10,96602618.0,10|10,94842861,634328,622291|622280,rs138142612|rs55752064,NC_000010.11:94842860:G:A|NC_000010.11:94762754:T:C,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94842861,rs138142612,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*18/*23,CYP2C19,"R329H, G91R",Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634280,10|10,96602618.0,10|10,94842861,634280,622291|622285,rs138142612|rs118203756,NC_000010.11:94842860:G:A|NC_000010.11:94775159:G:C,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94842861,rs138142612,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*9/*18,CYP2C19,R329H,Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634235,10,96602618.0,10,94842861,634235,622291,rs138142612,NC_000010.11:94842860:G:A,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94842861,rs138142612,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*18/*19,CYP2C19,"R329H, S51G",Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634231,10|10,96602618.0,10|10,94842861,634231,622291|166410,rs138142612|rs1564657013,NC_000010.11:94842860:G:A|NC_000010.11:94762855:A:G,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94842861,rs138142612,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*4B/*18,CYP2C19|LOC110599570,"R329H, M1V",Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634217,10|10|10,96602618.0,10|10|10,94842861,634217,622291|31939|47956,rs138142612|rs28399504|rs12248560,NC_000010.11:94842860:G:A|NC_000010.11:94762705:A:G|NC_000010.11:94761899:C:T,Diplotype,missense variant|initiator_codon_variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94842861,rs138142612,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*17/*18,CYP2C19,R329H,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634204,10,96602618.0,10,94842861,634204,622291,rs138142612,NC_000010.11:94842860:G:A,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94842861,rs138142612,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*18/*31,CYP2C19,"R329H, H78Y",Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634094,10|10,96602618.0,10|10,94842861,634094,622291|622284,rs138142612|rs1564660997,NC_000010.11:94842860:G:A|NC_000010.11:94775120:C:T,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94842861,rs138142612,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*18/*30,CYP2C19,"R329H, R73C",Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634093,10|10,96602618.0,10|10,94842861,634093,622291|622283,rs138142612|rs145328984,NC_000010.11:94842860:G:A|NC_000010.11:94775105:C:T,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94842861,rs138142612,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*12/*18,CYP2C19,R329H,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634055,10|10,96602618.0,10|10,94842861,634055,622291|622297,rs138142612|rs55640102,NC_000010.11:94842860:G:A|NC_000010.11:94852913:A:C,Diplotype,missense variant|stop lost,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94842861,rs138142612,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*18/*26,CYP2C19,"R329H, D256N",Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000633955,10|10,96602618.0,10|10,94842861,633955,622291|166409,rs138142612|rs375781227,NC_000010.11:94842860:G:A|NC_000010.11:94781943:G:A,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94842861,rs138142612,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*18/*25,CYP2C19,"R329H, F448L",Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000633954,10|10,96602618.0,10|10,94842861,633954,622291|622296,rs138142612|rs118203759,NC_000010.11:94842860:G:A|NC_000010.11:94852784:C:G,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94842861,rs138142612,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*7/*18,CYP2C19,R329H,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000633926,10,96602618.0,10,94842861,633926,622291,rs138142612,NC_000010.11:94842860:G:A,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94842861,rs138142612,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*6/*18,CYP2C19,R329H,Voriconazole response|Citalopram response|Sertraline response|Escitalopram response,VCV000633924,10,96602618.0,10,94842861,633924,622291,rs138142612,NC_000010.11:94842860:G:A,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94842861,rs138142612,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*4A/*18,CYP2C19,R329H,Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000633912,10,96602618.0,10,94842861,633912,622291,rs138142612,NC_000010.11:94842860:G:A,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94842861,rs138142612,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*3/*18,CYP2C19,R329H,Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000633909,10,96602618.0,10,94842861,633909,622291,rs138142612,NC_000010.11:94842860:G:A,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94842861,rs138142612,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*2/*18,CYP2C19,R329H,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000633903,10|10|10,96602618.0,10|10|10,94842861,633903,622291|31936|622287,rs138142612|rs4244285|rs12769205,NC_000010.11:94842860:G:A|NC_000010.11:94781858:G:A|NC_000010.11:94775366:A:G,Diplotype,missense variant|synonymous variant|intron variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94842861,rs138142612,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*18/*24,CYP2C19,"R329H, R335Q",Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000633900,10|10|10,96602618.0,10|10|10,94842861,633900,622291|622292|166407,rs138142612|rs118203757|rs377184510,NC_000010.11:94842860:G:A|NC_000010.11:94842878:G:A|NC_000010.11:94849963:A:G,Diplotype,missense variant|synonymous variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94842861,rs138142612,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*18/*22,CYP2C19,"R329H, R186P",Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000633899,10|10,96602618.0,10|10,94842861,633899,622291|622289,rs138142612|rs140278421,NC_000010.11:94842860:G:A|NC_000010.11:94780573:G:C,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94842861,rs138142612,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*18/*28,CYP2C19|LOC110599570,"R329H, I19L, V374I",Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000633888,10|10|10|10|10|10,96602618.0,10|10|10|10|10|10,94842861,633888,622291|622281|622272|622273|622293|622274,rs138142612|rs17882687|rs113164681|rs111490789|rs113934938|rs17878739,NC_000010.11:94842860:G:A|NC_000010.11:94762759:A:C|NC_000010.11:94760675:C:T|NC_000010.11:94760685:C:A|NC_000010.11:94842994:G:A|NC_000010.11:94761266:T:C,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94842861,rs138142612,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*11/*18,CYP2C19,"R329H, R150H",Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000633884,10|10,96602618.0,10|10,94842861,633884,622291|622288,rs138142612|rs58973490,NC_000010.11:94842860:G:A|NC_000010.11:94775506:G:A,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94842861,rs138142612,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*18,CYP2C19,R329H,CYP2C19: normal function,VCV000633842,10,96602618.0,10,94842861,633842,622291,rs138142612,NC_000010.11:94842860:G:A,"Haplotype, single variant",missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94842866,rs3758581,A,G,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,NM_000769.1(CYP2C19):c.991A>G (p.Ile331Val),CYP2C19,I331V,not provided,VCV000039354,10,96602623.0,10,94842866,39354,47952,rs3758581,NC_000010.11:94842865:A:G,single nucleotide variant,missense variant,Benign,"May 12, 2018","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chr10,94842879,rs118203757,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*24/*24,CYP2C19,R335Q,Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000638798,10|10,96602636.0,10|10,94842879,638798,622292|166407,rs118203757|rs377184510,NC_000010.11:94842878:G:A|NC_000010.11:94849963:A:G,Diplotype,missense variant|synonymous variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94842879,rs118203757,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,NM_000769.4(CYP2C19):c.1004G>A (p.Arg335Gln),CYP2C19,R335Q,nan,VCV000634859,10,96602636.0,10,94842879,634859,622292,rs118203757,NC_000010.11:94842878:G:A,single nucleotide variant,missense variant,no classification for the single variant,nan,no classification for the single variant,no classification for the single variant,nan,no classification for the single variant,no classification for the single variant,nan,no classification for the single variant,nan
chr10,94842879,rs118203757,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*3/*24,CYP2C19,R335Q,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634392,10|10,96602636.0,10|10,94842879,634392,622292|166407,rs118203757|rs377184510,NC_000010.11:94842878:G:A|NC_000010.11:94849963:A:G,Diplotype,missense variant|synonymous variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94842879,rs118203757,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*9/*24,CYP2C19,R335Q,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634388,10|10,96602636.0,10|10,94842879,634388,622292|166407,rs118203757|rs377184510,NC_000010.11:94842878:G:A|NC_000010.11:94849963:A:G,Diplotype,missense variant|synonymous variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94842879,rs118203757,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*24/*25,CYP2C19,"R335Q, F448L",Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634380,10|10|10,96602636.0,10|10|10,94842879,634380,622292|166407|622296,rs118203757|rs377184510|rs118203759,NC_000010.11:94842878:G:A|NC_000010.11:94849963:A:G|NC_000010.11:94852784:C:G,Diplotype,missense variant|synonymous variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94842879,rs118203757,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*24/*29,CYP2C19,"R335Q, K28I",Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634291,10|10|10,96602636.0,10|10|10,94842879,634291,622292|166407|622282,rs118203757|rs377184510|rs1564656981,NC_000010.11:94842878:G:A|NC_000010.11:94849963:A:G|NC_000010.11:94762787:A:T,Diplotype,missense variant|synonymous variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94842879,rs118203757,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*7/*24,CYP2C19,R335Q,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634253,10|10,96602636.0,10|10,94842879,634253,622292|166407,rs118203757|rs377184510,NC_000010.11:94842878:G:A|NC_000010.11:94849963:A:G,Diplotype,missense variant|synonymous variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94842879,rs118203757,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*23/*24,CYP2C19,"R335Q, G91R",Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634110,10|10|10,96602636.0,10|10|10,94842879,634110,622292|166407|622285,rs118203757|rs377184510|rs118203756,NC_000010.11:94842878:G:A|NC_000010.11:94849963:A:G|NC_000010.11:94775159:G:C,Diplotype,missense variant|synonymous variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94842879,rs118203757,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*14/*24,CYP2C19,"R335Q, L17P",Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634074,10|10|10,96602636.0,10|10|10,94842879,634074,622292|166407|622280,rs118203757|rs377184510|rs55752064,NC_000010.11:94842878:G:A|NC_000010.11:94849963:A:G|NC_000010.11:94762754:T:C,Diplotype,missense variant|synonymous variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94842879,rs118203757,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*8/*24,CYP2C19,R335Q,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634033,10|10,96602636.0,10|10,94842879,634033,622292|166407,rs118203757|rs377184510,NC_000010.11:94842878:G:A|NC_000010.11:94849963:A:G,Diplotype,missense variant|synonymous variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94842879,rs118203757,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*6/*24,CYP2C19,R335Q,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634027,10|10,96602636.0,10|10,94842879,634027,622292|166407,rs118203757|rs377184510,NC_000010.11:94842878:G:A|NC_000010.11:94849963:A:G,Diplotype,missense variant|synonymous variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94842879,rs118203757,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*5/*24,CYP2C19,R335Q,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634025,10|10,96602636.0,10|10,94842879,634025,622292|166407,rs118203757|rs377184510,NC_000010.11:94842878:G:A|NC_000010.11:94849963:A:G,Diplotype,missense variant|synonymous variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94842879,rs118203757,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*4A/*24,CYP2C19,R335Q,Voriconazole response|Escitalopram response|Sertraline response|Citalopram response,VCV000634018,10|10,96602636.0,10|10,94842879,634018,622292|166407,rs118203757|rs377184510,NC_000010.11:94842878:G:A|NC_000010.11:94849963:A:G,Diplotype,missense variant|synonymous variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94842879,rs118203757,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*19/*24,CYP2C19,"R335Q, S51G",Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000633970,10|10|10,96602636.0,10|10|10,94842879,633970,622292|166407|166410,rs118203757|rs377184510|rs1564657013,NC_000010.11:94842878:G:A|NC_000010.11:94849963:A:G|NC_000010.11:94762855:A:G,Diplotype,missense variant|synonymous variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94842879,rs118203757,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*17/*24,CYP2C19,R335Q,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000633897,10|10,96602636.0,10|10,94842879,633897,622292|166407,rs118203757|rs377184510,NC_000010.11:94842878:G:A|NC_000010.11:94849963:A:G,Diplotype,missense variant|synonymous variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94842879,rs118203757,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*24,CYP2C19,R335Q,CYP2C19: no function,VCV000633890,10|10,96602636.0,10|10,94842879,633890,622292|166407,rs118203757|rs377184510,NC_000010.11:94842878:G:A|NC_000010.11:94849963:A:G,Haplotype,missense variant|synonymous variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94842995,rs113934938,G,A,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,NM_000769.4(CYP2C19):c.1120G>A (p.Val374Ile),CYP2C19,V374I,nan,VCV000634877,10,96602752.0,10,94842995,634877,622293,rs113934938,NC_000010.11:94842994:G:A,single nucleotide variant,missense variant,no classification for the single variant,nan,no classification for the single variant,no classification for the single variant,nan,no classification for the single variant,no classification for the single variant,nan,no classification for the single variant,nan
chr10,94849995,rs17879685,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*13/*13,CYP2C19,R410C,Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000638796,10,96609752.0,10,94849995,638796,622294,rs17879685,NC_000010.11:94849994:C:T,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94849995,rs17879685,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*4A/*13,CYP2C19,R410C,Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634362,10,96609752.0,10,94849995,634362,622294,rs17879685,NC_000010.11:94849994:C:T,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94849995,rs17879685,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*2/*13,CYP2C19,R410C,Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634360,10|10|10,96609752.0,10|10|10,94849995,634360,622294|31936|622287,rs17879685|rs4244285|rs12769205,NC_000010.11:94849994:C:T|NC_000010.11:94781858:G:A|NC_000010.11:94775366:A:G,Diplotype,missense variant|synonymous variant|intron variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94849995,rs17879685,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*13/*31,CYP2C19,"R410C, H78Y",Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634268,10|10,96609752.0,10|10,94849995,634268,622294|622284,rs17879685|rs1564660997,NC_000010.11:94849994:C:T|NC_000010.11:94775120:C:T,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94849995,rs17879685,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*13/*30,CYP2C19,"R410C, R73C",Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634267,10|10,96609752.0,10|10,94849995,634267,622294|622283,rs17879685|rs145328984,NC_000010.11:94849994:C:T|NC_000010.11:94775105:C:T,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94849995,rs17879685,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*13/*25,CYP2C19,"R410C, F448L",Escitalopram response|Voriconazole response|Citalopram response|Sertraline response,VCV000634227,10|10,96609752.0,10|10,94849995,634227,622294|622296,rs17879685|rs118203759,NC_000010.11:94849994:C:T|NC_000010.11:94852784:C:G,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94849995,rs17879685,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*13/*19,CYP2C19,"R410C, S51G",Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634226,10|10,96609752.0,10|10,94849995,634226,622294|166410,rs17879685|rs1564657013,NC_000010.11:94849994:C:T|NC_000010.11:94762855:A:G,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94849995,rs17879685,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*13/*16,CYP2C19,"R410C, R442C",Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634225,10|10,96609752.0,10|10,94849995,634225,622294|622295,rs17879685|rs192154563,NC_000010.11:94849994:C:T|NC_000010.11:94852764:C:T,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94849995,rs17879685,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*7/*13,CYP2C19,R410C,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634219,10,96609752.0,10,94849995,634219,622294,rs17879685,NC_000010.11:94849994:C:T,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94849995,rs17879685,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*13/*17,CYP2C19,R410C,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634202,10,96609752.0,10,94849995,634202,622294,rs17879685,NC_000010.11:94849994:C:T,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94849995,rs17879685,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*13/*34,CYP2C19|LOC110599570,"R410C, P3S, F4L",Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634070,10|10|10|10,96609752.0,10|10|10|10,94849995,634070,622294|622278|622279|622277,rs17879685|rs367543002|rs367543003|rs367543001,NC_000010.11:94849994:C:T|NC_000010.11:94762711:C:T|NC_000010.11:94762714:T:C|NC_000010.11:94762692:G:A,Diplotype,missense variant|5 prime UTR variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94849995,rs17879685,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*13/*29,CYP2C19,"R410C, K28I",Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634068,10|10,96609752.0,10|10,94849995,634068,622294|622282,rs17879685|rs1564656981,NC_000010.11:94849994:C:T|NC_000010.11:94762787:A:T,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94849995,rs17879685,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*13/*27,LOC110599570|CYP2C19,R410C,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634067,10|10,96609752.0,10|10,94849995,634067,622294|622275,rs17879685|rs7902257,NC_000010.11:94849994:C:T|NC_000010.11:94761664:G:A,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94849995,rs17879685,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*13/*23,CYP2C19,"R410C, G91R",Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634066,10|10,96609752.0,10|10,94849995,634066,622294|622285,rs17879685|rs118203756,NC_000010.11:94849994:C:T|NC_000010.11:94775159:G:C,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94849995,rs17879685,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*13/*14,CYP2C19,"R410C, L17P",Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634065,10|10,96609752.0,10|10,94849995,634065,622294|622280,rs17879685|rs55752064,NC_000010.11:94849994:C:T|NC_000010.11:94762754:T:C,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94849995,rs17879685,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*12/*13,CYP2C19,R410C,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634053,10|10,96609752.0,10|10,94849995,634053,622294|622297,rs17879685|rs55640102,NC_000010.11:94849994:C:T|NC_000010.11:94852913:A:C,Diplotype,missense variant|stop lost,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94849995,rs17879685,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*9/*13,CYP2C19,R410C,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000633961,10,96609752.0,10,94849995,633961,622294,rs17879685,NC_000010.11:94849994:C:T,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94849995,rs17879685,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*13/*26,CYP2C19,"R410C, D256N",Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000633945,10|10,96609752.0,10|10,94849995,633945,622294|166409,rs17879685|rs375781227,NC_000010.11:94849994:C:T|NC_000010.11:94781943:G:A,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94849995,rs17879685,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*8/*13,CYP2C19,R410C,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000633929,10,96609752.0,10,94849995,633929,622294,rs17879685,NC_000010.11:94849994:C:T,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94849995,rs17879685,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*6/*13,CYP2C19,R410C,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000633921,10,96609752.0,10,94849995,633921,622294,rs17879685,NC_000010.11:94849994:C:T,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94849995,rs17879685,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*5/*13,CYP2C19,R410C,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000633918,10,96609752.0,10,94849995,633918,622294,rs17879685,NC_000010.11:94849994:C:T,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94849995,rs17879685,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*4B/*13,CYP2C19|LOC110599570,"R410C, M1V",Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000633915,10|10|10,96609752.0,10|10|10,94849995,633915,622294|31939|47956,rs17879685|rs28399504|rs12248560,NC_000010.11:94849994:C:T|NC_000010.11:94762705:A:G|NC_000010.11:94761899:C:T,Diplotype,missense variant|initiator_codon_variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94849995,rs17879685,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*3/*13,CYP2C19,R410C,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000633906,10,96609752.0,10,94849995,633906,622294,rs17879685,NC_000010.11:94849994:C:T,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94849995,rs17879685,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*13/*35,CYP2C19,R410C,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000633895,10|10,96609752.0,10|10,94849995,633895,622294|622287,rs17879685|rs12769205,NC_000010.11:94849994:C:T|NC_000010.11:94775366:A:G,Diplotype,missense variant|intron variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94849995,rs17879685,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*13/*24,CYP2C19,"R410C, R335Q",Sertraline response|Voriconazole response|Citalopram response|Escitalopram response,VCV000633894,10|10|10,96609752.0,10|10|10,94849995,633894,622294|622292|166407,rs17879685|rs118203757|rs377184510,NC_000010.11:94849994:C:T|NC_000010.11:94842878:G:A|NC_000010.11:94849963:A:G,Diplotype,missense variant|synonymous variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94849995,rs17879685,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*13/*15,CYP2C19,"R410C, I19L",Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000633886,10|10,96609752.0,10|10,94849995,633886,622294|622281,rs17879685|rs17882687,NC_000010.11:94849994:C:T|NC_000010.11:94762759:A:C,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94849995,rs17879685,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*1/*13,CYP2C19|LOC110599570,R410C,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000633880,10|,96609752.0,10|10,94849995,633880,622294|622276,rs17879685,NC_000010.11:94849994:C:T,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94849995,rs17879685,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*13,CYP2C19,R410C,CYP2C19: normal function,VCV000633846,10,96609752.0,10,94849995,633846,622294,rs17879685,NC_000010.11:94849994:C:T,"Haplotype, single variant",missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94852738,rs56337013,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,NM_000769.1(CYP2C19):c.1297C>T (p.Arg433Trp),CYP2C19,R433W,CYP2C19: no function,VCV000016898,10,96612495.0,10,94852738,16898,31937,rs56337013,NC_000010.11:94852737:C:T,single nucleotide variant,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94852765,rs192154563,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*16/*16,CYP2C19,R442C,Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000638802,10,96612522.0,10,94852765,638802,622295,rs192154563,NC_000010.11:94852764:C:T,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94852765,rs192154563,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*16/*29,CYP2C19,"R442C, K28I",Sertraline response|Voriconazole response|Citalopram response|Escitalopram response,VCV000634403,10|10,96612522.0,10|10,94852765,634403,622295|622282,rs192154563|rs1564656981,NC_000010.11:94852764:C:T|NC_000010.11:94762787:A:T,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94852765,rs192154563,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*16/*27,LOC110599570|CYP2C19,R442C,Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634402,10|10,96612522.0,10|10,94852765,634402,622295|622275,rs192154563|rs7902257,NC_000010.11:94852764:C:T|NC_000010.11:94761664:G:A,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94852765,rs192154563,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*4B/*16,CYP2C19|LOC110599570,"R442C, M1V",Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634384,10|10|10,96612522.0,10|10|10,94852765,634384,622295|31939|47956,rs192154563|rs28399504|rs12248560,NC_000010.11:94852764:C:T|NC_000010.11:94762705:A:G|NC_000010.11:94761899:C:T,Diplotype,missense variant|initiator_codon_variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94852765,rs192154563,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*16/*17,CYP2C19,R442C,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634372,10,96612522.0,10,94852765,634372,622295,rs192154563,NC_000010.11:94852764:C:T,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94852765,rs192154563,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*16/*23,CYP2C19,"R442C, G91R",Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634276,10|10,96612522.0,10|10,94852765,634276,622295|622285,rs192154563|rs118203756,NC_000010.11:94852764:C:T|NC_000010.11:94775159:G:C,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94852765,rs192154563,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*12/*16,CYP2C19,R442C,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634263,10|10,96612522.0,10|10,94852765,634263,622295|622297,rs192154563|rs55640102,NC_000010.11:94852764:C:T|NC_000010.11:94852913:A:C,Diplotype,missense variant|stop lost,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94852765,rs192154563,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*8/*16,CYP2C19,R442C,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634247,10,96612522.0,10,94852765,634247,622295,rs192154563,NC_000010.11:94852764:C:T,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94852765,rs192154563,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*5/*16,CYP2C19,R442C,Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634242,10,96612522.0,10,94852765,634242,622295,rs192154563,NC_000010.11:94852764:C:T,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94852765,rs192154563,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*2/*16,CYP2C19,R442C,Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634238,10|10|10,96612522.0,10|10|10,94852765,634238,622295|31936|622287,rs192154563|rs4244285|rs12769205,NC_000010.11:94852764:C:T|NC_000010.11:94781858:G:A|NC_000010.11:94775366:A:G,Diplotype,missense variant|synonymous variant|intron variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94852765,rs192154563,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*9/*16,CYP2C19,R442C,Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634233,10,96612522.0,10,94852765,634233,622295,rs192154563,NC_000010.11:94852764:C:T,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94852765,rs192154563,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*16/*31,CYP2C19,"R442C, H78Y",Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634086,10|10,96612522.0,10|10,94852765,634086,622295|622284,rs192154563|rs1564660997,NC_000010.11:94852764:C:T|NC_000010.11:94775120:C:T,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94852765,rs192154563,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*14/*16,CYP2C19,"R442C, L17P",Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634072,10|10,96612522.0,10|10,94852765,634072,622295|622280,rs192154563|rs55752064,NC_000010.11:94852764:C:T|NC_000010.11:94762754:T:C,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94852765,rs192154563,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*7/*16,CYP2C19,R442C,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000633997,10,96612522.0,10,94852765,633997,622295,rs192154563,NC_000010.11:94852764:C:T,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94852765,rs192154563,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*6/*16,CYP2C19,R442C,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000633994,10,96612522.0,10,94852765,633994,622295,rs192154563,NC_000010.11:94852764:C:T,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94852765,rs192154563,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*4A/*16,CYP2C19,R442C,Escitalopram response|Voriconazole response|Citalopram response|Sertraline response,VCV000633982,10,96612522.0,10,94852765,633982,622295,rs192154563,NC_000010.11:94852764:C:T,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94852765,rs192154563,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*3/*16,CYP2C19,R442C,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000633979,10,96612522.0,10,94852765,633979,622295,rs192154563,NC_000010.11:94852764:C:T,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94852765,rs192154563,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*16/*35,CYP2C19,R442C,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000633968,10|10,96612522.0,10|10,94852765,633968,622295|622287,rs192154563|rs12769205,NC_000010.11:94852764:C:T|NC_000010.11:94775366:A:G,Diplotype,missense variant|intron variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94852765,rs192154563,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*16/*24,CYP2C19,"R442C, R335Q",Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000633967,10|10|10,96612522.0,10|10|10,94852765,633967,622295|622292|166407,rs192154563|rs118203757|rs377184510,NC_000010.11:94852764:C:T|NC_000010.11:94842878:G:A|NC_000010.11:94849963:A:G,Diplotype,missense variant|synonymous variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94852765,rs192154563,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*16/*26,CYP2C19,"R442C, D256N",Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000633951,10|10,96612522.0,10|10,94852765,633951,622295|166409,rs192154563|rs375781227,NC_000010.11:94852764:C:T|NC_000010.11:94781943:G:A,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94852765,rs192154563,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*16/*25,CYP2C19,"R442C, F448L",Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000633950,10|10,96612522.0,10|10,94852765,633950,622295|622296,rs192154563|rs118203759,NC_000010.11:94852764:C:T|NC_000010.11:94852784:C:G,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94852765,rs192154563,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*16/*19,CYP2C19,"R442C, S51G",Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000633949,10|10,96612522.0,10|10,94852765,633949,622295|166410,rs192154563|rs1564657013,NC_000010.11:94852764:C:T|NC_000010.11:94762855:A:G,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94852765,rs192154563,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*15/*16,CYP2C19,"R442C, I19L",Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000633946,10|10,96612522.0,10|10,94852765,633946,622295|622281,rs192154563|rs17882687,NC_000010.11:94852764:C:T|NC_000010.11:94762759:A:C,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94852765,rs192154563,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*1/*16,CYP2C19|LOC110599570,R442C,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000633932,10|,96612522.0,10|10,94852765,633932,622295|622276,rs192154563,NC_000010.11:94852764:C:T,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94852765,rs192154563,C,T,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*16,CYP2C19,R442C,CYP2C19: decreased function,VCV000633849,10,96612522.0,10,94852765,633849,622295,rs192154563,NC_000010.11:94852764:C:T,"Haplotype, single variant",missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94852785,rs118203759,C,G,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*25/*25,CYP2C19,F448L,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000638792,10,96612542.0,10,94852785,638792,622296,rs118203759,NC_000010.11:94852784:C:G,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94852785,rs118203759,C,G,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*6/*25,CYP2C19,F448L,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634385,10,96612542.0,10,94852785,634385,622296,rs118203759,NC_000010.11:94852784:C:G,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94852785,rs118203759,C,G,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*5/*25,CYP2C19,F448L,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634244,10,96612542.0,10,94852785,634244,622296,rs118203759,NC_000010.11:94852784:C:G,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94852785,rs118203759,C,G,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*3/*25,CYP2C19,F448L,Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634239,10,96612542.0,10,94852785,634239,622296,rs118203759,NC_000010.11:94852784:C:G,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94852785,rs118203759,C,G,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*17/*25,CYP2C19,F448L,Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634229,10,96612542.0,10,94852785,634229,622296,rs118203759,NC_000010.11:94852784:C:G,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94852785,rs118203759,C,G,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*25/*29,CYP2C19,"F448L, K28I",Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634125,10|10,96612542.0,10|10,94852785,634125,622296|622282,rs118203759|rs1564656981,NC_000010.11:94852784:C:G|NC_000010.11:94762787:A:T,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94852785,rs118203759,C,G,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*23/*25,CYP2C19,"F448L, G91R",Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634111,10|10,96612542.0,10|10,94852785,634111,622296|622285,rs118203759|rs118203756,NC_000010.11:94852784:C:G|NC_000010.11:94775159:G:C,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94852785,rs118203759,C,G,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*14/*25,CYP2C19,"F448L, L17P",Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634075,10|10,96612542.0,10|10,94852785,634075,622296|622280,rs118203759|rs55752064,NC_000010.11:94852784:C:G|NC_000010.11:94762754:T:C,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94852785,rs118203759,C,G,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*8/*25,CYP2C19,F448L,Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634002,10,96612542.0,10,94852785,634002,622296,rs118203759,NC_000010.11:94852784:C:G,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94852785,rs118203759,C,G,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*7/*25,CYP2C19,F448L,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000633999,10,96612542.0,10,94852785,633999,622296,rs118203759,NC_000010.11:94852784:C:G,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94852785,rs118203759,C,G,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*4A/*25,CYP2C19,F448L,Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000633984,10,96612542.0,10,94852785,633984,622296,rs118203759,NC_000010.11:94852784:C:G,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94852785,rs118203759,C,G,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*9/*25,CYP2C19,F448L,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000633963,10,96612542.0,10,94852785,633963,622296,rs118203759,NC_000010.11:94852784:C:G,Diplotype,missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94852785,rs118203759,C,G,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*25,CYP2C19,F448L,CYP2C19: decreased function,VCV000633935,10,96612542.0,10,94852785,633935,622296,rs118203759,NC_000010.11:94852784:C:G,"Haplotype, single variant",missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94852914,rs55640102,A,C,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*12/*12,CYP2C19,nan,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000638205,10,96612671.0,10,94852914,638205,622297,rs55640102,NC_000010.11:94852913:A:C,Diplotype,stop lost,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94852914,rs55640102,A,C,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*9/*12,CYP2C19,nan,Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634425,10,96612671.0,10,94852914,634425,622297,rs55640102,NC_000010.11:94852913:A:C,Diplotype,stop lost,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94852914,rs55640102,A,C,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*12/*26,CYP2C19,D256N,Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634398,10|10,96612671.0,10|10,94852914,634398,622297|166409,rs55640102|rs375781227,NC_000010.11:94852913:A:C|NC_000010.11:94781943:G:A,Diplotype,stop lost|missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94852914,rs55640102,A,C,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*12/*15,CYP2C19,I19L,Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634324,10|10,96612671.0,10|10,94852914,634324,622297|622281,rs55640102|rs17882687,NC_000010.11:94852913:A:C|NC_000010.11:94762759:A:C,Diplotype,stop lost|missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94852914,rs55640102,A,C,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*12/*14,CYP2C19,L17P,Escitalopram response|Voriconazole response|Citalopram response|Sertraline response,VCV000634323,10|10,96612671.0,10|10,94852914,634323,622297|622280,rs55640102|rs55752064,NC_000010.11:94852913:A:C|NC_000010.11:94762754:T:C,Diplotype,stop lost|missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94852914,rs55640102,A,C,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*1/*12,CYP2C19|LOC110599570,nan,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634320,10|,96612671.0,10|10,94852914,634320,622297|622276,rs55640102,NC_000010.11:94852913:A:C,Diplotype,stop lost,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94852914,rs55640102,A,C,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*5/*12,CYP2C19,nan,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634309,10,96612671.0,10,94852914,634309,622297,rs55640102,NC_000010.11:94852913:A:C,Diplotype,stop lost,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94852914,rs55640102,A,C,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*3/*12,CYP2C19,nan,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634299,10,96612671.0,10,94852914,634299,622297,rs55640102,NC_000010.11:94852913:A:C,Diplotype,stop lost,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94852914,rs55640102,A,C,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*2/*12,CYP2C19,nan,Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634284,10|10|10,96612671.0,10|10|10,94852914,634284,622297|31936|622287,rs55640102|rs4244285|rs12769205,NC_000010.11:94852913:A:C|NC_000010.11:94781858:G:A|NC_000010.11:94775366:A:G,Diplotype,stop lost|synonymous variant|intron variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94852914,rs55640102,A,C,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*12/*25,CYP2C19,F448L,Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634265,10|10,96612671.0,10|10,94852914,634265,622297|622296,rs55640102|rs118203759,NC_000010.11:94852913:A:C|NC_000010.11:94852784:C:G,Diplotype,stop lost|missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94852914,rs55640102,A,C,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*12/*24,CYP2C19,R335Q,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634264,10|10|10,96612671.0,10|10|10,94852914,634264,622297|622292|166407,rs55640102|rs118203757|rs377184510,NC_000010.11:94852913:A:C|NC_000010.11:94842878:G:A|NC_000010.11:94849963:A:G,Diplotype,stop lost|missense variant|synonymous variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94852914,rs55640102,A,C,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*8/*12,CYP2C19,nan,Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634190,10,96612671.0,10,94852914,634190,622297,rs55640102,NC_000010.11:94852913:A:C,Diplotype,stop lost,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94852914,rs55640102,A,C,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*7/*12,CYP2C19,nan,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634183,10,96612671.0,10,94852914,634183,622297,rs55640102,NC_000010.11:94852913:A:C,Diplotype,stop lost,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94852914,rs55640102,A,C,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*6/*12,CYP2C19,nan,Escitalopram response|Sertraline response|Voriconazole response|Citalopram response,VCV000634176,10,96612671.0,10,94852914,634176,622297,rs55640102,NC_000010.11:94852913:A:C,Diplotype,stop lost,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94852914,rs55640102,A,C,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*4B/*12,CYP2C19|LOC110599570,M1V,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634165,10|10|10,96612671.0,10|10|10,94852914,634165,622297|31939|47956,rs55640102|rs28399504|rs12248560,NC_000010.11:94852913:A:C|NC_000010.11:94762705:A:G|NC_000010.11:94761899:C:T,Diplotype,stop lost|missense variant|initiator_codon_variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94852914,rs55640102,A,C,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*4A/*12,CYP2C19,nan,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634158,10,96612671.0,10,94852914,634158,622297,rs55640102,NC_000010.11:94852913:A:C,Diplotype,stop lost,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94852914,rs55640102,A,C,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*12/*29,CYP2C19,K28I,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634061,10|10,96612671.0,10|10,94852914,634061,622297|622282,rs55640102|rs1564656981,NC_000010.11:94852913:A:C|NC_000010.11:94762787:A:T,Diplotype,stop lost|missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94852914,rs55640102,A,C,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*12/*23,CYP2C19,G91R,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634058,10|10,96612671.0,10|10,94852914,634058,622297|622285,rs55640102|rs118203756,NC_000010.11:94852913:A:C|NC_000010.11:94775159:G:C,Diplotype,stop lost|missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94852914,rs55640102,A,C,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*12/*19,CYP2C19,S51G,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634056,10|10,96612671.0,10|10,94852914,634056,622297|166410,rs55640102|rs1564657013,NC_000010.11:94852913:A:C|NC_000010.11:94762855:A:G,Diplotype,stop lost|missense variant,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94852914,rs55640102,A,C,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*12/*17,CYP2C19,nan,Voriconazole response|Citalopram response|Escitalopram response|Sertraline response,VCV000634054,10,96612671.0,10,94852914,634054,622297,rs55640102,NC_000010.11:94852913:A:C,Diplotype,stop lost,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94852914,rs55640102,A,C,.,PASS,PX=CYP2C19,GT,0/0,CYP2C19_NM,CYP2C19*12,CYP2C19,nan,CYP2C19: uncertain function,VCV000633853,10,96612671.0,10,94852914,633853,622297,rs55640102,NC_000010.11:94852913:A:C,"Haplotype, single variant",stop lost,drug response,nan,practice guideline,nan,nan,nan,nan,nan,nan,nan
chr10,94938683,rs114071557,A,G,.,PASS,PX=CYP2C9,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr10,94938719,.,T,G,.,PASS,PX=CYP2C9,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr10,94938737,rs67807361,C,A,.,PASS,PX=CYP2C9,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr10,94938771,rs142240658,C,T,.,PASS,PX=CYP2C9,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr10,94938788,.,C,T,.,PASS,PX=CYP2C9,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr10,94938800,rs1364419386,G,A,.,PASS,PX=CYP2C9,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr10,94938803,rs2031308986,A,G,.,PASS,PX=CYP2C9,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr10,94938828,rs564813580,A,G,.,PASS,PX=CYP2C9,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr10,94941897,rs371055887,G,C,.,PASS,PX=CYP2C9,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr10,94941915,.,G,A,.,PASS,PX=CYP2C9,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr10,94941958,rs72558187,T,C,.,PASS,PX=CYP2C9,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr10,94941975,.,G,A,.,PASS,PX=CYP2C9,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr10,94941976,.,G,C,.,PASS,PX=CYP2C9,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr10,94941982,rs762239445,G,T,.,PASS,PX=CYP2C9,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr10,94942018,.,T,C,.,PASS,PX=CYP2C9,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr10,94942205,rs1304490498,CAATGGAAAGA,C,.,PASS,PX=CYP2C9,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr10,94942216,rs774607211,A,G,.,PASS,PX=CYP2C9,GT,0/0,CYP2C9_NM,NM_000771.4(CYP2C9):c.356A>G (p.Lys119Arg),CYP2C9,K119R,Warfarin response,VCV003376535,10,96701973,10,94942216,3376535,3535720,nan,NC_000010.11:94942215:A:G,single nucleotide variant,missense variant,drug response,nan,no assertion criteria provided,nan,nan,nan,nan,nan,nan,nan
chr10,94942230,rs767576260,C,T,.,PASS,PX=CYP2C9,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr10,94942231,rs12414460,G,A,.,PASS,PX=CYP2C9,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr10,94942233,rs375805362,C,T,.,PASS,PX=CYP2C9,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr10,94942234,rs72558189,G,"A,T",.,PASS,PX=CYP2C9,GT,0/0,CYP2C9_NM,NM_000771.4(CYP2C9):c.374G>A (p.Arg125His),CYP2C9,R125H,not provided,VCV001167372,10,96701991,10,94942234,1167372,1156516,rs72558189,NC_000010.11:94942233:G:A,single nucleotide variant,missense variant,Benign,"Aug 21, 2021","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chr10,94942243,rs1375956433,T,G,.,PASS,PX=CYP2C9,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr10,94942249,rs200965026,C,"G,T",.,PASS,PX=CYP2C9,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr10,94942254,rs199523631,C,T,.,PASS,PX=CYP2C9,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr10,94942255,rs200183364,G,A,.,PASS,PX=CYP2C9,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr10,94942290,rs1799853,C,T,.,PASS,PX=CYP2C9,GT,0/0,CYP2C9_NM,NM_000771.4(CYP2C9):c.430= (p.Arg144=),CYP2C9,nan,nan,VCV000242622,10,96702047,10,94942290,242622,175331,rs1799853,NC_000010.11:94942289:C:C,single nucleotide variant,no sequence alteration,no classification for the single variant,nan,no classification for the single variant,no classification for the single variant,nan,no classification for the single variant,no classification for the single variant,nan,no classification for the single variant,nan
chr10,94942290,rs1799853,C,T,.,PASS,PX=CYP2C9,GT,0/0,CYP2C9_NM,NM_000771.3(CYP2C9):c.[430C>T;1075A=],CYP2C9,R144C,Warfarin response,VCV000177709,10|10,96702047,10|10,94942290,177709,23448|175053,rs1799853|rs1057910|rs2032229276,NC_000010.11:94942289:C:T|NC_000010.11:94981295:A:A,Haplotype,missense variant|no sequence alteration,drug response,"Nov 20, 2006",no assertion criteria provided,nan,nan,nan,nan,nan,nan,nan
chr10,94942290,rs1799853,C,T,.,PASS,PX=CYP2C9,GT,0/0,CYP2C9_NM,NM_000771.3(CYP2C9):c.[430C=;1075A=],CYP2C9,nan,Warfarin response,VCV000163020,10|10,96702047,10|10,94942290,163020,175331|175053,rs1799853|rs1057910|rs2032229276,NC_000010.11:94942289:C:C|NC_000010.11:94981295:A:A,Haplotype,no sequence alteration,drug response,"Mar 10, 2008",no assertion criteria provided,nan,nan,nan,nan,nan,nan,nan
chr10,94942290,rs1799853,C,T,.,PASS,PX=CYP2C9,GT,0/0,CYP2C9_NM,CYP2C9*2,CYP2C9,R144C,Flurbiprofen response|Piroxicam response|Lesinurad response|not specified|not provided,VCV000008409,10,96702047,10,94942290,8409,23448,rs1799853,NC_000010.11:94942289:C:T,single nucleotide variant,missense variant,Likely benign; drug response; other,"Feb 11, 2019","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chr10,94942291,rs141489852,G,A,.,PASS,PX=CYP2C9,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr10,94942305,rs754487195,G,A,.,PASS,PX=CYP2C9,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr10,94942306,rs1289704600,C,T,.,PASS,PX=CYP2C9,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr10,94942308,rs17847037,C,T,.,PASS,PX=CYP2C9,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr10,94942309,rs7900194,G,"A,T",.,PASS,PX=CYP2C9,GT,0/0,CYP2C9_NM,CYP2C9*8,CYP2C9,R150H,Lesinurad response|Flurbiprofen response|not provided|Piroxicam response,VCV000226024,10,96702066,10,94942309,226024,227771,rs7900194,NC_000010.11:94942308:G:A,single nucleotide variant,missense variant,Benign/Likely benign; drug response,"Jul 3, 2023","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chr10,94947782,rs72558190,C,A,.,PASS,PX=CYP2C9,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr10,94947785,rs774550549,C,T,.,PASS,PX=CYP2C9,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr10,94947869,.,A,G,.,PASS,PX=CYP2C9,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr10,94947907,.,A,C,.,PASS,PX=CYP2C9,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr10,94947917,rs1326630788,T,C,.,PASS,PX=CYP2C9,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr10,94947938,rs2031531005,A,T,.,PASS,PX=CYP2C9,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr10,94947939,rs370100007,G,T,.,PASS,PX=CYP2C9,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr10,94949129,.,A,G,.,PASS,PX=CYP2C9,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr10,94949144,.,C,T,.,PASS,PX=CYP2C9,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr10,94949145,rs772782449,C,T,.,PASS,PX=CYP2C9,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr10,94949161,.,AT,A,.,PASS,PX=CYP2C9,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr10,94949217,rs2256871,A,G,.,PASS,PX=CYP2C9,GT,0/0,CYP2C9_NM,NM_000771.4(CYP2C9):c.752A>G (p.His251Arg),CYP2C9,H251R,not provided,VCV000773002,10,96708974,10,94949217,773002,701489,rs2256871,NC_000010.11:94949216:A:G,single nucleotide variant,missense variant,Benign,"Mar 10, 2020","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chr10,94949280,rs9332130,A,G,.,PASS,PX=CYP2C9,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr10,94949281,rs9332131,GA,G,.,PASS,PX=CYP2C9,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr10,94972119,rs182132442,C,A,.,PASS,PX=CYP2C9,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr10,94972123,.,C,G,.,PASS,PX=CYP2C9,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr10,94972134,.,A,G,.,PASS,PX=CYP2C9,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr10,94972179,rs72558192,A,G,.,PASS,PX=CYP2C9,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr10,94972180,rs988617574,C,G,.,PASS,PX=CYP2C9,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr10,94972183,.,A,T,.,PASS,PX=CYP2C9,GT,0/0,CYP2C9_NM,NM_000771.4(CYP2C9):c.899A>T (p.Glu300Val),CYP2C9,E300V,not specified,VCV003270586,10,96731940,10,94972183,3270586,3420148,nan,NC_000010.11:94972182:A:T,single nucleotide variant,missense variant,Uncertain significance,"May 20, 2024","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chr10,94972233,rs1237225311,C,T,.,PASS,PX=CYP2C9,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr10,94981199,.,G,T,.,PASS,PX=CYP2C9,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr10,94981201,rs57505750,T,C,.,PASS,PX=CYP2C9,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr10,94981224,rs28371685,C,T,.,PASS,PX=CYP2C9,GT,0/0,CYP2C9_NM,CYP2C9*11,CYP2C9,R335W,not provided|Lesinurad response|Flurbiprofen response|Piroxicam response,VCV000370010,10,96740981,10,94981224,370010,354244,rs28371685,NC_000010.11:94981223:C:T,single nucleotide variant,missense variant,Benign/Likely benign; drug response,"Jan 18, 2024","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chr10,94981225,rs367826293,G,A,.,PASS,PX=CYP2C9,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr10,94981230,rs1274535931,C,A,.,PASS,PX=CYP2C9,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr10,94981250,rs750820937,C,A,.,PASS,PX=CYP2C9,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr10,94981258,rs1297714792,C,T,.,PASS,PX=CYP2C9,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr10,94981281,rs749060448,G,A,.,PASS,PX=CYP2C9,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr10,94981296,rs1057910,A,C,.,PASS,PX=CYP2C9,GT,0/0,CYP2C9_NM,NM_000771.4(CYP2C9):c.1075= (p.Ile359=),CYP2C9,nan,nan,VCV000242623,10,96741053,10,94981296,242623,175053,rs1057910|rs2032229276,NC_000010.11:94981295:A:A,single nucleotide variant,no sequence alteration,no classification for the single variant,nan,no classification for the single variant,no classification for the single variant,nan,no classification for the single variant,no classification for the single variant,nan,no classification for the single variant,nan
chr10,94981296,rs1057910,A,C,.,PASS,PX=CYP2C9,GT,0/0,CYP2C9_NM,NM_000771.3(CYP2C9):c.[430C=;1075A>C],CYP2C9,I359L,Warfarin response,VCV000163021,10|10,96741053,10|10,94981296,163021,23447|175331,rs1057910|rs1799853,NC_000010.11:94981295:A:C|NC_000010.11:94942289:C:C,Haplotype,missense variant|no sequence alteration,drug response,"Nov 20, 2006",no assertion criteria provided,nan,nan,nan,nan,nan,nan,nan
chr10,94981296,rs1057910,A,C,.,PASS,PX=CYP2C9,GT,0/0,CYP2C9_NM,CYP2C9*3,CYP2C9,I359L,Flurbiprofen response|Piroxicam response|Lesinurad response|not provided,VCV000008408,10,96741053,10,94981296,8408,23447,rs1057910,NC_000010.11:94981295:A:C,single nucleotide variant,missense variant,drug response; other,"Feb 11, 2019","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chr10,94981297,rs56165452,T,C,.,PASS,PX=CYP2C9,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr10,94981301,rs28371686,C,G,.,PASS,PX=CYP2C9,GT,0/0,CYP2C9_NM,CYP2C9*5,CYP2C9,D360E,Lesinurad response|Flurbiprofen response|not provided|Piroxicam response,VCV000225984,10,96741058,10,94981301,225984,227774,rs28371686,NC_000010.11:94981300:C:G,single nucleotide variant,missense variant,Benign/Likely benign; drug response; other,"Jan 20, 2020","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chr10,94981302,rs1250577724,C,A,.,PASS,PX=CYP2C9,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr10,94981305,rs578144976,C,G,.,PASS,PX=CYP2C9,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr10,94981365,.,C,T,.,PASS,PX=CYP2C9,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr10,94981371,rs542577750,G,A,.,PASS,PX=CYP2C9,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr10,94986042,rs764211126,A,G,.,PASS,PX=CYP2C9,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr10,94986073,rs72558193,A,C,.,PASS,PX=CYP2C9,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr10,94986136,rs1254213342,A,C,.,PASS,PX=CYP2C9,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr10,94986174,rs1441296358,G,C,.,PASS,PX=CYP2C9,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr10,94988852,rs776908257,C,T,.,PASS,PX=CYP2C9,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr10,94988855,.,A,T,.,PASS,PX=CYP2C9,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr10,94988880,.,G,T,.,PASS,PX=CYP2C9,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr10,94988917,rs769942899,G,C,.,PASS,PX=CYP2C9,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr10,94988925,rs202201137,A,G,.,PASS,PX=CYP2C9,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr10,94988955,rs767284820,T,C,.,PASS,PX=CYP2C9,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr10,94988984,rs781583846,G,A,.,PASS,PX=CYP2C9,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr10,94989020,rs9332239,C,T,.,PASS,PX=CYP2C9,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr10,94989023,rs868182778,G,T,.,PASS,PX=CYP2C9,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr12,21172734,rs139257324,C,T,.,PASS,PX=SLCO1B1,GT,0/0,SLCO1B1_NM,NM_006446.5(SLCO1B1):c.169C>T (p.Arg57Trp),SLCO1B1,R57W,Rotor syndrome,VCV000881967,12,21325668,12,21172734,881967,869622,rs139257324,NC_000012.12:21172733:C:T,single nucleotide variant,missense variant,Uncertain significance,"Apr 27, 2017","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chr12,21172776,rs373327528,G,A,.,PASS,PX=SLCO1B1,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr12,21172782,rs56101265,T,C,.,PASS,PX=SLCO1B1,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr12,21174595,rs56061388,T,C,.,PASS,PX=SLCO1B1,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr12,21176804,rs2306283,A,G,.,PASS,PX=SLCO1B1,GT,0/0,SLCO1B1_NM,NM_006446.5(SLCO1B1):c.388A>G (p.Asn130Asp),SLCO1B1,N130D,not provided|Rotor syndrome|not specified,VCV000259983,12,21329738,12,21176804,259983,254471,rs2306283,NC_000012.12:21176803:A:G,single nucleotide variant,missense variant,Benign,"Nov 29, 2024","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chr12,21176868,rs2306282,A,G,.,PASS,PX=SLCO1B1,GT,0/0,SLCO1B1_NM,NM_006446.5(SLCO1B1):c.452A>G (p.Asn151Ser),SLCO1B1,N151S,Rotor syndrome,VCV000883909,12,21329802,12,21176868,883909,869626,rs2306282,NC_000012.12:21176867:A:G,single nucleotide variant,missense variant,Benign,"Apr 27, 2017","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chr12,21176871,.,G,A,.,PASS,PX=SLCO1B1,GT,0/0,SLCO1B1_NM,NM_006446.5(SLCO1B1):c.455G>C (p.Arg152Thr),SLCO1B1,R152T,Rotor syndrome,VCV000883910,12,21329805,12,21176871,883910,869627,rs145144129,NC_000012.12:21176870:G:C,single nucleotide variant,missense variant,Uncertain significance,"Sep 14, 2023","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chr12,21176879,rs11045819,C,A,.,PASS,PX=SLCO1B1,GT,0/0,SLCO1B1_NM,NM_006446.5(SLCO1B1):c.463C>A (p.Pro155Thr),SLCO1B1,P155T,Rotor syndrome|not provided,VCV000307937,12,21329813,12,21176879,307937,324092,rs11045819,NC_000012.12:21176878:C:A,single nucleotide variant,missense variant,Benign,"Nov 29, 2024","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chr12,21176883,rs72559745,A,G,.,PASS,PX=SLCO1B1,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr12,21176898,rs77271279,G,T,.,PASS,PX=SLCO1B1,GT,0/0,SLCO1B1_NM,NM_006446.5(SLCO1B1):c.481+1G>T,SLCO1B1,nan,Rotor syndrome,VCV000307938,12,21329832,12,21176898,307938,331457,rs77271279,NC_000012.12:21176897:G:T,single nucleotide variant,splice donor variant,Conflicting classifications of pathogenicity,"Nov 15, 2024","criteria provided, conflicting classifications",nan,nan,nan,nan,nan,nan,nan
chr12,21178612,rs141467543,A,G,.,PASS,PX=SLCO1B1,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr12,21178615,rs4149056,T,C,.,PASS,PX=SLCO1B1,GT,0/0,SLCO1B1_NM,NM_006446.5(SLCO1B1):c.521T>C (p.Val174Ala),SLCO1B1,V174A,pravastatin response - Toxicity|rosuvastatin response - Toxicity|simvastatin response - Metabolism/PK|fluvastatin response - Metabolism/PK|fluvastatin response - Toxicity|lovastatin acid response - Metabolism/PK|lovastatin response - Metabolism/PK|lovastatin response - Toxicity|pitavastatin response - Metabolism/PK|simvastatin acid response - Metabolism/PK|rosuvastatin response - Metabolism/PK|atorvastatin response - Metabolism/PK|atorvastatin response - Toxicity|hmg coa reductase inhibitors response - Toxicity|simvastatin response - Toxicity,VCV000037346,12,21331549,12,21178615,37346,40587,rs4149056,NC_000012.12:21178614:T:C,single nucleotide variant,missense variant,drug response,"Feb 15, 2022",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr12,21178957,rs79135870,A,G,.,PASS,PX=SLCO1B1,GT,0/0,SLCO1B1_NM,NM_006446.5(SLCO1B1):c.664A>G (p.Ile222Val),SLCO1B1,I222V,Rotor syndrome,VCV000811089,12,21331891,12,21178957,811089,799674,rs79135870,NC_000012.12:21178956:A:G,single nucleotide variant,missense variant,Conflicting classifications of pathogenicity,"Mar 19, 2024","criteria provided, conflicting classifications",nan,nan,nan,nan,nan,nan,nan
chr12,21196951,rs11045852,A,G,.,PASS,PX=SLCO1B1,GT,0/0,SLCO1B1_NM,NM_006446.5(SLCO1B1):c.733A>G (p.Ile245Val),SLCO1B1,I245V,Rotor syndrome|not provided,VCV000307942,12,21349885,12,21196951,307942,331458,rs11045852,NC_000012.12:21196950:A:G,single nucleotide variant,missense variant,Benign/Likely benign,"Sep 27, 2024","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chr12,21196975,rs183501729,C,T,.,PASS,PX=SLCO1B1,GT,0/0,SLCO1B1_NM,NM_006446.5(SLCO1B1):c.757C>T (p.Arg253Ter),SLCO1B1,R253*,Rotor syndrome,VCV000030439,12,21349909,12,21196975,30439,39396,rs183501729,NC_000012.12:21196974:C:T,single nucleotide variant,nonsense,Pathogenic,"May 30, 2024","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chr12,21196976,rs11045853,G,A,.,PASS,PX=SLCO1B1,GT,0/0,SLCO1B1_NM,NM_006446.5(SLCO1B1):c.758G>A (p.Arg253Gln),SLCO1B1,R253Q,Rotor syndrome,VCV000880627,12,21349910,12,21196976,880627,869630,rs11045853,NC_000012.12:21196975:G:A,single nucleotide variant,missense variant,Uncertain significance,"Aug 18, 2019","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chr12,21200544,rs72559747,C,G,.,PASS,PX=SLCO1B1,GT,0/0,SLCO1B1_NM,NM_006446.5(SLCO1B1):c.1007C>G (p.Pro336Arg),SLCO1B1,P336R,Rotor syndrome,VCV000882039,12,21353478,12,21200544,882039,869633,rs72559747,NC_000012.12:21200543:C:G,single nucleotide variant,missense variant,Benign,"Apr 27, 2017","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chr12,21200595,rs55901008,T,C,.,PASS,PX=SLCO1B1,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr12,21202553,rs1228465562,T,G,.,PASS,PX=SLCO1B1,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr12,21202555,rs59113707,C,G,.,PASS,PX=SLCO1B1,GT,0/0,SLCO1B1_NM,NM_006446.5(SLCO1B1):c.1200C>G (p.Phe400Leu),SLCO1B1,F400L,not provided|Rotor syndrome,VCV000307946,12,21355489,12,21202555,307946,331466,rs59113707,NC_000012.12:21202554:C:G,single nucleotide variant,missense variant,Benign/Likely benign,"Mar 1, 2025","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chr12,21202649,rs56387224,A,G,.,PASS,PX=SLCO1B1,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr12,21202664,rs142965323,G,A,.,PASS,PX=SLCO1B1,GT,0/0,SLCO1B1_NM,NM_006446.5(SLCO1B1):c.1309G>A (p.Gly437Arg),SLCO1B1,G437R,Rotor syndrome,VCV000882042,12,21355598,12,21202664,882042,869636,rs142965323,NC_000012.12:21202663:G:A,single nucleotide variant,missense variant,Uncertain significance,"Apr 28, 2017","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chr12,21205921,rs72559748,A,G,.,PASS,PX=SLCO1B1,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr12,21205999,rs59502379,G,C,.,PASS,PX=SLCO1B1,GT,0/0,SLCO1B1_NM,NM_006446.5(SLCO1B1):c.1463G>C (p.Gly488Ala),SLCO1B1,G488A,Rotor syndrome|not provided,VCV000307954,12,21358933,12,21205999,307954,331506,rs59502379,NC_000012.12:21205998:G:C,single nucleotide variant,missense variant,Likely benign,"Jun 27, 2024","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chr12,21206031,rs74064213,A,G,.,PASS,PX=SLCO1B1,GT,0/0,SLCO1B1_NM,NM_006446.5(SLCO1B1):c.1495A>G (p.Ile499Val),SLCO1B1,I499V,not provided|Rotor syndrome,VCV000307955,12,21358965,12,21206031,307955,316599,rs74064213,NC_000012.12:21206030:A:G,single nucleotide variant,missense variant,Benign/Likely benign,"Sep 27, 2024","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chr12,21222355,rs71581941,C,T,.,PASS,PX=SLCO1B1,GT,0/0,SLCO1B1_NM,NM_006446.5(SLCO1B1):c.1738C>T (p.Arg580Ter),SLCO1B1,R580*,not provided|Rotor syndrome,VCV000030437,12,21375289,12,21222355,30437,39394,rs71581941,NC_000012.12:21222354:C:T,single nucleotide variant,nonsense,Pathogenic,"Jul 29, 2024","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chr12,21239042,rs34671512,A,C,.,PASS,PX=SLCO1B1,GT,0/0,SLCO1B1_NM,NM_006446.5(SLCO1B1):c.1929A>C (p.Leu643Phe),SLCO1B1,L643F,not provided|Rotor syndrome,VCV000307959,12,21391976,12,21239042,307959,331512,rs34671512,NC_000012.12:21239041:A:C,single nucleotide variant,missense variant,Benign,"Nov 28, 2024","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chr12,21239077,rs56199088,A,G,.,PASS,PX=SLCO1B1,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr12,21239113,rs55737008,A,G,.,PASS,PX=SLCO1B1,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr12,21239145,rs200995543,C,T,.,PASS,PX=SLCO1B1,GT,0/0,SLCO1B1_NM,NM_006446.5(SLCO1B1):c.2032C>T (p.His678Tyr),SLCO1B1,H678Y,Rotor syndrome,VCV000880703,12,21392079,12,21239145,880703,869641,rs200995543,NC_000012.12:21239144:C:T,single nucleotide variant,missense variant,Uncertain significance,"Apr 27, 2017","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chr12,21239158,rs140790673,C,T,.,PASS,PX=SLCO1B1,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr13,48037748,rs769369441,T,C,.,PASS,PX=NUDT15,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr13,48037749,.,G,C,.,PASS,PX=NUDT15,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr13,48037782,rs746071566,AGGAGTC,"A,AGGAGTCGGAGTC",.,PASS,PX=NUDT15,GT,0/0,NUDT15_NM,NM_018283.4(NUDT15):c.36A>C (p.Pro12=),NUDT15,nan,not provided,VCV003234192,13,48611918,13,48037782,3234192,3393315,rs61746486,NC_000013.11:48037781:A:C,single nucleotide variant,synonymous variant|non-coding transcript variant,Likely benign,"Dec 1, 2024","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chr13,48037798,rs186364861,G,A,.,PASS,PX=NUDT15,GT,0/0,NUDT15_NM,NM_018283.4(NUDT15):c.52G>A (p.Val18Ile),NUDT15,V18I,"NUDT15-related disorder|Thiopurines, poor metabolism of, 2",VCV000225203,13,48611934,13,48037798,225203,227131,rs186364861,NC_000013.11:48037797:G:A,single nucleotide variant,missense variant|non-coding transcript variant,Likely benign; drug response,"Mar 11, 2019",no assertion criteria provided,nan,nan,nan,nan,nan,nan,nan
chr13,48037825,rs777311140,C,CGCGG,.,PASS,PX=NUDT15,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr13,48037834,rs1202487323,C,T,.,PASS,PX=NUDT15,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr13,48037847,rs766023281,G,C,.,PASS,PX=NUDT15,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr13,48037849,.,A,G,.,PASS,PX=NUDT15,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr13,48037885,rs1950545307,G,A,.,PASS,PX=NUDT15,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr13,48037902,rs149436418,C,G,.,PASS,PX=NUDT15,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr13,48040977,rs1457579126,GA,G,.,PASS,PX=NUDT15,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr13,48041103,rs761191455,T,TG,.,PASS,PX=NUDT15,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr13,48041113,rs1368252918,G,T,.,PASS,PX=NUDT15,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr13,48045690,rs768324690,C,G,.,PASS,PX=NUDT15,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr13,48045719,rs116855232,C,T,.,PASS,PX=NUDT15,GT,0/0,NUDT15_NM,NM_018283.4(NUDT15):c.415C>T (p.Arg139Cys),NUDT15,R139C,azathioprine response - Toxicity|mercaptopurine response - Dosage,VCV000225201,13,48619855,13,48045719,225201,227129,rs116855232,NC_000013.11:48045718:C:T,single nucleotide variant,missense variant|non-coding transcript variant,drug response,"Mar 24, 2021",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr13,48045720,rs147390019,G,A,.,PASS,PX=NUDT15,GT,0/0,NUDT15_NM,NM_018283.4(NUDT15):c.416G>A (p.Arg139His),NUDT15,R139H,"Thiopurines, poor metabolism of, 2",VCV000225202,13,48619856,13,48045720,225202,227130,rs147390019,NC_000013.11:48045719:G:A,single nucleotide variant,missense variant|non-coding transcript variant,drug response,"Oct 25, 2016",no assertion criteria provided,nan,nan,nan,nan,nan,nan,nan
chr13,48045771,rs139551410,T,A,.,PASS,PX=NUDT15,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr16,31096368,rs9923231,C,T,.,PASS,PX=VKORC1,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr19,15878779,rs3093200,G,T,.,PASS,PX=CYP4F2,GT,0/0,CYP4F2_NM,NM_001082.5(CYP4F2):c.1555C>A (p.Leu519Met),CYP4F2,L519M,CYP4F2-related disorder,VCV003056325,19,15989589,19,15878779,3056325,3216842,rs3093200,NC_000019.10:15878778:G:T,single nucleotide variant,missense variant,Likely benign,"May 5, 2023",no assertion criteria provided,nan,nan,nan,nan,nan,nan,nan
chr19,15878920,rs4020346,T,C,.,PASS,PX=CYP4F2,GT,0/0,CYP4F2_NM,NM_001082.5(CYP4F2):c.1414A>G (p.Thr472Ala),CYP4F2,T472A,CYP4F2-related disorder,VCV003059292,19,15989730,19,15878920,3059292,3197008,rs4020346,NC_000019.10:15878919:T:C,single nucleotide variant,missense variant,Likely benign,"Oct 17, 2019",no assertion criteria provided,nan,nan,nan,nan,nan,nan,nan
chr19,15879412,rs138971789,C,T,.,PASS,PX=CYP4F2,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr19,15879621,rs2108622,C,T,.,PASS,PX=CYP4F2,GT,0/0,CYP4F2_NM,NM_001082.5(CYP4F2):c.1297G>A (p.Val433Met),CYP4F2,V433M,warfarin response - Dosage|acenocoumarol response - Dosage,VCV000225969,19,15990431,19,15879621,225969,227800,rs2108622,NC_000019.10:15879620:C:T,single nucleotide variant,missense variant,drug response,"Mar 24, 2021",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,15886018,rs145174239,G,C,.,PASS,PX=CYP4F2,GT,0/0,CYP4F2_NM,NM_001082.5(CYP4F2):c.1021C>G (p.Leu341Val),CYP4F2,L341V,not provided,VCV000771928,19,15996828,19,15886018,771928,704833,rs145174239,NC_000019.10:15886017:G:C,single nucleotide variant,missense variant,Benign,"Jul 16, 2018","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chr19,15889671,rs144233412,C,A,.,PASS,PX=CYP4F2,GT,0/0,CYP4F2_NM,NM_001082.5(CYP4F2):c.670G>T (p.Ala224Ser),CYP4F2,A224S,not specified,VCV003499336,19,16000481,19,15889671,3499336,3654891,nan,NC_000019.10:15889670:C:A,single nucleotide variant,missense variant,Uncertain significance,"Aug 29, 2024","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chr19,15890405,rs3093153,C,A,.,PASS,PX=CYP4F2,GT,0/0,CYP4F2_NM,NM_001082.5(CYP4F2):c.554G>T (p.Gly185Val),CYP4F2,G185V,CYP4F2-related disorder,VCV003055377,19,16001215,19,15890405,3055377,3206534,rs3093153,NC_000019.10:15890404:C:A,single nucleotide variant,missense variant,Benign,"May 6, 2019",no assertion criteria provided,nan,nan,nan,nan,nan,nan,nan
chr19,15892541,rs145875499,C,T,.,PASS,PX=CYP4F2,GT,0/0,CYP4F2_NM,NM_001082.5(CYP4F2):c.385G>A (p.Glu129Lys),CYP4F2|LOC126862873,E129K,not specified,VCV002357571,19,16003351,19,15892541,2357571,2352138,rs145875499,NC_000019.10:15892540:C:T,single nucleotide variant,missense variant,Likely benign,"Oct 6, 2022","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chr19,15895527,rs114396708,G,A,.,PASS,PX=CYP4F2,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr19,15895560,rs144455532,G,T,.,PASS,PX=CYP4F2,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr19,15897466,rs201380574,C,T,.,PASS,PX=CYP4F2,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr19,15897473,rs115517770,G,A,.,PASS,PX=CYP4F2,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr19,15897566,rs114099324,C,G,.,PASS,PX=CYP4F2,GT,0/0,CYP4F2_NM,NM_001082.5(CYP4F2):c.46G>C (p.Ala16Pro),CYP4F2,A16P,CYP4F2-related disorder,VCV003052405,19,16008376,19,15897566,3052405,3213083,rs114099324,NC_000019.10:15897565:C:G,single nucleotide variant,missense variant,Benign,"Aug 26, 2019",no assertion criteria provided,nan,nan,nan,nan,nan,nan,nan
chr19,15897578,rs3093105,A,C,.,PASS,PX=CYP4F2,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr19,38433867,rs193922744,T,G,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.38T>G (p.Leu13Arg),RYR1,L13R,"Malignant hyperthermia, susceptibility to, 1",VCV000133129,19,38924507,19,38433867,133129,136876,rs193922744,NC_000019.10:38433866:T:G,single nucleotide variant,missense variant,Likely pathogenic,"Apr 7, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38440747,rs193922745,CGAT,C,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.48C>T (p.Asp16=),RYR1,nan,"RYR1-related disorder|Malignant hyperthermia, susceptibility to, 1",VCV002911867,19,38931387,19,38440747,2911867,3075846,rs750329137,NC_000019.10:38440746:C:T,single nucleotide variant,synonymous variant,Likely benign,"Dec 5, 2024","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chr19,38440796,rs193922746,A,G,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.97A>C (p.Lys33Gln),RYR1,K33Q,Inborn genetic diseases,VCV002236131,19,38931436,19,38440796,2236131,2231615,rs193922746,NC_000019.10:38440795:A:C,single nucleotide variant,missense variant,Uncertain significance,"Jul 9, 2021","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chr19,38440796,rs193922746,A,G,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.97A>G (p.Lys33Glu),RYR1,K33E,"Malignant hyperthermia, susceptibility to, 1",VCV000055831,19,38931436,19,38440796,55831,70489,rs193922746,NC_000019.10:38440795:A:G,single nucleotide variant,missense variant,Likely pathogenic,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38440802,rs193922747,T,C,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.103T>C (p.Cys35Arg),RYR1,C35R,"isoflurane response - Toxicity|enflurane response - Toxicity|halothane response - Toxicity|desflurane response - Toxicity|succinylcholine response - Toxicity|sevoflurane response - Toxicity|methoxyflurane response - Toxicity|Malignant hyperthermia, susceptibility to, 1",VCV000132995,19,38931442,19,38440802,132995,136743,rs193922747,NC_000019.10:38440801:T:C,single nucleotide variant,missense variant,Pathogenic; drug response,"Mar 24, 2021",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38440818,.,G,C,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.119G>T (p.Gly40Val),RYR1,G40V,not provided,VCV003340407,19,38931458,19,38440818,3340407,3499663,nan,NC_000019.10:38440817:G:T,single nucleotide variant,missense variant,Uncertain significance,"Jun 29, 2023","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chr19,38440818,.,G,C,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.119G>C (p.Gly40Ala),RYR1,G40A,"Malignant hyperthermia, susceptibility to, 1",VCV001210306,19,38931458,19,38440818,1210306,1200298,rs2145320724,NC_000019.10:38440817:G:C,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38440829,rs193922748,C,T,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.130C>T (p.Arg44Cys),RYR1,R44C,"Malignant hyperthermia, susceptibility to, 1|succinylcholine response - Toxicity|sevoflurane response - Toxicity|methoxyflurane response - Toxicity|isoflurane response - Toxicity|halothane response - Toxicity|enflurane response - Toxicity|desflurane response - Toxicity",VCV000133045,19,38931469,19,38440829,133045,136793,rs193922748,NC_000019.10:38440828:C:T,single nucleotide variant,missense variant,Likely pathogenic; drug response,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38440830,rs139161723,G,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.131G>C (p.Arg44Pro),RYR1,R44P,RYR1-related disorder,VCV002829750,19,38931470,19,38440830,2829750,2990412,rs139161723,NC_000019.10:38440829:G:C,single nucleotide variant,missense variant,Likely pathogenic,"Jan 17, 2023","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chr19,38440830,rs139161723,G,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.131G>A (p.Arg44His),RYR1,R44H,"Malignant hyperthermia, susceptibility to, 1",VCV000133046,19,38931470,19,38440830,133046,136794,rs139161723,NC_000019.10:38440829:G:A,single nucleotide variant,missense variant,Uncertain significance,"Apr 7, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38440851,rs193922749,C,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.152C>T (p.Thr51Ile),RYR1,T51I,"Malignant hyperthermia, susceptibility to, 1",VCV003069782,19,38931491,19,38440851,3069782,3233358,rs193922749,NC_000019.10:38440850:C:T,single nucleotide variant,missense variant,Uncertain significance,"Mar 9, 2023","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chr19,38440851,rs193922749,C,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.152C>A (p.Thr51Asn),RYR1,T51N,"Malignant hyperthermia, susceptibility to, 1",VCV000133099,19,38931491,19,38440851,133099,136846,rs193922749,NC_000019.10:38440850:C:A,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38442361,rs118192160,G,"A,T",.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.178G>C (p.Asp60His),RYR1,D60H,not specified|RYR1-related disorder,VCV001355582,19,38933001,19,38442361,1355582,1509333,rs118192160,NC_000019.10:38442360:G:C,single nucleotide variant,missense variant,Uncertain significance,"Apr 30, 2025","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chr19,38442361,rs118192160,G,"A,T",.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.178G>T (p.Asp60Tyr),RYR1,D60Y,"Malignant hyperthermia, susceptibility to, 1",VCV001214005,19,38933001,19,38442361,1214005,1203998,rs118192160,NC_000019.10:38442360:G:T,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38442361,rs118192160,G,"A,T",.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.178G>A (p.Asp60Asn),RYR1,D60N,"Malignant hyperthermia, susceptibility to, 1",VCV000065932,19,38933001,19,38442361,65932,76840,rs118192160,NC_000019.10:38442360:G:A,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38442373,rs995399438,T,C,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.190T>C (p.Cys64Arg),RYR1,C64R,Malignant hyperthermia of anesthesia,VCV000590492,19,38933013,19,38442373,590492,581417,rs995399438,NC_000019.10:38442372:T:C,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38442395,rs118192113,C,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.212C>A (p.Ser71Tyr),RYR1,S71Y,"Malignant hyperthermia, susceptibility to, 1",VCV000065993,19,38933035,19,38442395,65993,76901,rs118192113,NC_000019.10:38442394:C:A,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38442434,rs186983396,C,T,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.251C>T (p.Thr84Met),RYR1,T84M,Malignant hyperthermia of anesthesia,VCV000808527,19,38933074,19,38442434,808527,797800,rs186983396,NC_000019.10:38442433:C:T,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38442434,rs186983396,C,T,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.251C>G (p.Thr84Arg),RYR1,T84R,"Central core myopathy|Congenital multicore myopathy with external ophthalmoplegia|Congenital myopathy with fiber type disproportion|Malignant hyperthermia, susceptibility to, 1|King Denborough syndrome|not provided",VCV000430468,19,38933074,19,38442434,430468,422263,rs186983396,NC_000019.10:38442433:C:G,single nucleotide variant,missense variant,Uncertain significance,"Feb 8, 2022","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chr19,38443790,rs142474192,G,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.418G>A (p.Ala140Thr),RYR1,A140T,"Malignant hyperthermia, susceptibility to, 1",VCV000544412,19,38934430,19,38443790,544412,532935,rs142474192,NC_000019.10:38443789:G:A,single nucleotide variant,missense variant,Likely benign,"Mar 18, 2021",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38444179,.,C,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.455C>T (p.Ala152Val),RYR1,A152V,not provided,VCV003903338,19,38934819,19,38444179,3903338,4019212,nan,NC_000019.10:38444178:C:T,single nucleotide variant,missense variant,Likely pathogenic,"Dec 10, 2024","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chr19,38444179,.,C,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.455C>A (p.Ala152Asp),RYR1,A152D,"Malignant hyperthermia, susceptibility to, 1",VCV000448182,19,38934819,19,38444179,448182,442197,rs1555763641,NC_000019.10:38444178:C:A,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38444187,rs193922750,C,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.463C>A (p.Gln155Lys),RYR1,Q155K,"Malignant hyperthermia, susceptibility to, 1",VCV000133132,19,38934827,19,38444187,133132,136879,rs193922750,NC_000019.10:38444186:C:A,single nucleotide variant,missense variant,Likely pathogenic,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38444191,rs193922751,G,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.467G>A (p.Arg156Lys),RYR1,R156K,"Malignant hyperthermia, susceptibility to, 1",VCV000133133,19,38934831,19,38444191,133133,136880,rs193922751,NC_000019.10:38444190:G:A,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38444203,rs193922752,A,G,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.479A>C (p.Glu160Ala),RYR1,E160A,not provided,VCV000590541,19,38934843,19,38444203,590541,581420,rs193922752,NC_000019.10:38444202:A:C,single nucleotide variant,missense variant,Uncertain significance,"Apr 25, 2016","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chr19,38444203,rs193922752,A,G,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.479A>G (p.Glu160Gly),RYR1,E160G,"Malignant hyperthermia, susceptibility to, 1",VCV000133136,19,38934843,19,38444203,133136,136883,rs193922752,NC_000019.10:38444202:A:G,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38444211,rs118192161,C,T,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.487C>A (p.Arg163Ser),RYR1,R163S,"Congenital multicore myopathy with external ophthalmoplegia|Malignant hyperthermia, susceptibility to, 1",VCV001030861,19,38934851,19,38444211,1030861,1018552,rs118192161,NC_000019.10:38444210:C:A,single nucleotide variant,missense variant,Uncertain significance,"Sep 13, 2023","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chr19,38444211,rs118192161,C,T,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.487C>T (p.Arg163Cys),RYR1,R163C,"enflurane response - Toxicity|desflurane response - Toxicity|Malignant hyperthermia, susceptibility to, 1|succinylcholine response - Toxicity|sevoflurane response - Toxicity|methoxyflurane response - Toxicity|isoflurane response - Toxicity|halothane response - Toxicity",VCV000012967,19,38934851,19,38444211,12967,28006,rs118192161,NC_000019.10:38444210:C:T,single nucleotide variant,missense variant,Pathogenic; drug response,"Mar 29, 2022",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38444212,rs193922753,G,"A,T",.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.488G>A (p.Arg163His),RYR1,R163H,"Malignant hyperthermia, susceptibility to, 1",VCV000635269,19,38934852,19,38444212,635269,623101,rs193922753,NC_000019.10:38444211:G:A,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38444212,rs193922753,G,"A,T",.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.488G>T (p.Arg163Leu),RYR1,R163L,"Malignant hyperthermia, susceptibility to, 1|succinylcholine response - Toxicity|sevoflurane response - Toxicity|methoxyflurane response - Toxicity|isoflurane response - Toxicity|halothane response - Toxicity|enflurane response - Toxicity|desflurane response - Toxicity",VCV000133137,19,38934852,19,38444212,133137,136884,rs193922753,NC_000019.10:38444211:G:T,single nucleotide variant,missense variant,Pathogenic; drug response,"May 22, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38444217,rs193922754,G,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.493G>A (p.Gly165Arg),RYR1,G165R,"Malignant hyperthermia, susceptibility to, 1",VCV000133139,19,38934857,19,38444217,133139,136886,rs193922754,NC_000019.10:38444216:G:A,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38444220,rs193922755,G,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.496G>A (p.Asp166Asn),RYR1,D166N,"Malignant hyperthermia, susceptibility to, 1",VCV000133140,19,38934860,19,38444220,133140,136887,rs193922755,NC_000019.10:38444219:G:A,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38444221,rs193922756,A,G,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.497A>G (p.Asp166Gly),RYR1,D166G,"Malignant hyperthermia, susceptibility to, 1",VCV000133141,19,38934861,19,38444221,133141,136888,rs193922756,NC_000019.10:38444220:A:G,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38444250,rs761616815,G,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.526G>A (p.Glu176Lys),RYR1,E176K,Malignant hyperthermia of anesthesia,VCV000198090,19,38934890,19,38444250,198090,195251,rs761616815,NC_000019.10:38444249:G:A,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38444252,.,G,T,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.528G>A (p.Glu176=),RYR1,nan,RYR1-related disorder,VCV002180439,19,38934892,19,38444252,2180439,1909255,rs1568436081,NC_000019.10:38444251:G:A,single nucleotide variant,synonymous variant,Likely benign,"Feb 3, 2022","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chr19,38444252,.,G,T,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.528G>T (p.Glu176Asp),RYR1,E176D,Malignant hyperthermia of anesthesia,VCV000590556,19,38934892,19,38444252,590556,581423,rs1568436081,NC_000019.10:38444251:G:T,single nucleotide variant,missense variant,Uncertain significance,"Apr 7, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38444253,rs193922757,C,T,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.529C>T (p.Arg177Cys),RYR1,R177C,"Malignant hyperthermia, susceptibility to, 1",VCV000133147,19,38934893,19,38444253,133147,136894,rs193922757,NC_000019.10:38444252:C:T,single nucleotide variant,missense variant,Pathogenic,"Mar 16, 2021",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38444257,.,A,"C,G",.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.533A>G (p.Tyr178Cys),RYR1,Y178C,Malignant hyperthermia of anesthesia,VCV001330371,19,38934897,19,38444257,1330371,1321051,rs193922758,NC_000019.10:38444256:A:G,single nucleotide variant,missense variant,Likely pathogenic,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38444257,.,A,"C,G",.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.533A>C (p.Tyr178Ser),RYR1,Y178S,"Malignant hyperthermia, susceptibility to, 1",VCV001210301,19,38934897,19,38444257,1210301,1200299,rs193922758,NC_000019.10:38444256:A:C,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38444257,.,A,"C,G",.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.533A>T (p.Tyr178Phe),RYR1,Y178F,not provided,VCV000133148,19,38934897,19,38444257,133148,136895,rs193922758,NC_000019.10:38444256:A:T,single nucleotide variant,missense variant,not provided,nan,no classification provided,nan,nan,nan,nan,nan,nan,nan
chr19,38444671,rs771058055,G,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.625G>A (p.Glu209Lys),RYR1,E209K,Malignant hyperthermia of anesthesia,VCV000478249,19,38935311,19,38444671,478249,468654,rs771058055,NC_000019.10:38444670:G:A,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38446481,rs727504129,C,T,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.641C>T (p.Thr214Met),RYR1,T214M,Malignant hyperthermia of anesthesia,VCV000167614,19,38937121,19,38446481,167614,177297,rs727504129,NC_000019.10:38446480:C:T,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38446492,rs193922759,G,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.652G>A (p.Val218Ile),RYR1,V218I,"Malignant hyperthermia, susceptibility to, 1",VCV000133160,19,38937132,19,38446492,133160,136907,rs193922759,NC_000019.10:38446491:G:A,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38446517,rs112596687,T,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.677T>C (p.Met226Thr),RYR1,M226T,RYR1-related disorder,VCV001440509,19,38937157,19,38446517,1440509,1461794,rs112596687,NC_000019.10:38446516:T:C,single nucleotide variant,missense variant,Uncertain significance,"Dec 16, 2020","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chr19,38446517,rs112596687,T,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.677T>A (p.Met226Lys),RYR1,M226K,"Malignant hyperthermia, susceptibility to, 1",VCV000133170,19,38937157,19,38446517,133170,136917,rs112596687,NC_000019.10:38446516:T:A,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38446520,rs193922760,A,T,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.680A>T (p.Asp227Val),RYR1,D227V,"Malignant hyperthermia, susceptibility to, 1",VCV000133171,19,38937160,19,38446520,133171,136918,rs193922760,NC_000019.10:38446519:A:T,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38446710,rs1801086,G,"A,C",.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.742G>T (p.Gly248Trp),RYR1,G248W,"Malignant hyperthermia, susceptibility to, 1|not specified|Central core myopathy|Congenital multicore myopathy with external ophthalmoplegia|Malignant hyperthermia, susceptibility to, 1|King Denborough syndrome|RYR1-related disorder",VCV001476084,19,38937350,19,38446710,1476084,1423803,rs1801086,NC_000019.10:38446709:G:T,single nucleotide variant,missense variant,Conflicting classifications of pathogenicity,"Jun 17, 2024","criteria provided, conflicting classifications",nan,nan,nan,nan,nan,nan,nan
chr19,38446710,rs1801086,G,"A,C",.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.742G>C (p.Gly248Arg),RYR1,G248R,"Malignant hyperthermia, susceptibility to, 1",VCV000133203,19,38937350,19,38446710,133203,136950,rs1801086,NC_000019.10:38446709:G:C,single nucleotide variant,missense variant,Pathogenic,"Sep 8, 2022",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38446710,rs1801086,G,"A,C",.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.742G>A (p.Gly248Arg),RYR1,G248R,"Malignant hyperthermia, susceptibility to, 1",VCV000012965,19,38937350,19,38446710,12965,28004,rs1801086,NC_000019.10:38446709:G:A,single nucleotide variant,missense variant,Likely pathogenic,"Apr 7, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38448500,rs752652072,C,T,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.946C>T (p.Arg316Cys),RYR1,R316C,Malignant hyperthermia of anesthesia,VCV000889434,19,38939140,19,38448500,889434,880425,rs752652072,NC_000019.10:38448499:C:T,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38448501,rs193922761,G,T,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.947G>A (p.Arg316His),RYR1,R316H,"King Denborough syndrome|Central core myopathy|Congenital multicore myopathy with external ophthalmoplegia|Congenital myopathy with fiber type disproportion|Malignant hyperthermia, susceptibility to, 1|RYR1-related disorder|Malignant hyperthermia, susceptibility to, 1|King Denborough syndrome|not specified",VCV001367389,19,38939141,19,38448501,1367389,1405109,rs193922761,NC_000019.10:38448500:G:A,single nucleotide variant,missense variant,Conflicting classifications of pathogenicity,"Apr 17, 2025","criteria provided, conflicting classifications",nan,nan,nan,nan,nan,nan,nan
chr19,38448501,rs193922761,G,T,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.947G>T (p.Arg316Leu),RYR1,R316L,"Malignant hyperthermia, susceptibility to, 1",VCV000133242,19,38939141,19,38448501,133242,136987,rs193922761,NC_000019.10:38448500:G:T,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38448673,rs193922762,C,T,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.982C>A (p.Arg328=),RYR1,nan,RYR1-related disorder,VCV002920346,19,38939313,19,38448673,2920346,623102,rs193922762,NC_000019.10:38448672:C:A,single nucleotide variant,synonymous variant,Likely benign,"Jul 14, 2024","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chr19,38448673,rs193922762,C,T,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.982C>T (p.Arg328Trp),RYR1,R328W,"Malignant hyperthermia, susceptibility to, 1|desflurane response - Toxicity|enflurane response - Toxicity|succinylcholine response - Toxicity|halothane response - Toxicity|isoflurane response - Toxicity|methoxyflurane response - Toxicity|sevoflurane response - Toxicity",VCV000133245,19,38939313,19,38448673,133245,136990,rs193922762,NC_000019.10:38448672:C:T,single nucleotide variant,missense variant,Likely pathogenic; drug response,"Apr 7, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38448680,.,T,TGGA,.,PASS,PX=RYR1,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr19,38448712,rs121918592,G,"A,C",.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.1021G>C (p.Gly341Arg),RYR1,G341R,"Malignant hyperthermia, susceptibility to, 1",VCV000132992,19,38939352,19,38448712,132992,136741,rs121918592,NC_000019.10:38448711:G:C,single nucleotide variant,missense variant,Pathogenic,"Mar 14, 2022",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38448712,rs121918592,G,"A,C",.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.1021G>A (p.Gly341Arg),RYR1,G341R,"Malignant hyperthermia, susceptibility to, 1",VCV000012969,19,38939352,19,38448712,12969,28008,rs121918592,NC_000019.10:38448711:G:A,single nucleotide variant,missense variant,Pathogenic,"Mar 18, 2021",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38448715,.,G,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.1024G>A (p.Glu342Lys),RYR1,E342K,"Malignant hyperthermia, susceptibility to, 1",VCV001214000,19,38939355,19,38448715,1214000,1203993,rs2145361853,NC_000019.10:38448714:G:A,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38448791,rs113332073,G,"A,T",.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.1100G>T (p.Arg367Leu),RYR1,R367L,"Malignant hyperthermia, susceptibility to, 1",VCV000133004,19,38939431,19,38448791,133004,136752,rs113332073,NC_000019.10:38448790:G:T,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38448791,rs113332073,G,"A,T",.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.1100G>A (p.Arg367Gln),RYR1,R367Q,"Malignant hyperthermia, susceptibility to, 1",VCV000133003,19,38939431,19,38448791,133003,136751,rs113332073,NC_000019.10:38448790:G:A,single nucleotide variant,missense variant,Uncertain significance,"Apr 7, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38451785,.,C,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.1144C>A (p.His382Asn),RYR1,H382N,"Malignant hyperthermia, susceptibility to, 1",VCV001210303,19,38942425,19,38451785,1210303,1200300,rs2145374470,NC_000019.10:38451784:C:A,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38451842,rs193922764,C,"A,G,T",.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.1201C>A (p.Arg401Ser),RYR1,R401S,"Malignant hyperthermia, susceptibility to, 1",VCV001214004,19,38942482,19,38451842,1214004,1203997,rs193922764,NC_000019.10:38451841:C:A,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38451842,rs193922764,C,"A,G,T",.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.1201C>T (p.Arg401Cys),RYR1,R401C,"Malignant hyperthermia, susceptibility to, 1|desflurane response - Toxicity|succinylcholine response - Toxicity|sevoflurane response - Toxicity|methoxyflurane response - Toxicity|isoflurane response - Toxicity|halothane response - Toxicity|enflurane response - Toxicity",VCV000133029,19,38942482,19,38451842,133029,136777,rs193922764,NC_000019.10:38451841:C:T,single nucleotide variant,missense variant,Pathogenic; drug response,"Mar 29, 2022",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38451842,rs193922764,C,"A,G,T",.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.1201C>G (p.Arg401Gly),RYR1,R401G,Malignant hyperthermia of anesthesia,VCV000133028,19,38942482,19,38451842,133028,136776,rs193922764,NC_000019.10:38451841:C:G,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38451843,rs193922766,G,"A,T",.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.1202G>T (p.Arg401Leu),RYR1,R401L,"Malignant hyperthermia, susceptibility to, 1",VCV000983140,19,38942483,19,38451843,983140,971127,rs193922766,NC_000019.10:38451842:G:T,single nucleotide variant,missense variant,Likely pathogenic,"Apr 7, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38451843,rs193922766,G,"A,T",.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.1202G>A (p.Arg401His),RYR1,R401H,"Malignant hyperthermia, susceptibility to, 1",VCV000133030,19,38942483,19,38451843,133030,136778,rs193922766,NC_000019.10:38451842:G:A,single nucleotide variant,missense variant,Pathogenic,"Mar 18, 2021",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38451850,rs118192116,C,G,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.1209C>T (p.Ile403=),RYR1,nan,RYR1-related disorder,VCV001116873,19,38942490,19,38451850,1116873,1106427,rs118192116,NC_000019.10:38451849:C:T,single nucleotide variant,synonymous variant,Likely benign,"Oct 19, 2022","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chr19,38451850,rs118192116,C,G,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.1209C>G (p.Ile403Met),RYR1,I403M,"Malignant hyperthermia, susceptibility to, 1|succinylcholine response - Toxicity|sevoflurane response - Toxicity|methoxyflurane response - Toxicity|halothane response - Toxicity|isoflurane response - Toxicity|enflurane response - Toxicity|desflurane response - Toxicity",VCV000012968,19,38942490,19,38451850,12968,28007,rs118192116,NC_000019.10:38451849:C:G,single nucleotide variant,missense variant,Uncertain significance; drug response,"May 20, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38452985,.,C,T,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.1411C>G (p.Arg471Gly),RYR1,R471G,"Malignant hyperthermia, susceptibility to, 1",VCV003387644,19,38943625,19,38452985,3387644,3546775,nan,NC_000019.10:38452984:C:G,single nucleotide variant,missense variant,Uncertain significance,"Mar 5, 2024","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chr19,38452985,.,C,T,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.1411C>A (p.Arg471Ser),RYR1,R471S,"not provided|Malignant hyperthermia, susceptibility to, 1",VCV003368903,19,38943625,19,38452985,3368903,3528095,nan,NC_000019.10:38452984:C:A,single nucleotide variant,missense variant,Uncertain significance,"Aug 6, 2024","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chr19,38452985,.,C,T,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.1411C>T (p.Arg471Cys),RYR1,R471C,Malignant hyperthermia of anesthesia,VCV001018682,19,38943625,19,38452985,1018682,1013681,rs1376393998,NC_000019.10:38452984:C:T,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38452996,rs193922767,G,T,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.1422G>C (p.Gln474His),RYR1,Q474H,RYR1-related disorder,VCV003636220,19,38943636,19,38452996,3636220,3764140,nan,NC_000019.10:38452995:G:C,single nucleotide variant,missense variant,Uncertain significance,"Oct 3, 2024","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chr19,38452996,rs193922767,G,T,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.1422G>A (p.Gln474=),RYR1,nan,"Malignant hyperthermia, susceptibility to, 1|RYR1-related disorder",VCV001156489,19,38943636,19,38452996,1156489,1148772,rs193922767,NC_000019.10:38452995:G:A,single nucleotide variant,synonymous variant,Likely benign,"May 14, 2024","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chr19,38452996,rs193922767,G,T,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.1422G>T (p.Gln474His),RYR1,Q474H,"Malignant hyperthermia, susceptibility to, 1",VCV000133063,19,38943636,19,38452996,133063,136811,rs193922767,NC_000019.10:38452995:G:T,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38455247,rs147723844,A,G,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.1453A>G (p.Met485Val),LOC129391106|RYR1,M485V,"Malignant hyperthermia, susceptibility to, 1",VCV000133076,19,38945887,19,38455247,133076,136823,rs147723844,NC_000019.10:38455246:A:G,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38455253,.,C,G,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.1459C>G (p.Leu487Val),LOC129391106|RYR1,L487V,Malignant hyperthermia of anesthesia,VCV001210307,19,38945893,19,38455253,1210307,1200301,rs780898260,NC_000019.10:38455252:C:G,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38455253,.,C,G,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.1459C>T (p.Leu487=),LOC129391106|RYR1,nan,"not specified|RYR1-related disorder|Malignant hyperthermia, susceptibility to, 1",VCV001139622,19,38945893,19,38455253,1139622,1127814,rs780898260,NC_000019.10:38455252:C:T,single nucleotide variant,synonymous variant,Likely benign,"Feb 18, 2025","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chr19,38455254,.,T,C,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.1460T>C (p.Leu487Pro),LOC129391106|RYR1,L487P,Malignant hyperthermia of anesthesia,VCV000567662,19,38945894,19,38455254,567662,572380,rs1008860336,NC_000019.10:38455253:T:C,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38455269,rs901087791,G,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.1475G>A (p.Arg492His),LOC129391106|RYR1,R492H,Malignant hyperthermia of anesthesia,VCV001050940,19,38945909,19,38455269,1050940,1051230,rs901087791,NC_000019.10:38455268:G:A,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38455347,.,T,C,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.1553T>C (p.Val518Ala),LOC129391106|RYR1,V518A,Malignant hyperthermia of anesthesia,VCV000590482,19,38945987,19,38455347,590482,581442,rs1195513704,NC_000019.10:38455346:T:C,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38455359,rs118192162,A,"C,G",.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.1565A>G (p.Tyr522Cys),RYR1,Y522C,"Malignant hyperthermia, susceptibility to, 1",VCV000133100,19,38945999,19,38455359,133100,136847,rs118192162,NC_000019.10:38455358:A:G,single nucleotide variant,missense variant,Likely pathogenic,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38455359,rs118192162,A,"C,G",.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.1565A>C (p.Tyr522Ser),RYR1,Y522S,"succinylcholine response - Toxicity|sevoflurane response - Toxicity|methoxyflurane response - Toxicity|isoflurane response - Toxicity|halothane response - Toxicity|enflurane response - Toxicity|desflurane response - Toxicity|Malignant hyperthermia, susceptibility to, 1",VCV000012993,19,38945999,19,38455359,12993,28032,rs118192162,NC_000019.10:38455358:A:C,single nucleotide variant,missense variant,Pathogenic; drug response,"Mar 24, 2021",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38455463,rs111888148,G,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.1589G>T (p.Arg530Leu),RYR1,R530L,not specified,VCV000212096,19,38946103,19,38455463,212096,208582,rs111888148,NC_000019.10:38455462:G:T,single nucleotide variant,missense variant,Uncertain significance,"Dec 1, 2014","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chr19,38455463,rs111888148,G,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.1589G>A (p.Arg530His),RYR1,R530H,"Malignant hyperthermia, susceptibility to, 1",VCV000133101,19,38946103,19,38455463,133101,136848,rs111888148,NC_000019.10:38455462:G:A,single nucleotide variant,missense variant,Likely pathogenic,"May 20, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38455471,rs193922768,C,"A,T",.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.1597C>A (p.Arg533Ser),RYR1,R533S,"Malignant hyperthermia, susceptibility to, 1",VCV000291315,19,38946111,19,38455471,291315,275550,rs193922768,NC_000019.10:38455470:C:A,single nucleotide variant,missense variant,Uncertain significance,"Apr 7, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38455471,rs193922768,C,"A,T",.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.1597C>T (p.Arg533Cys),RYR1,R533C,"Malignant hyperthermia, susceptibility to, 1|succinylcholine response - Toxicity|sevoflurane response - Toxicity|methoxyflurane response - Toxicity|isoflurane response - Toxicity|halothane response - Toxicity|enflurane response - Toxicity|desflurane response - Toxicity",VCV000133102,19,38946111,19,38455471,133102,136849,rs193922768,NC_000019.10:38455470:C:T,single nucleotide variant,missense variant,Pathogenic; drug response,"Mar 24, 2021",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38455472,rs144336148,G,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.1598G>T (p.Arg533Leu),RYR1,R533L,"RYR1-related disorder|Malignant hyperthermia, susceptibility to, 1",VCV002068396,19,38946112,19,38455472,2068396,2125919,rs144336148,NC_000019.10:38455471:G:T,single nucleotide variant,missense variant,Uncertain significance,"Mar 14, 2024","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chr19,38455472,rs144336148,G,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.1598G>A (p.Arg533His),RYR1,R533H,"Malignant hyperthermia, susceptibility to, 1",VCV000133103,19,38946112,19,38455472,133103,136850,rs144336148,NC_000019.10:38455471:G:A,single nucleotide variant,missense variant,Uncertain significance,"Apr 10, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38455489,rs193922769,T,"C,G",.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.1615T>G (p.Phe539Val),RYR1,F539V,Malignant hyperthermia of anesthesia,VCV001210317,19,38946129,19,38455489,1210317,1200302,rs193922769,NC_000019.10:38455488:T:G,single nucleotide variant,missense variant,Likely pathogenic,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38455489,rs193922769,T,"C,G",.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.1615T>C (p.Phe539Leu),RYR1,F539L,"Malignant hyperthermia, susceptibility to, 1",VCV000133104,19,38946129,19,38455489,133104,136851,rs193922769,NC_000019.10:38455488:T:C,single nucleotide variant,missense variant,Likely pathogenic,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38455504,.,G,T,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.1630G>T (p.Asp544Tyr),RYR1,D544Y,"Malignant hyperthermia, susceptibility to, 1",VCV001210298,19,38946144,19,38455504,1210298,1200303,rs113812662,NC_000019.10:38455503:G:T,single nucleotide variant,missense variant,Likely pathogenic,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38455528,rs193922770,C,T,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.1654C>A (p.Arg552=),RYR1,nan,RYR1-related disorder,VCV001653200,19,38946168,19,38455528,1653200,1547773,rs193922770,NC_000019.10:38455527:C:A,single nucleotide variant,synonymous variant,Likely benign,"Nov 18, 2020","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chr19,38455528,rs193922770,C,T,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.1654C>T (p.Arg552Trp),RYR1,R552W,"succinylcholine response - Toxicity|sevoflurane response - Toxicity|methoxyflurane response - Toxicity|isoflurane response - Toxicity|Malignant hyperthermia, susceptibility to, 1|enflurane response - Toxicity|halothane response - Toxicity|desflurane response - Toxicity",VCV000133106,19,38946168,19,38455528,133106,136853,rs193922770,NC_000019.10:38455527:C:T,single nucleotide variant,missense variant,Likely pathogenic; drug response,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38457539,rs118204423,G,C,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.1834G>C (p.Ala612Pro),RYR1,A612P,"Malignant hyperthermia, susceptibility to, 1",VCV001210299,19,38948179,19,38457539,1210299,1200304,rs118204423,NC_000019.10:38457538:G:C,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38457539,rs118204423,G,C,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.1834G>A (p.Ala612Thr),RYR1,A612T,"not provided|RYR1-related disorder|Malignant hyperthermia, susceptibility to, 1",VCV000590489,19,38948179,19,38457539,590489,581449,rs118204423,NC_000019.10:38457538:G:A,single nucleotide variant,missense variant,Uncertain significance,"Feb 5, 2024","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chr19,38457545,rs118192172,C,T,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.1840C>G (p.Arg614Gly),RYR1,R614G,RYR1-related disorder,VCV000544395,19,38948185,19,38457545,544395,532911,rs118192172,NC_000019.10:38457544:C:G,single nucleotide variant,missense variant,Likely pathogenic,"Mar 23, 2023","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chr19,38457545,rs118192172,C,T,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.1840C>T (p.Arg614Cys),RYR1,R614C,"enflurane response - Toxicity|desflurane response - Toxicity|succinylcholine response - Toxicity|sevoflurane response - Toxicity|methoxyflurane response - Toxicity|isoflurane response - Toxicity|halothane response - Toxicity|Malignant hyperthermia, susceptibility to, 1",VCV000012964,19,38948185,19,38457545,12964,28003,rs118192172,NC_000019.10:38457544:C:T,single nucleotide variant,missense variant,Pathogenic; drug response,"Mar 24, 2021",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38457546,rs193922772,G,T,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.1841G>A (p.Arg614His),RYR1,R614H,"Malignant hyperthermia, susceptibility to, 1|RYR1-related disorder|not provided",VCV000635268,19,38948186,19,38457546,635268,623103,rs193922772,NC_000019.10:38457545:G:A,single nucleotide variant,missense variant,Likely pathogenic,"Sep 26, 2023","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chr19,38457546,rs193922772,G,T,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.1841G>T (p.Arg614Leu),RYR1,R614L,"Malignant hyperthermia, susceptibility to, 1|desflurane response - Toxicity|succinylcholine response - Toxicity|sevoflurane response - Toxicity|methoxyflurane response - Toxicity|isoflurane response - Toxicity|halothane response - Toxicity|enflurane response - Toxicity",VCV000133108,19,38948186,19,38457546,133108,136855,rs193922772,NC_000019.10:38457545:G:T,single nucleotide variant,missense variant,Pathogenic; drug response,"Mar 24, 2021",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38458175,rs747177274,G,C,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.2050G>C (p.Gly684Arg),RYR1,G684R,"Malignant hyperthermia, susceptibility to, 1",VCV001214003,19,38948815,19,38458175,1214003,1203996,rs747177274,NC_000019.10:38458174:G:C,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38458247,rs138874610,G,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.2122G>A (p.Asp708Asn),RYR1,D708N,"Malignant hyperthermia, susceptibility to, 1",VCV000159840,19,38948887,19,38458247,159840,169548,rs138874610,NC_000019.10:38458246:G:A,single nucleotide variant,missense variant,Uncertain significance,"Apr 7, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38460461,rs376149732,C,T,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.2447C>T (p.Pro816Leu),RYR1,P816L,Malignant hyperthermia of anesthesia,VCV000478213,19,38951101,19,38460461,478213,470638,rs376149732,NC_000019.10:38460460:C:T,single nucleotide variant,missense variant,Likely benign,"Nov 9, 2021",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38460551,rs193922775,C,T,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.2537C>T (p.Ser846Leu),RYR1,S846L,"Malignant hyperthermia, susceptibility to, 1",VCV000133117,19,38951191,19,38460551,133117,136864,rs193922775,NC_000019.10:38460550:C:T,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38463499,rs370634440,G,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.2654G>T (p.Arg885Leu),RYR1,R885L,not provided|Central core myopathy,VCV001030858,19,38954139,19,38463499,1030858,1018553,rs370634440,NC_000019.10:38463498:G:T,single nucleotide variant,missense variant,Uncertain significance,"Jan 10, 2025","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chr19,38463499,rs370634440,G,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.2654G>A (p.Arg885His),RYR1,R885H,"Malignant hyperthermia, susceptibility to, 1",VCV000212100,19,38954139,19,38463499,212100,208586,rs370634440,NC_000019.10:38463498:G:A,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38464649,rs148623597,G,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.2797G>A (p.Ala933Thr),RYR1,A933T,"Malignant hyperthermia, susceptibility to, 1",VCV000161363,19,38955289,19,38464649,161363,171229,rs148623597,NC_000019.10:38464648:G:A,single nucleotide variant,missense variant,Benign,"Mar 17, 2021",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38466144,rs778241277,G,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.2924G>A (p.Arg975Gln),RYR1,R975Q,"Malignant hyperthermia, susceptibility to, 1",VCV000590508,19,38956784,19,38466144,590508,581467,rs778241277,NC_000019.10:38466143:G:A,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38466216,rs180714609,G,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.2996G>A (p.Arg999His),RYR1,R999H,"Malignant hyperthermia, susceptibility to, 1",VCV000133122,19,38956856,19,38466216,133122,136869,rs180714609,NC_000019.10:38466215:G:A,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38466315,rs141942845,G,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.3095G>T (p.Arg1032Leu),RYR1,R1032L,"Malignant hyperthermia, susceptibility to, 1",VCV003069655,19,38956955,19,38466315,3069655,3233231,rs141942845,NC_000019.10:38466314:G:T,single nucleotide variant,missense variant,Uncertain significance,"Feb 24, 2023","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chr19,38466315,rs141942845,G,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.3095G>A (p.Arg1032His),RYR1,R1032H,Malignant hyperthermia of anesthesia,VCV000374974,19,38956955,19,38466315,374974,361886,rs141942845,NC_000019.10:38466314:G:A,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38466347,rs111272095,C,T,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.3127C>T (p.Arg1043Cys),RYR1,R1043C,"Malignant hyperthermia, susceptibility to, 1",VCV000133124,19,38956987,19,38466347,133124,136871,rs111272095,NC_000019.10:38466346:C:T,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38466386,rs2145447772,G,"A,C",.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.3166G>A (p.Asp1056Asn),RYR1,D1056N,"Malignant hyperthermia, susceptibility to, 1",VCV001210310,19,38957026,19,38466386,1210310,1200305,rs2145447772,NC_000019.10:38466385:G:A,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38466386,rs2145447772,G,"A,C",.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.3166G>C (p.Asp1056His),RYR1,D1056H,Malignant hyperthermia of anesthesia,VCV001210300,19,38957026,19,38466386,1210300,1200306,rs2145447772,NC_000019.10:38466385:G:C,single nucleotide variant,missense variant,Likely pathogenic,"Apr 7, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38466392,.,G,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.3172G>A (p.Glu1058Lys),RYR1,E1058K,"Malignant hyperthermia, susceptibility to, 1",VCV000978526,19,38957032,19,38466392,978526,574947,rs1968107192,NC_000019.10:38466391:G:A,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38467655,rs749040743,G,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.3224G>A (p.Arg1075Gln),RYR1,R1075Q,Malignant hyperthermia of anesthesia,VCV000433176,19,38958295,19,38467655,433176,426749,rs749040743,NC_000019.10:38467654:G:A,single nucleotide variant,missense variant,Likely benign,"Mar 14, 2022",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38469002,rs193922776,C,T,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.3418C>T (p.Arg1140Cys),RYR1,R1140C,"Malignant hyperthermia, susceptibility to, 1",VCV000133126,19,38959642,19,38469002,133126,136873,rs193922776,NC_000019.10:38469001:C:T,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38469111,rs549201486,C,T,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.3527C>T (p.Thr1176Ile),RYR1,T1176I,Malignant hyperthermia of anesthesia,VCV000590517,19,38959751,19,38469111,590517,581476,rs549201486,NC_000019.10:38469110:C:T,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38469404,.,A,C,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.3656A>C (p.Gln1219Pro),RYR1,Q1219P,"Malignant hyperthermia, susceptibility to, 1",VCV001210309,19,38960044,19,38469404,1210309,1200307,rs2145463700,NC_000019.10:38469403:A:C,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38469415,rs936513262,G,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.3667G>A (p.Glu1223Lys),RYR1,E1223K,Malignant hyperthermia of anesthesia,VCV001004840,19,38960055,19,38469415,1004840,998522,rs936513262,NC_000019.10:38469414:G:A,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38473635,rs34694816,A,G,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.4024A>G (p.Ser1342Gly),RYR1,S1342G,"Malignant hyperthermia, susceptibility to, 1",VCV000093265,19,38964275,19,38473635,93265,99172,rs34694816,NC_000019.10:38473634:A:G,single nucleotide variant,missense variant,Benign,"Mar 17, 2021",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38475335,rs137933390,A,G,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.4178A>G (p.Lys1393Arg),RYR1,K1393R,Malignant hyperthermia of anesthesia,VCV000093269,19,38965975,19,38475335,93269,99176,rs137933390,NC_000019.10:38475334:A:G,single nucleotide variant,missense variant,Benign,"Jan 3, 2022",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38477816,rs145573319,A,G,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.4400A>T (p.Lys1467Met),RYR1,K1467M,RYR1-related disorder,VCV000665349,19,38968456,19,38477816,665349,647986,rs145573319,NC_000019.10:38477815:A:T,single nucleotide variant,missense variant,Uncertain significance,"Nov 29, 2022","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chr19,38477816,rs145573319,A,G,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.4400A>G (p.Lys1467Arg),RYR1,K1467R,"Malignant hyperthermia, susceptibility to, 1",VCV000161371,19,38968456,19,38477816,161371,171232,rs145573319,NC_000019.10:38477815:A:G,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38483293,rs146429605,A,G,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.4711A>G (p.Ile1571Val),RYR1,I1571V,"Malignant hyperthermia, susceptibility to, 1",VCV000159851,19,38973933,19,38483293,159851,169559,rs146429605,NC_000019.10:38483292:A:G,single nucleotide variant,missense variant,Likely benign,"Mar 18, 2021",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38483329,rs754476250,C,T,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.4747C>T (p.Arg1583Cys),RYR1,R1583C,Malignant hyperthermia of anesthesia,VCV000329032,19,38973969,19,38483329,329032,349757,rs754476250,NC_000019.10:38483328:C:T,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38483345,rs151029675,C,T,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.4763C>T (p.Pro1588Leu),RYR1,P1588L,Malignant hyperthermia of anesthesia,VCV000329033,19,38973985,19,38483345,329033,348723,rs151029675,NC_000019.10:38483344:C:T,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38483357,rs193922777,C,T,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.4775C>A (p.Pro1592Gln),RYR1,P1592Q,"Malignant hyperthermia, susceptibility to, 1|not provided",VCV000590539,19,38973997,19,38483357,590539,581494,rs193922777,NC_000019.10:38483356:C:A,single nucleotide variant,missense variant,Uncertain significance,"Mar 5, 2024","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chr19,38483357,rs193922777,C,T,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.4775C>T (p.Pro1592Leu),RYR1,P1592L,"Malignant hyperthermia, susceptibility to, 1",VCV000133135,19,38973997,19,38483357,133135,136882,rs193922777,NC_000019.10:38483356:C:T,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38485679,.,T,C,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.5024T>C (p.Leu1675Pro),RYR1,L1675P,Malignant hyperthermia of anesthesia,VCV001213825,19,38976319,19,38485679,1213825,1203818,rs2145542250,NC_000019.10:38485678:T:C,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38485688,rs781104539,A,G,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.5033A>G (p.Asn1678Ser),RYR1,N1678S,"Malignant hyperthermia, susceptibility to, 1",VCV001214007,19,38976328,19,38485688,1214007,1204000,rs781104539,NC_000019.10:38485687:A:G,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38485691,rs146504767,G,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.5036G>A (p.Arg1679His),RYR1,R1679H,"Malignant hyperthermia, susceptibility to, 1",VCV000161364,19,38976331,19,38485691,161364,171234,rs146504767,NC_000019.10:38485690:G:A,single nucleotide variant,missense variant,Likely benign,"Mar 18, 2021",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38485787,rs754785770,A,G,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.5132A>G (p.Tyr1711Cys),RYR1,Y1711C,"Malignant hyperthermia, susceptibility to, 1",VCV000544383,19,38976427,19,38485787,544383,532988,rs754785770,NC_000019.10:38485786:A:G,single nucleotide variant,missense variant,Uncertain significance,"May 20, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38485787,rs754785770,A,G,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.5132A>C (p.Tyr1711Ser),RYR1,Y1711S,not provided|RYR1-related disorder,VCV000382697,19,38976427,19,38485787,382697,376442,rs754785770,NC_000019.10:38485786:A:C,single nucleotide variant,missense variant,Uncertain significance,"Oct 5, 2022","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chr19,38485838,rs193922781,C,T,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.5183C>T (p.Ser1728Phe),RYR1,S1728F,"Malignant hyperthermia, susceptibility to, 1",VCV000133144,19,38976478,19,38485838,133144,136891,rs193922781,NC_000019.10:38485837:C:T,single nucleotide variant,missense variant,Likely pathogenic,"May 20, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38485841,rs193922782,T,G,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.5186T>G (p.Met1729Arg),RYR1,M1729R,"Malignant hyperthermia, susceptibility to, 1",VCV000133145,19,38976481,19,38485841,133145,136892,rs193922782,NC_000019.10:38485840:T:G,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38485972,rs192863857,C,T,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.5317C>G (p.Pro1773Ala),RYR1,P1773A,RYR1-related disorder,VCV000934558,19,38976612,19,38485972,934558,938660,rs192863857,NC_000019.10:38485971:C:G,single nucleotide variant,missense variant,Uncertain significance,"Feb 11, 2022","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chr19,38485972,rs192863857,C,T,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.5317C>T (p.Pro1773Ser),RYR1,P1773S,"Malignant hyperthermia, susceptibility to, 1",VCV000224382,19,38976612,19,38485972,224382,226119,rs192863857,NC_000019.10:38485971:C:T,single nucleotide variant,missense variant,Benign,"Mar 17, 2021",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38485996,rs372958050,T,C,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.5341T>C (p.Cys1781Arg),RYR1,C1781R,Malignant hyperthermia of anesthesia,VCV001009683,19,38976636,19,38485996,1009683,998529,rs372958050,NC_000019.10:38485995:T:C,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38486015,rs34934920,C,T,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.5360C>T (p.Pro1787Leu),RYR1,P1787L,"Malignant hyperthermia, susceptibility to, 1",VCV000133149,19,38976655,19,38486015,133149,136896,rs34934920,NC_000019.10:38486014:C:T,single nucleotide variant,missense variant,Benign,"Mar 17, 2021",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38486095,.,A,G,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.5440A>G (p.Met1814Val),RYR1,M1814V,Malignant hyperthermia of anesthesia,VCV001213826,19,38976735,19,38486095,1213826,1203819,rs2145545032,NC_000019.10:38486094:A:G,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38486096,rs193922783,T,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.5441T>A (p.Met1814Lys),RYR1,M1814K,"Malignant hyperthermia, susceptibility to, 1",VCV000133150,19,38976736,19,38486096,133150,136897,rs193922783,NC_000019.10:38486095:T:A,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38490151,rs145801146,C,T,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.5890C>T (p.Arg1964Cys),RYR1,R1964C,Malignant hyperthermia of anesthesia,VCV001213827,19,38980791,19,38490151,1213827,1203820,rs145801146,NC_000019.10:38490150:C:T,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38490642,.,A,C,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.6037A>C (p.Lys2013Gln),RYR1,K2013Q,"Malignant hyperthermia, susceptibility to, 1",VCV001210319,19,38981282,19,38490642,1210319,1200308,rs2145564171,NC_000019.10:38490641:A:C,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38492540,rs35364374,G,T,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.6178G>T (p.Gly2060Cys),RYR1,G2060C,"Malignant hyperthermia, susceptibility to, 1",VCV000093279,19,38983180,19,38492540,93279,99186,rs35364374,NC_000019.10:38492539:G:T,single nucleotide variant,missense variant,Benign,"Mar 17, 2021",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38494379,rs746818096,T,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.6302T>A (p.Met2101Lys),RYR1,M2101K,Malignant hyperthermia of anesthesia,VCV000544517,19,38985019,19,38494379,544517,533355,rs746818096,NC_000019.10:38494378:T:A,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38494381,rs770593660,G,C,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.6304G>C (p.Val2102Leu),RYR1,V2102L,"Malignant hyperthermia, susceptibility to, 1",VCV001210308,19,38985021,19,38494381,1210308,1200309,rs770593660,NC_000019.10:38494380:G:C,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38494381,rs770593660,G,C,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.6304G>T (p.Val2102Leu),RYR1,V2102L,"Malignant hyperthermia, susceptibility to, 1|Central core myopathy|Congenital multicore myopathy with external ophthalmoplegia|Malignant hyperthermia, susceptibility to, 1|King Denborough syndrome|Congenital myopathy with fiber type disproportion|RYR1-related disorder",VCV000580243,19,38985021,19,38494381,580243,572409,rs770593660,NC_000019.10:38494380:G:T,single nucleotide variant,missense variant,Uncertain significance,"Aug 8, 2023","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chr19,38494426,rs193922788,G,C,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.6349G>C (p.Val2117Leu),RYR1,V2117L,"Malignant hyperthermia, susceptibility to, 1",VCV000133156,19,38985066,19,38494426,133156,136903,rs193922788,NC_000019.10:38494425:G:C,single nucleotide variant,missense variant,Likely pathogenic,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38494454,.,G,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.6377G>A (p.Arg2126Gln),RYR1,R2126Q,Malignant hyperthermia of anesthesia,VCV001213820,19,38985094,19,38494454,1213820,1203813,rs1469128640,NC_000019.10:38494453:G:A,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38494464,rs117886618,C,G,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.6387C>T (p.Asp2129=),RYR1,nan,"Malignant hyperthermia, susceptibility to, 1|RYR1-related disorder|not provided|not specified",VCV000329050,19,38985104,19,38494464,329050,348733,rs117886618,NC_000019.10:38494463:C:T,single nucleotide variant,synonymous variant,Benign/Likely benign,"Jan 30, 2025","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chr19,38494464,rs117886618,C,G,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.6387C>G (p.Asp2129Glu),RYR1,D2129E,"Malignant hyperthermia, susceptibility to, 1",VCV000133157,19,38985104,19,38494464,133157,136904,rs117886618,NC_000019.10:38494463:C:G,single nucleotide variant,missense variant,Likely pathogenic,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38494465,rs193922789,G,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.6388G>A (p.Gly2130Arg),RYR1,G2130R,"Malignant hyperthermia, susceptibility to, 1",VCV000133158,19,38985105,19,38494465,133158,136905,rs193922789,NC_000019.10:38494464:G:A,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38494555,rs143398211,G,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.6478G>C (p.Gly2160Arg),RYR1,G2160R,RYR1-related disorder,VCV000998406,19,38985195,19,38494555,998406,998538,rs143398211,NC_000019.10:38494554:G:C,single nucleotide variant,missense variant,Uncertain significance,"Sep 1, 2021","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chr19,38494555,rs143398211,G,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.6478G>A (p.Gly2160Ser),RYR1,G2160S,"Malignant hyperthermia, susceptibility to, 1",VCV000161374,19,38985195,19,38494555,161374,171236,rs143398211,NC_000019.10:38494554:G:A,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38494564,rs118192175,C,T,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.6487C>G (p.Arg2163Gly),RYR1,R2163G,RYR1-related disorder,VCV002760642,19,38985204,19,38494564,2760642,2921821,rs118192175,NC_000019.10:38494563:C:G,single nucleotide variant,missense variant,Likely pathogenic,"Sep 14, 2023","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chr19,38494564,rs118192175,C,T,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.6487C>T (p.Arg2163Cys),RYR1,R2163C,"sevoflurane response - Toxicity|succinylcholine response - Toxicity|methoxyflurane response - Toxicity|isoflurane response - Toxicity|halothane response - Toxicity|enflurane response - Toxicity|desflurane response - Toxicity|Malignant hyperthermia, susceptibility to, 1",VCV000012973,19,38985204,19,38494564,12973,28012,rs118192175,NC_000019.10:38494563:C:T,single nucleotide variant,missense variant,Pathogenic; drug response,"Mar 14, 2022",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38494565,rs118192163,G,"A,C,T",.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.6488G>T (p.Arg2163Leu),RYR1,R2163L,Malignant hyperthermia of anesthesia,VCV000590571,19,38985205,19,38494565,590571,581517,rs118192163,NC_000019.10:38494564:G:T,single nucleotide variant,missense variant,Likely pathogenic,"Nov 21, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38494565,rs118192163,G,"A,C,T",.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.6488G>C (p.Arg2163Pro),RYR1,R2163P,"Malignant hyperthermia, susceptibility to, 1",VCV000133159,19,38985205,19,38494565,133159,136906,rs118192163,NC_000019.10:38494564:G:C,single nucleotide variant,missense variant,Likely pathogenic,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38494565,rs118192163,G,"A,C,T",.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.6488G>A (p.Arg2163His),RYR1,R2163H,"desflurane response - Toxicity|enflurane response - Toxicity|Malignant hyperthermia, susceptibility to, 1|succinylcholine response - Toxicity|sevoflurane response - Toxicity|methoxyflurane response - Toxicity|halothane response - Toxicity|isoflurane response - Toxicity",VCV000012974,19,38985205,19,38494565,12974,28013,rs118192163,NC_000019.10:38494564:G:A,single nucleotide variant,missense variant,Pathogenic; drug response,"Mar 29, 2022",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38494579,rs118192176,G,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.6502G>C (p.Val2168Leu),RYR1,V2168L,"Malignant hyperthermia, susceptibility to, 1|RYR1-related disorder",VCV002146721,19,38985219,19,38494579,2146721,1870371,rs118192176,NC_000019.10:38494578:G:C,single nucleotide variant,missense variant,Conflicting classifications of pathogenicity,"Dec 18, 2023","criteria provided, conflicting classifications",nan,nan,nan,nan,nan,nan,nan
chr19,38494579,rs118192176,G,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.6502G>A (p.Val2168Met),RYR1,V2168M,"Malignant hyperthermia, susceptibility to, 1|methoxyflurane response - Toxicity|sevoflurane response - Toxicity|halothane response - Toxicity|isoflurane response - Toxicity|desflurane response - Toxicity|enflurane response - Toxicity|succinylcholine response - Toxicity",VCV000012976,19,38985219,19,38494579,12976,28015,rs118192176,NC_000019.10:38494578:G:A,single nucleotide variant,missense variant,Pathogenic; drug response,"Mar 29, 2022",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38494621,rs193922790,A,T,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.6544A>T (p.Ile2182Phe),RYR1,I2182F,"Malignant hyperthermia, susceptibility to, 1",VCV000133161,19,38985261,19,38494621,133161,136908,rs193922790,NC_000019.10:38494620:A:T,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38494625,rs959170123,G,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.6548G>A (p.Gly2183Glu),RYR1,G2183E,"Malignant hyperthermia, susceptibility to, 1",VCV001214008,19,38985265,19,38494625,1214008,1204001,rs959170123,NC_000019.10:38494624:G:A,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38494625,rs959170123,G,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.6548G>C (p.Gly2183Ala),RYR1,G2183A,RYR1-related disorder,VCV000478258,19,38985265,19,38494625,478258,468689,rs959170123,NC_000019.10:38494624:G:C,single nucleotide variant,missense variant,Uncertain significance,"Mar 19, 2022","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chr19,38496265,rs193922791,C,T,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.6599C>G (p.Ala2200Gly),RYR1,A2200G,"Congenital multicore myopathy with external ophthalmoplegia|Central core myopathy|Malignant hyperthermia, susceptibility to, 1",VCV000891882,19,38986905,19,38496265,891882,880439,rs193922791,NC_000019.10:38496264:C:G,single nucleotide variant,missense variant,Uncertain significance,"Apr 27, 2017","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chr19,38496265,rs193922791,C,T,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.6599C>T (p.Ala2200Val),RYR1,A2200V,"Malignant hyperthermia, susceptibility to, 1",VCV000133162,19,38986905,19,38496265,133162,136909,rs193922791,NC_000019.10:38496264:C:T,single nucleotide variant,missense variant,Uncertain significance,"Apr 10, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38496278,rs141646642,C,G,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.6612C>T (p.His2204=),RYR1,nan,"RYR1-related disorder|not specified|not provided|Malignant hyperthermia, susceptibility to, 1",VCV000256537,19,38986918,19,38496278,256537,256984,rs141646642,NC_000019.10:38496277:C:T,single nucleotide variant,synonymous variant,Benign/Likely benign,"Mar 1, 2025","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chr19,38496278,rs141646642,C,G,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.6612C>G (p.His2204Gln),RYR1,H2204Q,"Malignant hyperthermia, susceptibility to, 1",VCV000133163,19,38986918,19,38496278,133163,136910,rs141646642,NC_000019.10:38496277:C:G,single nucleotide variant,missense variant,Likely pathogenic,"May 22, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38496283,rs118192177,C,"G,T",.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.6617C>G (p.Thr2206Arg),RYR1,T2206R,not provided,VCV000133164,19,38986923,19,38496283,133164,136911,rs118192177,NC_000019.10:38496282:C:G,single nucleotide variant,missense variant,not provided,nan,no classification provided,nan,nan,nan,nan,nan,nan,nan
chr19,38496283,rs118192177,C,"G,T",.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.6617C>T (p.Thr2206Met),RYR1,T2206M,"Malignant hyperthermia, susceptibility to, 1",VCV000012977,19,38986923,19,38496283,12977,28016,rs118192177,NC_000019.10:38496282:C:T,single nucleotide variant,missense variant,Pathogenic,"Mar 14, 2022",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38496294,rs193922792,G,T,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.6628G>A (p.Val2210Ile),RYR1,V2210I,"Malignant hyperthermia, susceptibility to, 1",VCV003072134,19,38986934,19,38496294,3072134,3232311,rs193922792,NC_000019.10:38496293:G:A,single nucleotide variant,missense variant,Uncertain significance,"Jun 26, 2023","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chr19,38496294,rs193922792,G,T,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.6628G>C (p.Val2210Leu),RYR1,V2210L,"Malignant hyperthermia, susceptibility to, 1|RYR1-related disorder",VCV001430890,19,38986934,19,38496294,1430890,1467567,rs193922792,NC_000019.10:38496293:G:C,single nucleotide variant,missense variant,Uncertain significance,"Dec 13, 2023","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chr19,38496294,rs193922792,G,T,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.6628G>T (p.Val2210Phe),RYR1,V2210F,"Malignant hyperthermia, susceptibility to, 1",VCV000133165,19,38986934,19,38496294,133165,136912,rs193922792,NC_000019.10:38496293:G:T,single nucleotide variant,missense variant,Likely pathogenic,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38496301,rs193922793,T,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.6635T>C (p.Val2212Ala),RYR1,V2212A,RYR1-related disorder,VCV000133167,19,38986941,19,38496301,133167,136914,rs193922793,NC_000019.10:38496300:T:C,single nucleotide variant,missense variant,Uncertain significance,"Jun 13, 2022","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chr19,38496301,rs193922793,T,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.6635T>A (p.Val2212Asp),RYR1,V2212D,"Malignant hyperthermia, susceptibility to, 1",VCV000133166,19,38986941,19,38496301,133166,136913,rs193922793,NC_000019.10:38496300:T:A,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38496306,rs193922795,G,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.6640G>A (p.Val2214Ile),RYR1,V2214I,"Malignant hyperthermia, susceptibility to, 1",VCV000133168,19,38986946,19,38496306,133168,136915,rs193922795,NC_000019.10:38496305:G:A,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38496415,rs199870223,C,T,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.6670C>T (p.Arg2224Cys),RYR1,R2224C,"Malignant hyperthermia, susceptibility to, 1",VCV000224387,19,38987055,19,38496415,224387,226124,rs199870223,NC_000019.10:38496414:C:T,single nucleotide variant,missense variant,Likely benign,"Mar 18, 2021",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38496416,rs537994744,G,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.6671G>A (p.Arg2224His),RYR1,R2224H,"Malignant hyperthermia, susceptibility to, 1",VCV000478260,19,38987056,19,38496416,478260,468693,rs537994744,NC_000019.10:38496415:G:A,single nucleotide variant,missense variant,Uncertain significance,"Apr 7, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38496455,.,G,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.6710G>A (p.Cys2237Tyr),RYR1,C2237Y,"Malignant hyperthermia, susceptibility to, 1",VCV001065119,19,38987095,19,38496455,1065119,1053425,rs2145586397,NC_000019.10:38496454:G:A,single nucleotide variant,missense variant,Uncertain significance,"Apr 7, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38496487,rs763352221,C,T,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.6742C>T (p.Arg2248Cys),RYR1,R2248C,Malignant hyperthermia of anesthesia,VCV000568713,19,38987127,19,38496487,568713,570715,rs763352221,NC_000019.10:38496486:C:T,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38496488,rs140152019,G,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.6743G>A (p.Arg2248His),RYR1,R2248H,Malignant hyperthermia of anesthesia,VCV000590574,19,38987128,19,38496488,590574,581520,rs140152019,NC_000019.10:38496487:G:A,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38496502,rs917523269,C,T,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.6757C>T (p.His2253Tyr),RYR1,H2253Y,"Malignant hyperthermia, susceptibility to, 1",VCV000590575,19,38987142,19,38496502,590575,581521,rs917523269,NC_000019.10:38496501:C:T,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38496901,rs193922797,G,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.6838G>T (p.Val2280Phe),RYR1,V2280F,"not provided|Malignant hyperthermia, susceptibility to, 1|Congenital myopathy with fiber type disproportion|Malignant hyperthermia, susceptibility to, 1|Central core myopathy|Congenital multicore myopathy with external ophthalmoplegia",VCV000546504,19,38987541,19,38496901,546504,536983,rs193922797,NC_000019.10:38496900:G:T,single nucleotide variant,missense variant,Uncertain significance,"Jun 26, 2023","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chr19,38496901,rs193922797,G,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.6838G>A (p.Val2280Ile),RYR1,V2280I,"Malignant hyperthermia, susceptibility to, 1",VCV000133172,19,38987541,19,38496901,133172,136919,rs193922797,NC_000019.10:38496900:G:A,single nucleotide variant,missense variant,Likely pathogenic,"May 20, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38496910,rs118192121,A,C,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.6847A>C (p.Asn2283His),RYR1,N2283H,"Malignant hyperthermia, susceptibility to, 1",VCV000065968,19,38987550,19,38496910,65968,76876,rs118192121,NC_000019.10:38496909:A:C,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38499177,rs34390345,A,G,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.6961A>T (p.Ile2321Phe),RYR1,I2321F,RYR1-related disorder,VCV001482847,19,38989817,19,38499177,1482847,1464830,rs34390345,NC_000019.10:38499176:A:T,single nucleotide variant,missense variant,Uncertain significance,"Oct 19, 2021","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chr19,38499177,rs34390345,A,G,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.6961A>G (p.Ile2321Val),RYR1,I2321V,"Malignant hyperthermia, susceptibility to, 1",VCV000133173,19,38989817,19,38499177,133173,136920,rs34390345,NC_000019.10:38499176:A:G,single nucleotide variant,missense variant,Benign,"Mar 18, 2021",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38499223,rs112563513,G,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.7007G>T (p.Arg2336Leu),RYR1,R2336L,RYR1-related disorder,VCV002038577,19,38989863,19,38499223,2038577,2101645,rs112563513,NC_000019.10:38499222:G:T,single nucleotide variant,missense variant,Likely pathogenic,"Dec 9, 2021","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chr19,38499223,rs112563513,G,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.7007G>A (p.Arg2336His),RYR1,R2336H,"Malignant hyperthermia, susceptibility to, 1|succinylcholine response - Toxicity|sevoflurane response - Toxicity|methoxyflurane response - Toxicity|halothane response - Toxicity|isoflurane response - Toxicity|enflurane response - Toxicity|desflurane response - Toxicity",VCV000133174,19,38989863,19,38499223,133174,136921,rs112563513,NC_000019.10:38499222:G:A,single nucleotide variant,missense variant,Pathogenic; drug response,"Jul 10, 2022",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38499234,.,T,C,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.7018T>C (p.Phe2340Leu),RYR1,F2340L,Malignant hyperthermia of anesthesia,VCV001213821,19,38989874,19,38499234,1213821,1203814,rs1969983957,NC_000019.10:38499233:T:C,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38499234,.,T,C,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.7018T>A (p.Phe2340Ile),RYR1,F2340I,RYR1-related disorder,VCV000841702,19,38989874,19,38499234,841702,847606,rs1969983957,NC_000019.10:38499233:T:A,single nucleotide variant,missense variant,Uncertain significance,"Jan 14, 2019","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chr19,38499241,rs147213895,A,G,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.7025A>G (p.Asn2342Ser),RYR1,N2342S,"RYR1-related myopathy|Malignant hyperthermia, susceptibility to, 1",VCV000133175,19,38989881,19,38499241,133175,136922,rs147213895,NC_000019.10:38499240:A:G,single nucleotide variant,missense variant,Benign/Likely benign,"Feb 10, 2025",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38499639,rs193922798,G,C,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.7032G>C (p.Glu2344Asp),RYR1,E2344D,Malignant hyperthermia of anesthesia,VCV000133178,19,38990279,19,38499639,133178,136925,rs193922798,NC_000019.10:38499638:G:C,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38499642,.,C,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.7035C>T (p.Ser2345=),RYR1,nan,"RYR1-related disorder|Malignant hyperthermia, susceptibility to, 1",VCV002723750,19,38990282,19,38499642,2723750,2881662,rs1448949048,NC_000019.10:38499641:C:T,single nucleotide variant,synonymous variant,Likely benign,"Dec 4, 2024","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chr19,38499642,.,C,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.7035C>A (p.Ser2345Arg),RYR1,S2345R,"Malignant hyperthermia, susceptibility to, 1",VCV001210320,19,38990282,19,38499642,1210320,1200310,rs1448949048,NC_000019.10:38499641:C:A,single nucleotide variant,missense variant,Likely pathogenic,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38499642,.,C,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.7035C>G (p.Ser2345Arg),RYR1,S2345R,RYR1-related disorder|not provided,VCV000590578,19,38990282,19,38499642,590578,581524,rs1448949048,NC_000019.10:38499641:C:G,single nucleotide variant,missense variant,Conflicting classifications of pathogenicity,"Mar 23, 2023","criteria provided, conflicting classifications",nan,nan,nan,nan,nan,nan,nan
chr19,38499643,rs193922799,G,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.7036G>A (p.Val2346Met),RYR1,V2346M,"Malignant hyperthermia, susceptibility to, 1",VCV000133179,19,38990283,19,38499643,133179,136926,rs193922799,NC_000019.10:38499642:G:A,single nucleotide variant,missense variant,Uncertain significance,"Feb 28, 2024",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38499644,rs121918596,TGGA,T,.,PASS,PX=RYR1,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr19,38499650,rs193922801,A,G,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.7043A>G (p.Glu2348Gly),RYR1,E2348G,"Malignant hyperthermia, susceptibility to, 1",VCV000133181,19,38990290,19,38499650,133181,136928,rs193922801,NC_000019.10:38499649:A:G,single nucleotide variant,missense variant,Likely pathogenic,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38499655,rs193922802,G,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.7048G>A (p.Ala2350Thr),RYR1,A2350T,"Malignant hyperthermia, susceptibility to, 1|desflurane response - Toxicity|succinylcholine response - Toxicity|sevoflurane response - Toxicity|methoxyflurane response - Toxicity|isoflurane response - Toxicity|halothane response - Toxicity|enflurane response - Toxicity",VCV000133182,19,38990295,19,38499655,133182,136929,rs193922802,NC_000019.10:38499654:G:A,single nucleotide variant,missense variant,Pathogenic; drug response,"Mar 24, 2021",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38499667,.,G,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.7060G>A (p.Val2354Met),RYR1,V2354M,"Malignant hyperthermia, susceptibility to, 1",VCV000590580,19,38990307,19,38499667,590580,581526,rs746971794,NC_000019.10:38499666:G:A,single nucleotide variant,missense variant,Likely pathogenic,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38499670,rs193922803,C,T,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.7063C>T (p.Arg2355Trp),RYR1,R2355W,"Malignant hyperthermia, susceptibility to, 1|desflurane response - Toxicity|succinylcholine response - Toxicity|methoxyflurane response - Toxicity|sevoflurane response - Toxicity|isoflurane response - Toxicity|enflurane response - Toxicity|halothane response - Toxicity",VCV000133183,19,38990310,19,38499670,133183,136930,rs193922803,NC_000019.10:38499669:C:T,single nucleotide variant,missense variant,Pathogenic; drug response,"Mar 24, 2021",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38499680,.,T,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.7073T>A (p.Ile2358Asn),RYR1,I2358N,"Malignant hyperthermia, susceptibility to, 1",VCV000803553,19,38990320,19,38499680,803553,791924,rs1600820232,NC_000019.10:38499679:T:A,single nucleotide variant,missense variant,Uncertain significance,"Apr 7, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38499682,rs769482889,C,T,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.7075C>T (p.Arg2359Trp),RYR1,R2359W,"Malignant hyperthermia, susceptibility to, 1",VCV000449521,19,38990322,19,38499682,449521,446109,rs769482889,NC_000019.10:38499681:C:T,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38499683,.,G,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.7076G>A (p.Arg2359Gln),RYR1,R2359Q,"Malignant hyperthermia, susceptibility to, 1",VCV000573252,19,38990323,19,38499683,573252,572427,rs1387126664,NC_000019.10:38499682:G:A,single nucleotide variant,missense variant,Likely pathogenic,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38499691,rs762401851,G,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.7084G>A (p.Glu2362Lys),RYR1,E2362K,"Malignant hyperthermia, susceptibility to, 1",VCV001214002,19,38990331,19,38499691,1214002,1203995,rs762401851,NC_000019.10:38499690:G:A,single nucleotide variant,missense variant,Likely pathogenic,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38499692,rs193922804,A,G,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.7085A>G (p.Glu2362Gly),RYR1,E2362G,"Malignant hyperthermia, susceptibility to, 1",VCV000133184,19,38990332,19,38499692,133184,136931,rs193922804,NC_000019.10:38499691:A:G,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38499696,.,C,G,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.7089C>G (p.Cys2363Trp),RYR1,C2363W,"Malignant hyperthermia, susceptibility to, 1",VCV000478267,19,38990336,19,38499696,478267,470699,rs2228071,NC_000019.10:38499695:C:G,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38499696,.,C,G,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.7089C>T (p.Cys2363=),RYR1,nan,"not provided|Central core myopathy|Malignant hyperthermia, susceptibility to, 1|Congenital multicore myopathy with external ophthalmoplegia|Neuromuscular disease, congenital, with uniform type 1 fiber|RYR1-related disorder|not specified",VCV000093284,19,38990336,19,38499696,93284,99191,rs2228071,NC_000019.10:38499695:C:T,single nucleotide variant,synonymous variant,Benign,"Feb 4, 2025","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chr19,38499697,rs193922805,T,G,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.7090T>G (p.Phe2364Val),RYR1,F2364V,"Malignant hyperthermia, susceptibility to, 1",VCV000133185,19,38990337,19,38499697,133185,136932,rs193922805,NC_000019.10:38499696:T:G,single nucleotide variant,missense variant,Likely pathogenic,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38499704,rs193922806,C,G,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.7097C>G (p.Pro2366Arg),RYR1,P2366R,"Malignant hyperthermia, susceptibility to, 1",VCV000133186,19,38990344,19,38499704,133186,136933,rs193922806,NC_000019.10:38499703:C:G,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38499706,rs146306934,G,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.7099G>T (p.Ala2367Ser),RYR1,A2367S,RYR1-related disorder,VCV003636229,19,38990346,19,38499706,3636229,3764149,nan,NC_000019.10:38499705:G:T,single nucleotide variant,missense variant,Uncertain significance,"May 12, 2024","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chr19,38499706,rs146306934,G,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.7099G>A (p.Ala2367Thr),RYR1,A2367T,"Malignant hyperthermia, susceptibility to, 1",VCV000133187,19,38990346,19,38499706,133187,136934,rs146306934,NC_000019.10:38499705:G:A,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38499719,.,A,G,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.7112A>G (p.Glu2371Gly),RYR1,E2371G,"Malignant hyperthermia, susceptibility to, 1",VCV001330355,19,38990359,19,38499719,1330355,1321035,rs2145600668,NC_000019.10:38499718:A:G,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38499730,.,G,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.7123G>C (p.Gly2375Arg),RYR1,G2375R,"Malignant hyperthermia, susceptibility to, 1|Central core myopathy",VCV000803554,19,38990370,19,38499730,803554,791925,rs1568501059,NC_000019.10:38499729:G:C,single nucleotide variant,missense variant,Likely pathogenic,"Oct 22, 2024","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chr19,38499730,.,G,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.7123G>A (p.Gly2375Arg),RYR1,G2375R,"Malignant hyperthermia, susceptibility to, 1",VCV000590582,19,38990370,19,38499730,590582,581528,rs1568501059,NC_000019.10:38499729:G:A,single nucleotide variant,missense variant,Likely pathogenic,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38499731,rs193922807,G,C,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.7124G>A (p.Gly2375Glu),RYR1,G2375E,not provided,VCV001012447,19,38990371,19,38499731,1012447,1001106,rs193922807,NC_000019.10:38499730:G:A,single nucleotide variant,missense variant,Likely pathogenic,"Dec 1, 2020","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chr19,38499731,rs193922807,G,C,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.7124G>C (p.Gly2375Ala),RYR1,G2375A,"Malignant hyperthermia, susceptibility to, 1|desflurane response - Toxicity|succinylcholine response - Toxicity|sevoflurane response - Toxicity|methoxyflurane response - Toxicity|isoflurane response - Toxicity|halothane response - Toxicity|enflurane response - Toxicity",VCV000133189,19,38990371,19,38499731,133189,136936,rs193922807,NC_000019.10:38499730:G:C,single nucleotide variant,missense variant,Pathogenic; drug response,"Jul 11, 2022",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38499806,rs976108591,A,G,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.7199A>G (p.Asp2400Gly),RYR1,D2400G,"Malignant hyperthermia, susceptibility to, 1",VCV000582065,19,38990446,19,38499806,582065,573059,rs976108591,NC_000019.10:38499805:A:G,single nucleotide variant,missense variant,Uncertain significance,"Apr 7, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38499817,rs111364296,G,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.7210G>T (p.Glu2404Ter),RYR1,E2404*,RYR1-related disorder,VCV000573880,19,38990457,19,38499817,573880,574953,rs111364296,NC_000019.10:38499816:G:T,single nucleotide variant,nonsense,Pathogenic,"Jul 5, 2018","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chr19,38499817,rs111364296,G,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.7210G>A (p.Glu2404Lys),RYR1,E2404K,"Malignant hyperthermia, susceptibility to, 1",VCV000161379,19,38990457,19,38499817,161379,171237,rs111364296,NC_000019.10:38499816:G:A,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38499975,rs193922809,G,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.7282G>T (p.Ala2428Ser),RYR1,A2428S,Central core myopathy,VCV003065285,19,38990615,19,38499975,3065285,3225308,rs193922809,NC_000019.10:38499974:G:T,single nucleotide variant,missense variant,Likely pathogenic,"Mar 26, 2024","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chr19,38499975,rs193922809,G,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.7282G>A (p.Ala2428Thr),RYR1,A2428T,"Malignant hyperthermia, susceptibility to, 1|succinylcholine response - Toxicity|sevoflurane response - Toxicity|methoxyflurane response - Toxicity|isoflurane response - Toxicity|halothane response - Toxicity|enflurane response - Toxicity|desflurane response - Toxicity",VCV000133193,19,38990615,19,38499975,133193,136940,rs193922809,NC_000019.10:38499974:G:A,single nucleotide variant,missense variant,Likely pathogenic; drug response,"Apr 7, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38499984,rs193922810,G,"A,T",.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.7291G>T (p.Asp2431Tyr),RYR1,D2431Y,"Malignant hyperthermia, susceptibility to, 1",VCV000133195,19,38990624,19,38499984,133195,136942,rs193922810,NC_000019.10:38499983:G:T,single nucleotide variant,missense variant,Likely pathogenic,"Apr 7, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38499984,rs193922810,G,"A,T",.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.7291G>A (p.Asp2431Asn),RYR1,D2431N,"Malignant hyperthermia, susceptibility to, 1",VCV000133194,19,38990624,19,38499984,133194,136941,rs193922810,NC_000019.10:38499983:G:A,single nucleotide variant,missense variant,Likely pathogenic,"Apr 7, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38499985,.,A,T,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.7292A>T (p.Asp2431Val),RYR1,D2431V,"Malignant hyperthermia, susceptibility to, 1",VCV001210302,19,38990625,19,38499985,1210302,1200311,rs2145602229,NC_000019.10:38499984:A:T,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38499993,rs121918593,G,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.7300G>A (p.Gly2434Arg),RYR1,G2434R,"enflurane response - Toxicity|halothane response - Toxicity|desflurane response - Toxicity|Malignant hyperthermia, susceptibility to, 1|succinylcholine response - Toxicity|sevoflurane response - Toxicity|methoxyflurane response - Toxicity|isoflurane response - Toxicity",VCV000012970,19,38990633,19,38499993,12970,28009,rs121918593,NC_000019.10:38499992:G:A,single nucleotide variant,missense variant,Pathogenic; drug response,"Jul 11, 2022",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38499997,rs28933396,G,"A,T",.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.7304G>T (p.Arg2435Leu),RYR1,R2435L,"Malignant hyperthermia, susceptibility to, 1",VCV000133196,19,38990637,19,38499997,133196,136943,rs28933396,NC_000019.10:38499996:G:T,single nucleotide variant,missense variant,Likely pathogenic,"Apr 7, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38499997,rs28933396,G,"A,T",.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.7304G>A (p.Arg2435His),RYR1,R2435H,"enflurane response - Toxicity|desflurane response - Toxicity|Malignant hyperthermia, susceptibility to, 1|succinylcholine response - Toxicity|sevoflurane response - Toxicity|methoxyflurane response - Toxicity|isoflurane response - Toxicity|halothane response - Toxicity",VCV000012966,19,38990637,19,38499997,12966,28005,rs28933396,NC_000019.10:38499996:G:A,single nucleotide variant,missense variant,Pathogenic; drug response,"Mar 24, 2021",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38500000,.,G,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.7307G>A (p.Cys2436Tyr),RYR1,C2436Y,Malignant hyperthermia of anesthesia,VCV001330372,19,38990640,19,38500000,1330372,1321052,rs2145602328,NC_000019.10:38499999:G:A,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38500003,rs193922812,C,T,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.7310C>T (p.Ala2437Val),RYR1,A2437V,"Malignant hyperthermia, susceptibility to, 1",VCV000133197,19,38990643,19,38500003,133197,136944,rs193922812,NC_000019.10:38500002:C:T,single nucleotide variant,missense variant,Likely pathogenic,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38500010,rs193922813,G,C,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.7317G>C (p.Glu2439Asp),RYR1,E2439D,"Malignant hyperthermia, susceptibility to, 1",VCV000133198,19,38990650,19,38500010,133198,136945,rs193922813,NC_000019.10:38500009:G:C,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38500636,rs118192124,C,T,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.7354C>T (p.Arg2452Trp),RYR1,R2452W,"Malignant hyperthermia, susceptibility to, 1|succinylcholine response - Toxicity|isoflurane response - Toxicity|methoxyflurane response - Toxicity|sevoflurane response - Toxicity|desflurane response - Toxicity|enflurane response - Toxicity|halothane response - Toxicity",VCV000065979,19,38991276,19,38500636,65979,76887,rs118192124,NC_000019.10:38500635:C:T,single nucleotide variant,missense variant,Likely pathogenic; drug response,"Apr 7, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38500637,rs193922815,G,"A,C",.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.7355G>C (p.Arg2452Pro),RYR1,R2452P,"Malignant hyperthermia, susceptibility to, 1",VCV001210314,19,38991277,19,38500637,1210314,1200312,rs193922815,NC_000019.10:38500636:G:C,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38500637,rs193922815,G,"A,C",.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.7355G>A (p.Arg2452Gln),RYR1,R2452Q,"Malignant hyperthermia, susceptibility to, 1",VCV000133201,19,38991277,19,38500637,133201,136948,rs193922815,NC_000019.10:38500636:G:A,single nucleotide variant,missense variant,Uncertain significance,"Dec 21, 2021",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38500640,rs118192123,T,C,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.7358T>C (p.Ile2453Thr),RYR1,I2453T,"Malignant hyperthermia, susceptibility to, 1",VCV000065953,19,38991280,19,38500640,65953,76861,rs118192123,NC_000019.10:38500639:T:C,single nucleotide variant,missense variant,Likely pathogenic,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38500642,rs193922816,C,T,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.7360C>A (p.Arg2454Ser),RYR1,R2454S,RYR1-related disorder,VCV002745548,19,38991282,19,38500642,2745548,2907606,rs193922816,NC_000019.10:38500641:C:A,single nucleotide variant,missense variant,Likely pathogenic,"Jul 20, 2023","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chr19,38500642,rs193922816,C,T,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.7360C>T (p.Arg2454Cys),RYR1,R2454C,"Malignant hyperthermia, susceptibility to, 1|desflurane response - Toxicity|succinylcholine response - Toxicity|sevoflurane response - Toxicity|methoxyflurane response - Toxicity|isoflurane response - Toxicity|halothane response - Toxicity|enflurane response - Toxicity",VCV000133202,19,38991282,19,38500642,133202,136949,rs193922816,NC_000019.10:38500641:C:T,single nucleotide variant,missense variant,Pathogenic; drug response,"Mar 11, 2022",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38500643,rs118192122,G,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.7361G>A (p.Arg2454His),RYR1,R2454H,"Malignant hyperthermia, susceptibility to, 1|desflurane response - Toxicity|methoxyflurane response - Toxicity|sevoflurane response - Toxicity|succinylcholine response - Toxicity|enflurane response - Toxicity|halothane response - Toxicity|isoflurane response - Toxicity",VCV000065980,19,38991283,19,38500643,65980,76888,rs118192122,NC_000019.10:38500642:G:A,single nucleotide variant,missense variant,Pathogenic; drug response,"Mar 24, 2021",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38500654,rs28933397,C,T,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.7372C>T (p.Arg2458Cys),RYR1,R2458C,"desflurane response - Toxicity|succinylcholine response - Toxicity|sevoflurane response - Toxicity|methoxyflurane response - Toxicity|isoflurane response - Toxicity|halothane response - Toxicity|enflurane response - Toxicity|Malignant hyperthermia, susceptibility to, 1",VCV000012971,19,38991294,19,38500654,12971,28010,rs28933397,NC_000019.10:38500653:C:T,single nucleotide variant,missense variant,Likely pathogenic; drug response,"Apr 7, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38500655,rs121918594,G,"A,T",.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.7373G>T (p.Arg2458Leu),RYR1,R2458L,"Malignant hyperthermia, susceptibility to, 1",VCV000590585,19,38991295,19,38500655,590585,581531,rs121918594,NC_000019.10:38500654:G:T,single nucleotide variant,missense variant,Likely pathogenic,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38500655,rs121918594,G,"A,T",.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.7373G>A (p.Arg2458His),RYR1,R2458H,enflurane response - Toxicity|desflurane response - Toxicity|succinylcholine response - Toxicity|sevoflurane response - Toxicity|methoxyflurane response - Toxicity|isoflurane response - Toxicity|halothane response - Toxicity,VCV000012972,19,38991295,19,38500655,12972,28011,rs121918594,NC_000019.10:38500654:G:A,single nucleotide variant,missense variant,drug response,"Mar 24, 2021",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38500667,rs551223467,C,T,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.7385C>T (p.Pro2462Leu),RYR1,P2462L,"Malignant hyperthermia, susceptibility to, 1",VCV000329061,19,38991307,19,38500667,329061,348743,rs551223467,NC_000019.10:38500666:C:T,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38500863,rs193922817,C,T,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.7487C>G (p.Pro2496Arg),RYR1,P2496R,not provided|RYR1-related disorder,VCV000159859,19,38991503,19,38500863,159859,169567,rs193922817,NC_000019.10:38500862:C:G,single nucleotide variant,missense variant,Uncertain significance,"Jun 13, 2019","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chr19,38500863,rs193922817,C,T,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.7487C>T (p.Pro2496Leu),RYR1,P2496L,"Malignant hyperthermia, susceptibility to, 1",VCV000133204,19,38991503,19,38500863,133204,136951,rs193922817,NC_000019.10:38500862:C:T,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38500898,rs118192178,C,"G,T",.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.7522C>A (p.Arg2508Ser),RYR1,R2508S,Congenital multicore myopathy with external ophthalmoplegia,VCV003237453,19,38991538,19,38500898,3237453,3396574,rs118192178,NC_000019.10:38500897:C:A,single nucleotide variant,missense variant,Likely pathogenic,"Nov 30, 2023","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chr19,38500898,rs118192178,C,"G,T",.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.7522C>G (p.Arg2508Gly),RYR1,R2508G,"Malignant hyperthermia, susceptibility to, 1",VCV000133206,19,38991538,19,38500898,133206,136953,rs118192178,NC_000019.10:38500897:C:G,single nucleotide variant,missense variant,Uncertain significance,"May 20, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38500898,rs118192178,C,"G,T",.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.7522C>T (p.Arg2508Cys),RYR1,R2508C,"Malignant hyperthermia, susceptibility to, 1",VCV000065981,19,38991538,19,38500898,65981,76889,rs118192178,NC_000019.10:38500897:C:T,single nucleotide variant,missense variant,Likely pathogenic,"May 20, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38500899,rs193922818,G,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.7523G>C (p.Arg2508Pro),RYR1,R2508P,RYR1-related disorder,VCV003692780,19,38991539,19,38500899,3692780,3828278,nan,NC_000019.10:38500898:G:C,single nucleotide variant,missense variant,Likely pathogenic,"Feb 16, 2024","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chr19,38500899,rs193922818,G,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.7523G>A (p.Arg2508His),RYR1,R2508H,"Malignant hyperthermia, susceptibility to, 1|succinylcholine response - Toxicity|sevoflurane response - Toxicity|methoxyflurane response - Toxicity|halothane response - Toxicity|isoflurane response - Toxicity|enflurane response - Toxicity|desflurane response - Toxicity",VCV000133207,19,38991539,19,38500899,133207,136954,rs193922818,NC_000019.10:38500898:G:A,single nucleotide variant,missense variant,Likely pathogenic; drug response,"Apr 7, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38500904,rs193922819,T,C,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.7528T>C (p.Tyr2510His),RYR1,Y2510H,Malignant hyperthermia of anesthesia,VCV000133208,19,38991544,19,38500904,133208,136955,rs193922819,NC_000019.10:38500903:T:C,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38502652,rs767553612,A,G,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.7760A>G (p.Tyr2587Cys),RYR1,Y2587C,Malignant hyperthermia of anesthesia,VCV001056224,19,38993292,19,38502652,1056224,1051259,rs767553612,NC_000019.10:38502651:A:G,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38502663,rs193922822,C,"G,T",.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.7771C>T (p.Arg2591Trp),RYR1,R2591W,Malignant hyperthermia of anesthesia,VCV000133211,19,38993303,19,38502663,133211,136958,rs193922822,NC_000019.10:38502662:C:T,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38502663,rs193922822,C,"G,T",.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.7771C>G (p.Arg2591Gly),RYR1,R2591G,Malignant hyperthermia of anesthesia,VCV000093291,19,38993303,19,38502663,93291,99198,rs193922822,NC_000019.10:38502662:C:G,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38502669,.,C,G,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.7777C>T (p.Arg2593Cys),RYR1,R2593C,"Malignant hyperthermia, susceptibility to, 1|RYR1-related disorder",VCV003069421,19,38993309,19,38502669,3069421,3230047,rs756685891,NC_000019.10:38502668:C:T,single nucleotide variant,missense variant,Uncertain significance,"Jul 2, 2024","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chr19,38502669,.,C,G,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.7777C>G (p.Arg2593Gly),RYR1,R2593G,Malignant hyperthermia of anesthesia,VCV001330356,19,38993309,19,38502669,1330356,1321036,rs756685891,NC_000019.10:38502668:C:G,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38502670,rs751180702,G,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.7778G>A (p.Arg2593His),RYR1,R2593H,Malignant hyperthermia of anesthesia,VCV000654130,19,38993310,19,38502670,654130,648014,rs751180702,NC_000019.10:38502669:G:A,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38502679,rs193922824,C,T,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.7787C>G (p.Thr2596Ser),RYR1,T2596S,"Central core myopathy|Congenital multicore myopathy with external ophthalmoplegia|Malignant hyperthermia, susceptibility to, 1",VCV000890267,19,38993319,19,38502679,890267,880443,rs193922824,NC_000019.10:38502678:C:G,single nucleotide variant,missense variant,Uncertain significance,"Nov 30, 2023","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chr19,38502679,rs193922824,C,T,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.7787C>T (p.Thr2596Ile),RYR1,T2596I,Malignant hyperthermia of anesthesia,VCV000133212,19,38993319,19,38502679,133212,136959,rs193922824,NC_000019.10:38502678:C:T,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38502708,rs748575133,T,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.7816T>A (p.Cys2606Ser),RYR1,C2606S,Malignant hyperthermia of anesthesia,VCV001330357,19,38993348,19,38502708,1330357,1321037,rs748575133,NC_000019.10:38502707:T:A,single nucleotide variant,missense variant,Likely benign,"Dec 21, 2021",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38502923,rs914804033,G,"A,C",.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.7879G>C (p.Val2627Leu),RYR1,V2627L,Malignant hyperthermia of anesthesia,VCV001330358,19,38993563,19,38502923,1330358,1321038,rs914804033,NC_000019.10:38502922:G:C,single nucleotide variant,missense variant,Likely pathogenic,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38502923,rs914804033,G,"A,C",.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.7879G>A (p.Val2627Met),RYR1,V2627M,Malignant hyperthermia of anesthesia,VCV000872586,19,38993563,19,38502923,872586,860563,rs914804033,NC_000019.10:38502922:G:A,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38504298,.,G,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.8005G>A (p.Glu2669Lys),RYR1,E2669K,Malignant hyperthermia of anesthesia,VCV001330359,19,38994938,19,38504298,1330359,1321039,rs2145626689,NC_000019.10:38504297:G:A,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38504319,rs193922826,C,T,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.8026C>G (p.Arg2676Gly),RYR1,R2676G,not specified,VCV003895913,19,38994959,19,38504319,3895913,4011786,nan,NC_000019.10:38504318:C:G,single nucleotide variant,missense variant,Uncertain significance,"Mar 26, 2025","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chr19,38504319,rs193922826,C,T,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.8026C>T (p.Arg2676Trp),RYR1,R2676W,Malignant hyperthermia of anesthesia,VCV000133217,19,38994959,19,38504319,133217,28024,rs193922826,NC_000019.10:38504318:C:T,single nucleotide variant,missense variant,Likely pathogenic,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38504319,rs193922826,C,T,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.2(RYR1):c.[8026C>T;8360C>G],LOC126862902|RYR1,"R2676W, T2787S","Malignant hyperthermia, susceptibility to, 1",VCV000012985,19|19,38994959,19|19,38504319,12985,28024|38459,rs193922826|rs35180584,NC_000019.10:38504318:C:T|NC_000019.10:38505357:C:G,Haplotype,missense variant,risk factor,"Jan 1, 2004",no assertion criteria provided,nan,nan,nan,nan,nan,nan,nan
chr19,38504347,rs781126470,C,T,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.8054C>T (p.Ser2685Phe),RYR1,S2685F,Malignant hyperthermia of anesthesia,VCV001308515,19,38994987,19,38504347,1308515,1296137,rs781126470,NC_000019.10:38504346:C:T,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38504868,rs193922827,G,C,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.8188G>C (p.Asp2730His),RYR1,D2730H,Malignant hyperthermia of anesthesia,VCV000133218,19,38995508,19,38504868,133218,136964,rs193922827,NC_000019.10:38504867:G:C,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38504869,rs112196644,A,G,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.8189A>G (p.Asp2730Gly),RYR1,D2730G,Malignant hyperthermia of anesthesia,VCV000133219,19,38995509,19,38504869,133219,136965,rs112196644,NC_000019.10:38504868:A:G,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38504878,rs193922828,G,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.8198G>C (p.Gly2733Ala),RYR1,G2733A,RYR1-related disorder,VCV001058964,19,38995518,19,38504878,1058964,1051263,rs193922828,NC_000019.10:38504877:G:C,single nucleotide variant,missense variant,Uncertain significance,"Oct 15, 2020","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chr19,38504878,rs193922828,G,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.8198G>T (p.Gly2733Val),RYR1,G2733V,not provided,VCV000590607,19,38995518,19,38504878,590607,581550,rs193922828,NC_000019.10:38504877:G:T,single nucleotide variant,missense variant,Uncertain significance,"Apr 12, 2016","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chr19,38504878,rs193922828,G,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.8198G>A (p.Gly2733Asp),RYR1,G2733D,Malignant hyperthermia of anesthesia,VCV000133220,19,38995518,19,38504878,133220,136966,rs193922828,NC_000019.10:38504877:G:A,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38505061,rs193922829,G,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.8290G>A (p.Glu2764Lys),RYR1,E2764K,Malignant hyperthermia of anesthesia,VCV000133221,19,38995701,19,38505061,133221,136967,rs193922829,NC_000019.10:38505060:G:A,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38505325,rs147707463,C,T,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.8327C>T (p.Ser2776Phe),LOC126862902|RYR1,S2776F,"Malignant hyperthermia, susceptibility to, 1",VCV000197946,19,38995965,19,38505325,197946,195107,rs147707463,NC_000019.10:38505324:C:T,single nucleotide variant,missense variant,Likely benign,"Mar 18, 2021",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38505358,rs35180584,C,G,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.8360C>G (p.Thr2787Ser),LOC126862902|RYR1,T2787S,Malignant hyperthermia of anesthesia,VCV000133223,19,38995998,19,38505358,133223,38459,rs35180584,NC_000019.10:38505357:C:G,single nucleotide variant,missense variant,Benign,"Dec 22, 2021",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38505923,rs193922830,C,T,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.8518C>G (p.Arg2840Gly),LOC126862902|RYR1,R2840G,"Malignant hyperthermia, susceptibility to, 1|RYR1-related disorder",VCV003069702,19,38996563,19,38505923,3069702,3233278,rs193922830,NC_000019.10:38505922:C:G,single nucleotide variant,missense variant,Uncertain significance,"Oct 22, 2024","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chr19,38505923,rs193922830,C,T,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.8518C>T (p.Arg2840Trp),LOC126862902|RYR1,R2840W,Malignant hyperthermia of anesthesia,VCV000133226,19,38996563,19,38505923,133226,136971,rs193922830,NC_000019.10:38505922:C:T,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38505932,rs768535909,T,C,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.8527T>C (p.Ser2843Pro),LOC126862902|RYR1,S2843P,Malignant hyperthermia of anesthesia,VCV001330360,19,38996572,19,38505932,1330360,1321040,rs768535909,NC_000019.10:38505931:T:C,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38506361,rs193922831,T,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.8600T>A (p.Leu2867Gln),LOC126862902|RYR1,L2867Q,Malignant hyperthermia of anesthesia,VCV000133230,19,38997001,19,38506361,133230,136975,rs193922831,NC_000019.10:38506360:T:A,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38506492,rs112772310,G,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.8638G>A (p.Glu2880Lys),RYR1,E2880K,Malignant hyperthermia of anesthesia,VCV000133232,19,38997132,19,38506492,133232,136977,rs112772310,NC_000019.10:38506491:G:A,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38506508,.,C,G,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.8654C>T (p.Thr2885Met),RYR1,T2885M,"not provided|Malignant hyperthermia, susceptibility to, 1|Inborn genetic diseases",VCV002435622,19,38997148,19,38506508,2435622,2410870,rs1159304367,NC_000019.10:38506507:C:T,single nucleotide variant,missense variant,Uncertain significance,"Sep 23, 2024","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chr19,38506508,.,C,G,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.8654C>G (p.Thr2885Arg),RYR1,T2885R,Malignant hyperthermia of anesthesia,VCV001330361,19,38997148,19,38506508,1330361,1321041,rs1159304367,NC_000019.10:38506507:C:G,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38506865,.,C,T,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.8729C>T (p.Thr2910Met),RYR1,T2910M,Malignant hyperthermia of anesthesia,VCV001330362,19,38997505,19,38506865,1330362,1321042,rs1291499059,NC_000019.10:38506864:C:T,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38507821,.,C,T,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.8926C>T (p.His2976Tyr),RYR1,H2976Y,Malignant hyperthermia of anesthesia,VCV001330363,19,38998461,19,38507821,1330363,1321043,rs2145643832,NC_000019.10:38507820:C:T,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38511590,rs147303895,G,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.9152G>A (p.Arg3051His),RYR1,R3051H,Malignant hyperthermia of anesthesia,VCV000544516,19,39002230,19,38511590,544516,532927,rs147303895,NC_000019.10:38511589:G:A,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38512279,.,G,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.9268G>A (p.Ala3090Thr),RYR1,A3090T,Malignant hyperthermia of anesthesia,VCV001330364,19,39002919,19,38512279,1330364,1321044,rs2145662576,NC_000019.10:38512278:G:A,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38512321,rs193922832,G,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.9310G>A (p.Glu3104Lys),RYR1,E3104K,"Malignant hyperthermia, susceptibility to, 1|succinylcholine response - Toxicity|sevoflurane response - Toxicity|methoxyflurane response - Toxicity|isoflurane response - Toxicity|halothane response - Toxicity|enflurane response - Toxicity|desflurane response - Toxicity",VCV000133240,19,39002961,19,38512321,133240,136985,rs193922832,NC_000019.10:38512320:G:A,single nucleotide variant,missense variant,Likely pathogenic; drug response,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38512367,rs193922833,G,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.9356G>T (p.Arg3119Leu),RYR1,R3119L,"Malignant hyperthermia, susceptibility to, 1|Central core myopathy|King Denborough syndrome|Congenital multicore myopathy with external ophthalmoplegia|Congenital myopathy with fiber type disproportion|RYR1-related disorder|not provided",VCV000993848,19,39003007,19,38512367,993848,982182,rs193922833,NC_000019.10:38512366:G:T,single nucleotide variant,missense variant,Uncertain significance,"Mar 17, 2024","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chr19,38512367,rs193922833,G,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.9356G>A (p.Arg3119His),RYR1,R3119H,Malignant hyperthermia of anesthesia,VCV000133241,19,39003007,19,38512367,133241,136986,rs193922833,NC_000019.10:38512366:G:A,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38515052,.,C,T,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.9499C>T (p.Arg3167Ter),RYR1,R3167*,Malignant hyperthermia of anesthesia,VCV000590630,19,39005692,19,38515052,590630,581569,rs1171637302,NC_000019.10:38515051:C:T,single nucleotide variant,nonsense,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38516167,rs199738299,A,G,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.9635A>G (p.Glu3212Gly),RYR1,E3212G,Malignant hyperthermia of anesthesia,VCV000329090,19,39006807,19,38516167,329090,348771,rs199738299,NC_000019.10:38516166:A:G,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38516181,.,T,C,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.9649T>C (p.Ser3217Pro),RYR1,S3217P,Malignant hyperthermia of anesthesia,VCV001330365,19,39006821,19,38516181,1330365,1321045,rs113422327,NC_000019.10:38516180:T:C,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38516184,rs553055844,G,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.9652G>A (p.Val3218Met),RYR1,V3218M,Malignant hyperthermia of anesthesia,VCV001010267,19,39006824,19,38516184,1010267,998555,rs553055844,NC_000019.10:38516183:G:A,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38516208,.,G,C,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.9676G>C (p.Glu3226Gln),RYR1,E3226Q,Malignant hyperthermia of anesthesia,VCV001330366,19,39006848,19,38516208,1330366,1321046,rs1970963163,NC_000019.10:38516207:G:C,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38517431,rs375626634,T,C,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.9758T>C (p.Ile3253Thr),RYR1,I3253T,"Malignant hyperthermia, susceptibility to, 1",VCV000159865,19,39008071,19,38517431,159865,169570,rs375626634,NC_000019.10:38517430:T:C,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38517470,.,T,C,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.9797T>C (p.Met3266Thr),RYR1,M3266T,Malignant hyperthermia of anesthesia,VCV001330367,19,39008110,19,38517470,1330367,1321047,rs2145682010,NC_000019.10:38517469:T:C,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38517521,rs757753317,G,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.9848G>A (p.Arg3283Gln),RYR1,R3283Q,Malignant hyperthermia of anesthesia,VCV001303276,19,39008161,19,38517521,1303276,1293554,rs757753317,NC_000019.10:38517520:G:A,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38517523,.,T,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.9850T>A (p.Trp3284Arg),RYR1,W3284R,Malignant hyperthermia of anesthesia,VCV001330368,19,39008163,19,38517523,1330368,1321048,rs1555788577,NC_000019.10:38517522:T:A,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38517523,.,T,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.9850T>C (p.Trp3284Arg),RYR1,W3284R,Distal arthrogryposis|not provided,VCV000523379,19,39008163,19,38517523,523379,514097,rs1555788577,NC_000019.10:38517522:T:C,single nucleotide variant,missense variant,Conflicting classifications of pathogenicity,"May 2, 2024","criteria provided, conflicting classifications",nan,nan,nan,nan,nan,nan,nan
chr19,38517541,rs112151058,G,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.9868G>A (p.Glu3290Lys),RYR1,E3290K,Malignant hyperthermia of anesthesia,VCV001330369,19,39008181,19,38517541,1330369,1321049,rs112151058,NC_000019.10:38517540:G:A,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38519237,rs118204421,C,T,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.10042C>T (p.Arg3348Cys),RYR1,R3348C,"Malignant hyperthermia, susceptibility to, 1",VCV000329095,19,39009877,19,38519237,329095,349774,rs118204421,NC_000019.10:38519236:C:T,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38519238,rs193922834,G,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.10043G>A (p.Arg3348His),RYR1,R3348H,"Malignant hyperthermia, susceptibility to, 1",VCV000132988,19,39009878,19,38519238,132988,136737,rs193922834,NC_000019.10:38519237:G:A,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38519292,rs137932199,G,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.[10097G>A;11798A>G4711A>G],RYR1,"R3366H, Y3928C, I1571V",Arrhythmogenic right ventricular cardiomyopathy|not provided,VCV003236838,19|19|19,39009932,19|19|19,38519292,3236838,136739|136769|169559,rs137932199|rs147136339|rs146429605,NC_000019.10:38519291:G:A|NC_000019.10:38543550:A:G|NC_000019.10:38483292:A:G,Haplotype,missense variant,Conflicting classifications of pathogenicity,"Sep 9, 2024","criteria provided, conflicting classifications",nan,nan,nan,nan,nan,nan,nan
chr19,38519292,rs137932199,G,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.10097G>T (p.Arg3366Leu),RYR1,R3366L,"RYR1-related disorder|not provided|Malignant hyperthermia, susceptibility to, 1",VCV000598974,19,39009932,19,38519292,598974,590088,rs137932199,NC_000019.10:38519291:G:T,single nucleotide variant,missense variant,Conflicting classifications of pathogenicity,"Oct 13, 2024","criteria provided, conflicting classifications",nan,nan,nan,nan,nan,nan,nan
chr19,38519292,rs137932199,G,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.10097G>A (p.Arg3366His),RYR1,R3366H,"Malignant hyperthermia, susceptibility to, 1",VCV000132990,19,39009932,19,38519292,132990,136739,rs137932199,NC_000019.10:38519291:G:A,single nucleotide variant,missense variant,Likely benign,"Mar 14, 2022",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38519295,rs118192126,A,G,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.10100A>G (p.Lys3367Arg),RYR1,K3367R,"RYR1-related myopathy|Malignant hyperthermia, susceptibility to, 1",VCV000065956,19,39009935,19,38519295,65956,76864,rs118192126,NC_000019.10:38519294:A:G,single nucleotide variant,missense variant,Conflicting classifications of pathogenicity,"Nov 18, 2024",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38519424,.,C,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.10229C>G (p.Pro3410Arg),RYR1,P3410R,not provided|RYR1-related disorder,VCV002994339,19,39010064,19,38519424,2994339,3152007,rs769196275,NC_000019.10:38519423:C:G,single nucleotide variant,missense variant,Conflicting classifications of pathogenicity,"Dec 11, 2023","criteria provided, conflicting classifications",nan,nan,nan,nan,nan,nan,nan
chr19,38519424,.,C,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.10229C>A (p.Pro3410Gln),RYR1,P3410Q,"Malignant hyperthermia, susceptibility to, 1",VCV001210305,19,39010064,19,38519424,1210305,1200313,rs769196275,NC_000019.10:38519423:C:A,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38519424,.,C,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.10229C>T (p.Pro3410Leu),RYR1,P3410L,"Malignant hyperthermia, susceptibility to, 1|RYR1-related disorder|not provided",VCV000590363,19,39010064,19,38519424,590363,581586,rs769196275,NC_000019.10:38519423:C:T,single nucleotide variant,missense variant,Conflicting classifications of pathogenicity,"May 30, 2024","criteria provided, conflicting classifications",nan,nan,nan,nan,nan,nan,nan
chr19,38519432,.,A,T,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.10237A>T (p.Ile3413Phe),RYR1,I3413F,"Malignant hyperthermia, susceptibility to, 1",VCV001210312,19,39010072,19,38519432,1210312,1200314,rs2145689573,NC_000019.10:38519431:A:T,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38519447,.,A,G,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.10252A>G (p.Asn3418Asp),RYR1,N3418D,"Malignant hyperthermia, susceptibility to, 1",VCV001210304,19,39010087,19,38519447,1210304,1200315,rs2145689666,NC_000019.10:38519446:A:G,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38525432,.,C,T,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.10556C>T (p.Pro3519Leu),RYR1,"P3514L, P3519L","Malignant hyperthermia, susceptibility to, 1",VCV000803555,19,39016072,19,38525432,803555,791926,rs1600921854,NC_000019.10:38525431:C:T,single nucleotide variant,missense variant,Uncertain significance,"Apr 7, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38525492,rs143987857,G,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.10616G>A (p.Arg3539His),RYR1,"R3539H, R3534H",Malignant hyperthermia of anesthesia,VCV000132997,19,39016132,19,38525492,132997,136745,rs143987857,NC_000019.10:38525491:G:A,single nucleotide variant,missense variant,Likely benign,"Nov 10, 2021",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38527707,rs55876273,G,C,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.10747G>C (p.Glu3583Gln),RYR1,E3578Q,"Malignant hyperthermia, susceptibility to, 1",VCV000132999,19,39018347,19,38527707,132999,136747,rs55876273,NC_000019.10:38527706:G:C,single nucleotide variant,missense variant,Benign,"Mar 17, 2021",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38527710,.,G,C,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.10750G>C (p.Glu3584Gln),RYR1,"E3579Q, E3584Q","Malignant hyperthermia, susceptibility to, 1",VCV001213683,19,39018350,19,38527710,1213683,1203676,rs1600930723,NC_000019.10:38527709:G:C,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38527710,.,G,C,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.10750G>A (p.Glu3584Lys),RYR1,"E3579K, E3584K","not provided|Malignant hyperthermia, susceptibility to, 1",VCV000808564,19,39018350,19,38527710,808564,797837,rs1600930723,NC_000019.10:38527709:G:A,single nucleotide variant,missense variant,Uncertain significance,"Oct 2, 2023","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chr19,38528372,.,G,T,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.10891G>T (p.Ala3631Ser),RYR1,"A3626S, A3631S","Malignant hyperthermia, susceptibility to, 1",VCV001213682,19,39019012,19,38528372,1213682,1203675,rs1367333710,NC_000019.10:38528371:G:T,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38529002,.,G,C,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.11086G>C (p.Asp3696His),RYR1,"D3691H, D3696H","Malignant hyperthermia, susceptibility to, 1",VCV001210315,19,39019642,19,38529002,1210315,1200316,rs2145724998,NC_000019.10:38529001:G:C,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38529036,rs193922838,G,T,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.11120G>A (p.Arg3707His),RYR1,"R3702H, R3707H",Central core myopathy|RYR1-related disorder,VCV001708098,19,39019676,19,38529036,1708098,1706395,rs193922838,NC_000019.10:38529035:G:A,single nucleotide variant,missense variant,Uncertain significance,"Oct 29, 2023","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chr19,38529036,rs193922838,G,T,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.11120G>C (p.Arg3707Pro),RYR1,"R3707P, R3702P",RYR1-related disorder,VCV001387681,19,39019676,19,38529036,1387681,1474405,rs193922838,NC_000019.10:38529035:G:C,single nucleotide variant,missense variant,Uncertain significance,"Apr 14, 2021","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chr19,38529036,rs193922838,G,T,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.11120G>T (p.Arg3707Leu),RYR1,"R3707L, R3702L","Malignant hyperthermia, susceptibility to, 1",VCV000133005,19,39019676,19,38529036,133005,136753,rs193922838,NC_000019.10:38529035:G:T,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38529042,.,C,T,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.11126C>T (p.Ala3709Val),RYR1,"A3709V, A3704V","Malignant hyperthermia, susceptibility to, 1",VCV000478157,19,39019682,19,38529042,478157,470193,rs1555791418,NC_000019.10:38529041:C:T,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38529048,rs375915752,C,T,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.11132C>A (p.Thr3711Lys),RYR1,"T3711K, T3706K",RYR1-related disorder,VCV003636243,19,39019688,19,38529048,3636243,3764163,nan,NC_000019.10:38529047:C:A,single nucleotide variant,missense variant,Likely pathogenic,"Aug 7, 2024","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chr19,38529048,rs375915752,C,T,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.11132C>T (p.Thr3711Met),RYR1,"T3706M, T3711M","Malignant hyperthermia, susceptibility to, 1",VCV001120229,19,39019688,19,38529048,1120229,1109125,rs375915752,NC_000019.10:38529047:C:T,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38529048,rs375915752,C,T,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.11132C>G (p.Thr3711Arg),RYR1,"T3711R, T3706R","RYR1-related disorder|Malignant hyperthermia, susceptibility to, 1|not provided",VCV000590375,19,39019688,19,38529048,590375,581598,rs375915752,NC_000019.10:38529047:C:G,single nucleotide variant,missense variant,Conflicting classifications of pathogenicity,"Dec 21, 2024","criteria provided, conflicting classifications",nan,nan,nan,nan,nan,nan,nan
chr19,38534726,rs4802584,C,G,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.11266C>G (p.Gln3756Glu),RYR1,Q3751E,"Malignant hyperthermia, susceptibility to, 1",VCV000133011,19,39025366,19,38534726,133011,136759,rs4802584,NC_000019.10:38534725:C:G,single nucleotide variant,missense variant,Benign,"Mar 17, 2021",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38534774,rs763112609,C,T,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.11314C>G (p.Arg3772Gly),RYR1,"R3772G, R3767G",not provided,VCV000590380,19,39025414,19,38534774,590380,581603,rs763112609,NC_000019.10:38534773:C:G,single nucleotide variant,missense variant,Uncertain significance,"Jul 6, 2018","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chr19,38534774,rs763112609,C,T,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.11314C>T (p.Arg3772Trp),RYR1,"R3772W, R3767W","Malignant hyperthermia, susceptibility to, 1",VCV000478159,19,39025414,19,38534774,478159,470195,rs763112609,NC_000019.10:38534773:C:T,single nucleotide variant,missense variant,Uncertain significance,"Apr 7, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38534775,rs193922839,G,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.11315G>T (p.Arg3772Leu),RYR1,"R3772L, R3767L","RYR1-related disorder|Malignant hyperthermia, susceptibility to, 1|not provided",VCV000808566,19,39025415,19,38534775,808566,797839,rs193922839,NC_000019.10:38534774:G:T,single nucleotide variant,missense variant,Conflicting classifications of pathogenicity,"Mar 24, 2024","criteria provided, conflicting classifications",nan,nan,nan,nan,nan,nan,nan
chr19,38534775,rs193922839,G,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.11320del (p.Ala3774fs),RYR1,A3769fs,RYR1-related disorder|not provided,VCV000590381,19,39025415,19,38534775,590381,581604,rs768698639,NC_000019.10:38534774:GGGGGG:GGGGG,Deletion,frameshift variant,Pathogenic/Likely pathogenic,"Jul 5, 2022","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chr19,38534775,rs193922839,G,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.11315G>A (p.Arg3772Gln),RYR1,"R3772Q, R3767Q","Malignant hyperthermia, susceptibility to, 1",VCV000133012,19,39025415,19,38534775,133012,136760,rs193922839,NC_000019.10:38534774:G:A,single nucleotide variant,missense variant,Likely pathogenic,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38535197,rs111565359,G,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.11416G>A (p.Gly3806Arg),RYR1,"G3801R, G3806R",Malignant hyperthermia of anesthesia,VCV001120230,19,39025837,19,38535197,1120230,1109126,rs111565359,NC_000019.10:38535196:G:A,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38535998,rs140616359,G,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.11518G>A (p.Val3840Ile),RYR1,"V3840I, V3835I","Malignant hyperthermia, susceptibility to, 1",VCV000133013,19,39026638,19,38535998,133013,136761,rs140616359,NC_000019.10:38535997:G:A,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38543365,rs148399313,G,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.11708G>C (p.Arg3903Pro),RYR1,"R3898P, R3903P","Malignant hyperthermia, susceptibility to, 1",VCV003073277,19,39034005,19,38543365,3073277,3234233,rs148399313,NC_000019.10:38543364:G:C,single nucleotide variant,missense variant,Uncertain significance,"Sep 4, 2023","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chr19,38543365,rs148399313,G,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.11708G>T (p.Arg3903Leu),RYR1,"R3903L, R3898L",RYR1-related disorder,VCV002901490,19,39034005,19,38543365,2901490,3068281,rs148399313,NC_000019.10:38543364:G:T,single nucleotide variant,missense variant,Likely pathogenic,"Oct 10, 2023","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chr19,38543365,rs148399313,G,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.11708G>A (p.Arg3903Gln),RYR1,"R3903Q, R3898Q","Malignant hyperthermia, susceptibility to, 1",VCV000133017,19,39034005,19,38543365,133017,136765,rs148399313,NC_000019.10:38543364:G:A,single nucleotide variant,missense variant,Likely pathogenic,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38543380,.,A,T,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.11723A>G (p.Asn3908Ser),RYR1,"N3903S, N3908S","Malignant hyperthermia, susceptibility to, 1",VCV003074186,19,39034020,19,38543380,3074186,3231322,rs141803364,NC_000019.10:38543379:A:G,single nucleotide variant,missense variant,Uncertain significance,"Dec 1, 2023","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chr19,38543380,.,A,T,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.11723A>T (p.Asn3908Ile),RYR1,"N3903I, N3908I","Malignant hyperthermia, susceptibility to, 1",VCV001210318,19,39034020,19,38543380,1210318,1200317,rs141803364,NC_000019.10:38543379:A:T,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38543405,rs193922840,T,G,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.11748T>G (p.Ile3916Met),RYR1,"I3916M, I3911M","Malignant hyperthermia, susceptibility to, 1",VCV000133018,19,39034045,19,38543405,133018,136766,rs193922840,NC_000019.10:38543404:T:G,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38543551,rs147136339,A,G,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.11798A>G (p.Tyr3933Cys),RYR1,Y3928C,"RYR1-related disorder|King Denborough syndrome|Congenital multicore myopathy with external ophthalmoplegia|Malignant hyperthermia, susceptibility to, 1|Central core myopathy|RYR1-related myopathy|not specified|Congenital myopathy with fiber type disproportion|Congenital multicore myopathy with external ophthalmoplegia|Malignant hyperthermia, susceptibility to, 1|Central core myopathy|not provided|Central core myopathy|Malignant hyperthermia, susceptibility to, 1|See cases",VCV000133021,19,39034191,19,38543551,133021,136769,rs147136339,NC_000019.10:38543550:A:G,single nucleotide variant,missense variant,Conflicting classifications of pathogenicity,"May 5, 2025","criteria provided, conflicting classifications",nan,nan,nan,nan,nan,nan,nan
chr19,38543566,.,G,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.11813G>A (p.Gly3938Asp),RYR1,"G3938D, G3933D","Malignant hyperthermia, susceptibility to, 1",VCV000933345,19,39034206,19,38543566,933345,938673,rs1972296024,NC_000019.10:38543565:G:A,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38543810,.,C,T,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.11947C>T (p.Arg3983Cys),RYR1,"R3978C, R3983C","Malignant hyperthermia, susceptibility to, 1",VCV000650932,19,39034450,19,38543810,650932,648051,rs1600989183,NC_000019.10:38543809:C:T,single nucleotide variant,missense variant,Uncertain significance,"Apr 7, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38543816,rs118204422,T,C,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.11953T>C (p.Trp3985Arg),RYR1,"W3985R, W3980R","Malignant hyperthermia, susceptibility to, 1",VCV000133025,19,39034456,19,38543816,133025,136773,rs118204422,NC_000019.10:38543815:T:C,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38543821,rs193922842,C,G,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.11958C>G (p.Asp3986Glu),RYR1,"D3986E, D3981E","Malignant hyperthermia, susceptibility to, 1",VCV000133026,19,39034461,19,38543821,133026,136774,rs193922842,NC_000019.10:38543820:C:G,single nucleotide variant,missense variant,Uncertain significance,"Sep 8, 2022",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38543832,rs193922843,G,T,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.11969G>C (p.Gly3990Ala),RYR1,"G3990A, G3985A",RYR1-related disorder,VCV000836110,19,39034472,19,38543832,836110,847649,rs193922843,NC_000019.10:38543831:G:C,single nucleotide variant,missense variant,Uncertain significance,"Apr 25, 2019","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chr19,38543832,rs193922843,G,T,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.11969G>T (p.Gly3990Val),RYR1,"G3990V, G3985V","succinylcholine response - Toxicity|sevoflurane response - Toxicity|methoxyflurane response - Toxicity|isoflurane response - Toxicity|Malignant hyperthermia, susceptibility to, 1|halothane response - Toxicity|enflurane response - Toxicity|desflurane response - Toxicity",VCV000133027,19,39034472,19,38543832,133027,136775,rs193922843,NC_000019.10:38543831:G:T,single nucleotide variant,missense variant,Pathogenic; drug response,"Sep 8, 2022",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38546460,rs755088027,G,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.12028G>A (p.Glu4010Lys),RYR1,"E4005K, E4010K","Malignant hyperthermia, susceptibility to, 1",VCV001019540,19,39037100,19,38546460,1019540,1013716,rs755088027,NC_000019.10:38546459:G:A,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38546496,rs773040531,A,G,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.12064A>G (p.Met4022Val),RYR1,"M4017V, M4022V","Malignant hyperthermia, susceptibility to, 1",VCV001120227,19,39037136,19,38546496,1120227,1109127,rs773040531,NC_000019.10:38546495:A:G,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38548253,.,A,T,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.12115A>T (p.Ile4039Phe),RYR1,"I4034F, I4039F","Malignant hyperthermia, susceptibility to, 1",VCV001210313,19,39038893,19,38548253,1210313,1200318,rs2145790232,NC_000019.10:38548252:A:T,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38548259,rs144685735,C,T,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.12121C>T (p.Arg4041Trp),RYR1,"R4041W, R4036W","Malignant hyperthermia, susceptibility to, 1",VCV000133032,19,39038899,19,38548259,133032,136780,rs144685735,NC_000019.10:38548258:C:T,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38548287,rs193922844,C,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.12149C>A (p.Ser4050Tyr),RYR1,"S4050Y, S4045Y","Malignant hyperthermia, susceptibility to, 1",VCV000133033,19,39038927,19,38548287,133033,136781,rs193922844,NC_000019.10:38548286:C:A,single nucleotide variant,missense variant,Likely pathogenic,"Apr 7, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38548380,rs373406011,C,T,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.12242C>T (p.Thr4081Met),RYR1,"T4081M, T4076M","Malignant hyperthermia, susceptibility to, 1",VCV001029908,19,39039020,19,38548380,1029908,1018559,rs373406011,NC_000019.10:38548379:C:T,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38561140,.,G,C,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.12310G>A (p.Gly4104Ser),RYR1,"G4099S, G4104S","not provided|King Denborough syndrome|Malignant hyperthermia, susceptibility to, 1|Congenital myopathy with fiber type disproportion|Congenital multicore myopathy with external ophthalmoplegia|Central core myopathy|RYR1-related disorder",VCV001400496,19,39051780,19,38561140,1400496,1440723,rs769120898,NC_000019.10:38561139:G:A,single nucleotide variant,missense variant,Uncertain significance,"Dec 29, 2024","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chr19,38561140,.,G,C,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.12310G>C (p.Gly4104Arg),RYR1,"G4099R, G4104R","Malignant hyperthermia, susceptibility to, 1",VCV001214006,19,39051780,19,38561140,1214006,1203999,rs769120898,NC_000019.10:38561139:G:C,single nucleotide variant,missense variant,Likely benign,"Mar 18, 2021",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38561185,rs193922848,A,T,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.12355A>T (p.Asn4119Tyr),RYR1,"N4119Y, N4114Y","Malignant hyperthermia, susceptibility to, 1",VCV000133036,19,39051825,19,38561185,133036,136784,rs193922848,NC_000019.10:38561184:A:T,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38561213,.,C,T,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.12383C>T (p.Ala4128Val),RYR1,"A4123V, A4128V","Malignant hyperthermia, susceptibility to, 1",VCV001210311,19,39051853,19,38561213,1210311,1200319,rs2145830877,NC_000019.10:38561212:C:T,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38561228,rs201321695,A,G,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.12398A>G (p.Glu4133Gly),RYR1,"E4128G, E4133G",Malignant hyperthermia of anesthesia,VCV000654427,19,39051868,19,38561228,654427,648053,rs201321695,NC_000019.10:38561227:A:G,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38561236,rs193922849,C,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.12406C>T (p.Arg4136Cys),RYR1,"R4131C, R4136C",RYR1-related disorder,VCV002900786,19,39051876,19,38561236,2900786,3057677,rs193922849,NC_000019.10:38561235:C:T,single nucleotide variant,missense variant,Uncertain significance,"Sep 8, 2023","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chr19,38561236,rs193922849,C,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.12406C>A (p.Arg4136Ser),RYR1,"R4136S, R4131S",Malignant hyperthermia of anesthesia,VCV000133037,19,39051876,19,38561236,133037,136785,rs193922849,NC_000019.10:38561235:C:A,single nucleotide variant,missense variant,Likely benign,"Mar 16, 2021",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38561243,rs193922850,T,C,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.12413T>C (p.Ile4138Thr),RYR1,"I4138T, I4133T",Malignant hyperthermia of anesthesia,VCV000133038,19,39051883,19,38561243,133038,136786,rs193922850,NC_000019.10:38561242:T:C,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38561362,.,G,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.12532G>A (p.Gly4178Ser),RYR1,"G4178S, G4173S","Malignant hyperthermia, susceptibility to, 1",VCV000374083,19,39052002,19,38561362,374083,361053,rs1057518885,NC_000019.10:38561361:G:A,single nucleotide variant,missense variant,Uncertain significance,"Apr 10, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38561363,.,G,T,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.12533G>T (p.Gly4178Val),RYR1,"G4178V, G4173V",Malignant hyperthermia of anesthesia,VCV000590405,19,39052003,19,38561363,590405,581625,rs1568576165,NC_000019.10:38561362:G:T,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38561383,rs151119428,G,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.12553G>T (p.Ala4185Ser),RYR1,"A4180S, A4185S",not specified,VCV003629586,19,39052023,19,38561383,3629586,3762265,nan,NC_000019.10:38561382:G:T,single nucleotide variant,missense variant,Uncertain significance,"Nov 29, 2024","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chr19,38561383,rs151119428,G,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.12553G>A (p.Ala4185Thr),RYR1,"A4185T, A4180T",Malignant hyperthermia of anesthesia,VCV000224402,19,39052023,19,38561383,224402,226140,rs151119428,NC_000019.10:38561382:G:A,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38565023,.,T,G,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.12689T>G (p.Met4230Arg),RYR1,"M4230R, M4225R",Malignant hyperthermia of anesthesia,VCV000590413,19,39055663,19,38565023,590413,581633,rs1568581848,NC_000019.10:38565022:T:G,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38565034,rs193922852,G,"C,T",.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.12700G>A (p.Val4234Met),RYR1,"V4229M, V4234M","Malignant hyperthermia, susceptibility to, 1|RYR1-related disorder",VCV002634840,19,39055674,19,38565034,2634840,2804363,rs193922852,NC_000019.10:38565033:G:A,single nucleotide variant,missense variant,Conflicting classifications of pathogenicity,"Nov 25, 2023","criteria provided, conflicting classifications",nan,nan,nan,nan,nan,nan,nan
chr19,38565034,rs193922852,G,"C,T",.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.12700G>T (p.Val4234Leu),RYR1,"V4229L, V4234L",Malignant hyperthermia of anesthesia,VCV001071064,19,39055674,19,38565034,1071064,1064712,rs193922852,NC_000019.10:38565033:G:T,single nucleotide variant,missense variant,Likely pathogenic,"Apr 7, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38565034,rs193922852,G,"C,T",.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.12700G>C (p.Val4234Leu),RYR1,"V4234L, V4229L",Malignant hyperthermia of anesthesia,VCV000133040,19,39055674,19,38565034,133040,136788,rs193922852,NC_000019.10:38565033:G:C,single nucleotide variant,missense variant,Likely pathogenic,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38565182,rs193922853,A,T,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.12848A>T (p.Glu4283Val),RYR1,"E4283V, E4278V",Malignant hyperthermia of anesthesia,VCV000133042,19,39055822,19,38565182,133042,136790,rs193922853,NC_000019.10:38565181:A:T,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38565215,rs587784372,C,T,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.12881C>T (p.Thr4294Met),RYR1,"T4294M, T4289M","Malignant hyperthermia, susceptibility to, 1",VCV000159834,19,39055855,19,38565215,159834,169579,rs587784372,NC_000019.10:38565214:C:T,single nucleotide variant,missense variant,Benign,"Mar 17, 2021",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38565218,rs193922855,C,T,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.12884C>T (p.Ala4295Val),RYR1,"A4295V, A4290V","Malignant hyperthermia, susceptibility to, 1",VCV000133043,19,39055858,19,38565218,133043,136791,rs193922855,NC_000019.10:38565217:C:T,single nucleotide variant,missense variant,Benign,"Mar 18, 2021",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38566978,rs139647387,A,G,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.13505A>G (p.Glu4502Gly),RYR1,"E4502G, E4497G","Malignant hyperthermia, susceptibility to, 1",VCV000161366,19,39057618,19,38566978,161366,171242,rs139647387,NC_000019.10:38566977:A:G,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38566986,rs150396398,G,C,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.13513G>C (p.Asp4505His),RYR1,"D4505H, D4500H","Malignant hyperthermia, susceptibility to, 1",VCV000093252,19,39057626,19,38566986,93252,99159,rs150396398,NC_000019.10:38566985:G:C,single nucleotide variant,missense variant,Benign,"Mar 17, 2021",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38570619,rs771741606,C,T,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.13672C>G (p.Arg4558Gly),RYR1,"R4553G, R4558G",RYR1-related disorder,VCV000646594,19,39061259,19,38570619,646594,648073,rs771741606,NC_000019.10:38570618:C:G,single nucleotide variant,missense variant,Pathogenic,"Jun 13, 2022","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chr19,38570619,rs771741606,C,T,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.13672C>T (p.Arg4558Trp),RYR1,"R4558W, R4553W",Malignant hyperthermia of anesthesia,VCV000478187,19,39061259,19,38570619,478187,470821,rs771741606,NC_000019.10:38570618:C:T,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38570620,rs118192130,G,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.13673G>A (p.Arg4558Gln),RYR1,"R4558Q, R4553Q","Malignant hyperthermia, susceptibility to, 1",VCV000065984,19,39061260,19,38570620,65984,76892,rs118192130,NC_000019.10:38570619:G:A,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38570649,.,C,G,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.13702C>G (p.Leu4568Val),RYR1,"L4563V, L4568V","Malignant hyperthermia, susceptibility to, 1",VCV000803556,19,39061289,19,38570649,803556,791927,rs1599646668,NC_000019.10:38570648:C:G,single nucleotide variant,missense variant,Uncertain significance,"Apr 7, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38572032,rs143520367,C,T,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.13760C>T (p.Pro4587Leu),RYR1,"P4587L, P4582L",Malignant hyperthermia of anesthesia,VCV000161377,19,39062672,19,38572032,161377,171243,rs143520367,NC_000019.10:38572031:C:T,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38572185,rs118192135,G,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.13913G>T (p.Gly4638Val),RYR1,"G4633V, G4638V",King Denborough syndrome,VCV003256762,19,39062825,19,38572185,3256762,3415518,nan,NC_000019.10:38572184:G:T,single nucleotide variant,missense variant,Likely pathogenic,"Jun 1, 2022",no assertion criteria provided,nan,nan,nan,nan,nan,nan,nan
chr19,38572185,rs118192135,G,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.13913G>A (p.Gly4638Asp),RYR1,"G4638D, G4633D",Malignant hyperthermia of anesthesia,VCV000065941,19,39062825,19,38572185,65941,76849,rs118192135,NC_000019.10:38572184:G:A,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38572190,rs756850145,A,G,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.13918A>T (p.Met4640Leu),RYR1,"M4635L, M4640L",RYR1-related disorder,VCV001477946,19,39062830,19,38572190,1477946,1436824,rs756850145,NC_000019.10:38572189:A:T,single nucleotide variant,missense variant,Uncertain significance,"Oct 3, 2024","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chr19,38572190,rs756850145,A,G,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.13918A>G (p.Met4640Val),RYR1,"M4640V, M4635V","Malignant hyperthermia, susceptibility to, 1",VCV000803557,19,39062830,19,38572190,803557,791928,rs756850145,NC_000019.10:38572189:A:G,single nucleotide variant,missense variant,Uncertain significance,"Apr 7, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38572206,rs193922860,G,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.13934G>C (p.Arg4645Pro),RYR1,"R4640P, R4645P",RYR1-related disorder,VCV001495160,19,39062846,19,38572206,1495160,1368946,rs193922860,NC_000019.10:38572205:G:C,single nucleotide variant,missense variant,Uncertain significance,"Aug 2, 2021","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chr19,38572206,rs193922860,G,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.13934G>A (p.Arg4645Gln),RYR1,"R4645Q, R4640Q",Malignant hyperthermia of anesthesia,VCV000133053,19,39062846,19,38572206,133053,136801,rs193922860,NC_000019.10:38572205:G:A,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38572262,rs759500310,T,C,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.13990T>C (p.Cys4664Arg),RYR1,"C4659R, C4664R",Malignant hyperthermia of anesthesia,VCV001120228,19,39062902,19,38572262,1120228,1109128,rs759500310,NC_000019.10:38572261:T:C,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38572266,rs193922862,TC,CT,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.13994T>C (p.Leu4665Pro),RYR1,"L4660P, L4665P",RYR1-related disorder,VCV001067471,19,39062906,19,38572266,1067471,1056577,rs2145870526,NC_000019.10:38572265:T:C,single nucleotide variant,missense variant,Pathogenic,"Aug 10, 2022","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chr19,38573180,rs193922863,C,T,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.14002C>T (p.Pro4668Ser),RYR1,"P4668S, P4663S",Malignant hyperthermia of anesthesia,VCV000133056,19,39063820,19,38573180,133056,136804,rs193922863,NC_000019.10:38573179:C:T,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38573229,rs193922864,T,C,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.14051T>C (p.Phe4684Ser),RYR1,"F4684S, F4679S",Malignant hyperthermia of anesthesia,VCV000133057,19,39063869,19,38573229,133057,136805,rs193922864,NC_000019.10:38573228:T:C,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38573304,rs118192140,C,T,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.14126C>G (p.Thr4709Arg),RYR1,"T4704R, T4709R",RYR1-related disorder,VCV002132034,19,39063944,19,38573304,2132034,2187875,rs118192140,NC_000019.10:38573303:C:G,single nucleotide variant,missense variant,Likely pathogenic,"Sep 23, 2022","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chr19,38573304,rs118192140,C,T,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.14126C>T (p.Thr4709Met),RYR1,"T4709M, T4704M","Malignant hyperthermia, susceptibility to, 1",VCV000065996,19,39063944,19,38573304,65996,76904,rs118192140,NC_000019.10:38573303:C:T,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38575957,rs200766617,G,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.14168G>T (p.Arg4723Leu),RYR1,"R4718L, R4723L","Malignant hyperthermia, susceptibility to, 1",VCV003075343,19,39066597,19,38575957,3075343,3232910,rs200766617,NC_000019.10:38575956:G:T,single nucleotide variant,missense variant,Uncertain significance,"Jan 11, 2024","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chr19,38575957,rs200766617,G,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.14168G>A (p.Arg4723His),RYR1,"R4718H, R4723H",Malignant hyperthermia of anesthesia,VCV000849226,19,39066597,19,38575957,849226,847671,rs200766617,NC_000019.10:38575956:G:A,single nucleotide variant,missense variant,Likely benign,"Mar 16, 2021",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38577931,.,A,C,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.14186A>G (p.His4729Arg),RYR1,"H4724R, H4729R",RYR1-related disorder,VCV002742310,19,39068571,19,38577931,2742310,2903080,rs1568601643,NC_000019.10:38577930:A:G,single nucleotide variant,missense variant,Uncertain significance,"Dec 25, 2023","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chr19,38577931,.,A,C,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.14186A>C (p.His4729Pro),RYR1,"H4729P, H4724P",Malignant hyperthermia of anesthesia,VCV000590447,19,39068571,19,38577931,590447,581664,rs1568601643,NC_000019.10:38577930:A:C,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38577942,rs193922865,T,G,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.14197T>G (p.Tyr4733Asp),RYR1,"Y4733D, Y4728D",Malignant hyperthermia of anesthesia,VCV000133058,19,39068582,19,38577942,133058,136806,rs193922865,NC_000019.10:38577941:T:G,single nucleotide variant,missense variant,Uncertain significance,"Apr 7, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38577946,rs193922866,G,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.14201G>A (p.Gly4734Glu),RYR1,"G4734E, G4729E",Malignant hyperthermia of anesthesia,VCV000133059,19,39068586,19,38577946,133059,136807,rs193922866,NC_000019.10:38577945:G:A,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38577954,rs193922867,C,T,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.14209C>T (p.Arg4737Trp),RYR1,"R4737W, R4732W",Malignant hyperthermia of anesthesia,VCV000133060,19,39068594,19,38577954,133060,136808,rs193922867,NC_000019.10:38577953:C:T,single nucleotide variant,missense variant,Likely pathogenic,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38577955,rs193922868,G,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.14210G>A (p.Arg4737Gln),RYR1,"R4737Q, R4732Q","Malignant hyperthermia, susceptibility to, 1",VCV000133061,19,39068595,19,38577955,133061,136809,rs193922868,NC_000019.10:38577954:G:A,single nucleotide variant,missense variant,Pathogenic,"May 20, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38578015,rs768360593,G,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.14270G>A (p.Arg4757His),RYR1,"R4757H, R4752H",Malignant hyperthermia of anesthesia,VCV000285857,19,39068655,19,38578015,285857,270094,rs768360593,NC_000019.10:38578014:G:A,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38578205,.,G,T,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.14364+1G>T,RYR1,nan,Malignant hyperthermia of anesthesia,VCV001330370,19,39068845,19,38578205,1330370,1321050,rs1974046221,NC_000019.10:38578204:G:T,single nucleotide variant,splice donor variant,Uncertain significance,"Jan 3, 2022",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38578205,.,G,T,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.14364+1G>A,RYR1,nan,"Malignant hyperthermia, susceptibility to, 1|Central core myopathy|RYR1-related disorder|not provided",VCV001176378,19,39068845,19,38578205,1176378,1166312,rs1974046221,NC_000019.10:38578204:G:A,single nucleotide variant,splice donor variant,Conflicting classifications of pathogenicity,"Mar 28, 2024","criteria provided, conflicting classifications",nan,nan,nan,nan,nan,nan,nan
chr19,38580004,rs118192167,A,G,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.14387A>G (p.Tyr4796Cys),RYR1,"Y4796C, Y4791C","succinylcholine response - Toxicity|methoxyflurane response - Toxicity|sevoflurane response - Toxicity|isoflurane response - Toxicity|halothane response - Toxicity|enflurane response - Toxicity|desflurane response - Toxicity|Malignant hyperthermia, susceptibility to, 1",VCV000012979,19,39070644,19,38580004,12979,28018,rs118192167,NC_000019.10:38580003:A:G,single nucleotide variant,missense variant,Uncertain significance; drug response,"May 22, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38580039,.,TT,AA,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.14422T>A (p.Phe4808Ile),RYR1,"F4808I, F4803I",not provided,VCV000133067,19,39070679,19,38580039,133067,136815,rs193922872,NC_000019.10:38580038:T:A,single nucleotide variant,missense variant,not provided,nan,no classification provided,nan,nan,nan,nan,nan,nan,nan
chr19,38580041,.,C,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.14424C>T (p.Phe4808=),RYR1,nan,RYR1-related disorder,VCV001985686,19,39070681,19,38580041,1985686,2039637,rs780689135,NC_000019.10:38580040:C:T,single nucleotide variant,synonymous variant,Likely benign,"Apr 6, 2023","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chr19,38580041,.,C,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.14424C>A (p.Phe4808Leu),RYR1,"F4803L, F4808L",Malignant hyperthermia of anesthesia,VCV001213684,19,39070681,19,38580041,1213684,1203677,rs780689135,NC_000019.10:38580040:C:A,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38580041,.,C,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.14424C>G (p.Phe4808Leu),RYR1,"F4808L, F4803L",not provided,VCV000590452,19,39070681,19,38580041,590452,581669,rs780689135,NC_000019.10:38580040:C:G,single nucleotide variant,missense variant,Uncertain significance,"Oct 30, 2013","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chr19,38580066,rs143988412,A,T,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.14449A>G (p.Ile4817Val),RYR1,"I4812V, I4817V","RYR1-related disorder|Congenital myopathy with fiber type disproportion|King Denborough syndrome|Congenital multicore myopathy with external ophthalmoplegia|Central core myopathy|Malignant hyperthermia, susceptibility to, 1|not provided",VCV001331337,19,39070706,19,38580066,1331337,1322012,rs143988412,NC_000019.10:38580065:A:G,single nucleotide variant,missense variant,Uncertain significance,"Sep 28, 2022","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chr19,38580066,rs143988412,A,T,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.14449A>T (p.Ile4817Phe),RYR1,"I4817F, I4812F",Malignant hyperthermia of anesthesia,VCV000133068,19,39070706,19,38580066,133068,136816,rs143988412,NC_000019.10:38580065:A:T,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38580075,rs193922873,G,"A,T",.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.14458G>A (p.Gly4820Arg),RYR1,"G4820R, G4815R",Malignant hyperthermia of anesthesia,VCV000590453,19,39070715,19,38580075,590453,581670,rs193922873,NC_000019.10:38580074:G:A,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38580075,rs193922873,G,"A,T",.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.14458G>T (p.Gly4820Trp),RYR1,"G4820W, G4815W",Malignant hyperthermia of anesthesia,VCV000133069,19,39070715,19,38580075,133069,136817,rs193922873,NC_000019.10:38580074:G:T,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38580088,rs193922874,T,C,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.14471T>C (p.Leu4824Pro),RYR1,"L4824P, L4819P",Malignant hyperthermia of anesthesia,VCV000133070,19,39070728,19,38580088,133070,136818,rs193922874,NC_000019.10:38580087:T:C,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38580094,rs121918595,C,T,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.14477C>T (p.Thr4826Ile),RYR1,"T4826I, T4821I","succinylcholine response - Toxicity|sevoflurane response - Toxicity|methoxyflurane response - Toxicity|isoflurane response - Toxicity|halothane response - Toxicity|enflurane response - Toxicity|desflurane response - Toxicity|Malignant hyperthermia, susceptibility to, 1",VCV000012978,19,39070734,19,38580094,12978,28017,rs121918595,NC_000019.10:38580093:C:T,single nucleotide variant,missense variant,Pathogenic; drug response,"Mar 24, 2021",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38580114,rs193922876,C,T,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.14497C>T (p.His4833Tyr),RYR1,"H4833Y, H4828Y","Malignant hyperthermia, susceptibility to, 1|succinylcholine response - Toxicity|sevoflurane response - Toxicity|methoxyflurane response - Toxicity|isoflurane response - Toxicity|halothane response - Toxicity|enflurane response - Toxicity|desflurane response - Toxicity",VCV000133072,19,39070754,19,38580114,133072,136820,rs193922876,NC_000019.10:38580113:C:T,single nucleotide variant,missense variant,Likely pathogenic; drug response,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38580126,.,C,G,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.14509C>A (p.Gln4837Lys),RYR1,"Q4832K, Q4837K",RYR1-related disorder|Inborn genetic diseases,VCV001365749,19,39070766,19,38580126,1365749,1398739,rs1568604577,NC_000019.10:38580125:C:A,single nucleotide variant,missense variant,Uncertain significance,"Aug 12, 2024","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chr19,38580126,.,C,G,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.14509C>G (p.Gln4837Glu),RYR1,"Q4837E, Q4832E",Malignant hyperthermia of anesthesia,VCV000590454,19,39070766,19,38580126,590454,581671,rs1568604577,NC_000019.10:38580125:C:G,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38580370,rs193922878,C,G,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.14512C>G (p.Leu4838Val),RYR1,"L4838V, L4833V","Malignant hyperthermia, susceptibility to, 1|succinylcholine response - Toxicity|sevoflurane response - Toxicity|methoxyflurane response - Toxicity|isoflurane response - Toxicity|halothane response - Toxicity|enflurane response - Toxicity|desflurane response - Toxicity",VCV000133074,19,39071010,19,38580370,133074,136822,rs193922878,NC_000019.10:38580369:C:G,single nucleotide variant,missense variant,Likely pathogenic; drug response,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38580382,rs193922879,G,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.14524G>A (p.Val4842Met),RYR1,"V4842M, V4837M",Malignant hyperthermia of anesthesia,VCV000133075,19,39071022,19,38580382,133075,38832,rs193922879,NC_000019.10:38580381:G:A,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38580397,.,G,C,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.14539G>C (p.Val4847Leu),RYR1,"V4847L, V4842L",RYR1-related disorder,VCV000590456,19,39071037,19,38580397,590456,581673,rs1568605042,NC_000019.10:38580396:G:C,single nucleotide variant,missense variant,Pathogenic,"Dec 9, 2023","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chr19,38580403,rs118192168,G,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.14545G>T (p.Val4849Phe),RYR1,"V4844F, V4849F",RYR1-related disorder,VCV000965443,19,39071043,19,38580403,965443,958634,rs118192168,NC_000019.10:38580402:G:T,single nucleotide variant,missense variant,Likely pathogenic,"Jul 11, 2022","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chr19,38580403,rs118192168,G,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.14545G>A (p.Val4849Ile),RYR1,"V4849I, V4844I",enflurane response - Toxicity|desflurane response - Toxicity|sevoflurane response - Toxicity|succinylcholine response - Toxicity|methoxyflurane response - Toxicity|isoflurane response - Toxicity|halothane response - Toxicity,VCV000012984,19,39071043,19,38580403,12984,28023,rs118192168,NC_000019.10:38580402:G:A,single nucleotide variant,missense variant,drug response,"Mar 24, 2021",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38580416,.,C,T,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.14558C>A (p.Thr4853Asn),RYR1,"T4848N, T4853N",RYR1-related disorder,VCV002001954,19,39071056,19,38580416,2001954,2051300,rs1555803922,NC_000019.10:38580415:C:A,single nucleotide variant,missense variant,Pathogenic,"Nov 15, 2023","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chr19,38580416,.,C,T,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.14558C>T (p.Thr4853Ile),RYR1,"T4853I, T4848I",Malignant hyperthermia of anesthesia,VCV000544455,19,39071056,19,38580416,544455,533057,rs1555803922,NC_000019.10:38580415:C:T,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38580425,rs193922880,C,G,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.14567C>G (p.Ala4856Gly),RYR1,"A4856G, A4851G",Malignant hyperthermia of anesthesia,VCV000133077,19,39071065,19,38580425,133077,136824,rs193922880,NC_000019.10:38580424:C:G,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38580439,rs118192181,C,T,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.14581C>A (p.Arg4861Ser),RYR1,"R4861S, R4856S",RYR1-related disorder|not provided,VCV002027376,19,39071079,19,38580439,2027376,2081449,rs118192181,NC_000019.10:38580438:C:A,single nucleotide variant,missense variant,Conflicting classifications of pathogenicity,"Oct 12, 2022","criteria provided, conflicting classifications",nan,nan,nan,nan,nan,nan,nan
chr19,38580439,rs118192181,C,T,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.14581C>G (p.Arg4861Gly),RYR1,"R4856G, R4861G",RYR1-related disorder,VCV000943431,19,39071079,19,38580439,943431,938679,rs118192181,NC_000019.10:38580438:C:G,single nucleotide variant,missense variant,Likely pathogenic,"Nov 29, 2022","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chr19,38580439,rs118192181,C,T,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.14581C>T (p.Arg4861Cys),RYR1,"R4861C, R4856C",Malignant hyperthermia of anesthesia,VCV000065986,19,39071079,19,38580439,65986,76894,rs118192181,NC_000019.10:38580438:C:T,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38580440,rs63749869,G,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.14582G>C (p.Arg4861Pro),RYR1,"R4856P, R4861P",RYR1-related disorder,VCV001066439,19,39071080,19,38580440,1066439,1056579,rs63749869,NC_000019.10:38580439:G:C,single nucleotide variant,missense variant,Pathogenic,"Mar 21, 2024","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chr19,38580440,rs63749869,G,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.14582G>A (p.Arg4861His),RYR1,"R4861H, R4856H","RYR1-related myopathy|enflurane response - Toxicity|desflurane response - Toxicity|succinylcholine response - Toxicity|sevoflurane response - Toxicity|methoxyflurane response - Toxicity|isoflurane response - Toxicity|halothane response - Toxicity|Malignant hyperthermia, susceptibility to, 1",VCV000012982,19,39071080,19,38580440,12982,28021,rs63749869,NC_000019.10:38580439:G:A,single nucleotide variant,missense variant,Conflicting classifications of pathogenicity; drug response,"Aug 27, 2024",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38580485,rs113210953,A,G,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.14627A>G (p.Lys4876Arg),RYR1,"K4876R, K4871R",Malignant hyperthermia of anesthesia,VCV000133081,19,39071125,19,38580485,133081,136828,rs113210953,NC_000019.10:38580484:A:G,single nucleotide variant,missense variant,Pathogenic,"Nov 21, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38580497,rs193922883,T,C,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.14639T>A (p.Met4880Lys),RYR1,"M4880K, M4875K",RYR1-related disorder|not provided,VCV000285088,19,39071137,19,38580497,285088,269325,rs193922883,NC_000019.10:38580496:T:A,single nucleotide variant,missense variant,Uncertain significance,"Aug 1, 2019","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chr19,38580497,rs193922883,T,C,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.14639T>C (p.Met4880Thr),RYR1,"M4880T, M4875T",Malignant hyperthermia of anesthesia,VCV000133082,19,39071137,19,38580497,133082,136829,rs193922883,NC_000019.10:38580496:T:C,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38584974,rs118192151,G,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.14678G>T (p.Arg4893Leu),RYR1,"R4888L, R4893L","Malignant hyperthermia, susceptibility to, 1|Central core myopathy|Congenital multicore myopathy with external ophthalmoplegia|King Denborough syndrome|RYR1-related disorder",VCV002738605,19,39075614,19,38584974,2738605,2905843,rs118192151,NC_000019.10:38584973:G:T,single nucleotide variant,missense variant,Likely pathogenic,"Mar 29, 2024","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chr19,38584974,rs118192151,G,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.14678G>A (p.Arg4893Gln),RYR1,"R4893Q, R4888Q",Malignant hyperthermia of anesthesia,VCV000065988,19,39075614,19,38584974,65988,76896,rs118192151,NC_000019.10:38584973:G:A,single nucleotide variant,missense variant,Uncertain significance,"Apr 7, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38584974,rs118192151,G,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.14678G>C (p.Arg4893Pro),RYR1,"R4893P, R4888P",Central core myopathy,VCV000065987,19,39075614,19,38584974,65987,76895,rs118192151,NC_000019.10:38584973:G:C,single nucleotide variant,missense variant,Pathogenic,"May 11, 2010",no assertion criteria provided,nan,nan,nan,nan,nan,nan,nan
chr19,38584976,rs193922888,G,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.14680G>C (p.Ala4894Pro),RYR1,"A4894P, A4889P",RYR1-related disorder|not provided,VCV000133088,19,39075616,19,38584976,133088,136835,rs193922888,NC_000019.10:38584975:G:C,single nucleotide variant,missense variant,Conflicting classifications of pathogenicity,"Sep 9, 2024","criteria provided, conflicting classifications",nan,nan,nan,nan,nan,nan,nan
chr19,38584976,rs193922888,G,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.14680G>A (p.Ala4894Thr),RYR1,"A4894T, A4889T",Malignant hyperthermia of anesthesia,VCV000133087,19,39075616,19,38584976,133087,136834,rs193922888,NC_000019.10:38584975:G:A,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38584989,rs118192170,T,C,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.14693T>G (p.Ile4898Ser),RYR1,"I4893S, I4898S",RYR1-related disorder,VCV002010693,19,39075629,19,38584989,2010693,2063483,rs118192170,NC_000019.10:38584988:T:G,single nucleotide variant,missense variant,Uncertain significance,"Oct 3, 2024","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chr19,38584989,rs118192170,T,C,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.14693T>A (p.Ile4898Asn),RYR1,"I4898N, I4893N",not provided,VCV000590470,19,39075629,19,38584989,590470,581687,rs118192170,NC_000019.10:38584988:T:A,single nucleotide variant,missense variant,Uncertain significance,"Jan 11, 2017","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chr19,38584989,rs118192170,T,C,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.14693T>C (p.Ile4898Thr),RYR1,"I4898T, I4893T","enflurane response - Toxicity|desflurane response - Toxicity|Malignant hyperthermia, susceptibility to, 1|succinylcholine response - Toxicity|sevoflurane response - Toxicity|isoflurane response - Toxicity|methoxyflurane response - Toxicity|halothane response - Toxicity",VCV000012975,19,39075629,19,38584989,12975,28014,rs118192170,NC_000019.10:38584988:T:C,single nucleotide variant,missense variant,Uncertain significance; drug response,"May 22, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38585078,.,A,G,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.14782A>G (p.Ile4928Val),RYR1,"I4928V, I4923V",Malignant hyperthermia of anesthesia,VCV000590472,19,39075718,19,38585078,590472,581689,rs1286759539,NC_000019.10:38585077:A:G,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38585099,.,G,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.14803G>A (p.Gly4935Ser),RYR1,"G4930S, G4935S",Malignant hyperthermia of anesthesia,VCV001210316,19,39075739,19,38585099,1210316,1200320,rs2145913747,NC_000019.10:38585098:G:A,single nucleotide variant,missense variant,Likely pathogenic,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38585947,rs111657878,T,C,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.14813T>C (p.Ile4938Thr),RYR1,"I4933T, I4938T","Malignant hyperthermia, susceptibility to, 1",VCV001214001,19,39076587,19,38585947,1214001,1203994,rs111657878,NC_000019.10:38585946:T:C,single nucleotide variant,missense variant,Uncertain significance,"Nov 21, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38585948,rs118192159,C,G,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.14814C>T (p.Ile4938=),RYR1,nan,"Malignant hyperthermia, susceptibility to, 1|RYR1-related disorder|not specified",VCV000403410,19,39076588,19,38585948,403410,390410,rs118192159,NC_000019.10:38585947:C:T,single nucleotide variant,synonymous variant,Likely benign,"Jan 6, 2025","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chr19,38585948,rs118192159,C,G,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.14814C>G (p.Ile4938Met),RYR1,"I4938M, I4933M",Malignant hyperthermia of anesthesia,VCV000065955,19,39076588,19,38585948,65955,76863,rs118192159,NC_000019.10:38585947:C:G,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38585951,rs193922895,C,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.14817C>G (p.Asp4939Glu),RYR1,"D4939E, D4934E",not provided,VCV000590474,19,39076591,19,38585951,590474,581691,rs193922895,NC_000019.10:38585950:C:G,single nucleotide variant,missense variant,Conflicting classifications of pathogenicity,"Dec 19, 2019","criteria provided, conflicting classifications",nan,nan,nan,nan,nan,nan,nan
chr19,38585951,rs193922895,C,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.14817C>T (p.Asp4939=),RYR1,nan,"not provided|Malignant hyperthermia, susceptibility to, 1|RYR1-related disorder",VCV000497467,19,39076591,19,38585951,497467,488891,rs193922895,NC_000019.10:38585950:C:T,single nucleotide variant,synonymous variant,Conflicting classifications of pathogenicity,"Jan 15, 2025","criteria provided, conflicting classifications",nan,nan,nan,nan,nan,nan,nan
chr19,38585951,rs193922895,C,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.14817C>A (p.Asp4939Glu),RYR1,"D4939E, D4934E",Malignant hyperthermia of anesthesia,VCV000133093,19,39076591,19,38585951,133093,136840,rs193922895,NC_000019.10:38585950:C:A,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38585952,rs118192158,G,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.14818G>A (p.Ala4940Thr),RYR1,"A4940T, A4935T","Malignant hyperthermia, susceptibility to, 1",VCV000065927,19,39076592,19,38585952,65927,76835,rs118192158,NC_000019.10:38585951:G:A,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38585959,rs193922896,G,T,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.14825G>T (p.Gly4942Val),RYR1,"G4942V, G4937V","Malignant hyperthermia, susceptibility to, 1",VCV000133094,19,39076599,19,38585959,133094,136841,rs193922896,NC_000019.10:38585958:G:T,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38586101,rs193922898,T,A,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.14879T>A (p.Phe4960Tyr),RYR1,"F4960Y, F4955Y","Malignant hyperthermia, susceptibility to, 1",VCV000133096,19,39076741,19,38586101,133096,136843,rs193922898,NC_000019.10:38586100:T:A,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38586140,rs146876145,C,T,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.14918C>T (p.Pro4973Leu),RYR1,"P4973L, P4968L","Malignant hyperthermia, susceptibility to, 1",VCV000133098,19,39076780,19,38586140,133098,136845,rs146876145,NC_000019.10:38586139:C:T,single nucleotide variant,missense variant,Likely pathogenic,"May 20, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38586190,.,A,G,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.14968A>G (p.Met4990Val),RYR1,"M4985V, M4990V",Malignant hyperthermia of anesthesia,VCV001213824,19,39076830,19,38586190,1213824,1203817,rs2145918316,NC_000019.10:38586189:A:G,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38587362,.,G,C,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.15059G>C (p.Trp5020Ser),RYR1,"W5015S, W5020S",Malignant hyperthermia of anesthesia,VCV001213822,19,39078002,19,38587362,1213822,1203815,rs2145922063,NC_000019.10:38587361:G:C,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,38587363,.,G,C,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.15060G>T (p.Trp5020Cys),RYR1,"W5015C, W5020C","Malignant hyperthermia, susceptibility to, 1",VCV003068327,19,39078003,19,38587363,3068327,3227661,rs2145922066,NC_000019.10:38587362:G:T,single nucleotide variant,missense variant,Uncertain significance,"Feb 23, 2022","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chr19,38587363,.,G,C,.,PASS,PX=RYR1,GT,0/0,RYR1_NM,NM_000540.3(RYR1):c.15060G>C (p.Trp5020Cys),RYR1,"W5015C, W5020C",Malignant hyperthermia of anesthesia,VCV001213823,19,39078003,19,38587363,1213823,1203816,rs2145922066,NC_000019.10:38587362:G:C,single nucleotide variant,missense variant,Uncertain significance,"Apr 6, 2023",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,39248147,rs12979860,C,T,.,PASS,PX=IFNL3,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr19,40991224,rs34223104,T,C,.,PASS,PX=CYP2B6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr19,40991367,rs34883432,A,T,.,PASS,PX=CYP2B6,GT,0/0,CYP2B6_NM,NM_000767.5(CYP2B6):c.62A>T (p.Gln21Leu),CYP2B6,Q21L,CYP2B6-related disorder,VCV003041988,19,41497272,19,40991367,3041988,3210483,rs34883432,NC_000019.10:40991366:A:T,single nucleotide variant,missense variant,Likely benign,"May 9, 2019",no assertion criteria provided,nan,nan,nan,nan,nan,nan,nan
chr19,40991369,rs8192709,C,T,.,PASS,PX=CYP2B6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr19,40991381,rs33973337,A,T,.,PASS,PX=CYP2B6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr19,40991388,rs33980385,A,G,.,PASS,PX=CYP2B6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr19,40991390,rs33926104,C,A,.,PASS,PX=CYP2B6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr19,40991391,rs34284776,G,C,.,PASS,PX=CYP2B6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr19,40991441,rs35303484,A,G,.,PASS,PX=CYP2B6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr19,41004015,rs281864907,T,A,.,PASS,PX=CYP2B6,GT,0/0,CYP2B6_NM,NM_000767.5(CYP2B6):c.186T>A (p.Tyr62Ter),CYP2B6,Y62*,Efavirenz response,VCV000143910,19,41509920,19,41004015,143910,153633,rs281864907,NC_000019.10:41004014:T:A,single nucleotide variant,nonsense,drug response,"Oct 11, 2012",no assertion criteria provided,nan,nan,nan,nan,nan,nan,nan
chr19,41004125,rs36060847,G,A,.,PASS,PX=CYP2B6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr19,41004133,rs148009906,G,A,.,PASS,PX=CYP2B6,GT,0/0,CYP2B6_NM,NM_000767.5(CYP2B6):c.304G>T (p.Ala102Ser),CYP2B6,A102S,not specified,VCV002589387,19,41510038,19,41004133,2589387,2764403,rs148009906,NC_000019.10:41004132:G:T,single nucleotide variant,missense variant,Uncertain significance,"Aug 10, 2023","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chr19,41004158,rs186335453,G,T,.,PASS,PX=CYP2B6,GT,0/0,CYP2B6_NM,NM_000767.5(CYP2B6):c.329G>T (p.Gly110Val),CYP2B6,G110V,Efavirenz response,VCV000120172,19,41510063,19,41004158,120172,125780,rs186335453,NC_000019.10:41004157:G:T,single nucleotide variant,missense variant,drug response,"May 15, 2015",no assertion criteria provided,nan,nan,nan,nan,nan,nan,nan
chr19,41004303,rs139801276,T,C,.,PASS,PX=CYP2B6,GT,0/0,CYP2B6_NM,NM_000767.5(CYP2B6):c.341T>C (p.Ile114Thr),CYP2B6,I114T,Efavirenz response,VCV000120173,19,41510208,19,41004303,120173,125781,rs139801276,NC_000019.10:41004302:T:C,single nucleotide variant,missense variant,drug response,"May 15, 2015",no assertion criteria provided,nan,nan,nan,nan,nan,nan,nan
chr19,41004377,rs12721655,A,G,.,PASS,PX=CYP2B6,GT,0/0,CYP2B6_NM,NM_000767.5(CYP2B6):c.415A>G (p.Lys139Glu),CYP2B6,K139E,not provided,VCV003033395,19,41510282,19,41004377,3033395,3201912,rs12721655,NC_000019.10:41004376:A:G,single nucleotide variant,missense variant,Likely benign,"Oct 1, 2024","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chr19,41004380,rs535039125,C,T,.,PASS,PX=CYP2B6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr19,41004381,rs35773040,G,A,.,PASS,PX=CYP2B6,GT,0/0,CYP2B6_NM,NM_000767.5(CYP2B6):c.419G>A (p.Arg140Gln),CYP2B6,R140Q,not provided,VCV002649918,19,41510286,19,41004381,2649918,2808715,rs35773040,NC_000019.10:41004380:G:A,single nucleotide variant,missense variant,Likely benign,"Jan 1, 2023","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chr19,41004406,rs145884402,G,T,.,PASS,PX=CYP2B6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr19,41006919,rs3826711,C,G,.,PASS,PX=CYP2B6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr19,41006923,rs36056539,C,T,.,PASS,PX=CYP2B6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr19,41006936,rs3745274,G,T,.,PASS,PX=CYP2B6,GT,0/0,CYP2B6_NM,NM_000767.5(CYP2B6):c.516G>T (p.Gln172His),CYP2B6,Q172H,efavirenz response - Metabolism/PK|efavirenz response - Toxicity|nevirapine response - Metabolism/PK,VCV000029671,19,41512841,19,41006936,29671,38626,rs3745274,NC_000019.10:41006935:G:T,single nucleotide variant,missense variant,drug response,"Mar 24, 2021",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,41006967,rs58871670,G,A,.,PASS,PX=CYP2B6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr19,41006968,rs373489637,T,G,.,PASS,PX=CYP2B6,GT,0/0,CYP2B6_NM,NM_000767.5(CYP2B6):c.548T>G (p.Val183Gly),CYP2B6,V183G,Efavirenz response,VCV000120174,19,41512873,19,41006968,120174,125782,rs373489637,NC_000019.10:41006967:T:G,single nucleotide variant,missense variant,drug response,"May 15, 2015",no assertion criteria provided,nan,nan,nan,nan,nan,nan,nan
chr19,41007013,rs36079186,T,C,.,PASS,PX=CYP2B6,GT,0/0,CYP2B6_NM,NM_000767.5(CYP2B6):c.593T>C (p.Met198Thr),CYP2B6,M198T,Efavirenz response,VCV000143912,19,41512918,19,41007013,143912,153635,rs36079186,NC_000019.10:41007012:T:C,single nucleotide variant,missense variant,drug response,"Jan 1, 2006",no assertion criteria provided,nan,nan,nan,nan,nan,nan,nan
chr19,41009313,.,A,C,.,PASS,PX=CYP2B6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr19,41009350,rs45482602,C,A,.,PASS,PX=CYP2B6,GT,0/0,CYP2B6_NM,NM_000767.5(CYP2B6):c.777C>T (p.Ser259=),CYP2B6,nan,CYP2B6-related disorder,VCV003040512,19,41515255,19,41009350,3040512,3214041,rs45482602,NC_000019.10:41009349:C:T,single nucleotide variant,synonymous variant,Likely benign,"Feb 7, 2020",no assertion criteria provided,nan,nan,nan,nan,nan,nan,nan
chr19,41009350,rs45482602,C,A,.,PASS,PX=CYP2B6,GT,0/0,CYP2B6_NM,NM_000767.5(CYP2B6):c.777C>A (p.Ser259Arg),CYP2B6,S259R,not provided,VCV002649919,19,41515255,19,41009350,2649919,2808716,rs45482602,NC_000019.10:41009349:C:A,single nucleotide variant,missense variant,Likely benign,"Sep 1, 2023","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chr19,41009358,rs2279343,A,G,.,PASS,PX=CYP2B6,GT,0/0,CYP2B6_NM,NM_000767.5(CYP2B6):c.785A>G (p.Lys262Arg),CYP2B6,K262R,not provided|Efavirenz response,VCV000120171,19,41515263,19,41009358,120171,125779,rs2279343,NC_000019.10:41009357:A:G,single nucleotide variant,missense variant,Benign,"Aug 5, 2015","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chr19,41010006,rs139029625,G,C,.,PASS,PX=CYP2B6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr19,41010088,rs34698757,C,G,.,PASS,PX=CYP2B6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr19,41010108,rs193922917,C,A,.,PASS,PX=CYP2B6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr19,41012316,rs28399499,T,C,.,PASS,PX=CYP2B6,GT,0/0,CYP2B6_NM,NM_000767.5(CYP2B6):c.983T>C (p.Ile328Thr),CYP2B6,I328T,nevirapine response - Toxicity,VCV000225985,19,41518221,19,41012316,225985,227805,rs28399499,NC_000019.10:41012315:T:C,single nucleotide variant,missense variant,drug response,"Mar 24, 2021",reviewed by expert panel,nan,nan,nan,nan,nan,nan,nan
chr19,41012339,rs34826503,C,T,.,PASS,PX=CYP2B6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr19,41012393,rs754621576,T,C,.,PASS,PX=CYP2B6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr19,41012394,rs780991919,A,G,.,PASS,PX=CYP2B6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr19,41012465,rs34097093,C,T,.,PASS,PX=CYP2B6,GT,0/0,CYP2B6_NM,NM_000767.5(CYP2B6):c.1132C>T (p.Arg378Ter),CYP2B6,R378*,Efavirenz response,VCV000143911,19,41518370,19,41012465,143911,153634,rs34097093,NC_000019.10:41012464:C:T,single nucleotide variant,nonsense,drug response,"Jan 1, 2006",no assertion criteria provided,nan,nan,nan,nan,nan,nan,nan
chr19,41012466,rs200458614,G,A,.,PASS,PX=CYP2B6,GT,0/0,CYP2B6_NM,NM_000767.5(CYP2B6):c.1133G>A (p.Arg378Gln),CYP2B6,R378Q,not specified,VCV003079497,19,41518371,19,41012466,3079497,3239647,rs200458614,NC_000019.10:41012465:G:A,single nucleotide variant,missense variant,Uncertain significance,"Sep 29, 2023","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chr19,41012471,rs201500445,T,C,.,PASS,PX=CYP2B6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr19,41012478,rs200238771,T,A,.,PASS,PX=CYP2B6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr19,41012693,rs35979566,T,A,.,PASS,PX=CYP2B6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr19,41012740,rs193922918,G,A,.,PASS,PX=CYP2B6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr19,41012803,rs35010098,C,A,.,PASS,PX=CYP2B6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr19,41016652,rs764288403,G,A,.,PASS,PX=CYP2B6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr19,41016679,rs374099483,G,A,.,PASS,PX=CYP2B6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr19,41016726,rs3211369,A,G,.,PASS,PX=CYP2B6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr19,41016741,rs117872433,G,A,.,PASS,PX=CYP2B6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr19,41016778,rs564083989,G,A,.,PASS,PX=CYP2B6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr19,41016805,.,A,T,.,PASS,PX=CYP2B6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr19,41016810,rs3211371,C,"A,T",.,PASS,PX=CYP2B6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr22,42126578,rs1440526469,C,T,.,PASS,PX=CYP2D6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr22,42126605,rs568495591,G,A,.,PASS,PX=CYP2D6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr22,42126611,rs1135840,C,G,.,PASS,PX=CYP2D6,GT,0/0,CYP2D6_NM,NM_000106.6(CYP2D6):c.1457= (p.Ser486=),CYP2D6,nan,not specified|not provided,VCV000516889,22,42522613,22,42126611,516889,508193,rs1135840,NC_000022.11:42126610:C:C,single nucleotide variant,no sequence alteration,Benign/Likely benign,"Apr 4, 2024","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chr22,42126611,rs1135840,C,G,.,PASS,PX=CYP2D6,GT,0/0,CYP2D6_NM,NM_000106.6(CYP2D6):c.1457G>C (p.Ser486Thr),CYP2D6,"S486T, S435T",not specified|not provided,VCV000242701,22,42522613,22,42126611,242701,38485,rs1135840,NC_000022.11:42126610:C:G,single nucleotide variant,missense variant,Benign; other,"Apr 4, 2024","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chr22,42126611,rs1135840,C,G,.,PASS,PX=CYP2D6,GT,0/0,CYP2D6_NM,NM_000106.5(CYP2D6):c.[886C>T;457G>C],CYP2D6,"S486T, S435T, R296C, R245C","Debrisoquine, ultrarapid metabolism of",VCV000016895,22|22,42522613,22|22,42126611,16895,38485|31934,rs1135840|rs16947,NC_000022.11:42126610:C:G|NC_000022.11:42127940:G:A,Haplotype,missense variant,drug response,"May 18, 2015",no assertion criteria provided,nan,nan,nan,nan,nan,nan,nan
chr22,42126619,rs28371736,G,A,.,PASS,PX=CYP2D6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr22,42126622,rs747998333,A,G,.,PASS,PX=CYP2D6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr22,42126623,rs75467367,G,C,.,PASS,PX=CYP2D6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr22,42126624,rs74478221,C,T,.,PASS,PX=CYP2D6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr22,42126625,.,A,G,.,PASS,PX=CYP2D6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr22,42126627,.,A,C,.,PASS,PX=CYP2D6,GT,0/0,CYP2D6_NM,NM_000106.6(CYP2D6):c.1441T>C (p.Phe481Leu),CYP2D6,"F430L, F481L",Tramadol response,VCV000829711,22,42522629,22,42126627,829711,817909,rs1135838,NC_000022.11:42126626:A:G,single nucleotide variant,missense variant,drug response,"Apr 28, 2018",no assertion criteria provided,nan,nan,nan,nan,nan,nan,nan
chr22,42126633,.,C,G,.,PASS,PX=CYP2D6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr22,42126634,.,A,C,.,PASS,PX=CYP2D6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr22,42126635,rs766507177,T,G,.,PASS,PX=CYP2D6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr22,42126636,rs28371735,G,A,.,PASS,PX=CYP2D6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr22,42126647,rs141756339,C,T,.,PASS,PX=CYP2D6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr22,42126656,rs765776661,C,CCAGTGGGCA,.,PASS,PX=CYP2D6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr22,42126658,rs1135836,A,G,.,PASS,PX=CYP2D6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr22,42126660,rs1135835,T,C,.,PASS,PX=CYP2D6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr22,42126663,rs1135833,G,C,.,PASS,PX=CYP2D6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr22,42126667,rs1135832,C,G,.,PASS,PX=CYP2D6,GT,0/0,CYP2D6_NM,NM_000106.6(CYP2D6):c.1401G>A (p.Ser467=),CYP2D6,nan,Tramadol response,VCV000829710,22,42522669,22,42126667,829710,817910,rs1135832,NC_000022.11:42126666:C:T,single nucleotide variant,synonymous variant,drug response,"Apr 28, 2018",no assertion criteria provided,nan,nan,nan,nan,nan,nan,nan
chr22,42126681,.,G,C,.,PASS,PX=CYP2D6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr22,42126697,.,G,T,.,PASS,PX=CYP2D6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr22,42126715,rs760940331,C,T,.,PASS,PX=CYP2D6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr22,42126719,rs369177208,C,T,.,PASS,PX=CYP2D6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr22,42126735,rs751092905,C,T,.,PASS,PX=CYP2D6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr22,42126746,rs532668079,C,T,.,PASS,PX=CYP2D6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr22,42126747,rs730882251,G,A,.,PASS,PX=CYP2D6,GT,0/0,CYP2D6_NM,NM_000106.6(CYP2D6):c.1321C>T (p.Arg441Cys),CYP2D6,"R441C, R390C",not provided,VCV000183246,22,42522749,22,42126747,183246,181379,rs730882251,NC_000022.11:42126746:G:A,single nucleotide variant,missense variant,drug response,nan,no assertion criteria provided,nan,nan,nan,nan,nan,nan,nan
chr22,42126749,rs267608319,C,T,.,PASS,PX=CYP2D6,GT,0/0,CYP2D6_NM,NM_000106.6(CYP2D6):c.1319G>A (p.Arg440His),CYP2D6,"R440H, R389H",not provided,VCV000183247,22,42522751,22,42126749,183247,181380,rs267608319,NC_000022.11:42126748:C:T,single nucleotide variant,missense variant,drug response,nan,no assertion criteria provided,nan,nan,nan,nan,nan,nan,nan
chr22,42126752,rs569439709,C,T,.,PASS,PX=CYP2D6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr22,42126877,rs3021084,G,A,.,PASS,PX=CYP2D6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr22,42126896,rs763964554,G,A,.,PASS,PX=CYP2D6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr22,42126914,rs28371733,C,T,.,PASS,PX=CYP2D6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr22,42126926,rs747089665,G,A,.,PASS,PX=CYP2D6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr22,42126938,rs769157652,C,T,.,PASS,PX=CYP2D6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr22,42126956,rs1931013246,T,G,.,PASS,PX=CYP2D6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr22,42126962,rs1602566413,C,G,.,PASS,PX=CYP2D6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr22,42126980,rs757396767,TGA,T,.,PASS,PX=CYP2D6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr22,42127457,rs77312092,C,T,.,PASS,PX=CYP2D6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr22,42127473,rs75386357,C,T,.,PASS,PX=CYP2D6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr22,42127512,rs61745683,C,T,.,PASS,PX=CYP2D6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr22,42127514,.,A,G,.,PASS,PX=CYP2D6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr22,42127523,rs1555888910,A,G,.,PASS,PX=CYP2D6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr22,42127526,rs1058172,C,T,.,PASS,PX=CYP2D6,GT,0/0,CYP2D6_NM,NM_000106.6(CYP2D6):c.1094G>A (p.Arg365His),CYP2D6,"R314H, R365H",Tramadol response,VCV000828892,22,42523528,22,42127526,828892,817934,rs1058172,NC_000022.11:42127525:C:T,single nucleotide variant,missense variant,drug response,"Apr 28, 2018",no assertion criteria provided,nan,nan,nan,nan,nan,nan,nan
chr22,42127530,rs72549346,G,GCA,.,PASS,PX=CYP2D6,GT,0/0,CYP2D6_NM,NM_000106.6(CYP2D6):c.1090C>T (p.Gln364Ter),CYP2D6,"Q313*, Q364*",Tramadol response,VCV000828890,22,42523532,22,42127530,828890,817936,rs1569019727,NC_000022.11:42127529:G:A,single nucleotide variant,nonsense,drug response,"Apr 28, 2018",no assertion criteria provided,nan,nan,nan,nan,nan,nan,nan
chr22,42127556,rs202102799,T,C,.,PASS,PX=CYP2D6,GT,0/0,CYP2D6_NM,NM_000106.6(CYP2D6):c.1064A>G (p.Tyr355Cys),CYP2D6,"Y304C, Y355C",not provided,VCV002653238,22,42523558,22,42127556,2653238,2819616,rs202102799,NC_000022.11:42127555:T:C,single nucleotide variant,missense variant,Likely benign,"May 1, 2025","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chr22,42127565,rs61736517,T,C,.,PASS,PX=CYP2D6,GT,0/0,CYP2D6_NM,NM_000106.6(CYP2D6):c.1055A>T (p.His352Leu),CYP2D6,"H352L, H301L",not specified,VCV002287538,22,42523567,22,42127565,2287538,2282529,rs61736517,NC_000022.11:42127564:T:A,single nucleotide variant,missense variant,Uncertain significance,"May 4, 2022","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chr22,42127589,rs76088846,C,T,.,PASS,PX=CYP2D6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr22,42127590,rs72549347,G,A,.,PASS,PX=CYP2D6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr22,42127593,rs267608295,G,C,.,PASS,PX=CYP2D6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr22,42127602,.,C,T,.,PASS,PX=CYP2D6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr22,42127605,rs141824015,T,G,.,PASS,PX=CYP2D6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr22,42127608,rs59421388,C,T,.,PASS,PX=CYP2D6,GT,0/0,CYP2D6_NM,NM_000106.6(CYP2D6):c.1012G>A (p.Val338Met),CYP2D6,"V338M, V287M",not provided,VCV000598263,22,42523610,22,42127608,598263,589324,rs59421388,NC_000022.11:42127607:C:T,single nucleotide variant,missense variant,Likely benign; other,"Aug 6, 2018","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chr22,42127610,rs748712690,T,C,.,PASS,PX=CYP2D6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr22,42127611,rs78209835,C,T,.,PASS,PX=CYP2D6,GT,0/0,CYP2D6_NM,NM_000106.6(CYP2D6):c.1009G>A (p.Asp337Asn),CYP2D6,"D286N, D337N",not provided,VCV002653239,22,42523613,22,42127611,2653239,2819617,rs78209835,NC_000022.11:42127610:C:T,single nucleotide variant,missense variant,Likely benign,"Nov 1, 2022","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chr22,42127619,rs72549348,T,G,.,PASS,PX=CYP2D6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr22,42127631,rs141009491,C,G,.,PASS,PX=CYP2D6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr22,42127634,rs3915951,C,A,.,PASS,PX=CYP2D6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr22,42127803,rs28371725,C,T,.,PASS,PX=CYP2D6,GT,0/0,CYP2D6_NM,CYP2D6*41,CYP2D6,nan,not provided|Tamoxifen response|Deutetrabenazine response,VCV000039381,22,42523805,22,42127803,39381,47984,rs28371725,NC_000022.11:42127802:C:T,single nucleotide variant,intron variant,Likely benign; drug response; other,"May 1, 2019","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chr22,42127841,rs72549349,C,G,.,PASS,PX=CYP2D6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr22,42127845,rs730882170,GCACATCCGGATGTAGGATC,G,.,PASS,PX=CYP2D6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr22,42127852,rs79292917,C,T,.,PASS,PX=CYP2D6,GT,0/0,CYP2D6_NM,NM_000106.6(CYP2D6):c.975G>A (p.Pro325=),CYP2D6,nan,not provided,VCV002653240,22,42523854,22,42127852,2653240,2819618,rs79292917,NC_000022.11:42127851:C:T,single nucleotide variant,synonymous variant,Likely benign,"Jun 1, 2022","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chr22,42127856,rs5030867,T,G,.,PASS,PX=CYP2D6,GT,0/0,CYP2D6_NM,NM_000106.5(CYP2D6):c.971A>C (p.His324Pro),CYP2D6,"H324P, H273P",not provided,VCV000039385,22,42523858,22,42127856,39385,47988,rs5030867,NC_000022.11:42127855:T:G,single nucleotide variant,missense variant,Likely benign; other,"Aug 6, 2018","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chr22,42127899,.,T,C,.,PASS,PX=CYP2D6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr22,42127922,rs1406719554,A,G,.,PASS,PX=CYP2D6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr22,42127938,rs949717872,T,G,.,PASS,PX=CYP2D6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr22,42127941,rs16947,G,A,.,PASS,PX=CYP2D6,GT,0/0,CYP2D6_NM,NM_000106.6(CYP2D6):c.886= (p.Arg296=),CYP2D6,nan,not provided|not specified,VCV000516890,22,42523943,22,42127941,516890,508196,rs16947,NC_000022.11:42127940:G:G,single nucleotide variant,no sequence alteration,Benign/Likely benign,"Apr 4, 2024","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chr22,42127941,rs16947,G,A,.,PASS,PX=CYP2D6,GT,0/0,CYP2D6_NM,NM_000106.6(CYP2D6):c.886C>T (p.Arg296Cys),CYP2D6,"R296C, R245C",not specified|not provided,VCV000242771,22,42523943,22,42127941,242771,31934,rs16947,NC_000022.11:42127940:G:A,single nucleotide variant,missense variant,Benign,"Apr 4, 2024","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chr22,42127962,rs267608279,TG,T,.,PASS,PX=CYP2D6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr22,42127973,rs1135829,T,C,.,PASS,PX=CYP2D6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr22,42128173,rs5030656,CCTT,C,.,PASS,PX=CYP2D6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr22,42128181,rs1135828,A,T,.,PASS,PX=CYP2D6,GT,0/0,CYP2D6_NM,NM_000106.6(CYP2D6):c.836T>A (p.Met279Lys),CYP2D6,"M279K, M228K",Tramadol response,VCV000828887,22,42524183,22,42128181,828887,817952,rs1135828,NC_000022.11:42128180:A:T,single nucleotide variant,missense variant,drug response,"Apr 28, 2018",no assertion criteria provided,nan,nan,nan,nan,nan,nan,nan
chr22,42128185,rs77913725,C,T,.,PASS,PX=CYP2D6,GT,0/0,CYP2D6_NM,NM_000106.6(CYP2D6):c.832G>A (p.Glu278Lys),CYP2D6,"E227K, E278K",Tramadol response,VCV000828886,22,42524187,22,42128185,828886,817953,rs77913725,NC_000022.11:42128184:C:T,single nucleotide variant,missense variant,drug response,"Apr 28, 2018",no assertion criteria provided,nan,nan,nan,nan,nan,nan,nan
chr22,42128198,rs72549351,CTCAG,C,.,PASS,PX=CYP2D6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr22,42128200,rs368858603,C,CA,.,PASS,PX=CYP2D6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr22,42128211,rs72549352,C,CG,.,PASS,PX=CYP2D6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr22,42128212,rs367543000,G,A,.,PASS,PX=CYP2D6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr22,42128217,rs148769737,G,T,.,PASS,PX=CYP2D6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr22,42128235,rs267608297,G,A,.,PASS,PX=CYP2D6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr22,42128241,rs35742686,CT,C,.,PASS,PX=CYP2D6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr22,42128248,rs72549353,CAGTT,C,.,PASS,PX=CYP2D6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr22,42128272,.,T,G,.,PASS,PX=CYP2D6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr22,42128308,rs28371717,C,A,.,PASS,PX=CYP2D6,GT,0/0,CYP2D6_NM,NM_000106.6(CYP2D6):c.709G>T (p.Ala237Ser),CYP2D6,"A237S, A186S",not provided|not specified,VCV000513099,22,42524310,22,42128308,513099,507605,rs28371717,NC_000022.11:42128307:C:A,single nucleotide variant,missense variant,Benign/Likely benign,"Nov 1, 2023","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chr22,42128324,rs777691989,CAGG,C,.,PASS,PX=CYP2D6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr22,42128325,rs17002853,A,G,.,PASS,PX=CYP2D6,GT,0/0,CYP2D6_NM,NM_000106.6(CYP2D6):c.692T>C (p.Leu231Pro),CYP2D6,"L180P, L231P",Tramadol response,VCV000828875,22,42524327,22,42128325,828875,817964,rs17002853,NC_000022.11:42128324:A:G,single nucleotide variant,missense variant,drug response,"Apr 28, 2018",no assertion criteria provided,nan,nan,nan,nan,nan,nan,nan
chr22,42128329,rs373813287,G,A,.,PASS,PX=CYP2D6,GT,0/0,CYP2D6_NM,NM_000106.6(CYP2D6):c.688C>T (p.Leu230Phe),CYP2D6,"L230F, L179F",not specified,VCV002460658,22,42524331,22,42128329,2460658,2435927,rs373813287,NC_000022.11:42128328:G:A,single nucleotide variant,missense variant,Uncertain significance,"Feb 10, 2023","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chr22,42128340,rs140900383,G,A,.,PASS,PX=CYP2D6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr22,42128351,rs377725912,C,T,.,PASS,PX=CYP2D6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr22,42128795,.,AG,A,.,PASS,PX=CYP2D6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr22,42128807,rs567606867,C,T,.,PASS,PX=CYP2D6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr22,42128812,rs199535154,A,G,.,PASS,PX=CYP2D6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr22,42128813,rs150163869,G,A,.,PASS,PX=CYP2D6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr22,42128814,rs72549354,T,TC,.,PASS,PX=CYP2D6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr22,42128818,rs763609904,T,TC,.,PASS,PX=CYP2D6,GT,0/0,CYP2D6_NM,NM_000106.6(CYP2D6):c.632A>G (p.Glu211Gly),CYP2D6,"E211G, E160G",Tramadol response,VCV000828869,22,42524820,22,42128818,828869,817986,rs750439337,NC_000022.11:42128817:T:C,single nucleotide variant,missense variant,drug response,"Apr 28, 2018",no assertion criteria provided,nan,nan,nan,nan,nan,nan,nan
chr22,42128848,rs745365204,C,T,.,PASS,PX=CYP2D6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr22,42128864,rs755518310,C,T,.,PASS,PX=CYP2D6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr22,42128878,rs747884067,C,A,.,PASS,PX=CYP2D6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr22,42128879,rs2146937045,A,G,.,PASS,PX=CYP2D6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr22,42128903,.,T,TTA,.,PASS,PX=CYP2D6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr22,42128926,rs1459127426,T,C,.,PASS,PX=CYP2D6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr22,42128927,rs72549356,T,"TGGGGCGAAA,TGGGGCGAAAGGGGCGAAA",.,PASS,PX=CYP2D6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr22,42128932,rs556882139,C,T,.,PASS,PX=CYP2D6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr22,42128945,rs3892097,C,T,.,PASS,PX=CYP2D6,GT,0/0,CYP2D6_NM,CYP2D6*4,CYP2D6,nan,not specified|not provided|Deutetrabenazine response|Tamoxifen response,VCV000016889,22,42524947,22,42128945,16889,31928,rs3892097,NC_000022.11:42128944:C:T,single nucleotide variant,splice acceptor variant,Likely benign; drug response; other,"May 1, 2019","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chr22,42129033,rs5030865,C,"A,T",.,PASS,PX=CYP2D6,GT,0/0,CYP2D6_NM,NM_000106.5(CYP2D6):c.*264G>A (p.Gly169Arg),CYP2D6,G169R,not provided,VCV000039399,22,42525035,22,42129033,39399,47999,rs5030865,NC_000022.11:42129032:C:T,single nucleotide variant,missense variant|intron variant,Likely benign; other,"Aug 6, 2018","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chr22,42129033,rs5030865,C,"A,T",.,PASS,PX=CYP2D6,GT,0/0,CYP2D6_NM,NM_000106.5(CYP2D6):c.505G>T (p.Gly169Ter),CYP2D6,G169*,not provided,VCV000016892,22,42525035,22,42129033,16892,31931,rs5030865,NC_000022.11:42129032:C:A,single nucleotide variant,nonsense|intron variant,Likely benign; other,"Aug 6, 2018","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chr22,42129036,rs1135826,A,C,.,PASS,PX=CYP2D6,GT,0/0,CYP2D6_NM,NM_000106.6(CYP2D6):c.502T>G (p.Ser168Ala),CYP2D6,S168A,not specified,VCV002349106,22,42525038,22,42129036,2349106,2335774,rs1135826,NC_000022.11:42129035:A:C,single nucleotide variant,missense variant|intron variant,Likely benign,"Mar 25, 2022","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chr22,42129037,rs1135825,G,T,.,PASS,PX=CYP2D6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr22,42129042,rs1135824,T,C,.,PASS,PX=CYP2D6,GT,0/0,CYP2D6_NM,NM_000106.6(CYP2D6):c.496A>G (p.Asn166Asp),CYP2D6,N166D,not provided,VCV000675907,22,42525044,22,42129042,675907,656700,rs1135824,NC_000022.11:42129041:T:C,single nucleotide variant,missense variant|intron variant,Likely benign,"Jul 1, 2024","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chr22,42129044,rs201006451,G,A,.,PASS,PX=CYP2D6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr22,42129056,.,C,G,.,PASS,PX=CYP2D6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr22,42129071,rs267608302,T,"A,G",.,PASS,PX=CYP2D6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr22,42129075,rs28371710,C,T,.,PASS,PX=CYP2D6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr22,42129083,rs5030655,CA,C,.,PASS,PX=CYP2D6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr22,42129087,rs78482768,G,C,.,PASS,PX=CYP2D6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr22,42129098,rs569229126,T,C,.,PASS,PX=CYP2D6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr22,42129113,rs375135093,A,G,.,PASS,PX=CYP2D6,GT,0/0,CYP2D6_NM,NM_000106.6(CYP2D6):c.425T>C (p.Leu142Ser),CYP2D6,L142S,Tramadol response,VCV000829668,22,42525115,22,42129113,829668,817997,rs375135093,NC_000022.11:42129112:A:G,single nucleotide variant,missense variant|intron variant,drug response,"Apr 28, 2018",no assertion criteria provided,nan,nan,nan,nan,nan,nan,nan
chr22,42129130,rs1058164,C,G,.,PASS,PX=CYP2D6,GT,0/0,CYP2D6_NM,NM_000106.6(CYP2D6):c.408= (p.Val136=),CYP2D6,nan,Tramadol response,VCV000829665,22,42525132,22,42129130,829665,818000,nan,NC_000022.11:42129129:C:C,Variation,no sequence alteration|intron variant,drug response,"Apr 28, 2018",no assertion criteria provided,nan,nan,nan,nan,nan,nan,nan
chr22,42129132,rs61736512,C,T,.,PASS,PX=CYP2D6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr22,42129134,rs781457579,G,A,.,PASS,PX=CYP2D6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr22,42129155,rs1180015037,C,T,.,PASS,PX=CYP2D6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr22,42129156,rs376636053,A,G,.,PASS,PX=CYP2D6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr22,42129166,rs766391487,A,C,.,PASS,PX=CYP2D6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr22,42129174,rs1135823,C,A,.,PASS,PX=CYP2D6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr22,42129180,rs1135822,A,T,.,PASS,PX=CYP2D6,GT,0/0,CYP2D6_NM,NM_000106.6(CYP2D6):c.358T>C (p.Phe120Leu),CYP2D6,F120L,Tramadol response,VCV000829664,22,42525182,22,42129180,829664,818001,rs1135822,NC_000022.11:42129179:A:G,single nucleotide variant,missense variant|intron variant,drug response,"Apr 28, 2018",no assertion criteria provided,nan,nan,nan,nan,nan,nan,nan
chr22,42129183,rs374616348,C,"A,T",.,PASS,PX=CYP2D6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr22,42129740,.,T,C,.,PASS,PX=CYP2D6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr22,42129753,rs563185985,C,G,.,PASS,PX=CYP2D6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr22,42129759,rs535642512,C,T,.,PASS,PX=CYP2D6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr22,42129765,rs78459009,T,C,.,PASS,PX=CYP2D6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr22,42129770,rs28371706,G,"A,T",.,PASS,PX=CYP2D6,GT,0/0,CYP2D6_NM,CYP2D6*17,CYP2D6,"T107I, S486T, S435T, R296C, R245C",Tamoxifen response|Deutetrabenazine response,VCV000830235,22|22|22,42525772,22|22|22,42129770,830235,47982|38485|31934,rs28371706|rs1135840|rs16947,NC_000022.11:42129769:G:A|NC_000022.11:42126610:C:G|NC_000022.11:42127940:G:A,Haplotype,missense variant,drug response,"May 1, 2019","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chr22,42129770,rs28371706,G,"A,T",.,PASS,PX=CYP2D6,GT,0/0,CYP2D6_NM,CYP2D6*17,CYP2D6,T107I,not provided,VCV000039379,22,42525772,22,42129770,39379,47982,rs28371706,NC_000022.11:42129769:G:A,single nucleotide variant,missense variant,Likely benign; other,"Aug 6, 2018","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chr22,42129771,rs74802369,T,A,.,PASS,PX=CYP2D6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr22,42129779,rs76187628,A,G,.,PASS,PX=CYP2D6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr22,42129780,rs267608308,C,T,.,PASS,PX=CYP2D6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr22,42129799,rs76802407,G,C,.,PASS,PX=CYP2D6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr22,42129809,rs28371704,T,C,.,PASS,PX=CYP2D6,GT,0/0,CYP2D6_NM,NM_000106.6(CYP2D6):c.281A>G (p.His94Arg),CYP2D6,H94R,Tramadol response,VCV000829654,22,42525811,22,42129809,829654,818027,rs28371704,NC_000022.11:42129808:T:C,single nucleotide variant,missense variant,drug response,"Apr 28, 2018",no assertion criteria provided,nan,nan,nan,nan,nan,nan,nan
chr22,42129819,rs28371703,G,T,.,PASS,PX=CYP2D6,GT,0/0,CYP2D6_NM,NM_000106.6(CYP2D6):c.271C>A (p.Leu91Met),CYP2D6,L91M,Tramadol response,VCV000829652,22,42525821,22,42129819,829652,818029,rs28371703,NC_000022.11:42129818:G:T,single nucleotide variant,missense variant,drug response,"Apr 28, 2018",no assertion criteria provided,nan,nan,nan,nan,nan,nan,nan
chr22,42129821,rs267608309,G,A,.,PASS,PX=CYP2D6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr22,42129827,rs267608276,C,G,.,PASS,PX=CYP2D6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr22,42129836,rs267608310,G,A,.,PASS,PX=CYP2D6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr22,42129887,rs1456026511,A,C,.,PASS,PX=CYP2D6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr22,42129899,rs1415188318,C,T,.,PASS,PX=CYP2D6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr22,42129910,rs201377835,C,G,.,PASS,PX=CYP2D6,GT,0/0,CYP2D6_NM,NM_000106.6(CYP2D6):c.181-1G>C,CYP2D6,nan,not provided,VCV000676319,22,42525912,22,42129910,676319,670653,rs201377835,NC_000022.11:42129909:C:G,single nucleotide variant,splice acceptor variant,Likely benign,"Apr 12, 2018","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chr22,42130638,rs536109057,G,A,.,PASS,PX=CYP2D6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr22,42130654,rs774671100,C,CA,.,PASS,PX=CYP2D6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr22,42130667,rs118203758,C,T,.,PASS,PX=CYP2D6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr22,42130668,rs5030862,C,T,.,PASS,PX=CYP2D6,GT,0/0,CYP2D6_NM,NM_000106.5(CYP2D6):c.124G>A (p.Gly42Arg),CYP2D6,G42R,not provided,VCV000039387,22,42526670,22,42130668,39387,47990,rs5030862,NC_000022.11:42130667:C:T,single nucleotide variant,missense variant,Likely benign; other,"Aug 6, 2018","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chr22,42130670,rs373243894,G,A,.,PASS,PX=CYP2D6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr22,42130692,rs1065852,G,A,.,PASS,PX=CYP2D6,GT,0/0,CYP2D6_NM,CYP2D6*10,CYP2D6,P34S,not specified|not provided|Deutetrabenazine response|Tamoxifen response,VCV000016893,22,42526694,22,42130692,16893,31932,rs1065852,NC_000022.11:42130691:G:A,single nucleotide variant,missense variant,Likely benign; drug response; other,"May 1, 2019","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chr22,42130710,rs138100349,G,A,.,PASS,PX=CYP2D6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr22,42130715,rs28371696,C,T,.,PASS,PX=CYP2D6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr22,42130719,rs267608313,G,A,.,PASS,PX=CYP2D6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr22,42130727,.,AG,A,.,PASS,PX=CYP2D6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr22,42130761,rs769258,C,T,.,PASS,PX=CYP2D6,GT,0/0,CYP2D6_NM,NM_000106.6(CYP2D6):c.31G>A (p.Val11Met),CYP2D6,V11M,not provided,VCV000676320,22,42526763,22,42130761,676320,656702,rs769258,NC_000022.11:42130760:C:T,single nucleotide variant,missense variant,Likely benign,"Apr 12, 2018","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chr22,42130773,rs72549358,C,T,.,PASS,PX=CYP2D6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr22,42130778,rs773790593,G,A,.,PASS,PX=CYP2D6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chr22,42130782,rs1240247139,C,CT,.,PASS,PX=CYP2D6,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chrX,154532046,.,A,C,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.1502T>G (p.Phe501Cys),G6PD,"F501C, F531C",nan,VCV001723199,X,153760261,X,154532046,1723199,1770702,rs2523260532,NC_000023.11:154532045:A:C,single nucleotide variant,missense variant,no classification for the single variant,nan,no classification for the single variant,no classification for the single variant,nan,no classification for the single variant,no classification for the single variant,nan,no classification for the single variant,nan
chrX,154532055,.,CTCT,C,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.1493G>A (p.Arg498Lys),G6PD,"R528K, R498K","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV003646381,X,153760270,X,154532055,3646381,3776900,nan,NC_000023.11:154532054:C:T,single nucleotide variant,missense variant,Uncertain significance,"Mar 18, 2024","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chrX,154532055,.,CTCT,C,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.1493G>C (p.Arg498Thr),G6PD,"R498T, R528T","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV001426499,X,153760270,X,154532055,1426499,1366172,rs782422580,NC_000023.11:154532054:C:G,single nucleotide variant,missense variant,Uncertain significance,"Aug 21, 2022","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chrX,154532082,.,G,A,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.1466C>T (p.Pro489Leu),G6PD,"P489L, P519L","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV001722689,X,153760297,X,154532082,1722689,1780201,rs2523260637,NC_000023.11:154532081:G:A,single nucleotide variant,missense variant,Conflicting classifications of pathogenicity,"Jun 28, 2024","criteria provided, conflicting classifications",nan,nan,nan,nan,nan,nan,nan
chrX,154532083,.,G,A,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.1465C>T (p.Pro489Ser),G6PD,"P489S, P519S","not specified|Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV000811096,X,153760298,X,154532083,811096,800260,rs1603411177,NC_000023.11:154532082:G:A,single nucleotide variant,missense variant,Pathogenic,"Aug 12, 2022","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chrX,154532085,.,C,A,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.1463G>T (p.Gly488Val),G6PD,"G488V, G518V","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV001722688,X,153760300,X,154532085,1722688,1780200,rs2523260651,NC_000023.11:154532084:C:A,single nucleotide variant,missense variant,Pathogenic,"Aug 12, 2022","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chrX,154532086,.,C,T,.,PASS,PX=G6PD,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chrX,154532203,rs137852348,G,C,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.1442C>T (p.Pro481Leu),G6PD,"P481L, P511L",not provided,VCV003771514,X,153760418,X,154532203,3771514,3887663,nan,NC_000023.11:154532202:G:A,single nucleotide variant,missense variant,Likely pathogenic,"Jan 1, 2025","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chrX,154532203,rs137852348,G,C,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_000402.4(G6PD):c.1532C>G (p.Pro511Arg),G6PD,"P481R, P511R","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV000010415,X,153760418,X,154532203,10415,25454,rs137852348,NC_000023.11:154532202:G:C,single nucleotide variant,missense variant,Conflicting classifications of pathogenicity,"Aug 23, 2024","criteria provided, conflicting classifications",nan,nan,nan,nan,nan,nan,nan
chrX,154532231,.,T,G,.,PASS,PX=G6PD,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chrX,154532245,rs137852344,G,C,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_000402.4(G6PD):c.1490C>G (p.Pro497Arg),G6PD,"P467R, P497R","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV000010409,X,153760460,X,154532245,10409,25448,rs137852344,NC_000023.11:154532244:G:C,single nucleotide variant,missense variant,Likely pathogenic,"Sep 8, 2023","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chrX,154532257,rs72554664,C,T,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.1388G>T (p.Arg463Leu),G6PD,"R463L, R493L","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV002504081,X,153760472,X,154532257,2504081,2669010,rs72554664,NC_000023.11:154532256:C:A,single nucleotide variant,missense variant,Pathogenic,"Sep 30, 2022","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chrX,154532257,rs72554664,C,T,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_000402.4(G6PD):c.1478G>A (p.Arg493His),G6PD,"R463H, R493H","Inborn genetic diseases|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|Malaria, susceptibility to|not provided|Malaria, susceptibility to|G6PD deficiency|Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV000100059,X,153760472,X,154532257,100059,25428,rs72554664,NC_000023.11:154532256:C:T,single nucleotide variant,missense variant,Conflicting classifications of pathogenicity,"Jan 23, 2025","criteria provided, conflicting classifications",nan,nan,nan,nan,nan,nan,nan
chrX,154532258,.,G,"A,T",.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.1387C>T (p.Arg463Cys),G6PD,"R463C, R493C","Anemia, nonspherocytic hemolytic, due to G6PD deficiency|Malaria, susceptibility to",VCV001722638,X,153760473,X,154532258,1722638,1780151,rs1557229502,NC_000023.11:154532257:G:A,single nucleotide variant,missense variant,Pathogenic/Likely pathogenic,"Mar 21, 2024","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chrX,154532258,.,G,"A,T",.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.1387C>A (p.Arg463Ser),G6PD,"R463S, R493S","G6PD deficiency|Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV001722637,X,153760473,X,154532258,1722637,1780150,rs1557229502,NC_000023.11:154532257:G:T,single nucleotide variant,missense variant,Likely pathogenic,"Mar 10, 2025","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chrX,154532264,rs782608284,C,T,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.1381G>A (p.Ala461Thr),G6PD,"A461T, A491T","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV001722636,X,153760479,X,154532264,1722636,1780149,rs782608284,NC_000023.11:154532263:C:T,single nucleotide variant,missense variant,Likely pathogenic,"Aug 12, 2022","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chrX,154532265,.,C,G,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.1380G>C (p.Glu460Asp),G6PD,"E460D, E490D","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV001722635,X,153760480,X,154532265,1722635,1780148,rs2523261277,NC_000023.11:154532264:C:G,single nucleotide variant,missense variant,Likely pathogenic,"Aug 12, 2022","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chrX,154532269,rs72554665,C,"A,G",.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.[1376G>T;1502T>G],G6PD,"R459L, R489L, F501C, F531C","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV001722642,X|X,153760484,X|X,154532269,1722642,25419|1770702,rs72554665|rs2523260532,NC_000023.11:154532268:C:A|NC_000023.11:154532045:A:C,Haplotype,missense variant,Likely pathogenic,"Aug 12, 2022","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chrX,154532269,rs72554665,C,"A,G",.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.1376G>A (p.Arg459His),G6PD,"R489H, R459H","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV001485870,X,153760484,X,154532269,1485870,1468350,rs72554665,NC_000023.11:154532268:C:T,single nucleotide variant,missense variant,Likely pathogenic,"Aug 5, 2022","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chrX,154532269,rs72554665,C,"A,G",.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.1376del (p.Arg459fs),G6PD,"R459fs, R489fs","Anemia, nonspherocytic hemolytic, due to G6PD deficiency|not provided",VCV000993677,X,153760484,X,154532269,993677,982297,rs2070346743,NC_000023.11:154532268:C:,Deletion,frameshift variant,Pathogenic,"Aug 12, 2022","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chrX,154532269,rs72554665,C,"A,G",.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_000402.4(G6PD):c.1466G>T (p.Arg489Leu),G6PD,"R459L, R489L","Anemia, nonspherocytic hemolytic, due to G6PD deficiency|Malaria, susceptibility to|not provided|Malaria, susceptibility to|G6PD deficiency|Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV000100058,X,153760484,X,154532269,100058,25419,rs72554665,NC_000023.11:154532268:C:A,single nucleotide variant,missense variant,Pathogenic,"Jan 19, 2025","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chrX,154532269,rs72554665,C,"A,G",.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_000402.4(G6PD):c.1466G>C (p.Arg489Pro),G6PD,"R459P, R489P","G6PD deficiency|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|not provided|Malaria, susceptibility to",VCV000010422,X,153760484,X,154532269,10422,25461,rs72554665,NC_000023.11:154532268:C:G,single nucleotide variant,missense variant,Pathogenic,"Feb 5, 2024","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chrX,154532278,.,T,A,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.1367A>T (p.Asp456Val),G6PD,"D456V, D486V","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV001722632,X,153760493,X,154532278,1722632,1780145,rs2523261336,NC_000023.11:154532277:T:A,single nucleotide variant,missense variant,Likely pathogenic,"Aug 12, 2022","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chrX,154532279,.,C,G,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.1366G>C (p.Asp456His),G6PD,"D456H, D486H","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV001722631,X,153760494,X,154532279,1722631,1780144,rs782317415,NC_000023.11:154532278:C:G,single nucleotide variant,missense variant,Likely pathogenic,"Aug 12, 2022","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chrX,154532279,.,C,G,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.1366G>A (p.Asp456Asn),G6PD,"D456N, D486N","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV001685320,X,153760494,X,154532279,1685320,1677341,rs782317415,NC_000023.11:154532278:C:T,single nucleotide variant,missense variant,Likely pathogenic,"May 4, 2022","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chrX,154532389,rs137852324,C,T,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.1361G>T (p.Arg454Leu),G6PD,"R454L, R484L","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV001722630,X,153760604,X,154532389,1722630,1780143,rs137852324,NC_000023.11:154532388:C:A,single nucleotide variant,missense variant,Likely pathogenic,"Aug 12, 2022","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chrX,154532389,rs137852324,C,T,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.1361G>C (p.Arg454Pro),G6PD,"R454P, R484P","not provided|Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV001198343,X,153760604,X,154532389,1198343,1189071,rs137852324,NC_000023.11:154532388:C:G,single nucleotide variant,missense variant,Pathogenic,"Jul 15, 2024","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chrX,154532389,rs137852324,C,T,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_000402.4(G6PD):c.1451G>A (p.Arg484His),G6PD,"R454H, R484H","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV000010379,X,153760604,X,154532389,10379,25418,rs137852324,NC_000023.11:154532388:C:T,single nucleotide variant,missense variant,Pathogenic/Likely pathogenic,"Aug 12, 2022","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chrX,154532390,rs398123546,G,A,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.[1347G>C;1360C>T],G6PD,"R454C, R484C, Q449H, Q479H","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV001722628,X|X,153760605,X|X,154532390,1722628,99398|951688,rs398123546|rs1557229572,NC_000023.11:154532389:G:A|NC_000023.11:154532402:C:G,Haplotype,missense variant,Likely pathogenic,"Aug 12, 2022","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chrX,154532390,rs398123546,G,A,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.1360C>T (p.Arg454Cys),G6PD,"R454C, R484C","Anemia, nonspherocytic hemolytic, due to G6PD deficiency|Malaria, susceptibility to|not provided|Malaria, susceptibility to|G6PD deficiency|Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV000093493,X,153760605,X,154532390,93493,99398,rs398123546,NC_000023.11:154532389:G:A,single nucleotide variant,missense variant,Pathogenic,"May 1, 2025","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chrX,154532392,.,A,T,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.1358T>A (p.Val453Glu),G6PD,"V453E, V483E","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV001722629,X,153760607,X,154532392,1722629,1780142,rs2523261737,NC_000023.11:154532391:A:T,single nucleotide variant,missense variant,Likely pathogenic,"Jun 20, 2023","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chrX,154532403,.,C,G,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.1347G>C (p.Gln449His),G6PD,"Q449H, Q479H","not provided|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|Malaria, susceptibility to",VCV000958165,X,153760618,X,154532403,958165,951688,rs1557229572,NC_000023.11:154532402:C:G,single nucleotide variant,missense variant,Pathogenic/Likely pathogenic,"Mar 23, 2024","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chrX,154532408,.,T,C,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.1342A>G (p.Ser448Gly),G6PD,"S448G, S478G","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV001722626,X,153760623,X,154532408,1722626,1780140,rs2523261790,NC_000023.11:154532407:T:C,single nucleotide variant,missense variant,Likely pathogenic,"Aug 12, 2022","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chrX,154532411,rs137852317,C,T,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_000402.4(G6PD):c.1429G>A (p.Gly477Arg),G6PD,"G447R, G477R","Malaria, susceptibility to|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|not provided|Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV000010371,X,153760626,X,154532411,10371,25410,rs137852317,NC_000023.11:154532410:C:T,single nucleotide variant,missense variant,Pathogenic/Likely pathogenic,"Aug 12, 2022","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chrX,154532432,.,G,A,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.1318C>T (p.Leu440Phe),G6PD,"L440F, L470F","Anemia, nonspherocytic hemolytic, due to G6PD deficiency|not specified",VCV000439743,X,153760647,X,154532432,439743,433312,rs1557229599,NC_000023.11:154532431:G:A,single nucleotide variant,missense variant,Pathogenic/Likely pathogenic,"Feb 6, 2023","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chrX,154532434,rs137852337,C,G,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.1316G>A (p.Arg439His),G6PD,"R439H, R469H","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV003339512,X,153760649,X,154532434,3339512,3498779,nan,NC_000023.11:154532433:C:T,single nucleotide variant,missense variant,Uncertain significance,"Sep 1, 2024","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chrX,154532434,rs137852337,C,G,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_000402.4(G6PD):c.1406G>C (p.Arg469Pro),G6PD,"R439P, R469P","not provided|Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV000010399,X,153760649,X,154532434,10399,25438,rs137852337,NC_000023.11:154532433:C:G,single nucleotide variant,missense variant,Conflicting classifications of pathogenicity,"Sep 23, 2024","criteria provided, conflicting classifications",nan,nan,nan,nan,nan,nan,nan
chrX,154532458,.,A,C,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.1292T>G (p.Val431Gly),G6PD,"V431G, V461G","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV001722686,X,153760673,X,154532458,1722686,1780198,rs2523261999,NC_000023.11:154532457:A:C,single nucleotide variant,missense variant,Pathogenic,"Aug 12, 2022","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chrX,154532459,rs782098548,C,T,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.1291G>A (p.Val431Met),G6PD,"V431M, V461M","Malaria, susceptibility to|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|not specified",VCV001722623,X,153760674,X,154532459,1722623,1780137,rs782098548,NC_000023.11:154532458:C:T,single nucleotide variant,missense variant,Conflicting classifications of pathogenicity,"Apr 13, 2024","criteria provided, conflicting classifications",nan,nan,nan,nan,nan,nan,nan
chrX,154532570,.,G,T,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.1284C>A (p.Tyr428Ter),G6PD,"Y428*, Y458*","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV001722682,X,153760785,X,154532570,1722682,1780194,rs2523262389,NC_000023.11:154532569:G:T,single nucleotide variant,nonsense,Pathogenic,"Aug 12, 2022","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chrX,154532590,.,G,C,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.1264C>G (p.Leu422Val),G6PD,"L422V, L452V",nan,VCV001723198,X,153760805,X,154532590,1723198,1770701,rs2523262460,NC_000023.11:154532589:G:C,single nucleotide variant,missense variant,no classification for the single variant,nan,no classification for the single variant,no classification for the single variant,nan,no classification for the single variant,no classification for the single variant,nan,no classification for the single variant,nan
chrX,154532608,.,C,T,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.1246G>A (p.Glu416Lys),G6PD,"E416K, E446K","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV001722681,X,153760823,X,154532608,1722681,1780193,rs2523262484,NC_000023.11:154532607:C:T,single nucleotide variant,missense variant,Pathogenic/Likely pathogenic,"Sep 14, 2023","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chrX,154532623,.,T,C,.,PASS,PX=G6PD,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chrX,154532625,rs137852336,C,"G,T",.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.1229G>C (p.Gly410Ala),G6PD,"G410A, G440A","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV001722621,X,153760840,X,154532625,1722621,1780136,rs137852336,NC_000023.11:154532624:C:G,single nucleotide variant,missense variant,Likely pathogenic,"Aug 14, 2024","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chrX,154532625,rs137852336,C,"G,T",.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_000402.4(G6PD):c.1319G>A (p.Gly440Asp),G6PD,"G410D, G440D","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV000010398,X,153760840,X,154532625,10398,25437,rs137852336,NC_000023.11:154532624:C:T,single nucleotide variant,missense variant,Pathogenic,"Aug 12, 2022","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chrX,154532626,rs137852323,C,A,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_000402.4(G6PD):c.1318G>T (p.Gly440Cys),G6PD,"G410C, G440C","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV000010378,X,153760841,X,154532626,10378,25417,rs137852323,NC_000023.11:154532625:C:A,single nucleotide variant,missense variant,Pathogenic/Likely pathogenic,"Aug 14, 2023","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chrX,154532628,.,G,C,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.1226C>G (p.Pro409Arg),G6PD,"P409R, P439R","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV001722680,X,153760843,X,154532628,1722680,1780192,rs1557229670,NC_000023.11:154532627:G:C,single nucleotide variant,missense variant,Pathogenic,"Aug 12, 2022","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chrX,154532628,.,G,C,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.1226C>A (p.Pro409Gln),G6PD,"P409Q, P439Q","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV001722679,X,153760843,X,154532628,1722679,1780191,rs1557229670,NC_000023.11:154532627:G:T,single nucleotide variant,missense variant,Pathogenic,"Aug 12, 2022","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chrX,154532629,.,G,A,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.1225C>T (p.Pro409Ser),G6PD,"P409S, P439S","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV001722678,X,153760844,X,154532629,1722678,1780190,rs2523262545,NC_000023.11:154532628:G:A,single nucleotide variant,missense variant,Pathogenic,"Aug 12, 2022","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chrX,154532634,.,T,G,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.1220A>C (p.Lys407Thr),G6PD,"K407T, K437T","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV001722677,X,153760849,X,154532634,1722677,1780189,rs2523262550,NC_000023.11:154532633:T:G,single nucleotide variant,missense variant,Pathogenic,"Aug 12, 2022","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chrX,154532639,.,C,T,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.1215G>A (p.Met405Ile),G6PD,"M405I, M435I","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV001722676,X,153760854,X,154532639,1722676,1780188,rs2523262563,NC_000023.11:154532638:C:T,single nucleotide variant,missense variant,Pathogenic,"Aug 12, 2022","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chrX,154532649,.,G,T,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.1205C>A (p.Thr402Asn),G6PD,"T402N, T432N","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV001722675,X,153760864,X,154532649,1722675,1780187,rs2523262593,NC_000023.11:154532648:G:T,single nucleotide variant,missense variant,Pathogenic,"Aug 12, 2022","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chrX,154532661,.,T,C,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.1193A>G (p.Glu398Gly),G6PD,"E398G, E428G","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV001722620,X,153760876,X,154532661,1722620,1780135,rs2523262643,NC_000023.11:154532660:T:C,single nucleotide variant,missense variant,Likely pathogenic,"Aug 12, 2022","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chrX,154532662,rs137852325,C,T,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.1192G>A (p.Glu398Lys),G6PD,"E428K, E398K","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV000804134,X,153760877,X,154532662,804134,792173,rs137852325,NC_000023.11:154532661:C:T,single nucleotide variant,missense variant,Pathogenic,"Jan 10, 2025","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chrX,154532667,.,G,A,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.1187C>G (p.Pro396Arg),G6PD,"P396R, P426R","not provided|Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV000987108,X,153760882,X,154532667,987108,975606,rs1557229683,NC_000023.11:154532666:G:C,single nucleotide variant,missense variant,Pathogenic/Likely pathogenic,"Aug 12, 2022","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chrX,154532667,.,G,A,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.1187C>T (p.Pro396Leu),G6PD,"P426L, P396L","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV000470161,X,153760882,X,154532667,470161,471838,rs1557229683,NC_000023.11:154532666:G:A,single nucleotide variant,missense variant,Conflicting classifications of pathogenicity,"Aug 12, 2022","criteria provided, conflicting classifications",nan,nan,nan,nan,nan,nan,nan
chrX,154532674,rs137852335,C,G,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_000402.4(G6PD):c.1270G>C (p.Val424Leu),G6PD,"V394L, V424L","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV000010397,X,153760889,X,154532674,10397,25436,rs137852335,NC_000023.11:154532673:C:G,single nucleotide variant,missense variant,Likely pathogenic,"Aug 12, 2022","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chrX,154532676,rs137852316,C,T,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_000402.4(G6PD):c.1268G>A (p.Arg423His),G6PD,"R393H, R423H","Anemia, nonspherocytic hemolytic, due to G6PD deficiency|not specified|not provided",VCV000010370,X,153760891,X,154532676,10370,25409,rs137852316,NC_000023.11:154532675:C:T,single nucleotide variant,missense variant,Pathogenic,"Apr 11, 2023","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chrX,154532677,.,G,C,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.1177C>G (p.Arg393Gly),G6PD,"R393G, R423G","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV001722672,X,153760892,X,154532677,1722672,1780184,rs2148328873,NC_000023.11:154532676:G:C,single nucleotide variant,missense variant,Pathogenic,"Aug 12, 2022","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chrX,154532677,.,G,C,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.1177C>T (p.Arg393Cys),G6PD,"R393C, R423C","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV001066811,X,153760892,X,154532677,1066811,1056747,rs2148328873,NC_000023.11:154532676:G:A,single nucleotide variant,missense variant,Likely pathogenic,"Aug 12, 2022","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chrX,154532679,.,A,G,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.1175T>C (p.Ile392Thr),G6PD,"I392T, I422T","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV001722619,X,153760894,X,154532679,1722619,1780134,rs2523262719,NC_000023.11:154532678:A:G,single nucleotide variant,missense variant,Likely pathogenic,"Aug 12, 2022","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chrX,154532688,.,T,C,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.1166A>G (p.Glu389Gly),G6PD,"E389G, E419G","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV001722618,X,153760903,X,154532688,1722618,1780133,rs2523262731,NC_000023.11:154532687:T:C,single nucleotide variant,missense variant,Likely pathogenic,"Aug 12, 2022","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chrX,154532692,.,T,C,.,PASS,PX=G6PD,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chrX,154532694,rs137852321,C,T,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_000402.4(G6PD):c.1250G>A (p.Arg417His),G6PD,"R387H, R417H","Malaria, susceptibility to|Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV000010376,X,153760909,X,154532694,10376,25415,rs137852321,NC_000023.11:154532693:C:T,single nucleotide variant,missense variant,Pathogenic,"Nov 28, 2024","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chrX,154532695,rs137852334,G,A,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.[1159C>T;376A>G],G6PD,"R387C, R417C, N126D, N156D","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV001722617,X|X,153760910,X|X,154532695,1722617,25435|25399,rs137852334|rs1050829,NC_000023.11:154532694:G:A|NC_000023.11:154535276:T:C,Haplotype,missense variant,Likely pathogenic,"Aug 12, 2022","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chrX,154532695,rs137852334,G,A,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_000402.4(G6PD):c.1249C>T (p.Arg417Cys),G6PD,"R387C, R417C","not provided|Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV000010396,X,153760910,X,154532695,10396,25435,rs137852334,NC_000023.11:154532694:G:A,single nucleotide variant,missense variant,Pathogenic,"Dec 15, 2024","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chrX,154532698,rs137852320,T,C,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_000402.4(G6PD):c.1246A>G (p.Lys416Glu),G6PD,"K386E, K416E","not provided|Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV000010375,X,153760913,X,154532698,10375,25414,rs137852320,NC_000023.11:154532697:T:C,single nucleotide variant,missense variant,Pathogenic/Likely pathogenic,"Jan 21, 2025","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chrX,154532699,.,G,C,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.1155C>G (p.Cys385Trp),G6PD,"C385W, C415W","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV001722671,X,153760914,X,154532699,1722671,1780183,rs2523262775,NC_000023.11:154532698:G:C,single nucleotide variant,missense variant,Pathogenic,"Aug 12, 2022","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chrX,154532700,.,C,A,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.1154G>T (p.Cys385Phe),G6PD,"C385F, C415F","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV001722616,X,153760915,X,154532700,1722616,1780132,rs2523262780,NC_000023.11:154532699:C:A,single nucleotide variant,missense variant,Likely pathogenic,"Jan 19, 2024","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chrX,154532701,rs137852322,A,G,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.1153T>G (p.Cys385Gly),G6PD,"C385G, C415G","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV001722670,X,153760916,X,154532701,1722670,1780182,rs137852322,NC_000023.11:154532700:A:C,single nucleotide variant,missense variant,Pathogenic,"Aug 12, 2022","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chrX,154532701,rs137852322,A,G,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_000402.4(G6PD):c.1243T>C (p.Cys415Arg),G6PD,"C385R, C415R","G6PD TOMAH|Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV000010377,X,153760916,X,154532701,10377,25416,rs137852322,NC_000023.11:154532700:A:G,single nucleotide variant,missense variant,Pathogenic,"Aug 12, 2022","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chrX,154532713,.,A,G,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.1141T>C (p.Phe381Leu),G6PD,"F381L, F411L","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV001722615,X,153760928,X,154532713,1722615,1780131,rs2523262831,NC_000023.11:154532712:A:G,single nucleotide variant,missense variant,Likely pathogenic,"Aug 12, 2022","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chrX,154532715,.,A,G,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.1139T>A (p.Ile380Asn),G6PD,"I380N, I410N","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV004078695,X,153760930,X,154532715,4078695,4193420,nan,NC_000023.11:154532714:A:T,single nucleotide variant,missense variant,Uncertain significance,"Jan 14, 2024","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chrX,154532715,.,A,G,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.1139T>C (p.Ile380Thr),G6PD,"I380T, I410T","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV001722669,X,153760930,X,154532715,1722669,1780181,rs2523262863,NC_000023.11:154532714:A:G,single nucleotide variant,missense variant,Pathogenic,"Aug 12, 2022","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chrX,154532716,.,T,C,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.1138A>G (p.Ile380Val),G6PD,"I380V, I410V","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV001722668,X,153760931,X,154532716,1722668,1780180,rs2523262871,NC_000023.11:154532715:T:C,single nucleotide variant,missense variant,Pathogenic,"Aug 12, 2022","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chrX,154532722,rs371489738,C,T,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.1132G>A (p.Gly378Ser),G6PD,"G378S, G408S","not provided|Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV001722614,X,153760937,X,154532722,1722614,1780130,rs371489738,NC_000023.11:154532721:C:T,single nucleotide variant,missense variant,Conflicting classifications of pathogenicity,"Jan 16, 2025","criteria provided, conflicting classifications",nan,nan,nan,nan,nan,nan,nan
chrX,154532752,.,CGGCCTTGCGCTCGTTCAG,C,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_000402.4(G6PD):c.1192G>A (p.Glu398Lys),G6PD,"E398K, E368K","Anemia, nonspherocytic hemolytic, due to G6PD deficiency|not provided",VCV000010381,X,153760967,X,154532752,10381,25420,rs387906468,NC_000023.11:154532751:C:T,single nucleotide variant,missense variant,Pathogenic/Likely pathogenic,"Feb 24, 2023","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chrX,154532758,.,T,C,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.1096A>G (p.Lys366Glu),G6PD,"K366E, K396E","Anemia, nonspherocytic hemolytic, due to G6PD deficiency|Decreased glucosephosphate isomerase level|Hemolytic anemia",VCV000374205,X,153760973,X,154532758,374205,361085,rs1057518975,NC_000023.11:154532757:T:C,single nucleotide variant,missense variant,Uncertain significance,"Aug 12, 2022","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chrX,154532765,rs137852329,G,"C,T",.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.1089C>G (p.Asn363Lys),G6PD,"N363K, N393K","Inborn genetic diseases|Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV000986140,X,153760980,X,154532765,986140,974339,rs137852329,NC_000023.11:154532764:G:C,single nucleotide variant,missense variant,Pathogenic/Likely pathogenic,"Aug 12, 2022","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chrX,154532765,rs137852329,G,"C,T",.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_000402.4(G6PD):c.1179C>A (p.Asn393Lys),G6PD,"N363K, N393K","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV000010390,X,153760980,X,154532765,10390,25429,rs137852329,NC_000023.11:154532764:G:T,single nucleotide variant,missense variant,Likely pathogenic,"Aug 12, 2022","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chrX,154532772,rs137852345,G,A,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_000402.4(G6PD):c.1172C>T (p.Ala391Val),G6PD,"A361V, A391V","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV000010410,X,153760987,X,154532772,10410,25449,rs137852345,NC_000023.11:154532771:G:A,single nucleotide variant,missense variant,Likely pathogenic,"Aug 30, 2024","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chrX,154532773,.,C,T,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.1081G>A (p.Ala361Thr),G6PD,"A361T, A391T","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV001722610,X,153760988,X,154532773,1722610,1780126,rs2148328996,NC_000023.11:154532772:C:T,single nucleotide variant,missense variant,Likely pathogenic,"Aug 12, 2022","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chrX,154532797,rs137852333,G,A,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_000402.4(G6PD):c.1147C>T (p.Pro383Ser),G6PD,"P353S, P383S","Anemia, nonspherocytic hemolytic, due to G6PD deficiency|G6PD deficiency",VCV000010385,X,153761012,X,154532797,10385,25424,rs137852333,NC_000023.11:154532796:G:A,single nucleotide variant,missense variant,Pathogenic,"Jul 14, 2023","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chrX,154532802,.,C,A,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.1052G>T (p.Gly351Val),G6PD,"G351V, G381V","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV001722607,X,153761017,X,154532802,1722607,1780123,rs2070355916,NC_000023.11:154532801:C:A,single nucleotide variant,missense variant,Likely pathogenic,"Aug 12, 2022","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chrX,154532945,rs34193178,C,G,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.[1048G>C;406C>T],G6PD,"D350H, D380H, R136C, R166C","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV001722606,X|X,153761160,X|X,154532945,1722606,99394|1065247,rs34193178|rs979416826,NC_000023.11:154532944:C:G|NC_000023.11:154535246:G:A,Haplotype,missense variant,Likely pathogenic,"Aug 12, 2022","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chrX,154532945,rs34193178,C,G,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.1048G>C (p.Asp350His),G6PD,"D350H, D380H","not specified|not provided|G6PD deficiency|Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV000093489,X,153761160,X,154532945,93489,99394,rs34193178,NC_000023.11:154532944:C:G,single nucleotide variant,missense variant,Conflicting classifications of pathogenicity,"Dec 14, 2024","criteria provided, conflicting classifications",nan,nan,nan,nan,nan,nan,nan
chrX,154532956,rs398123544,T,A,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.1037A>T (p.Asn346Ile),G6PD,"N346I, N376I",not provided,VCV000093488,X,153761171,X,154532956,93488,99393,rs398123544,NC_000023.11:154532955:T:A,single nucleotide variant,missense variant,Uncertain significance,"Sep 14, 2012","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chrX,154532969,rs137852342,G,A,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_000402.4(G6PD):c.1114C>T (p.Leu372Phe),G6PD,"L342F, L372F","G6PD deficiency|not provided|Malaria, susceptibility to|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV000010405,X,153761184,X,154532969,10405,25444,rs137852342,NC_000023.11:154532968:G:A,single nucleotide variant,missense variant,Conflicting classifications of pathogenicity,"Aug 1, 2024","criteria provided, conflicting classifications",nan,nan,nan,nan,nan,nan,nan
chrX,154532987,.,T,C,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.1006A>G (p.Thr336Ala),G6PD,"T336A, T366A","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV001722603,X,153761202,X,154532987,1722603,1780121,rs2523263701,NC_000023.11:154532986:T:C,single nucleotide variant,missense variant,Likely pathogenic,"Aug 12, 2022","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chrX,154532989,.,G,T,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.1004C>A (p.Ala335Asp),G6PD,"A335D, A365D","Malaria, susceptibility to|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|Malaria, susceptibility to",VCV001068217,X,153761204,X,154532989,1068217,1056748,rs1557229854,NC_000023.11:154532988:G:T,single nucleotide variant,missense variant,Pathogenic/Likely pathogenic,"May 18, 2023","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chrX,154532990,rs5030869,C,T,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_000402.4(G6PD):c.1093G>A (p.Ala365Thr),G6PD,"A335T, A365T","Inborn genetic diseases|Malaria, susceptibility to|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|not provided|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|Malaria, susceptibility to",VCV000010363,X,153761205,X,154532990,10363,25402,rs5030869,NC_000023.11:154532989:C:T,single nucleotide variant,missense variant,Pathogenic,"Mar 4, 2025","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chrX,154533004,.,C,T,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.989G>A (p.Arg330His),G6PD,"R330H, R360H","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV001722701,X,153761219,X,154533004,1722701,1780208,rs868950643,NC_000023.11:154533003:C:T,single nucleotide variant,missense variant,Uncertain significance,"Jun 26, 2024","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chrX,154533012,.,CGTGGGGTCGTCCAGGTACCCTTTG,C,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.981G>A (p.Thr327=),G6PD,nan,G6PD-related disorder,VCV003032932,X,153761227,X,154533012,3032932,3190167,rs782593777,NC_000023.11:154533011:C:T,single nucleotide variant,synonymous variant,Likely benign,"Feb 23, 2021",no assertion criteria provided,nan,nan,nan,nan,nan,nan,nan
chrX,154533016,.,G,T,.,PASS,PX=G6PD,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chrX,154533025,rs76723693,A,G,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.[376A>G;968T>C],G6PD,"L323P, L353P, N126D, N156D","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV001065168,X|X,153761240,X|X,154533025,1065168,25427|25399,rs76723693|rs1050829,NC_000023.11:154533024:A:G|NC_000023.11:154535276:T:C,Haplotype,missense variant,Pathogenic,"Aug 12, 2022","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chrX,154533025,rs76723693,A,G,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.968T>C (p.Leu323Pro),G6PD,"L323P, L353P","G6PD deficiency|not provided|Malaria, susceptibility to|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|Malaria, susceptibility to|Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV000010388,X,153761240,X,154533025,10388,25427,rs76723693,NC_000023.11:154533024:A:G,single nucleotide variant,missense variant,Conflicting classifications of pathogenicity,"Feb 12, 2025","criteria provided, conflicting classifications",nan,nan,nan,nan,nan,nan,nan
chrX,154533029,rs137852347,A,G,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_000402.4(G6PD):c.1054T>C (p.Tyr352His),G6PD,"Y322H, Y352H","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV000010414,X,153761244,X,154533029,10414,25453,rs137852347,NC_000023.11:154533028:A:G,single nucleotide variant,missense variant,Likely pathogenic,"Aug 12, 2022","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chrX,154533031,.,C,T,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.962G>T (p.Gly321Val),G6PD,"G321V, G351V","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV003339509,X,153761246,X,154533031,3339509,3498776,nan,NC_000023.11:154533030:C:A,single nucleotide variant,missense variant,Likely pathogenic,"Sep 1, 2024","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chrX,154533031,.,C,T,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.962G>A (p.Gly321Glu),G6PD,"G321E, G351E","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV001722601,X,153761246,X,154533031,1722601,1780119,rs2523263867,NC_000023.11:154533030:C:T,single nucleotide variant,missense variant,Likely pathogenic,"Oct 24, 2023","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chrX,154533044,rs137852339,C,T,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_000402.4(G6PD):c.1039G>A (p.Glu347Lys),G6PD,"E317K, E347K","not provided|G6PD deficiency|Malaria, susceptibility to|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|Malaria, susceptibility to|Congenital nonspherocytic hemolytic anemia|Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV000010401,X,153761259,X,154533044,10401,25440,rs137852339,NC_000023.11:154533043:C:T,single nucleotide variant,missense variant,Pathogenic/Likely pathogenic,"Jun 12, 2025","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chrX,154533064,.,C,T,.,PASS,PX=G6PD,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chrX,154533072,.,C,G,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.921G>C (p.Gln307His),G6PD,"Q307H, Q337H","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV001722600,X,153761287,X,154533072,1722600,1780118,rs2523264021,NC_000023.11:154533071:C:G,single nucleotide variant,missense variant,Likely pathogenic,"Aug 12, 2022","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chrX,154533077,.,C,T,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.916G>A (p.Gly306Ser),G6PD,"G306S, G336S","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV001722647,X,153761292,X,154533077,1722647,1780158,rs2523264036,NC_000023.11:154533076:C:T,single nucleotide variant,missense variant,Pathogenic,"Aug 12, 2022","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chrX,154533083,.,C,A,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.910G>A (p.Val304Ile),G6PD,"V304I, V334I","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV003719769,X,153761298,X,154533083,3719769,3849588,nan,NC_000023.11:154533082:C:T,single nucleotide variant,missense variant,Uncertain significance,"Dec 13, 2024","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chrX,154533083,.,C,A,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.910G>T (p.Val304Phe),G6PD,"V304F, V334F","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV001722598,X,153761298,X,154533083,1722598,1780116,rs2523264055,NC_000023.11:154533082:C:A,single nucleotide variant,missense variant,Likely pathogenic,"Aug 12, 2022","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chrX,154533122,rs137852327,C,T,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.[376A>G;871G>A],G6PD,"V291M, V321M, N126D, N156D","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV001722597,X|X,153761337,X|X,154533122,1722597,25425|25399,rs137852327|rs1050829,NC_000023.11:154533121:C:T|NC_000023.11:154535276:T:C,Haplotype,missense variant,Likely pathogenic,"Aug 12, 2022","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chrX,154533122,rs137852327,C,T,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.[202G>A;871G>A],G6PD,"V291M, V321M, V68M, V98M","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV001722596,X|X,153761337,X|X,154533122,1722596,25425|25400,rs137852327|rs1050828,NC_000023.11:154533121:C:T|NC_000023.11:154536001:C:T,Haplotype,missense variant,Likely pathogenic,"Aug 12, 2022","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chrX,154533122,rs137852327,C,T,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_000402.4(G6PD):c.961G>A (p.Val321Met),G6PD,"V291M, V321M","G6PD deficient hemolytic anemia|G6PD deficiency|Malaria, susceptibility to|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|not provided|Inborn genetic diseases|Malaria, susceptibility to|Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV000010386,X,153761337,X,154533122,10386,25425,rs137852327,NC_000023.11:154533121:C:T,single nucleotide variant,missense variant,Pathogenic/Likely pathogenic,"May 20, 2025","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chrX,154533586,rs74575103,C,T,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_000402.4(G6PD):c.944G>A (p.Arg315His),G6PD,"R285H, R315H","Anemia, nonspherocytic hemolytic, due to G6PD deficiency|Malaria, susceptibility to|not provided",VCV000010362,X,153761801,X,154533586,10362,25401,rs74575103,NC_000023.11:154533585:C:T,single nucleotide variant,missense variant,Pathogenic/Likely pathogenic,"Jul 1, 2024","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chrX,154533587,.,G,A,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.853C>T (p.Arg285Cys),G6PD,"R285C, R315C","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV001722593,X,153761802,X,154533587,1722593,1780113,rs2523265386,NC_000023.11:154533586:G:A,single nucleotide variant,missense variant,Likely pathogenic,"Aug 12, 2022","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chrX,154533589,.,A,G,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.851T>C (p.Val284Ala),G6PD,"V284A, V314A","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV001722592,X,153761804,X,154533589,1722592,1780112,rs2523265393,NC_000023.11:154533588:A:G,single nucleotide variant,missense variant,Likely pathogenic,"Aug 12, 2022","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chrX,154533591,.,G,T,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.849C>T (p.Asp283=),G6PD,nan,"Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV002895885,X,153761806,X,154533591,2895885,3056660,rs192737996,NC_000023.11:154533590:G:A,single nucleotide variant,synonymous variant,Likely benign,"Apr 6, 2023","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chrX,154533592,.,T,C,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.848A>G (p.Asp283Gly),G6PD,"D283G, D313G","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV001722664,X,153761807,X,154533592,1722664,1780176,rs1557230040,NC_000023.11:154533591:T:C,single nucleotide variant,missense variant,Pathogenic,"Aug 12, 2022","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chrX,154533592,.,T,C,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.848A>T (p.Asp283Val),G6PD,"D283V, D313V","not provided|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|not specified",VCV000445710,X,153761807,X,154533592,445710,438982,rs1557230040,NC_000023.11:154533591:T:A,single nucleotide variant,missense variant,Conflicting classifications of pathogenicity,"Jun 5, 2025","criteria provided, conflicting classifications",nan,nan,nan,nan,nan,nan,nan
chrX,154533596,rs137852318,C,"A,G",.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.844G>T (p.Asp282Tyr),G6PD,"D282Y, D312Y","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV001722591,X,153761811,X,154533596,1722591,1780111,rs137852318,NC_000023.11:154533595:C:A,single nucleotide variant,missense variant,Likely pathogenic,"Aug 12, 2022","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chrX,154533596,rs137852318,C,"A,G",.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_000402.4(G6PD):c.934G>C (p.Asp312His),G6PD,"D282H, D312H","G6PD deficiency|Malaria, susceptibility to|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|not provided|Malaria, susceptibility to|Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV000010372,X,153761811,X,154533596,10372,25411,rs137852318,NC_000023.11:154533595:C:G,single nucleotide variant,missense variant,Pathogenic/Likely pathogenic,"Jul 15, 2025","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chrX,154533605,.,T,"A,C",.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.835A>G (p.Thr279Ala),G6PD,"T279A, T309A","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV001722590,X,153761820,X,154533605,1722590,1780110,rs2148329890,NC_000023.11:154533604:T:C,single nucleotide variant,missense variant,Likely pathogenic,"Sep 9, 2023","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chrX,154533605,.,T,"A,C",.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.835A>T (p.Thr279Ser),G6PD,"T279S, T309S","Anemia, nonspherocytic hemolytic, due to G6PD deficiency|G6PD deficiency|Malaria, susceptibility to",VCV001324435,X,153761820,X,154533605,1324435,1314707,rs2148329890,NC_000023.11:154533604:T:A,single nucleotide variant,missense variant,Conflicting classifications of pathogenicity,"Jul 2, 2024","criteria provided, conflicting classifications",nan,nan,nan,nan,nan,nan,nan
chrX,154533607,.,G,A,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.833C>T (p.Ser278Phe),G6PD,"S278F, S308F","not provided|Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV001722589,X,153761822,X,154533607,1722589,1780109,rs2523265461,NC_000023.11:154533606:G:A,single nucleotide variant,missense variant,Likely pathogenic,"Feb 16, 2025","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chrX,154533608,.,A,G,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.832T>C (p.Ser278Pro),G6PD,"S278P, S308P","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV001722588,X,153761823,X,154533608,1722588,1780108,rs2523265466,NC_000023.11:154533607:A:G,single nucleotide variant,missense variant,Likely pathogenic,"Aug 12, 2022","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chrX,154533614,.,G,A,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.826C>G (p.Pro276Ala),G6PD,"P276A, P306A","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV004078693,X,153761829,X,154533614,4078693,4193418,nan,NC_000023.11:154533613:G:C,single nucleotide variant,missense variant,Uncertain significance,"Aug 8, 2024","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chrX,154533614,.,G,A,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.826C>T (p.Pro276Ser),G6PD,"P276S, P306S","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV001722587,X,153761829,X,154533614,1722587,1780107,rs2523265494,NC_000023.11:154533613:G:A,single nucleotide variant,missense variant,Likely pathogenic,"Aug 12, 2022","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chrX,154533615,.,C,G,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.825G>C (p.Lys275Asn),G6PD,"K275N, K305N","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV001722586,X,153761830,X,154533615,1722586,1780106,rs2523265500,NC_000023.11:154533614:C:G,single nucleotide variant,missense variant,Likely pathogenic,"Aug 12, 2022","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chrX,154533619,.,T,A,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.821A>T (p.Glu274Val),G6PD,"E274V, E304V","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV001722761,X,153761834,X,154533619,1722761,1780264,rs2523265506,NC_000023.11:154533618:T:A,single nucleotide variant,missense variant,Likely pathogenic,"Aug 12, 2022","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chrX,154533620,.,C,T,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.820G>A (p.Glu274Lys),G6PD,"E274K, E304K","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV001722760,X,153761835,X,154533620,1722760,1780263,rs2523265511,NC_000023.11:154533619:C:T,single nucleotide variant,missense variant,Likely pathogenic,"Aug 12, 2022","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chrX,154533629,.,C,G,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.811G>A (p.Val271Met),G6PD,"V301M, V271M","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV003677304,X,153761844,X,154533629,3677304,3817505,nan,NC_000023.11:154533628:C:T,single nucleotide variant,missense variant,Uncertain significance,"Jul 15, 2024","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chrX,154533629,.,C,G,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.811G>C (p.Val271Leu),G6PD,"V271L, V301L","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV001722759,X,153761844,X,154533629,1722759,1780262,rs2523265547,NC_000023.11:154533628:C:G,single nucleotide variant,missense variant,Likely pathogenic,"Aug 12, 2022","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chrX,154533634,rs137852346,C,T,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_000402.4(G6PD):c.896G>A (p.Cys299Tyr),G6PD,"C269Y, C299Y","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV000010412,X,153761849,X,154533634,10412,25451,rs137852346,NC_000023.11:154533633:C:T,single nucleotide variant,missense variant,Likely pathogenic,"Aug 12, 2022","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chrX,154534036,.,G,C,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.769C>A (p.Arg257=),G6PD,nan,nan,VCV001723203,X,153762251,X,154534036,1723203,1780260,rs2070375134,NC_000023.11:154534035:G:T,single nucleotide variant,synonymous variant,no classification for the single variant,nan,no classification for the single variant,no classification for the single variant,nan,no classification for the single variant,no classification for the single variant,nan,no classification for the single variant,nan
chrX,154534036,.,G,C,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.769C>G (p.Arg257Gly),G6PD,"R287G, R257G","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV001044330,X,153762251,X,154534036,1044330,1035432,rs2070375134,NC_000023.11:154534035:G:C,single nucleotide variant,missense variant,Conflicting classifications of pathogenicity,"Aug 12, 2022","criteria provided, conflicting classifications",nan,nan,nan,nan,nan,nan,nan
chrX,154534074,.,TCAGTGC,T,.,PASS,PX=G6PD,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chrX,154534092,.,T,C,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.713A>G (p.Lys238Arg),G6PD,"K238R, K268R","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV001722661,X,153762307,X,154534092,1722661,1780173,rs2523266771,NC_000023.11:154534091:T:C,single nucleotide variant,missense variant,Pathogenic,"Aug 12, 2022","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chrX,154534102,rs782757170,G,A,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.703C>T (p.Leu235Phe),G6PD,"L235F, L265F","not specified|Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV001685832,X,153762317,X,154534102,1685832,1677845,rs782757170,NC_000023.11:154534101:G:A,single nucleotide variant,missense variant,Conflicting classifications of pathogenicity,"Jan 29, 2025","criteria provided, conflicting classifications",nan,nan,nan,nan,nan,nan,nan
chrX,154534110,.,C,T,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.695G>A (p.Cys232Tyr),G6PD,"C232Y, C262Y","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV001722750,X,153762325,X,154534110,1722750,1780253,rs2523266813,NC_000023.11:154534109:C:T,single nucleotide variant,missense variant,Likely pathogenic,"Aug 12, 2022","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chrX,154534116,.,ATGT,A,.,PASS,PX=G6PD,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chrX,154534125,rs137852328,C,"A,T",.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.[376A>G;680G>T],G6PD,"R227L, R257L, N126D, N156D","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV001722747,X|X,153762340,X|X,154534125,1722747,25426|25399,rs137852328|rs1050829,NC_000023.11:154534124:C:A|NC_000023.11:154535276:T:C,Haplotype,missense variant,Likely pathogenic,"Aug 12, 2022","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chrX,154534125,rs137852328,C,"A,T",.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_000402.4(G6PD):c.770G>A (p.Arg257Gln),G6PD,"R227Q, R257Q","Anemia, nonspherocytic hemolytic, due to G6PD deficiency|not specified|G6PD deficiency",VCV000010395,X,153762340,X,154534125,10395,25434,rs137852328,NC_000023.11:154534124:C:T,single nucleotide variant,missense variant,Conflicting classifications of pathogenicity,"Aug 23, 2022","criteria provided, conflicting classifications",nan,nan,nan,nan,nan,nan,nan
chrX,154534125,rs137852328,C,"A,T",.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.680G>T (p.Arg227Leu),G6PD,"R227L, R257L",G6PD deficiency,VCV000010387,X,153762340,X,154534125,10387,25426,rs137852328,NC_000023.11:154534124:C:A,single nucleotide variant,missense variant,Pathogenic,"Jun 1, 1988",no assertion criteria provided,nan,nan,nan,nan,nan,nan,nan
chrX,154534126,.,G,A,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.679C>G (p.Arg227Gly),G6PD,"R227G, R257G","Malaria, susceptibility to|Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV003598195,X,153762341,X,154534126,3598195,3729681,nan,NC_000023.11:154534125:G:C,single nucleotide variant,missense variant,Likely pathogenic,"Apr 13, 2024","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chrX,154534126,.,G,A,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.679C>T (p.Arg227Trp),G6PD,"R227W, R257W","G6PD deficiency|Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV001722659,X,153762341,X,154534126,1722659,1780170,rs1557230213,NC_000023.11:154534125:G:A,single nucleotide variant,missense variant,Pathogenic/Likely pathogenic,"Jan 30, 2025","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chrX,154534157,rs137852319,A,C,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.648T>C (p.Phe216=),G6PD,nan,"Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV001655105,X,153762372,X,154534157,1655105,1549678,rs137852319,NC_000023.11:154534156:A:G,single nucleotide variant,synonymous variant,Likely benign,"Jul 25, 2024","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chrX,154534157,rs137852319,A,C,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_000402.4(G6PD):c.738T>G (p.Phe246Leu),G6PD,"F216L, F246L","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV000010373,X,153762372,X,154534157,10373,25412,rs137852319,NC_000023.11:154534156:A:C,single nucleotide variant,missense variant,Likely pathogenic,"Aug 12, 2022","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chrX,154534345,rs137852326,C,A,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.[1037A>T;637G>T],G6PD,"V213L, V243L, N346I, N376I","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV001722605,X|X,153762560,X|X,154534345,1722605,25422|99393,rs137852326|rs398123544,NC_000023.11:154534344:C:A|NC_000023.11:154532955:T:A,Haplotype,missense variant,Likely pathogenic,"Aug 12, 2022","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chrX,154534345,rs137852326,C,A,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_000402.4(G6PD):c.727G>T (p.Val243Leu),G6PD,"V213L, V243L","not provided|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|See cases",VCV000010383,X,153762560,X,154534345,10383,25422,rs137852326,NC_000023.11:154534344:C:A,single nucleotide variant,missense variant,Pathogenic/Likely pathogenic,"Jan 9, 2025","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chrX,154534348,rs782754619,T,C,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.634A>G (p.Met212Val),G6PD,"M212V, M242V","Malaria, susceptibility to|not provided|Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV001722746,X,153762563,X,154534348,1722746,1780250,rs782754619,NC_000023.11:154534347:T:C,single nucleotide variant,missense variant,Conflicting classifications of pathogenicity,"Dec 11, 2023","criteria provided, conflicting classifications",nan,nan,nan,nan,nan,nan,nan
chrX,154534387,rs781865768,T,C,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.595A>G (p.Ile199Val),G6PD,"I199V, I229V","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV001722699,X,153762602,X,154534387,1722699,1780206,rs781865768,NC_000023.11:154534386:T:C,single nucleotide variant,missense variant,Pathogenic/Likely pathogenic,"Sep 1, 2024","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chrX,154534389,rs137852332,C,"G,T",.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_000402.4(G6PD):c.683G>A (p.Arg228His),G6PD,"R198H, R228H","Anemia, nonspherocytic hemolytic, due to G6PD deficiency|Malaria, susceptibility to",VCV000010417,X,153762604,X,154534389,10417,25456,rs137852332,NC_000023.11:154534388:C:T,single nucleotide variant,missense variant,Pathogenic/Likely pathogenic,"Jan 23, 2024","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chrX,154534389,rs137852332,C,"G,T",.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_000402.4(G6PD):c.683G>C (p.Arg228Pro),G6PD,"R198P, R228P","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV000010394,X,153762604,X,154534389,10394,25433,rs137852332,NC_000023.11:154534388:C:G,single nucleotide variant,missense variant,Likely pathogenic,"Aug 12, 2022","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chrX,154534390,rs137852330,G,A,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.592C>A (p.Arg198Ser),G6PD,"R198S, R228S","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV001722743,X,153762605,X,154534390,1722743,1780247,rs137852330,NC_000023.11:154534389:G:T,single nucleotide variant,missense variant,Likely pathogenic,"Aug 12, 2022","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chrX,154534390,rs137852330,G,A,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001042351.1(G6PD):c.[317C>G;544C>T;592C>T],G6PD,"R198C, R228C, R182W, R212W, S106C, S136C","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV000010392,X|X|X,153762605,X|X|X,154534390,10392,25430|38393|25431,rs137852330|rs267606836|rs267606835,NC_000023.11:154534389:G:A|NC_000023.11:154534437:G:A|NC_000023.11:154535335:G:C,Haplotype,missense variant,Likely pathogenic,"Aug 12, 2022","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chrX,154534390,rs137852330,G,A,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_000402.4(G6PD):c.682C>T (p.Arg228Cys),G6PD,"R198C, R228C","Malaria, susceptibility to|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|Malaria, susceptibility to|Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV000010391,X,153762605,X,154534390,10391,25430,rs137852330,NC_000023.11:154534389:G:A,single nucleotide variant,missense variant,Pathogenic,"Dec 12, 2024","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chrX,154534409,.,G,C,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.573C>G (p.Phe191Leu),G6PD,"F191L, F221L","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV001722740,X,153762624,X,154534409,1722740,1780244,rs782170731,NC_000023.11:154534408:G:C,single nucleotide variant,missense variant,Likely pathogenic,"Aug 12, 2022","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chrX,154534414,.,GGGA,G,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.568C>T (p.Leu190=),G6PD,nan,"Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV003671684,X,153762629,X,154534414,3671684,3805609,nan,NC_000023.11:154534413:G:A,single nucleotide variant,synonymous variant,Likely benign,"Sep 16, 2024","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chrX,154534419,rs5030868,G,A,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_000402.4(G6PD):c.653C>T (p.Ser218Phe),G6PD,"S188F, S218F","Hemolytic anemia, G6PD deficient (favism)|Inborn genetic diseases|G6PD deficient hemolytic anemia|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|Malaria, susceptibility to|not provided|Malaria, susceptibility to|G6PD deficiency|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|See cases",VCV000100057,X,153762634,X,154534419,100057,25407,rs5030868,NC_000023.11:154534418:G:A,single nucleotide variant,missense variant,Pathogenic/Likely pathogenic,"Jun 28, 2025","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chrX,154534438,rs267606836,G,A,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.544C>T (p.Arg182Trp),G6PD,"R182W, R212W",not specified,VCV000242750,X,153762653,X,154534438,242750,38393,rs267606836,NC_000023.11:154534437:G:A,single nucleotide variant,missense variant,Uncertain significance,"Sep 13, 2024","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chrX,154534440,rs5030872,T,A,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_000402.4(G6PD):c.632A>T (p.Asp211Val),G6PD,"D181V, D211V","not provided|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|G6PD deficiency|Malaria, susceptibility to",VCV000037203,X,153762655,X,154534440,37203,25421,rs5030872,NC_000023.11:154534439:T:A,single nucleotide variant,missense variant,Pathogenic/Likely pathogenic,"Dec 3, 2024","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chrX,154534440,rs5030872,T,A,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001042351.1(G6PD):c.[376A>G;542A>T],G6PD,"D181V, D211V, N126D, N156D","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV000010382,X|X,153762655,X|X,154534440,10382,25421|25399,rs5030872|rs1050829,NC_000023.11:154534439:T:A|NC_000023.11:154535276:T:C,Haplotype,missense variant,Likely pathogenic,"Aug 12, 2022","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chrX,154534447,.,T,A,.,PASS,PX=G6PD,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chrX,154534455,.,T,C,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.527A>G (p.Asp176Gly),G6PD,"D176G, D206G","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV001722737,X,153762670,X,154534455,1722737,1780242,rs2523268306,NC_000023.11:154534454:T:C,single nucleotide variant,missense variant,Likely pathogenic,"Aug 12, 2022","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chrX,154534463,.,G,C,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.519C>G (p.Phe173Leu),G6PD,"F173L, F203L","G6PD deficiency|Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV001722656,X,153762678,X,154534463,1722656,1780167,rs200111236,NC_000023.11:154534462:G:C,single nucleotide variant,missense variant,Pathogenic,"Nov 26, 2024","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chrX,154534463,.,G,C,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.519C>T (p.Phe173=),G6PD,nan,"not provided|Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV000714806,X,153762678,X,154534463,714806,729517,rs200111236,NC_000023.11:154534462:G:A,single nucleotide variant,synonymous variant,Benign/Likely benign,"Jan 8, 2025","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chrX,154534465,rs137852343,A,G,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_000402.4(G6PD):c.607T>C (p.Phe203Leu),G6PD,"F173L, F203L","Anemia, nonspherocytic hemolytic, due to G6PD deficiency|Malaria, susceptibility to",VCV000010407,X,153762680,X,154534465,10407,25446,rs137852343,NC_000023.11:154534464:A:G,single nucleotide variant,missense variant,Pathogenic,"Jul 26, 2023","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chrX,154534468,.,G,A,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.514C>T (p.Pro172Ser),G6PD,"P172S, P202S","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV001722735,X,153762683,X,154534468,1722735,1780240,rs2523268370,NC_000023.11:154534467:G:A,single nucleotide variant,missense variant,Likely pathogenic,"Aug 12, 2022","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chrX,154534485,.,C,T,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.497G>A (p.Arg166His),G6PD,"R166H, R196H","Malaria, susceptibility to|Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV001722734,X,153762700,X,154534485,1722734,1780239,rs2523268414,NC_000023.11:154534484:C:T,single nucleotide variant,missense variant,Pathogenic/Likely pathogenic,"Oct 22, 2023","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chrX,154534486,.,G,A,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.496C>T (p.Arg166Cys),G6PD,"R166C, R196C","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV001722733,X,153762701,X,154534486,1722733,1780238,rs2523268426,NC_000023.11:154534485:G:A,single nucleotide variant,missense variant,Pathogenic,"Sep 1, 2024","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chrX,154534489,rs137852331,T,C,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_000402.4(G6PD):c.583A>G (p.Asn195Asp),G6PD,"N165D, N195D","Anemia, nonspherocytic hemolytic, due to G6PD deficiency|Malaria, susceptibility to|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|Malaria, susceptibility to|not provided|not specified",VCV000010393,X,153762704,X,154534489,10393,25432,rs137852331,NC_000023.11:154534488:T:C,single nucleotide variant,missense variant,Pathogenic/Likely pathogenic,"Jan 23, 2025","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chrX,154534494,.,C,T,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.488G>A (p.Gly163Asp),G6PD,"G163D, G193D","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV001722732,X,153762709,X,154534494,1722732,1780237,rs2523268489,NC_000023.11:154534493:C:T,single nucleotide variant,missense variant,Likely pathogenic,"Aug 12, 2022","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chrX,154534495,rs137852314,C,T,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_000402.4(G6PD):c.577G>A (p.Gly193Ser),G6PD,"G163S, G193S","G6PD deficiency|Malaria, susceptibility to|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|not provided|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|Malaria, susceptibility to",VCV000010367,X,153762710,X,154534495,10367,25406,rs137852314,NC_000023.11:154534494:C:T,single nucleotide variant,missense variant,Pathogenic/Likely pathogenic,"Aug 20, 2025","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chrX,154535176,rs370918918,C,G,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.477G>C (p.Met159Ile),G6PD,"M189I, M159I","Anemia, nonspherocytic hemolytic, due to G6PD deficiency|not provided",VCV000706112,X,153763391,X,154535176,706112,694845,rs370918918,NC_000023.11:154535175:C:G,single nucleotide variant,missense variant,Conflicting classifications of pathogenicity,"Mar 25, 2025","criteria provided, conflicting classifications",nan,nan,nan,nan,nan,nan,nan
chrX,154535180,rs782487723,C,T,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.473G>A (p.Cys158Tyr),G6PD,"C158Y, C188Y","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV001722728,X,153763395,X,154535180,1722728,1780233,rs782487723,NC_000023.11:154535179:C:T,single nucleotide variant,missense variant,Likely pathogenic,"Aug 12, 2022","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chrX,154535187,rs137852313,C,T,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_000402.4(G6PD):c.556G>A (p.Glu186Lys),G6PD,"E156K, E186K","not provided|not specified|Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV000010364,X,153763402,X,154535187,10364,25403,rs137852313,NC_000023.11:154535186:C:T,single nucleotide variant,missense variant,Conflicting classifications of pathogenicity,"May 23, 2024","criteria provided, conflicting classifications",nan,nan,nan,nan,nan,nan,nan
chrX,154535190,.,G,C,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.463C>G (p.His155Asp),G6PD,"H155D, H185D","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV001722727,X,153763405,X,154535190,1722727,1770703,rs2523270765,NC_000023.11:154535189:G:C,single nucleotide variant,missense variant,Pathogenic/Likely pathogenic,"Mar 18, 2024","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chrX,154535211,.,C,T,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.442G>A (p.Glu148Lys),G6PD,"E148K, E178K","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV001722725,X,153763426,X,154535211,1722725,1780232,rs1191977862,NC_000023.11:154535210:C:T,single nucleotide variant,missense variant,Likely pathogenic,"Aug 12, 2022","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chrX,154535244,.,G,A,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.409C>T (p.Leu137Phe),G6PD,"L137F, L167F","Malaria, susceptibility to|Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV001722724,X,153763459,X,154535244,1722724,1780231,rs2523270927,NC_000023.11:154535243:G:A,single nucleotide variant,missense variant,Likely pathogenic,"Sep 23, 2023","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chrX,154535247,.,G,A,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.406C>T (p.Arg136Cys),G6PD,"R136C, R166C","Anemia, nonspherocytic hemolytic, due to G6PD deficiency|not provided|Malaria, susceptibility to",VCV001075240,X,153763462,X,154535247,1075240,1065247,rs979416826,NC_000023.11:154535246:G:A,single nucleotide variant,missense variant,Pathogenic/Likely pathogenic,"Feb 25, 2024","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chrX,154535249,rs782322505,T,G,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.404A>T (p.Asn135Ile),G6PD,"N135I, N165I",G6PD deficiency,VCV004072319,X,153763464,X,154535249,4072319,4186191,nan,NC_000023.11:154535248:T:A,single nucleotide variant,missense variant,Likely pathogenic,"Jul 10, 2024","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chrX,154535249,rs782322505,T,G,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.404A>G (p.Asn135Ser),G6PD,"N165S, N135S","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV003719607,X,153763464,X,154535249,3719607,3853291,nan,NC_000023.11:154535248:T:C,single nucleotide variant,missense variant,Likely pathogenic,"Feb 17, 2024","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chrX,154535249,rs782322505,T,G,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.404A>C (p.Asn135Thr),G6PD,"N135T, N165T","not provided|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|Malaria, susceptibility to|G6PD deficiency",VCV000854215,X,153763464,X,154535249,854215,849843,rs782322505,NC_000023.11:154535248:T:G,single nucleotide variant,missense variant,Pathogenic,"Dec 4, 2024","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chrX,154535261,.,C,A,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.392G>A (p.Gly131Glu),G6PD,"G131E, G161E","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV003718361,X,153763476,X,154535261,3718361,3849475,nan,NC_000023.11:154535260:C:T,single nucleotide variant,missense variant,Uncertain significance,"Jun 20, 2024","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chrX,154535261,.,C,A,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_000402.4(G6PD):c.482G>T (p.Gly161Val),G6PD,"G131V, G161V","Malaria, susceptibility to|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|not provided|Malaria, susceptibility to",VCV000010404,X,153763476,X,154535261,10404,25443,rs137852341,NC_000023.11:154535260:C:A,single nucleotide variant,missense variant,Pathogenic/Likely pathogenic,"Jan 8, 2025","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chrX,154535269,.,G,A,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.384C>T (p.Leu128=),G6PD,nan,"Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV001598354,X,153763484,X,154535269,1598354,1660960,rs2148331335,NC_000023.11:154535268:G:A,single nucleotide variant,synonymous variant,Likely benign,"Aug 29, 2023","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chrX,154535270,rs78365220,A,"C,G",.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.[375G>T;379G>T383T>C384C>T],G6PD,"L128P, L158P, M125I, M155I, A127S, A157S","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV001722723,X|X|X|X,153763485,X|X|X|X,154535270,1722723,99404|1660960|1780229|1780230,rs78365220|rs2148331335|rs782130334|rs2523271048,NC_000023.11:154535269:A:G|NC_000023.11:154535268:G:A|NC_000023.11:154535277:C:A|NC_000023.11:154535273:C:A,Haplotype,missense variant|synonymous variant,Likely pathogenic,"Aug 12, 2022","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chrX,154535270,rs78365220,A,"C,G",.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.383T>G (p.Leu128Arg),G6PD,"L128R, L158R","Malaria, susceptibility to|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|Malaria, susceptibility to|not provided",VCV000968939,X,153763485,X,154535270,968939,959209,rs78365220,NC_000023.11:154535269:A:C,single nucleotide variant,missense variant,Conflicting classifications of pathogenicity,"Oct 30, 2024","criteria provided, conflicting classifications",nan,nan,nan,nan,nan,nan,nan
chrX,154535270,rs78365220,A,"C,G",.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.383T>C (p.Leu128Pro),G6PD,"L128P, L158P","not provided|Malaria, susceptibility to|G6PD deficiency|Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV000093499,X,153763485,X,154535270,93499,99404,rs78365220,NC_000023.11:154535269:A:G,single nucleotide variant,missense variant,Pathogenic/Likely pathogenic,"Oct 10, 2024","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chrX,154535274,.,C,A,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.379G>T (p.Ala127Ser),G6PD,"A127S, A157S",nan,VCV001723202,X,153763489,X,154535274,1723202,1780230,rs2523271048,NC_000023.11:154535273:C:A,single nucleotide variant,missense variant,no classification for the single variant,nan,no classification for the single variant,no classification for the single variant,nan,no classification for the single variant,no classification for the single variant,nan,no classification for the single variant,nan
chrX,154535277,rs1050829,T,C,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.[376A>G;463C>G],G6PD,"N126D, N156D, H155D, H185D","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV001722726,X|X,153763492,X|X,154535277,1722726,25399|1770703,rs1050829|rs2523270765,NC_000023.11:154535276:T:C|NC_000023.11:154535189:G:C,Haplotype,missense variant,Likely pathogenic,"Aug 12, 2022","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chrX,154535277,rs1050829,T,C,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.[376A>G;563C>T],G6PD,"N126D, N156D, S188F, S218F","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV001722698,X|X,153763492,X|X,154535277,1722698,25399|25407,rs1050829|rs5030868,NC_000023.11:154535276:T:C|NC_000023.11:154534418:G:A,Haplotype,missense variant,Uncertain significance,"Aug 12, 2022","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chrX,154535277,rs1050829,T,C,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.[311G>A;376A>G],G6PD,"N126D, N156D, R104H, R134H","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV001722693,X|X,153763492,X|X,154535277,1722693,25399|773925,rs1050829|rs181277621,NC_000023.11:154535276:T:C|NC_000023.11:154535341:C:T,Haplotype,missense variant,Uncertain significance,"Aug 12, 2022","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chrX,154535277,rs1050829,T,C,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.376A>T (p.Asn126Tyr),G6PD,"N126Y, N156Y","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV001546331,X,153763492,X,154535277,1546331,1526181,rs1050829,NC_000023.11:154535276:T:A,single nucleotide variant,missense variant,Conflicting classifications of pathogenicity,"Jan 15, 2025","criteria provided, conflicting classifications",nan,nan,nan,nan,nan,nan,nan
chrX,154535277,rs1050829,T,C,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_000402.4(G6PD):c.466A>G (p.Asn156Asp),G6PD,"N126D, N156D","G6PD deficiency|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|Malaria, susceptibility to|Inborn genetic diseases|not specified|not provided|G6PD deficiency|Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV000100055,X,153763492,X,154535277,100055,25399,rs1050829,NC_000023.11:154535276:T:C,single nucleotide variant,missense variant,Conflicting classifications of pathogenicity,"Feb 18, 2025","criteria provided, conflicting classifications",nan,nan,nan,nan,nan,nan,nan
chrX,154535278,.,C,A,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.375G>T (p.Met125Ile),G6PD,"M125I, M155I",nan,VCV001723201,X,153763493,X,154535278,1723201,1780229,rs782130334,NC_000023.11:154535277:C:A,single nucleotide variant,missense variant,no classification for the single variant,nan,no classification for the single variant,no classification for the single variant,nan,no classification for the single variant,no classification for the single variant,nan,no classification for the single variant,nan
chrX,154535278,.,C,A,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.375G>C (p.Met125Ile),G6PD,"M125I, M155I","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV000703466,X,153763493,X,154535278,703466,694846,rs782130334,NC_000023.11:154535277:C:G,single nucleotide variant,missense variant,Likely benign,"Dec 10, 2024","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chrX,154535301,.,A,G,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.352T>C (p.Tyr118His),G6PD,"Y118H, Y148H","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV001722719,X,153763516,X,154535301,1722719,1780225,rs2523271160,NC_000023.11:154535300:A:G,single nucleotide variant,missense variant,Likely pathogenic,"Aug 12, 2022","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chrX,154535316,rs5030870,C,T,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.337G>T (p.Asp113Tyr),G6PD,"D113Y, D143Y",not provided,VCV000994389,X,153763531,X,154535316,994389,982301,rs5030870,NC_000023.11:154535315:C:A,single nucleotide variant,missense variant,Uncertain significance,"Sep 4, 2019","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chrX,154535316,rs5030870,C,T,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.337G>A (p.Asp113Asn),G6PD,"D113N, D143N","Anemia, nonspherocytic hemolytic, due to G6PD deficiency|not provided",VCV000281819,X,153763531,X,154535316,281819,266056,rs5030870,NC_000023.11:154535315:C:T,single nucleotide variant,missense variant,Uncertain significance,"Dec 7, 2024","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chrX,154535330,.,A,T,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.323T>A (p.Val108Glu),G6PD,"V108E, V138E","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV001685833,X,153763545,X,154535330,1685833,1677846,rs1557230626,NC_000023.11:154535329:A:T,single nucleotide variant,missense variant,Pathogenic,"May 4, 2022","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chrX,154535336,rs267606835,G,C,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.317C>T (p.Ser106Phe),G6PD,"S136F, S106F","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV002165896,X,153763551,X,154535336,2165896,1902436,rs267606835,NC_000023.11:154535335:G:A,single nucleotide variant,missense variant,Uncertain significance,"Jun 3, 2022","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chrX,154535336,rs267606835,G,C,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.317C>G (p.Ser106Cys),G6PD,"S106C, S136C",nan,VCV000242797,X,153763551,X,154535336,242797,25431,rs267606835,NC_000023.11:154535335:G:C,single nucleotide variant,missense variant,no classification for the single variant,nan,no classification for the single variant,no classification for the single variant,nan,no classification for the single variant,no classification for the single variant,nan,no classification for the single variant,nan
chrX,154535342,rs181277621,C,T,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.311G>A (p.Arg104His),G6PD,"R104H, R134H","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV000759406,X,153763557,X,154535342,759406,773925,rs181277621,NC_000023.11:154535341:C:T,single nucleotide variant,missense variant,Benign/Likely benign,"Sep 29, 2024","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chrX,154535367,.,GCTT,G,.,PASS,PX=G6PD,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chrX,154535379,.,G,A,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.274C>T (p.Pro92Ser),G6PD,"P122S, P92S","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV001722716,X,153763594,X,154535379,1722716,1780222,rs2523271431,NC_000023.11:154535378:G:A,single nucleotide variant,missense variant,Likely pathogenic,"Aug 12, 2022","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chrX,154535962,rs782308266,C,T,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.242G>A (p.Arg81His),G6PD,"R111H, R81H","not specified|Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV001512245,X,153764177,X,154535962,1512245,1478495,rs782308266,NC_000023.11:154535961:C:T,single nucleotide variant,missense variant,Conflicting classifications of pathogenicity,"Nov 1, 2024","criteria provided, conflicting classifications",nan,nan,nan,nan,nan,nan,nan
chrX,154535963,rs138687036,G,A,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.241C>T (p.Arg81Cys),G6PD,"R111C, R81C","not provided|Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV001722652,X,153764178,X,154535963,1722652,1780163,rs138687036,NC_000023.11:154535962:G:A,single nucleotide variant,missense variant,Pathogenic/Likely pathogenic,"Jan 1, 2025","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chrX,154535980,.,A,G,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.224T>C (p.Leu75Pro),G6PD,"L105P, L75P","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV001722714,X,153764195,X,154535980,1722714,1780220,rs2523272742,NC_000023.11:154535979:A:G,single nucleotide variant,missense variant,Likely pathogenic,"Aug 12, 2022","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chrX,154535995,rs782090947,T,C,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.209A>G (p.Tyr70Cys),G6PD,"Y100C, Y70C","Anemia, nonspherocytic hemolytic, due to G6PD deficiency|not provided|Malaria, susceptibility to",VCV000449323,X,153764210,X,154535995,449323,446587,rs782090947,NC_000023.11:154535994:T:C,single nucleotide variant,missense variant,Pathogenic/Likely pathogenic,"Jan 15, 2025","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chrX,154535996,rs137852349,A,G,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_000402.4(G6PD):c.298T>C (p.Tyr100His),G6PD,"Y100H, Y70H","not provided|Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV000010416,X,153764211,X,154535996,10416,25455,rs137852349,NC_000023.11:154535995:A:G,single nucleotide variant,missense variant,Pathogenic/Likely pathogenic,"Nov 25, 2024","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chrX,154536002,rs1050828,C,T,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.[202G>A;376A>G563C>T],G6PD,"V68M, V98M, N126D, N156D, S188F, S218F","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV001722697,X|X|X,153764217,X|X|X,154536002,1722697,25400|25399|25407,rs1050828|rs1050829|rs5030868,NC_000023.11:154536001:C:T|NC_000023.11:154535276:T:C|NC_000023.11:154534418:G:A,Haplotype,missense variant,Uncertain significance,"Aug 12, 2022","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chrX,154536002,rs1050828,C,T,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.[202G>A;563C>T],G6PD,"V68M, V98M, S188F, S218F","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV001722696,X|X,153764217,X|X,154536002,1722696,25400|25407,rs1050828|rs5030868,NC_000023.11:154536001:C:T|NC_000023.11:154534418:G:A,Haplotype,missense variant,Uncertain significance,"Aug 12, 2022","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chrX,154536002,rs1050828,C,T,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.[1264C>G;202G>A376A>G],G6PD,"V68M, V98M, N126D, N156D, L422V, L452V","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV001722622,X|X|X,153764217,X|X|X,154536002,1722622,25400|25399|1770701,rs1050828|rs1050829|rs2523262460,NC_000023.11:154536001:C:T|NC_000023.11:154535276:T:C|NC_000023.11:154532589:G:C,Haplotype,missense variant,Likely pathogenic,"Aug 12, 2022","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chrX,154536002,rs1050828,C,T,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_000402.4(G6PD):c.292G>A (p.Val98Met),G6PD,"V68M, V98M","Anemia, nonspherocytic hemolytic, due to G6PD deficiency|G6PD deficiency|Inborn genetic diseases|not specified|not provided|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|G6PD deficiency|Malaria, susceptibility to",VCV000037123,X,153764217,X,154536002,37123,25400,rs1050828,NC_000023.11:154536001:C:T,single nucleotide variant,missense variant,Pathogenic/Likely pathogenic,"Mar 4, 2025","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chrX,154536002,rs1050828,C,T,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,G6PD A-,G6PD,"V68M, V98M, N126D, N156D","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV000010361,X|X,153764217,X|X,154536002,10361,25400|25399,rs1050828|rs1050829,NC_000023.11:154536001:C:T|NC_000023.11:154535276:T:C,Haplotype,missense variant,Likely pathogenic/Established risk allele,"Dec 23, 2022","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chrX,154536008,.,A,T,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.196T>A (p.Phe66Ile),G6PD,"F96I, F66I","Anemia, nonspherocytic hemolytic, due to G6PD deficiency|not specified",VCV001374503,X,153764223,X,154536008,1374503,1453472,rs2070404146,NC_000023.11:154536007:A:T,single nucleotide variant,missense variant,Conflicting classifications of pathogenicity,"Oct 30, 2024","criteria provided, conflicting classifications",nan,nan,nan,nan,nan,nan,nan
chrX,154536019,.,G,"A,T",.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.185C>T (p.Pro62Leu),G6PD,"P62L, P92L","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV001722708,X,153764234,X,154536019,1722708,1780215,rs2523272874,NC_000023.11:154536018:G:A,single nucleotide variant,missense variant,Likely pathogenic,"Aug 12, 2022","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chrX,154536019,.,G,"A,T",.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.185C>A (p.Pro62His),G6PD,"P62H, P92H","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV001722707,X,153764234,X,154536019,1722707,1780214,rs2523272874,NC_000023.11:154536018:G:T,single nucleotide variant,missense variant,Likely pathogenic,"Aug 12, 2022","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chrX,154536021,.,CAGA,C,.,PASS,PX=G6PD,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chrX,154536025,.,A,G,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.179T>C (p.Leu60Pro),G6PD,"L60P, L90P","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV001722706,X,153764240,X,154536025,1722706,1780213,rs2523272918,NC_000023.11:154536024:A:G,single nucleotide variant,missense variant,Likely pathogenic,"Aug 12, 2022","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chrX,154536032,rs137852315,C,T,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_000402.4(G6PD):c.262G>A (p.Asp88Asn),G6PD,"D58N, D88N","Anemia, nonspherocytic hemolytic, due to G6PD deficiency|not specified",VCV000010369,X,153764247,X,154536032,10369,25408,rs137852315,NC_000023.11:154536031:C:T,single nucleotide variant,missense variant,Conflicting classifications of pathogenicity,"Jun 25, 2024","criteria provided, conflicting classifications",nan,nan,nan,nan,nan,nan,nan
chrX,154536034,.,C,T,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.170G>A (p.Arg57Gln),G6PD,"R57Q, R87Q","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV001722705,X,153764249,X,154536034,1722705,1780212,rs1000937138,NC_000023.11:154536033:C:T,single nucleotide variant,missense variant,Likely pathogenic,"Aug 12, 2022","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chrX,154536035,.,G,A,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.169C>T (p.Arg57Trp),G6PD,"R87W, R57W","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV002737448,X,153764250,X,154536035,2737448,2899095,rs2070404778,NC_000023.11:154536034:G:A,single nucleotide variant,missense variant,Uncertain significance,"Nov 1, 2022","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chrX,154536045,.,C,G,.,PASS,PX=G6PD,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chrX,154536151,.,G,A,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.148C>T (p.Pro50Ser),G6PD,"P50S, P80S","not provided|not specified|Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV001722704,X,153764366,X,154536151,1722704,1780211,rs2523273261,NC_000023.11:154536150:G:A,single nucleotide variant,missense variant,Conflicting classifications of pathogenicity,"Mar 4, 2025","criteria provided, conflicting classifications",nan,nan,nan,nan,nan,nan,nan
chrX,154536156,rs76645461,A,G,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.[143T>C;563C>T],G6PD,"I48T, I78T, S188F, S218F","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV001722739,X|X,153764371,X|X,154536156,1722739,25441|25407,rs76645461|rs5030868,NC_000023.11:154536155:A:G|NC_000023.11:154534418:G:A,Haplotype,missense variant,Likely pathogenic,"Aug 12, 2022","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chrX,154536156,rs76645461,A,G,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.[143T>C;202G>A],G6PD,"I48T, I78T, V68M, V98M","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV001722711,X|X,153764371,X|X,154536156,1722711,25441|25400,rs76645461|rs1050828,NC_000023.11:154536155:A:G|NC_000023.11:154536001:C:T,Haplotype,missense variant,Likely pathogenic,"Aug 12, 2022","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chrX,154536156,rs76645461,A,G,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_000402.4(G6PD):c.233T>C (p.Ile78Thr),G6PD,"I48T, I78T","Malaria, susceptibility to|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|not provided|G6PD deficiency|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|Malaria, susceptibility to",VCV000010402,X,153764371,X,154536156,10402,25441,rs76645461,NC_000023.11:154536155:A:G,single nucleotide variant,missense variant,Pathogenic/Likely pathogenic,"Apr 16, 2025","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chrX,154536168,rs78478128,G,C,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_000402.4(G6PD):c.221C>G (p.Ala74Gly),G6PD,"A44G, A74G","G6PD deficiency|Malaria, susceptibility to|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|not provided|Malaria, susceptibility to|Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV000010406,X,153764383,X,154536168,10406,25445,rs78478128,NC_000023.11:154536167:G:C,single nucleotide variant,missense variant,Pathogenic/Likely pathogenic,"Nov 19, 2024","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chrX,154536169,.,C,T,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.130G>A (p.Ala44Thr),G6PD,"A44T, A74T","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV001722650,X,153764384,X,154536169,1722650,1780161,rs2523273296,NC_000023.11:154536168:C:T,single nucleotide variant,missense variant,Pathogenic,"Nov 24, 2023","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chrX,154546045,rs137852338,CATG,C,.,PASS,PX=G6PD,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chrX,154546046,.,A,G,.,PASS,PX=G6PD,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chrX,154546057,.,T,C,.,PASS,PX=G6PD,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chrX,154546061,rs137852340,T,C,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_000402.4(G6PD):c.185A>G (p.His62Arg),G6PD|IKBKG,"H32R, H62R","Anemia, nonspherocytic hemolytic, due to G6PD deficiency|G6PD deficiency|Malaria, susceptibility to|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|Inborn genetic diseases|Early-onset coronary artery disease|Malaria, susceptibility to|not provided",VCV000010403,X,153774276,X,154546061,10403,25442,rs137852340,NC_000023.11:154546060:T:C,single nucleotide variant,missense variant|intron variant,Pathogenic,"Dec 31, 2024","criteria provided, multiple submitters, no conflicts",nan,nan,nan,nan,nan,nan,nan
chrX,154546116,.,C,T,.,PASS,PX=G6PD,GT,0/0,,,,,,,,,,,,,,,,,,,,,,,,,,
chrX,154546122,.,C,A,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.34G>A (p.Val12Met),G6PD|IKBKG,"V12M, V42M","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV002417454,X,153774337,X,154546122,2417454,1941288,rs797043472,NC_000023.11:154546121:C:T,single nucleotide variant,missense variant|intron variant,Uncertain significance,"Feb 19, 2024","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chrX,154546122,.,C,A,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.34G>T (p.Val12Leu),G6PD|IKBKG,"V12L, V42L","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV001722687,X,153774337,X,154546122,1722687,1780199,rs797043472,NC_000023.11:154546121:C:A,single nucleotide variant,missense variant|intron variant,Likely pathogenic,"Aug 12, 2022","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
chrX,154546131,.,G,A,.,PASS,PX=G6PD,GT,0/0,G6PD_NM,NM_001360016.2(G6PD):c.25C>T (p.Arg9Trp),G6PD|IKBKG,"R39W, R9W","Anemia, nonspherocytic hemolytic, due to G6PD deficiency",VCV001722690,X,153774346,X,154546131,1722690,1780202,rs1273138455,NC_000023.11:154546130:G:A,single nucleotide variant,missense variant|intron variant,Uncertain significance,"Aug 12, 2022","criteria provided, single submitter",nan,nan,nan,nan,nan,nan,nan
